data_2djk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2djk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.412 ' CE2' ' OH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.934 0.397 . . . . 72.450000000000003 110.837 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 t -69.03 -23.53 64.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 72.239999999999995 111.5 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.72 -38.71 62.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.084 0.468 . . . . 72.5 110.855 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 22.0 m-85 -80.28 -22.98 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.336 0.588 . . . . 72.349999999999994 109.743 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.408 ' HA ' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.4 -33.24 22.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.287 -0.87 . . . . 60.310000000000002 110.276 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -88.81 -12.97 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 62.32 110.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.69 84.73 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.41 -0.359 . . . . 75.400000000000006 111.078 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.57 20.54 29.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.82 -0.705 . . . . 63.509999999999998 112.676 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 pt -135.38 148.62 66.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 73.340000000000003 111.02 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 55' ' ' ILE . 48.2 Cg_exo -47.07 140.17 14.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.533 2.155 . . . . 52.020000000000003 112.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 28' ' ' TYR . 2.4 tt -102.5 123.19 45.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 71.5 110.645 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.62 93.32 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.878 -0.601 . . . . 55.439999999999998 111.282 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.431 ' CE2' HD13 ' A' ' 26' ' ' LEU . 63.5 m-85 -81.98 140.17 34.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.835 -0.621 . . . . 73.0 110.485 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.477 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 2.5 mp -132.3 85.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.467 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.628 ' CG ' HG23 ' A' ' 60' ' ' ILE . 3.8 m-85 -73.08 148.6 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.671 -0.492 . . . . 73.299999999999997 109.671 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -162.95 119.84 1.9 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.118 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.87 -9.46 58.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.583 -0.735 . . . . 74.299999999999997 110.116 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -99.97 99.89 10.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.479 . . . . 75.349999999999994 111.129 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.82 12.22 22.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 72.230000000000004 111.226 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 -45.32 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.435 -0.348 . . . . 60.310000000000002 110.833 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.39 13.88 26.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.369 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -40.77 -31.54 0.17 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.529 -0.305 . . . . 74.340000000000003 111.77 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.37 85.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 62.439999999999998 111.197 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -57.31 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 74.530000000000001 111.242 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.3 -56.38 22.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.106 0.479 . . . . 71.019999999999996 110.854 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 10.3 m -58.11 -22.44 50.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.764 . . . . 74.349999999999994 112.14 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -70.18 -61.29 1.83 Allowed 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.636 0.731 . . . . 72.400000000000006 109.233 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.55 -29.41 16.93 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 122.884 1.326 . . . . 64.25 108.707 177.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 24.2 mt -77.96 -25.05 47.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.435 -1.711 . . . . 73.420000000000002 111.346 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.32 -45.87 89.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.435 -0.802 . . . . 63.109999999999999 109.835 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.624 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.2 Cg_endo -82.3 -38.7 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.516 2.144 . . . . 74.430000000000007 110.646 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 44' ' ' LEU . 57.0 mt -51.24 -21.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 116.086 -0.506 . . . . 64.109999999999999 110.48 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -112.75 -25.84 8.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 71.120000000000005 111.249 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -61.56 -19.44 62.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.215 0.531 . . . . 72.150000000000006 109.841 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.6 -27.69 17.99 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.394 -0.821 . . . . 60.229999999999997 109.461 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.639 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.2 pt20 -124.49 41.01 3.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.405 -1.27 . . . . 74.319999999999993 110.621 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptt85 -70.85 -32.79 69.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.465 -0.788 . . . . 72.209999999999994 111.06 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.47 12.22 39.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 71.439999999999998 112.738 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 14.9 p -125.67 -27.82 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.777 0.288 . . . . 75.319999999999993 111.777 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 25' ' ' PRO . 70.0 mt -133.18 140.57 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.574 0.226 . . . . 65.239999999999995 110.636 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -90.94 97.22 11.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.789 0.328 . . . . 73.319999999999993 111.012 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CD2' ' CD1' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -77.85 113.64 15.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 75.340000000000003 111.515 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.9 126.73 3.99 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.549 -0.75 . . . . 71.140000000000001 112.131 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.411 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 11.5 p -86.1 148.02 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 111.068 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.628 HG23 ' CG ' ' A' ' 30' ' ' PHE . 12.0 tt -145.7 163.47 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 71.430000000000007 110.653 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.9 t0 -87.05 119.79 27.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 74.299999999999997 112.014 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . . . -83.43 2.15 38.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.702 0.287 . . . . 43.25 110.903 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 18.3 tptm -102.1 -33.04 9.84 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.47 -0.332 . . . . 73.310000000000002 111.7 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 -31.98 6.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.172 0.511 . . . . 73.030000000000001 110.457 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.35 -16.06 17.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 74.209999999999994 111.07 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.96 -38.88 0.03 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 114.441 0.537 . . . . 64.5 114.441 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -52.62 -25.86 11.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.279 0.54 . . . . 74.019999999999996 110.379 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -85.78 -12.5 50.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 61.130000000000003 111.546 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.51 ' N ' ' CE2' ' A' ' 30' ' ' PHE . . . -69.89 -42.19 73.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.685 0.278 . . . . 62.229999999999997 111.269 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.06 0.17 47.89 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.084 -1.055 . . . . 71.030000000000001 113.489 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -60.0 -11.02 4.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.376 -0.601 . . . . 50.32 109.376 177.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.65 -16.01 12.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.396 -0.82 . . . . 64.209999999999994 110.441 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.513 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -177.7 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.074 0.464 . . . . 55.399999999999999 112.228 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.505 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 87.9 mt -41.43 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.405 -0.816 . . . . 74.439999999999998 112.557 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -118.85 4.48 11.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.276 -0.875 . . . . 72.329999999999998 110.467 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p 58.21 32.61 22.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.516 . . . . 74.420000000000002 110.715 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 16.0 p-10 -82.17 -31.41 30.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.327 -0.397 . . . . 72.340000000000003 111.384 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 7.2 tttt -147.61 161.61 40.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 64.230000000000004 111.256 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -157.39 170.2 9.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.544 -0.753 . . . . 73.109999999999999 111.258 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.643 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.76 160.0 44.9 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 123.538 -1.443 . . . . 63.140000000000001 113.237 0.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.32 165.59 20.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.198 -0.91 . . . . 75.129999999999995 110.006 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 5.3 t80 -139.23 128.37 23.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.797 0.332 . . . . 74.340000000000003 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . . . -120.33 145.93 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 75.540000000000006 111.702 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 57.7 mt -123.26 86.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 70.340000000000003 110.082 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.84 125.96 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 73.209999999999994 111.187 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' A' ' 93' ' ' PHE . 9.8 mp0 -95.32 117.69 30.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.841 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 20' ' ' MET . 35.1 m -84.54 4.92 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.009 -0.541 . . . . 71.319999999999993 111.328 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.37 -41.64 5.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 73.150000000000006 110.793 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -15.32 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 44.119999999999997 110.957 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 78.08 32.68 0.36 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.527 0.68 . . . . 71.239999999999995 109.559 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -95.14 166.57 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 71.040000000000006 111.254 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 6.8 mmtm -142.6 97.14 3.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.553 -0.749 . . . . 75.519999999999996 110.92 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 17.2 m-85 -102.63 75.6 0.19 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 75.519999999999996 111.002 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 84.7 Cg_endo -78.35 -176.13 3.09 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 72.109999999999999 112.638 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -107.08 169.97 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 64.049999999999997 110.789 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.32 160.02 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 72.030000000000001 111.179 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 4.1 mp0 -117.47 26.86 9.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 62.530000000000001 110.902 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -157.63 23.64 0.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 72.430000000000007 110.602 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -113.32 -68.13 0.95 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.845 -0.616 . . . . 71.049999999999997 110.954 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 1.7 tt0 159.86 118.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.902 -0.59 . . . . 74.200000000000003 109.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.23 89.2 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 75.549999999999997 111.584 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.452 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -117.14 -155.94 0.61 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.809 -0.812 . . . . 72.030000000000001 108.809 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.88 -73.65 0.51 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.755 -0.831 . . . . 74.200000000000003 108.755 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.605 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.51 -34.16 0.21 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.86 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.03 61.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 64.019999999999996 112.432 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.617 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 41.0 mm -88.14 -47.91 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.757 -0.46 . . . . 74.420000000000002 109.757 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -54.44 -45.37 73.06 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 109.695 178.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -69.8 -48.0 60.75 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 110.156 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.577 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 18.4 t80 -52.38 -67.08 0.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 74.010000000000005 110.077 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 19.3 m -47.67 -40.14 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 64.200000000000003 109.966 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -56.96 -42.34 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.381 -0.827 . . . . 40.149999999999999 110.215 178.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.746 ' OD2' HG12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -74.65 -14.58 60.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.652 -0.703 . . . . 75.319999999999993 110.014 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -81.04 -61.29 2.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.558 -0.746 . . . . 73.219999999999999 108.997 178.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.477 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 21.9 t -55.77 -46.41 79.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.658 -1.155 . . . . 72.019999999999996 110.879 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.94 64.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 74.230000000000004 110.782 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.96 30.29 1.65 Allowed Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.578 -0.82 . . . . 74.530000000000001 111.663 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -101.81 -38.65 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.397 -0.402 . . . . 64.420000000000002 111.417 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.746 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -85.75 151.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.897 0.38 . . . . 70.430000000000007 110.628 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -145.15 173.94 3.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.947 -0.57 . . . . 65.140000000000001 111.274 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo . . . . . 0 C--N 1.345 0.344 0 C-N-CA 122.598 2.198 . . . . 73.010000000000005 112.36 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' SER . 17.0 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.818 0.342 . . . . 72.450000000000003 111.177 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.449 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m -53.98 -25.95 23.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.8 -38.54 18.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.02 0.438 . . . . 72.5 110.635 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 26.5 m-85 -78.08 -6.26 54.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 72.349999999999994 109.898 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.407 ' HA ' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.62 -54.42 3.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 60.310000000000002 110.045 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -17.35 64.23 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.85 -0.614 . . . . 62.32 110.919 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.74 -31.78 58.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.901 0.382 . . . . 75.400000000000006 111.021 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.38 5.99 64.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.935 -0.65 . . . . 63.509999999999998 112.596 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.62 156.41 53.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 73.340000000000003 110.989 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.95 142.74 96.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 52.020000000000003 112.594 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' CD2' ' A' ' 28' ' ' TYR . 3.2 tt -103.34 137.62 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 71.5 110.808 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.15 97.13 6.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.106 -0.497 . . . . 55.439999999999998 111.112 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.433 ' CD2' HD21 ' A' ' 26' ' ' LEU . 40.4 m-85 -85.99 127.47 34.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 73.0 109.985 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 44' ' ' LEU . 2.5 mt -121.51 83.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.13 0.419 . . . . 72.450000000000003 112.13 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.628 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.8 m-85 -71.96 144.43 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.959 -0.756 . . . . 73.299999999999997 108.959 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -155.1 117.37 4.21 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.430000000000007 111.082 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -80.17 -6.34 57.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.298 -0.865 . . . . 74.299999999999997 110.163 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.9 p -84.7 104.87 15.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 75.349999999999994 111.059 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.4 16.78 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 72.230000000000004 111.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -123.61 -42.05 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 60.310000000000002 110.778 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' ARG . 2.8 pt-20 -99.7 -8.85 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 71.430000000000007 111.574 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 36' ' ' GLU . 1.6 ptp180 -31.31 -40.47 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.366 0.506 . . . . 74.340000000000003 112.366 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -54.51 -51.5 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.965 0.412 . . . . 62.439999999999998 110.844 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.6 mt-10 -60.18 -36.75 78.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 110.963 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -63.52 -50.59 68.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 71.019999999999996 110.779 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 51.1 m -65.17 -22.51 66.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 74.349999999999994 111.242 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 45' ' ' LYS . 3.7 t70 -66.81 -61.2 2.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.582 0.706 . . . . 72.400000000000006 109.105 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.671 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -50.05 -31.69 13.65 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.662 1.22 . . . . 64.25 108.991 177.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.636 ' HB3' ' HE2' ' A' ' 57' ' ' PHE . 22.2 mt -76.48 -25.61 54.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.378 -1.737 . . . . 73.420000000000002 111.475 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 9.7 ttmm -51.6 -45.65 91.11 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.395 -0.82 . . . . 63.109999999999999 110.375 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 15.5 Cg_endo -83.76 -40.1 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.713 2.275 . . . . 74.430000000000007 111.649 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -54.92 -18.65 3.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.984 -0.686 . . . . 64.109999999999999 109.87 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.654 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -107.29 -30.82 8.5 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.813 -0.631 . . . . 71.120000000000005 111.213 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -60.83 -19.8 60.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.237 0.541 . . . . 72.150000000000006 109.888 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.2 -26.79 24.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.916 0.865 . . . . 60.229999999999997 109.029 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.654 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.7 pt20 -125.78 38.44 4.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.029 -1.441 . . . . 74.319999999999993 110.217 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -75.35 -25.21 57.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.446 -0.797 . . . . 72.209999999999994 110.992 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.78 20.16 20.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.811 -0.709 . . . . 71.439999999999998 112.137 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.78 -37.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.65 0.262 . . . . 75.319999999999993 111.262 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 ' CD1' ' NE2' ' A' ' 51' ' ' GLN . 43.6 mt -120.93 138.79 50.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 65.239999999999995 110.863 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -82.85 109.09 16.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.858 0.361 . . . . 73.319999999999993 110.324 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.636 ' HE2' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -80.94 119.86 24.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.644 0.735 . . . . 75.340000000000003 112.843 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -146.24 122.98 1.74 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.907 -1.042 . . . . 71.140000000000001 111.911 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -89.81 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 73.239999999999995 111.059 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.628 HG23 ' CG ' ' A' ' 30' ' ' PHE . 14.0 tt -141.9 164.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.430000000000007 110.699 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' N ' HG12 ' A' ' 60' ' ' ILE . 35.8 t0 -90.34 122.84 33.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 111.888 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . . . -85.49 6.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.71 0.291 . . . . 43.25 110.711 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 22.5 tptp -106.31 -32.82 7.99 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.349 -0.387 . . . . 73.310000000000002 111.559 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.38 -31.21 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.148 0.499 . . . . 73.030000000000001 110.731 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.77 -12.97 17.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.543 -0.753 . . . . 74.209999999999994 111.311 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -35.39 -33.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 N-CA-C 114.027 0.371 . . . . 64.5 114.027 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -12.21 4.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.061 0.458 . . . . 74.019999999999996 110.617 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -102.59 -6.79 22.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.66 -0.7 . . . . 61.130000000000003 110.971 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -71.1 -54.99 9.18 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.763 0.316 . . . . 62.229999999999997 110.963 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.39 7.5 75.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.916 -1.135 . . . . 71.030000000000001 113.738 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -8.74 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.02 -0.733 . . . . 50.32 109.02 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -114.2 -14.82 12.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.228 -0.896 . . . . 64.209999999999994 110.335 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.91 -69.91 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.261 0.553 . . . . 55.399999999999999 112.298 -178.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.506 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.2 mm? -40.31 170.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.092 -0.958 . . . . 74.439999999999998 112.419 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -110.01 -6.24 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 72.329999999999998 111.046 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 p 61.75 40.19 13.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.609 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.77 -33.01 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 72.340000000000003 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -149.51 163.25 38.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.111 -0.495 . . . . 64.230000000000004 110.427 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -153.34 177.45 1.96 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 73.109999999999999 111.126 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 35.0 Cg_exo -57.54 158.22 29.27 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.022 -1.241 . . . . 63.140000000000001 112.781 1.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.4 128.87 46.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.234 -0.894 . . . . 75.129999999999995 110.226 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 95' ' ' PHE . 49.5 t80 -108.65 117.83 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.654 -0.248 . . . . 74.340000000000003 110.437 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.18 132.85 56.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.35 0.5 . . . . 75.540000000000006 112.35 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 25.6 mm -100.88 140.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 70.340000000000003 109.973 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -128.24 129.52 46.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.985 0.421 . . . . 73.209999999999994 110.842 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.08 112.72 25.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 74.420000000000002 110.198 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 20' ' ' MET . 35.1 m -78.86 -0.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 111.708 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.73 -44.33 6.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 73.150000000000006 110.692 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.84 -7.23 14.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 44.119999999999997 111.413 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 68.96 24.87 6.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.09 0.471 . . . . 71.239999999999995 110.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -75.37 169.51 17.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.731 -0.668 . . . . 71.040000000000006 111.541 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.636 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 1.3 mptt -139.94 95.37 2.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 75.519999999999996 110.756 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 68.1 m-85 -103.52 71.41 0.15 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 75.519999999999996 111.277 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 67.4 Cg_endo -79.12 -175.5 2.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.667 2.245 . . . . 72.109999999999999 113.608 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 82' ' ' PHE . 25.0 t80 -112.02 175.16 5.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 64.049999999999997 110.578 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 3.0 m-20 -78.76 174.98 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 72.030000000000001 110.882 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -114.64 -11.99 12.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 62.530000000000001 111.297 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.63 5.25 5.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 72.430000000000007 111.041 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 1.8 tppt? -86.17 -6.05 59.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.097 -0.501 . . . . 71.049999999999997 111.294 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 32.6 tt0 81.9 132.22 0.05 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.174 0.512 . . . . 74.200000000000003 111.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.0 mp -109.02 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.41 -148.17 0.43 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 72.030000000000001 109.095 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.615 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -96.66 -70.81 0.7 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.97 -0.752 . . . . 74.200000000000003 108.97 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.594 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.11 -31.54 1.44 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.811 -0.631 . . . . 72.409999999999997 111.374 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -74.96 -33.0 61.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.688 -0.687 . . . . 64.019999999999996 111.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 102' ' ' THR . 44.2 mm -91.22 -45.71 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.39 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.594 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -60.0 -42.22 93.76 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 109.414 178.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.22 -50.73 29.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.244 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 40.6 t80 -51.72 -63.77 1.03 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.467 -0.333 . . . . 74.010000000000005 110.261 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.5 m -49.14 -44.15 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 64.200000000000003 110.042 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -54.45 -40.67 68.61 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.783 0.802 . . . . 40.149999999999999 109.009 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.9 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 16.4 t70 -61.53 -34.86 76.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.326 -1.306 . . . . 75.319999999999993 108.336 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 110' ' ' VAL . 0.7 OUTLIER -72.86 -66.86 0.61 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 73.219999999999999 110.902 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 113' ' ' PHE . 10.8 t -54.85 -45.21 74.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.22 -0.9 . . . . 72.019999999999996 111.994 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.44 70.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.856 0.36 . . . . 74.230000000000004 111.154 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.68 31.3 1.82 Allowed Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.06 -0.816 . . . . 74.530000000000001 111.06 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.9 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.43 -57.12 2.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.878 -0.661 . . . . 64.420000000000002 111.505 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.521 HG13 ' C ' ' A' ' 112' ' ' ASP . 44.7 mt -64.27 151.1 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.789 -0.448 . . . . 70.430000000000007 109.789 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.32 163.96 36.25 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.357 -0.383 . . . . 65.140000000000001 111.542 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.815 2.344 . . . . 73.010000000000005 112.519 -179.544 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 17.6 m-85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.056 0.455 . . . . 72.450000000000003 111.383 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -51.53 -34.44 36.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.797 -0.638 . . . . 72.239999999999995 111.422 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -70.86 -39.12 73.08 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.147 0.499 . . . . 72.5 110.725 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.409 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 18.0 m-85 -77.39 -9.19 58.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.634 . . . . 72.349999999999994 109.678 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -30.48 11.97 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.47 -0.787 . . . . 60.310000000000002 110.131 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -83.36 -17.93 40.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.685 -0.689 . . . . 62.32 110.572 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.7 -14.21 41.43 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.275 -0.42 . . . . 75.400000000000006 111.602 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.93 14.12 65.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 63.509999999999998 112.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.99 158.79 59.13 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.246 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HG2' HG12 ' A' ' 55' ' ' ILE . 26.7 Cg_endo -62.38 138.15 69.5 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 52.020000000000003 112.758 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 28' ' ' TYR . 1.5 tt -93.12 136.41 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.833 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.95 89.43 3.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 55.439999999999998 111.001 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 70.0 m-85 -81.19 136.6 35.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 73.0 110.404 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -131.53 89.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.855 0.359 . . . . 72.450000000000003 111.518 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.599 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.1 m-85 -70.88 149.18 47.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.303 -0.629 . . . . 73.299999999999997 109.303 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.73 119.07 2.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.233 0.54 . . . . 72.430000000000007 111.269 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.482 ' HG3' ' HB1' ' A' ' 62' ' ' ALA . 20.9 mt-10 -76.0 -7.23 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 74.299999999999997 109.972 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.6 p -76.53 123.44 26.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.209 -0.451 . . . . 75.349999999999994 110.848 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.12 9.52 18.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 72.230000000000004 111.087 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -50.43 2.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.404 -0.362 . . . . 60.310000000000002 110.735 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.69 15.04 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 111.196 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -49.1 -28.45 4.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 111.104 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.32 73.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 62.439999999999998 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 2.2 mm-40 -61.45 -48.91 79.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.736 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -58.45 -47.34 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 71.019999999999996 110.652 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 67.0 m -67.17 -20.69 65.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.349999999999994 111.218 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 15.6 t0 -67.68 -60.6 2.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 72.400000000000006 108.946 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.676 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.48 -33.64 9.76 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.65 1.214 . . . . 64.25 108.633 177.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HA ' HD13 ' A' ' 47' ' ' ILE . 25.9 mt -75.22 -25.95 58.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.317 -1.765 . . . . 73.420000000000002 112.188 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 3.4 mmpt? -51.44 -45.47 90.32 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 63.109999999999999 110.285 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.6 Cg_endo -83.26 -38.54 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.546 2.164 . . . . 74.430000000000007 111.13 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.681 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 24.0 mt -53.85 -17.35 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-N 116.367 -0.379 . . . . 64.109999999999999 110.14 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -114.98 -25.34 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.52 . . . . 71.120000000000005 111.151 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -64.91 -18.94 65.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.939 0.4 . . . . 72.150000000000006 110.669 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . . . -93.67 -9.95 36.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.81 . . . . 60.229999999999997 109.377 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.488 ' CG ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -136.67 27.62 3.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.221 -1.354 . . . . 74.319999999999993 110.885 -176.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.5 ptt180 -61.4 -33.24 73.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.586 -0.734 . . . . 72.209999999999994 111.156 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.33 9.02 45.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.811 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 51' ' ' GLN . 10.3 p -122.35 -29.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.78 0.29 . . . . 75.319999999999993 111.609 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG12 ' HG2' ' A' ' 25' ' ' PRO . 79.7 mt -131.87 141.35 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 65.239999999999995 110.807 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.409 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -94.61 94.83 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 73.319999999999993 110.063 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -69.23 134.76 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 75.340000000000003 111.641 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.87 113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.787 -1.097 . . . . 71.140000000000001 111.86 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.3 p -80.87 150.14 29.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 73.239999999999995 110.316 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.599 HG23 ' CG ' ' A' ' 30' ' ' PHE . 11.2 tt -147.4 163.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.105 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 60' ' ' ILE . 45.0 t0 -84.01 119.78 25.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.123 -0.49 . . . . 74.299999999999997 111.909 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' HB1' ' CG ' ' A' ' 79' ' ' PHE . . . -85.02 6.0 27.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.696 0.284 . . . . 43.25 110.859 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -106.25 -31.88 8.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.548 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.95 -32.27 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 73.030000000000001 110.638 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CG ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.95 -12.4 18.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.518 -0.764 . . . . 74.209999999999994 111.404 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -33.57 -36.54 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.208 0.443 . . . . 64.5 114.208 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.17 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 74.019999999999996 110.448 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -89.21 -11.63 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.482 -0.781 . . . . 61.130000000000003 111.461 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' N ' ' CE2' ' A' ' 30' ' ' PHE . . . -73.65 -44.12 57.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 111.76 0.281 . . . . 62.229999999999997 111.76 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' A' ' 74' ' ' LEU . . . -103.4 1.39 46.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.991 -1.099 . . . . 71.030000000000001 113.752 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -8.81 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.187 -0.671 . . . . 50.32 109.187 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -114.65 -15.81 11.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.325 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.504 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.36 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.155 0.502 . . . . 55.399999999999999 112.022 -178.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HB2' ' CA ' ' A' ' 70' ' ' GLY . 74.9 mt -44.88 178.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.275 -0.875 . . . . 74.439999999999998 112.168 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 5.25 8.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.61 -0.723 . . . . 72.329999999999998 110.597 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 p 59.06 36.86 24.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.694 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.75 -36.49 15.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 111.27 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 0.2 OUTLIER -137.31 161.18 36.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.123 0.487 . . . . 64.230000000000004 110.746 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CG ' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -159.44 169.04 11.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.738 -0.665 . . . . 73.109999999999999 111.607 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.613 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.8 161.87 40.47 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.395 -1.502 . . . . 63.140000000000001 113.12 0.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.12 161.17 29.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.478 -0.783 . . . . 75.129999999999995 110.038 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.4 t80 -132.3 123.39 26.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.67 0.272 . . . . 74.340000000000003 111.198 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.34 111.85 17.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 75.540000000000006 111.738 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 93' ' ' PHE . 6.8 mt -100.78 96.84 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.729 0.3 . . . . 70.340000000000003 110.822 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -89.6 147.8 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.474 -0.33 . . . . 73.209999999999994 110.584 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -106.69 114.15 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 74.420000000000002 110.851 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.8 0.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 110.968 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.46 -42.62 8.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.4 -0.364 . . . . 73.150000000000006 110.914 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.55 -7.88 10.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.487 -0.324 . . . . 44.119999999999997 111.454 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.53 62.19 0.21 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.413 -0.588 . . . . 71.239999999999995 109.413 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.468 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 1.3 tp60 -114.15 173.74 6.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.33 -0.85 . . . . 71.040000000000006 111.575 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -137.27 92.53 2.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.416 -0.811 . . . . 75.519999999999996 110.807 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 93.1 m-85 -104.77 68.7 0.16 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.638 -0.71 . . . . 75.519999999999996 111.314 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 76.5 Cg_endo -78.93 -175.58 2.83 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.263 1.975 . . . . 72.109999999999999 112.589 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -109.37 170.4 8.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.049999999999997 111.104 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.37 170.48 16.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 72.030000000000001 110.991 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 7.2 mt-30 -119.83 27.29 8.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 62.530000000000001 110.746 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.12 26.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.501 . . . . 72.430000000000007 110.662 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -112.0 0.05 15.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.996 -0.547 . . . . 71.049999999999997 111.668 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 78.31 98.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 74.200000000000003 110.325 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 5.8 mt -80.01 97.71 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 75.549999999999997 111.59 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -120.51 -151.34 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.707 -0.849 . . . . 72.030000000000001 108.707 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.59 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.43 -66.93 0.89 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.925 -0.768 . . . . 74.200000000000003 108.925 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.603 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.02 -39.0 5.24 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.669 -0.696 . . . . 72.409999999999997 111.752 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 64.019999999999996 112.28 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.681 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 50.1 mm -91.31 -48.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 74.420000000000002 110.235 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.603 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -57.09 -42.21 80.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.962 -0.755 . . . . 71.120000000000005 108.962 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.52 -51.06 31.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.038 -0.528 . . . . 73.420000000000002 110.036 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.556 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 67.5 t80 -50.4 -63.21 1.19 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 116.369 -0.378 . . . . 74.010000000000005 110.094 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.9 m -50.05 -41.97 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 64.200000000000003 109.494 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.1 t0 -53.61 -37.76 63.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.793 0.806 . . . . 40.149999999999999 108.959 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.3 t70 -66.84 -34.79 78.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.309 -1.314 . . . . 75.319999999999993 108.413 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.463 ' CB ' HD11 ' A' ' 118' ' ' ILE . 1.1 t80 -71.73 -68.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.244 -0.889 . . . . 73.219999999999999 110.984 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 113' ' ' PHE . 15.3 t -51.72 -46.86 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.268 -0.878 . . . . 72.019999999999996 111.996 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.66 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.230000000000004 111.018 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.56 31.01 2.06 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.575 -1.01 . . . . 74.530000000000001 110.575 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.886 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -102.92 -52.0 3.15 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.716 -0.742 . . . . 64.420000000000002 111.619 -178.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.543 HG13 ' C ' ' A' ' 112' ' ' ASP . 57.7 mt -65.75 153.05 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.49 -0.559 . . . . 70.430000000000007 109.49 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' N ' HG22 ' A' ' 118' ' ' ILE . 1.3 mt-10 -137.25 152.66 73.89 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 111.199 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 122.542 2.161 . . . . 73.010000000000005 112.552 -179.561 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.406 ' CE2' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.926 0.393 . . . . 72.450000000000003 111.202 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -56.45 -26.61 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 72.239999999999995 111.695 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.99 -43.69 61.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.013 0.435 . . . . 72.5 111.047 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.421 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 9.5 m-85 -78.97 -27.14 43.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.303 0.573 . . . . 72.349999999999994 109.718 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -29.82 38.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.127 -0.942 . . . . 60.310000000000002 110.473 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -98.14 -6.51 31.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.912 -0.586 . . . . 62.32 110.624 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.39 71.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.883 0.373 . . . . 75.400000000000006 111.015 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.74 54.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 63.509999999999998 112.602 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.12 156.54 76.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.706 0.289 . . . . 73.340000000000003 110.975 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 142.17 88.07 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.813 2.342 . . . . 52.020000000000003 112.874 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 28' ' ' TYR . 2.1 tt -99.53 133.08 44.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 71.5 110.776 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.88 86.89 2.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 55.439999999999998 111.061 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CE2' HD11 ' A' ' 26' ' ' LEU . 64.0 m-85 -75.06 141.03 43.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.606 -0.724 . . . . 73.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.505 HG12 ' CE2' ' A' ' 82' ' ' PHE . 1.9 mp -133.99 85.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.532 -0.303 . . . . 72.450000000000003 111.395 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.641 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.7 m-85 -72.15 145.42 48.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.758 -0.46 . . . . 73.299999999999997 109.758 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.74 117.3 3.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.153 0.502 . . . . 72.430000000000007 110.9 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 9.4 mt-10 -71.05 -12.43 61.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 74.299999999999997 110.396 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.26 97.54 7.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 111.218 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.94 5.9 41.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.726 -0.67 . . . . 72.230000000000004 110.986 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.72 -52.55 4.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.91 0.386 . . . . 60.310000000000002 110.508 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 13.22 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 71.430000000000007 111.108 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -46.55 -28.09 1.32 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.466 -0.334 . . . . 74.340000000000003 111.375 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.75 -45.61 78.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 110.764 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -66.73 -44.25 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.856 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.89 -57.12 12.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 110.817 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 20.4 m -63.33 -21.32 66.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.407 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 9.6 t70 -66.08 -65.39 0.68 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.546 0.688 . . . . 72.400000000000006 109.488 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.65 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.39 -31.82 6.72 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.653 1.216 . . . . 64.25 108.991 177.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 35.7 mt -77.53 -23.17 50.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.368 -1.742 . . . . 73.420000000000002 112.369 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 20.7 mttt -55.53 -43.62 99.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 63.109999999999999 110.152 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 23.9 Cg_endo -83.86 -41.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.648 2.232 . . . . 74.430000000000007 111.822 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -53.23 -22.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 C-N-CA 119.983 -0.687 . . . . 64.109999999999999 109.721 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -106.07 -27.66 10.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.549 -0.751 . . . . 71.120000000000005 111.211 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.1 tm-20 -59.43 -22.4 61.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.256 0.551 . . . . 72.150000000000006 109.921 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.43 29.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.303 -0.862 . . . . 60.229999999999997 109.464 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.644 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.8 pt20 -126.88 40.47 3.71 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.385 -1.28 . . . . 74.319999999999993 110.995 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptm180 -73.45 -32.25 64.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.662 . . . . 72.209999999999994 111.282 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.69 6.18 48.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 71.439999999999998 112.849 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 12.4 p -116.84 -31.94 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 75.319999999999993 111.259 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.406 HD13 ' NE2' ' A' ' 51' ' ' GLN . 28.4 mt -128.46 144.72 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 110.691 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.19 104.74 16.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.559 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.545 ' HE2' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -73.9 132.88 42.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.354 0.597 . . . . 75.340000000000003 112.065 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.71 108.26 0.36 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.196 -0.911 . . . . 71.140000000000001 112.509 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 22.1 p -75.76 152.33 37.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.701 0.286 . . . . 73.239999999999995 110.383 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.641 HG23 ' CG ' ' A' ' 30' ' ' PHE . 12.8 tt -149.97 164.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 71.430000000000007 110.856 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' N ' HG12 ' A' ' 60' ' ' ILE . 31.2 t0 -85.99 120.23 27.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 74.299999999999997 111.842 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . . . -85.2 5.29 30.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.698 0.285 . . . . 43.25 110.864 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -104.28 -33.04 8.81 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.45 -0.341 . . . . 73.310000000000002 111.543 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.32 -31.92 6.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.179 0.514 . . . . 73.030000000000001 110.684 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.04 -15.99 17.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 74.209999999999994 111.357 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -32.28 -37.46 0.04 OUTLIER Glycine 0 C--N 1.336 0.547 0 N-CA-C 114.301 0.48 . . . . 64.5 114.301 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.66 -17.27 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.43 . . . . 74.019999999999996 110.774 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -94.72 -9.24 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 61.130000000000003 111.214 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -73.24 -51.53 17.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.76 0.314 . . . . 62.229999999999997 111.434 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -91.33 1.34 76.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.861 -1.161 . . . . 71.030000000000001 113.911 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -60.87 -9.79 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.454 0.627 . . . . 50.32 109.462 177.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -115.78 -16.9 11.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 64.209999999999994 110.377 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.497 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -176.78 -71.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.24 0.459 . . . . 55.399999999999999 112.24 -178.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.509 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.8 mp -40.57 175.14 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 112.969 0.729 . . . . 74.439999999999998 112.969 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' CG ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -107.86 -21.7 12.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.105 -0.952 . . . . 72.329999999999998 110.851 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' ' CZ ' ' A' ' 79' ' ' PHE . 1.5 p 82.73 20.85 0.23 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.263 -1.014 . . . . 74.420000000000002 108.263 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -79.01 -48.76 13.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.663 -1.153 . . . . 72.340000000000003 111.51 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -118.98 158.86 24.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.207 0.527 . . . . 64.230000000000004 111.451 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.661 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -158.24 165.53 18.4 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.48 -0.782 . . . . 73.109999999999999 111.762 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 25.6 Cg_endo -61.9 157.15 59.09 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.158 -1.601 . . . . 63.140000000000001 112.915 0.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.47 164.44 15.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 75.129999999999995 109.363 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 29' ' ' ILE . 2.5 t80 -138.44 131.29 29.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 74.340000000000003 111.167 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . . . -122.6 147.42 46.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.540000000000006 111.661 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 57.5 mt -129.32 81.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 109.85 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.4 138.4 41.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 73.209999999999994 111.333 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.65 118.62 37.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.706 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 t -88.62 20.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 71.319999999999993 110.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.67 -38.96 2.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.057 -0.519 . . . . 73.150000000000006 110.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tttt -113.64 -15.25 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.394 -0.367 . . . . 44.119999999999997 110.922 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 34.5 t-20 79.6 21.05 0.61 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.237 0.542 . . . . 71.239999999999995 109.949 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -84.67 164.65 18.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.321 -0.854 . . . . 71.040000000000006 111.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' O ' ' CD ' ' A' ' 94' ' ' PRO . 6.2 mmtt -139.56 99.15 3.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.25 -0.886 . . . . 75.519999999999996 110.757 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 17.4 m-85 -101.14 70.99 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.656 -0.702 . . . . 75.519999999999996 111.538 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 90.8 Cg_endo -75.39 168.66 24.09 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.554 2.17 . . . . 72.109999999999999 112.384 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 106' ' ' ILE . 35.0 t80 -88.27 169.33 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.498 . . . . 64.049999999999997 110.684 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 2.9 m-20 -83.85 148.26 27.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 72.030000000000001 110.885 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 26.6 mt-30 -103.22 28.47 6.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.217 0.532 . . . . 62.530000000000001 110.381 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -155.94 18.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.73 -0.668 . . . . 72.430000000000007 110.648 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 1.5 ttmt -113.36 -7.89 13.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.137 -0.483 . . . . 71.049999999999997 111.611 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 22.3 tt0 83.97 97.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.258 0.552 . . . . 74.200000000000003 110.894 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.9 mt -72.84 93.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 75.549999999999997 111.153 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 4.8 p -111.15 -147.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.609 -0.515 . . . . 72.030000000000001 109.609 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.576 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -100.26 -59.83 1.64 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.39 -0.596 . . . . 74.200000000000003 109.39 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -56.14 -34.0 65.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.068 -0.969 . . . . 72.409999999999997 110.83 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.53 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.507 -0.77 . . . . 64.019999999999996 112.322 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.426 ' HB ' HG21 ' A' ' 47' ' ' ILE . 40.9 mm -89.93 -42.58 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 121.058 0.456 . . . . 74.420000000000002 110.552 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.704 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.8 pttt -61.79 -47.36 85.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.936 -0.764 . . . . 71.120000000000005 108.936 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.03 -51.47 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 73.420000000000002 110.324 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.6 ' CG ' HD12 ' A' ' 118' ' ' ILE . 67.9 t80 -54.63 -64.91 0.68 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.015 -0.539 . . . . 74.010000000000005 110.894 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 6.0 m -51.82 -37.4 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.127 0.489 . . . . 64.200000000000003 111.533 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.704 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -67.97 -35.79 78.96 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.694 -1.224 . . . . 40.149999999999999 107.694 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER -63.33 -37.27 86.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.347 -1.751 . . . . 75.319999999999993 108.025 177.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -63.8 -66.27 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.981 -1.009 . . . . 73.219999999999999 110.268 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 113' ' ' PHE . 10.4 t -58.09 -36.95 59.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.916 -1.038 . . . . 72.019999999999996 111.876 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.58 78.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 74.230000000000004 111.393 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.78 25.87 2.24 Favored Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 120.535 -0.84 . . . . 74.530000000000001 111.724 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -98.12 -57.78 2.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.2 -0.5 . . . . 64.420000000000002 111.014 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.6 HD12 ' CG ' ' A' ' 109' ' ' PHE . 8.9 mt -71.43 150.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.89 -0.595 . . . . 70.430000000000007 110.092 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.12 171.94 5.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.261 -0.427 . . . . 65.140000000000001 111.364 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--N 1.345 0.359 0 C-N-CA 122.607 2.204 . . . . 73.010000000000005 112.35 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.011 0.434 . . . . 72.450000000000003 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 t -65.88 -22.44 66.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 72.239999999999995 111.57 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 -41.47 71.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 72.5 110.92 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 13.3 m-85 -79.53 -24.31 42.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 72.349999999999994 109.746 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -42.41 29.01 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.269 -0.878 . . . . 60.310000000000002 110.359 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -85.26 -11.45 54.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 62.32 110.508 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.4 68.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 75.400000000000006 111.069 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.27 15.9 56.51 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 63.509999999999998 112.708 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pt -133.28 158.3 76.06 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.699 0.285 . . . . 73.340000000000003 110.933 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.46 138.9 88.34 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.631 2.22 . . . . 52.020000000000003 112.6 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.7 tt -99.65 135.94 40.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 71.5 111.007 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.432 ' HB1' ' CD1' ' A' ' 57' ' ' PHE . . . -109.01 100.49 9.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 55.439999999999998 111.037 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.436 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 11.4 m-85 -85.47 132.03 34.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 73.0 110.057 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.2 mt -127.71 83.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.743 -0.383 . . . . 72.450000000000003 111.277 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CG ' HG22 ' A' ' 60' ' ' ILE . 2.7 m-85 -71.51 149.79 45.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 109.801 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.57 116.87 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.28 0.562 . . . . 72.430000000000007 111.257 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 3.4 mt-10 -75.88 -7.97 55.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.208 -0.906 . . . . 74.299999999999997 110.027 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -99.84 92.63 5.39 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.179 -0.464 . . . . 75.349999999999994 111.094 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.76 6.38 35.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 72.230000000000004 111.488 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -34.49 10.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 60.310000000000002 110.779 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.98 9.66 16.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 71.430000000000007 111.317 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.8 -29.12 1.79 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.767 0.317 . . . . 74.340000000000003 111.335 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -54.74 -45.65 74.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 62.439999999999998 110.79 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.39 -36.36 81.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.772 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.438 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -66.4 -62.11 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.019999999999996 110.697 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.592 ' HA ' HD12 ' A' ' 44' ' ' LEU . 7.2 m -57.68 -25.93 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.953 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' LYS . 15.6 t0 -62.64 -59.7 4.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.531 0.681 . . . . 72.400000000000006 109.569 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.717 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.56 -33.36 9.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.601 1.191 . . . . 64.25 108.676 177.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -80.54 -17.58 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.831 -1.531 . . . . 73.420000000000002 112.185 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 4.8 tppt? -55.13 -42.84 98.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.207 -0.664 . . . . 63.109999999999999 109.207 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.717 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 11.8 Cg_endo -84.93 -38.64 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.69 2.26 . . . . 74.430000000000007 110.31 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.74 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 55.1 mt -50.21 -22.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.507 0 CA-C-N 115.975 -0.557 . . . . 64.109999999999999 109.847 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -112.49 -25.55 9.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.621 -0.718 . . . . 71.120000000000005 111.506 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -59.8 -20.4 56.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.255 0.55 . . . . 72.150000000000006 109.771 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.37 -30.24 18.52 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.833 0.825 . . . . 60.229999999999997 108.969 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.652 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -125.34 42.27 3.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.161 -1.381 . . . . 74.319999999999993 110.061 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.5 -29.14 46.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.153 -0.93 . . . . 72.209999999999994 111.04 -178.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 11.32 52.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 71.439999999999998 112.405 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.97 -33.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.636 0.255 . . . . 75.319999999999993 111.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -123.15 142.91 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 65.239999999999995 111.166 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.415 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.3 m-80 -90.57 87.7 6.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.755 -0.461 . . . . 73.319999999999993 109.755 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.48 ' CG ' ' HB1' ' A' ' 48' ' ' ALA . 3.0 m-85 -71.89 119.22 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 75.340000000000003 111.896 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -141.9 125.17 2.64 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.052 -0.976 . . . . 71.140000000000001 112.463 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.495 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 2.3 p -82.82 153.89 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.629 HG22 ' CG ' ' A' ' 30' ' ' PHE . 12.3 tt -150.68 164.16 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.028 -0.533 . . . . 71.430000000000007 110.531 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 60' ' ' ILE . 43.0 t0 -87.13 120.26 28.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.296 -0.411 . . . . 74.299999999999997 112.072 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.485 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . . . -85.02 6.25 26.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.965 -0.294 . . . . 43.25 110.898 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 8.1 ttmt -106.04 -33.02 8.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.449 -0.341 . . . . 73.310000000000002 111.455 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.3 -30.57 6.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 73.030000000000001 110.489 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.452 ' CG ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.66 -11.64 17.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.507 -0.769 . . . . 74.209999999999994 111.276 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.03 -37.59 0.18 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 114.119 0.407 . . . . 64.5 114.119 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.71 10.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 74.019999999999996 110.483 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -93.0 -8.17 43.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 61.130000000000003 111.247 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -75.16 -46.9 31.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.656 -0.247 . . . . 62.229999999999997 111.642 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -97.67 1.41 59.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.982 -1.104 . . . . 71.030000000000001 113.784 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -8.56 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.446 -0.576 . . . . 50.32 109.446 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -115.23 -15.61 11.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.398 -0.819 . . . . 64.209999999999994 110.17 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.44 -69.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.1 0.476 . . . . 55.399999999999999 112.135 -178.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.494 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 12.6 mt -42.52 174.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.277 -0.874 . . . . 74.439999999999998 112.151 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -120.29 3.67 10.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.539 -0.755 . . . . 72.329999999999998 110.345 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p 58.4 35.15 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.698 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.5 p30 -89.2 -31.27 18.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 72.340000000000003 111.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 28.1 tttt -143.53 157.27 44.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.108 0.48 . . . . 64.230000000000004 110.707 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -154.9 170.72 8.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.731 -0.668 . . . . 73.109999999999999 111.584 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 18.2 Cg_endo -60.24 162.09 36.68 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.422 -1.491 . . . . 63.140000000000001 113.013 0.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.92 162.41 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.755 . . . . 75.129999999999995 109.812 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 84' ' ' ILE . 42.0 t80 -138.49 124.6 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 111.132 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.63 148.43 43.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 111.499 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 93' ' ' PHE . 12.9 mm -128.58 90.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 110.346 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.74 139.19 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 73.209999999999994 110.899 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -108.34 110.38 21.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 110.76 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.33 0.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 111.153 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.42 -39.43 8.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.434 -0.348 . . . . 73.150000000000006 111.17 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 -6.51 9.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.63 -0.259 . . . . 44.119999999999997 111.525 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.6 t30 66.19 64.58 0.52 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.546 -0.538 . . . . 71.239999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.4 tp60 -122.26 169.66 10.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.5 -0.773 . . . . 71.040000000000006 111.735 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.562 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -134.96 92.01 2.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.204 -0.907 . . . . 75.519999999999996 111.602 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 70.0 m-85 -103.93 66.55 0.11 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.872 -0.603 . . . . 75.519999999999996 111.138 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 95.1 Cg_endo -77.18 -175.5 2.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.451 2.1 . . . . 72.109999999999999 112.998 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -112.66 168.61 9.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.847 -0.615 . . . . 64.049999999999997 110.943 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.469 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -72.44 176.3 5.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 72.030000000000001 110.733 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -118.18 -16.31 9.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 62.530000000000001 111.279 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -119.75 -8.13 9.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.829 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -70.96 -8.46 53.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.861 -0.609 . . . . 71.049999999999997 111.559 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.4 tt0 86.73 120.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.214 -0.448 . . . . 74.200000000000003 110.596 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.0 mt -103.94 110.01 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 111.59 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.21 -153.55 0.57 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.892 -0.781 . . . . 72.030000000000001 108.892 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.53 -66.16 0.95 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.624 -0.88 . . . . 74.200000000000003 108.624 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.659 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.19 -38.97 9.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.994 -1.003 . . . . 72.409999999999997 111.957 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -68.81 -32.88 72.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.69 0.626 . . . . 64.019999999999996 112.69 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.74 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 32.9 mm -91.24 -45.76 14.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 109.942 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.659 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -57.09 -45.77 83.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.844 -0.798 . . . . 71.120000000000005 108.844 178.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.36 36.8 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.774 -0.648 . . . . 73.420000000000002 110.125 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 48.7 t80 -49.77 -63.83 0.99 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.011 -0.366 . . . . 74.010000000000005 110.011 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 107' ' ' LYS . 8.3 m -49.17 -42.85 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.535 . . . . 64.200000000000003 109.569 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -52.97 -36.93 60.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.727 0.775 . . . . 40.149999999999999 109.204 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.893 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -69.3 -34.8 75.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 108.398 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 93' ' ' PHE . 2.0 t80 -71.75 -69.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.255 -0.884 . . . . 73.219999999999999 110.874 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.419 HG21 ' CD2' ' A' ' 113' ' ' PHE . 16.9 t -50.19 -47.46 24.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 72.019999999999996 111.987 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -36.96 67.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 74.230000000000004 111.019 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.75 29.41 2.24 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 110.864 -0.894 . . . . 74.530000000000001 110.864 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.893 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -101.76 -52.92 3.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.792 -0.704 . . . . 64.420000000000002 111.561 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.538 HG13 ' C ' ' A' ' 112' ' ' ASP . 55.9 mt -66.43 152.94 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.483 -0.562 . . . . 70.430000000000007 109.483 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.81 168.09 19.04 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.395 -0.366 . . . . 65.140000000000001 111.449 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo . . . . . 0 C--N 1.344 0.336 0 C-N-CA 122.776 2.318 . . . . 73.010000000000005 112.728 -179.586 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.711 0.291 . . . . 72.450000000000003 111.113 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -55.59 -24.03 30.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 72.239999999999995 111.237 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -83.04 -40.88 19.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 72.5 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 15.6 m-85 -77.13 -18.31 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.372 0.606 . . . . 72.349999999999994 109.59 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -32.17 17.23 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.091 -0.959 . . . . 60.310000000000002 110.233 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -90.9 -8.64 48.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.694 -0.685 . . . . 62.32 111.006 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.19 -56.21 10.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.935 0.397 . . . . 75.400000000000006 110.623 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.35 23.99 2.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.928 -0.653 . . . . 63.509999999999998 112.351 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.88 166.44 28.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.746 0.308 . . . . 73.340000000000003 111.296 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.25 141.49 69.09 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.607 2.205 . . . . 52.020000000000003 112.357 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.8 tt -105.46 128.04 53.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.522 . . . . 71.5 110.564 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 57' ' ' PHE . . . -100.75 86.6 3.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.093 0.473 . . . . 55.439999999999998 111.451 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.456 ' CE1' HD13 ' A' ' 26' ' ' LEU . 62.4 m-85 -75.81 136.82 40.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.573 -0.739 . . . . 73.0 110.264 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 2.8 mp -130.43 87.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.773 0.32 . . . . 72.450000000000003 111.178 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.627 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.5 m-85 -71.59 147.09 47.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.683 -0.488 . . . . 73.299999999999997 109.683 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -159.26 119.64 3.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.147 0.499 . . . . 72.430000000000007 110.828 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 12.1 mt-10 -74.32 -7.46 52.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.494 -0.776 . . . . 74.299999999999997 110.346 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -89.09 126.56 35.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 75.349999999999994 111.104 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.85 4.38 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.476 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.1 -38.33 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 60.310000000000002 110.474 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -104.34 15.96 27.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 111.074 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -59.23 -25.81 64.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 74.340000000000003 111.035 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -58.13 -44.08 87.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.365 . . . . 62.439999999999998 110.855 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.44 -42.93 82.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 74.530000000000001 110.981 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.06 -53.65 46.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 71.019999999999996 110.83 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 49.8 m -64.86 -22.84 67.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.214 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 30.3 t0 -65.29 -61.6 2.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.567 0.698 . . . . 72.400000000000006 109.244 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.643 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.41 -32.96 8.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.604 1.192 . . . . 64.25 108.746 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.637 ' HA ' HD13 ' A' ' 47' ' ' ILE . 43.3 mt -76.62 -24.04 53.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.463 -1.699 . . . . 73.420000000000002 112.388 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.0 mtpt -53.73 -44.68 98.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 63.109999999999999 110.13 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.9 Cg_endo -83.21 -38.86 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.532 2.155 . . . . 74.430000000000007 110.819 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.668 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 58.7 mt -49.78 -23.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.912 -0.585 . . . . 64.109999999999999 110.102 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.675 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -110.82 -26.19 9.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 71.120000000000005 111.465 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.62 -18.83 61.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.128 0.49 . . . . 72.150000000000006 110.04 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.96 -28.94 17.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.76 0.79 . . . . 60.229999999999997 109.409 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.1 pt20 -121.31 38.96 3.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.311 -1.313 . . . . 74.319999999999993 110.597 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.1 ptm180 -75.04 -27.05 59.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 72.209999999999994 111.406 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.03 14.97 28.59 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.903 -0.665 . . . . 71.439999999999998 112.618 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG13 ' CA ' ' A' ' 51' ' ' GLN . 7.5 p -128.81 -44.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 75.319999999999993 110.964 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.0 mt -118.06 146.24 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 65.239999999999995 110.527 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.08 102.11 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.889 0.376 . . . . 73.319999999999993 110.406 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.471 ' CD1' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -80.01 136.69 36.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.348 0.594 . . . . 75.340000000000003 111.587 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.6 126.71 1.65 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.148 -0.933 . . . . 71.140000000000001 111.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 p -88.4 153.67 21.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 73.239999999999995 110.415 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.627 HG23 ' CG ' ' A' ' 30' ' ' PHE . 10.8 tt -147.91 162.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 71.430000000000007 110.853 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.3 t0 -83.55 117.4 23.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.178 -0.465 . . . . 74.299999999999997 112.183 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.506 ' HB2' ' CG ' ' A' ' 79' ' ' PHE . . . -83.05 5.35 22.61 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.673 0.273 . . . . 43.25 110.788 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 17.6 ttmt -103.67 -33.23 9.03 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.526 -0.306 . . . . 73.310000000000002 111.622 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.54 -32.42 5.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.224 0.535 . . . . 73.030000000000001 110.57 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.33 -16.47 17.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 74.209999999999994 111.101 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.65 -39.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.442 0.537 . . . . 64.5 114.442 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -52.02 -26.71 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.25 0.548 . . . . 74.019999999999996 110.459 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -83.29 -13.48 55.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 61.130000000000003 111.611 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -71.73 -36.76 70.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.667 0.27 . . . . 62.229999999999997 111.558 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -108.07 -0.44 33.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.917 -1.135 . . . . 71.030000000000001 113.416 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -60.93 -10.68 6.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.507 -0.553 . . . . 50.32 109.507 177.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 73' ' ' ASN . 0.4 OUTLIER -113.93 -14.84 12.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.372 -0.831 . . . . 64.209999999999994 110.328 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.506 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.31 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.276 0.473 . . . . 55.399999999999999 112.276 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 73' ' ' ASN . 96.6 mt -43.14 178.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.514 -0.766 . . . . 74.439999999999998 112.913 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.94 -24.53 11.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.969 -1.014 . . . . 72.329999999999998 110.495 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 79' ' ' PHE . 1.5 p 78.95 21.54 0.68 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.206 -0.906 . . . . 74.420000000000002 108.609 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.67 -45.16 25.78 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.649 -1.159 . . . . 72.340000000000003 111.41 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -123.93 163.2 21.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.1 -0.5 . . . . 64.230000000000004 111.154 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -160.59 167.43 13.7 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 73.109999999999999 112.023 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 26.2 Cg_endo -62.34 158.1 60.37 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 123.16 -1.6 . . . . 63.140000000000001 113.05 0.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.31 167.59 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.737 . . . . 75.129999999999995 109.969 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 1.7 t80 -138.36 130.32 28.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.669 0.271 . . . . 74.340000000000003 110.778 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . . . -129.68 121.34 26.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.038 0.385 . . . . 75.540000000000006 112.038 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 HG22 ' CZ ' ' A' ' 113' ' ' PHE . 31.1 mt -103.63 93.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 110.346 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -85.05 141.77 30.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.768 0.318 . . . . 73.209999999999994 110.741 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -112.43 109.9 19.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.958 0.408 . . . . 74.420000000000002 111.072 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.2 -1.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.797 -0.638 . . . . 71.319999999999993 110.904 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.87 -42.67 11.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.919 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -118.8 -9.01 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.552 -0.294 . . . . 44.119999999999997 111.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 t30 75.46 57.05 0.06 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.353 0.597 . . . . 71.239999999999995 109.562 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.644 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -121.49 166.44 14.16 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.179 -0.919 . . . . 71.040000000000006 110.932 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.644 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 5.4 mmtt -141.42 98.19 3.31 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.413 -0.812 . . . . 75.519999999999996 110.663 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 64.1 m-85 -101.76 73.41 0.12 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.838 . . . . 75.519999999999996 110.866 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 53.7 Cg_endo -80.05 167.32 20.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 72.109999999999999 112.585 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' ' N ' ' A' ' 96' ' ' ASP . 40.5 t80 -96.08 166.15 11.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 64.049999999999997 110.828 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.402 ' N ' ' CD2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -63.67 173.81 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 72.030000000000001 110.392 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.415 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 mm-40 -117.15 -22.9 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.423 . . . . 62.530000000000001 111.369 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -127.52 25.61 6.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.378 . . . . 72.430000000000007 110.835 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.4 tppt? -93.33 -69.37 0.75 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.022 -0.536 . . . . 71.049999999999997 110.533 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 9.7 tt0 163.56 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.763 -0.653 . . . . 74.200000000000003 109.892 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 8.7 mt -91.25 88.09 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.549999999999997 111.735 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -112.25 -154.1 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.612 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.98 -67.57 0.85 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.741 -0.837 . . . . 74.200000000000003 108.741 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.632 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.82 -35.83 6.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.341 -0.845 . . . . 72.409999999999997 111.479 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -71.82 -33.38 68.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 64.019999999999996 112.426 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.668 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 50.0 mm -89.48 -46.43 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.113 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -58.47 -44.93 89.47 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.727 -0.67 . . . . 71.120000000000005 109.471 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.86 -49.01 50.77 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.696 -0.684 . . . . 73.420000000000002 110.123 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.638 ' O ' HD11 ' A' ' 118' ' ' ILE . 27.5 t80 -51.56 -67.2 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 74.010000000000005 109.822 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 21.9 m -47.16 -38.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.322 0.582 . . . . 64.200000000000003 109.869 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -57.87 -41.88 83.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.356 -0.838 . . . . 40.149999999999999 110.057 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.691 ' OD2' HG12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -77.16 -11.93 59.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.615 -0.721 . . . . 75.319999999999993 110.263 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -82.0 -61.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.74 0.781 . . . . 73.219999999999999 109.153 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.543 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 11.5 p -57.94 -37.29 60.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.302 -1.317 . . . . 72.019999999999996 110.885 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.05 86.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 74.230000000000004 110.431 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.85 1.53 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.722 -0.751 . . . . 74.530000000000001 111.558 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.46 -37.13 6.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.296 -0.452 . . . . 64.420000000000002 111.704 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.691 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.4 mt -86.54 150.0 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.16 0.505 . . . . 70.430000000000007 110.508 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.48 162.56 45.92 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.479 -0.782 . . . . 65.140000000000001 111.079 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 73.010000000000005 112.189 -179.544 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.416 ' CE2' ' OH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.92 0.39 . . . . 72.450000000000003 111.374 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -64.49 -26.67 68.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 72.239999999999995 111.666 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.35 -38.39 60.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 72.5 111.015 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 23.0 m-85 -79.12 -23.44 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.362 0.601 . . . . 72.349999999999994 109.593 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -25.47 23.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.118 -0.946 . . . . 60.310000000000002 110.379 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 t -95.31 -11.23 28.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.025 -0.534 . . . . 62.32 110.521 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.01 78.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.458 -0.337 . . . . 75.400000000000006 111.175 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 17.18 39.77 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.715 . . . . 63.509999999999998 112.666 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.97 161.1 65.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.718 0.294 . . . . 73.340000000000003 110.89 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.04 139.57 88.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.624 2.216 . . . . 52.020000000000003 112.688 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' A' ' 28' ' ' TYR . 2.3 tt -98.42 140.96 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 71.5 111.145 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 57' ' ' PHE . . . -114.94 88.22 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 55.439999999999998 111.023 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.418 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 81.6 m-85 -76.87 133.97 39.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.69 -0.687 . . . . 73.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 3.0 mt -125.76 85.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.501 -0.318 . . . . 72.450000000000003 111.093 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.624 ' CG ' HG22 ' A' ' 60' ' ' ILE . 3.6 m-85 -73.24 148.84 43.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.299 -0.63 . . . . 73.299999999999997 109.299 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -157.18 115.13 3.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.383 0.611 . . . . 72.430000000000007 111.326 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -84.72 -1.25 55.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.022 -0.99 . . . . 74.299999999999997 109.901 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 p -106.6 112.48 25.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.974 -0.557 . . . . 75.349999999999994 110.662 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.32 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 72.230000000000004 111.375 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.36 -55.17 5.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.091 0.472 . . . . 60.310000000000002 110.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.38 -3.42 55.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 71.430000000000007 110.902 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 -44.83 -38.77 4.78 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 111.15 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.22 -56.11 9.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.676 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 7.4 pt-20 -58.2 -31.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 74.530000000000001 110.576 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.74 -57.54 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.042 0.449 . . . . 71.019999999999996 110.448 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 25.6 m -63.43 -20.26 65.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 74.349999999999994 111.329 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t0 -65.94 -63.87 0.99 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.609 0.718 . . . . 72.400000000000006 109.345 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -47.85 -33.02 6.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.703 1.24 . . . . 64.25 108.684 177.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.1 mt -76.88 -23.32 52.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.43 -1.714 . . . . 73.420000000000002 112.467 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 10.8 mtpt -54.45 -43.95 98.37 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 116.431 -0.35 . . . . 63.109999999999999 110.073 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 21.0 Cg_endo -82.37 -39.85 0.15 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 110.543 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.651 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 47.1 mt -51.25 -22.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-N 116.045 -0.525 . . . . 64.109999999999999 109.948 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.685 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -111.22 -23.99 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.775 -0.648 . . . . 71.120000000000005 111.429 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -61.47 -20.74 63.49 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.195 0.521 . . . . 72.150000000000006 109.89 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.7 -26.54 19.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.422 -0.808 . . . . 60.229999999999997 109.338 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.685 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -125.66 42.21 3.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.441 -1.254 . . . . 74.319999999999993 110.793 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -76.32 -32.54 58.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.666 -0.697 . . . . 72.209999999999994 111.056 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.4 6.69 53.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.849 -0.691 . . . . 71.439999999999998 112.641 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 13.1 p -119.09 -34.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 75.319999999999993 111.23 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.94 143.95 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 65.239999999999995 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-80 -93.61 87.0 5.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 73.319999999999993 109.927 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.45 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 3.5 m-85 -69.89 136.71 50.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 75.340000000000003 111.234 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.63 129.63 2.32 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.389 -0.823 . . . . 71.140000000000001 111.961 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.446 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 50.0 p -89.38 151.58 21.97 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.039 0.447 . . . . 73.239999999999995 110.878 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.624 HG22 ' CG ' ' A' ' 30' ' ' PHE . 11.3 tt -148.07 163.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.503 -0.771 . . . . 71.430000000000007 110.422 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.2 t0 -87.08 120.98 28.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.379 -0.373 . . . . 74.299999999999997 111.883 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.482 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.98 5.09 23.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.788 -0.365 . . . . 43.25 111.073 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 29.2 ttmt -105.08 -34.15 8.06 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 111.735 0.272 . . . . 73.310000000000002 111.735 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.57 -30.51 7.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.218 0.532 . . . . 73.030000000000001 110.417 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' CG ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.77 -17.99 14.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.413 -0.812 . . . . 74.209999999999994 111.167 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -31.41 -39.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 114.239 0.456 . . . . 64.5 114.239 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.55 -19.03 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.058 0.429 . . . . 74.019999999999996 110.691 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -90.66 -11.83 38.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.805 -0.634 . . . . 61.130000000000003 111.183 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -69.19 -51.36 38.75 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.73 0.3 . . . . 62.229999999999997 111.048 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.52 1.75 69.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.739 -1.22 . . . . 71.030000000000001 113.778 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.61 -9.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.452 0.626 . . . . 50.32 109.668 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -114.29 -15.22 12.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.319 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.432 ' N ' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.16 -70.02 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.246 0.546 . . . . 55.399999999999999 112.264 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.554 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.6 mm? -40.86 171.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 114.89 -1.05 . . . . 74.439999999999998 112.375 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.24 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 72.329999999999998 110.832 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.0 p 53.75 38.13 27.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.383 . . . . 74.420000000000002 110.825 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.64 -29.84 33.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 72.340000000000003 110.769 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -150.69 163.81 37.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.243 -0.435 . . . . 64.230000000000004 110.36 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.482 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.61 173.15 5.23 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.915 -0.584 . . . . 73.109999999999999 111.787 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 19.1 Cg_endo -60.36 164.63 30.24 Favored 'Cis proline' 0 C--N 1.353 0.793 0 C-N-CA 123.363 -1.515 . . . . 63.140000000000001 113.076 0.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.49 167.62 16.04 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.394 -0.821 . . . . 75.129999999999995 109.532 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 2.1 t80 -143.58 112.1 6.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.645 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -109.44 126.42 53.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 75.540000000000006 111.429 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 11.8 mt -109.26 88.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.803 0.335 . . . . 70.340000000000003 110.42 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -84.92 138.5 32.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 73.209999999999994 110.6 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 115.28 29.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.922 0.391 . . . . 74.420000000000002 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 t -81.61 3.49 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.539 . . . . 71.319999999999993 110.827 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.99 -41.5 8.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.292 -0.413 . . . . 73.150000000000006 110.857 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -117.79 -15.93 10.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.637 -0.256 . . . . 44.119999999999997 111.308 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 35.4 t-20 81.18 40.75 0.05 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.324 0.583 . . . . 71.239999999999995 110.268 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.1 tp60 -91.6 -174.74 3.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.339 -0.846 . . . . 71.040000000000006 111.152 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.575 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -150.28 93.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.56 -0.745 . . . . 75.519999999999996 110.713 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 75.0 m-85 -105.18 70.07 0.2 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.835 -0.62 . . . . 75.519999999999996 111.353 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 52.0 Cg_endo -81.56 178.65 6.42 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.683 2.255 . . . . 72.109999999999999 112.968 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 37.1 t80 -113.05 164.45 13.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 64.049999999999997 110.505 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.449 ' N ' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -62.35 174.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 72.030000000000001 110.74 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.49 -23.27 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 62.530000000000001 111.21 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 24.93 6.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 110.847 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.3 tppt? -94.55 -77.3 0.47 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.019 -0.537 . . . . 71.049999999999997 110.534 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 3.8 tt0 173.74 105.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 74.200000000000003 110.4 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.0 mt -98.63 88.58 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.815 -0.63 . . . . 75.549999999999997 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -119.07 -164.68 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.28 -0.637 . . . . 72.030000000000001 109.28 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.557 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -79.76 -66.32 0.89 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.098 0.475 . . . . 74.200000000000003 110.099 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.554 ' N ' ' CD2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -48.98 -39.23 25.73 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.936 -1.029 . . . . 72.409999999999997 111.754 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -71.88 -34.94 69.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.067 -0.97 . . . . 64.019999999999996 113.412 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.651 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 46.2 mm -88.05 -44.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.0 0.429 . . . . 74.420000000000002 110.201 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB3' HG12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -54.66 -42.97 71.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.866 -0.606 . . . . 71.120000000000005 109.511 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.81 36.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.621 -0.718 . . . . 73.420000000000002 110.139 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 32.2 t80 -49.64 -64.74 0.72 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.631 -0.507 . . . . 74.010000000000005 109.631 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 16.7 m -49.97 -41.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.765 -0.458 . . . . 64.200000000000003 109.765 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -55.58 -36.96 67.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.686 0.755 . . . . 40.149999999999999 109.133 178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.906 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -68.03 -34.82 77.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.431 -1.259 . . . . 75.319999999999993 108.281 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.472 ' CB ' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -71.52 -69.05 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.099 -0.955 . . . . 73.219999999999999 111.025 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 113' ' ' PHE . 11.9 t -52.36 -46.05 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.284 -0.871 . . . . 72.019999999999996 112.101 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.66 69.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.843 0.354 . . . . 74.230000000000004 111.235 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.36 31.17 1.9 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.86 -0.896 . . . . 74.530000000000001 110.86 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.906 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -103.25 -56.22 2.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.848 -0.676 . . . . 64.420000000000002 111.373 -178.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.52 HG13 ' C ' ' A' ' 112' ' ' ASP . 50.4 mt -64.56 150.75 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.403 -0.591 . . . . 70.430000000000007 109.403 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -133.13 157.37 78.44 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 65.140000000000001 111.581 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.8 2.333 . . . . 73.010000000000005 112.611 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.853 0.358 . . . . 72.450000000000003 111.616 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.7 t -55.86 -30.83 62.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.051 -0.522 . . . . 72.239999999999995 111.965 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.09 -35.86 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.899 0.38 . . . . 72.5 111.251 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 11.7 m-85 -81.53 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 72.349999999999994 110.664 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.08 -28.85 9.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 60.310000000000002 110.577 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -97.15 -5.87 36.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.982 -0.554 . . . . 62.32 110.882 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.12 76.78 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.906 0.384 . . . . 75.400000000000006 111.026 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.62 15.67 22.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.859 -0.686 . . . . 63.509999999999998 112.459 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pt -133.35 154.37 80.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.340000000000003 111.096 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.34 145.12 99.27 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.84 2.36 . . . . 52.020000000000003 112.604 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' GLN . 3.1 tt -95.97 135.7 37.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.9 -0.591 . . . . 71.5 111.143 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.72 95.27 5.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 55.439999999999998 110.793 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.476 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 6.5 m-85 -82.3 130.75 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 73.0 110.371 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG2' ' CD1' ' A' ' 44' ' ' LEU . 2.3 mp -124.38 83.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.81 -0.356 . . . . 72.450000000000003 111.339 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 60' ' ' ILE . 4.8 m-85 -70.28 143.97 51.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.561 -0.533 . . . . 73.299999999999997 109.561 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -158.07 118.47 3.37 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.145 0.497 . . . . 72.430000000000007 111.028 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 23.4 mt-10 -71.26 -13.25 61.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 74.299999999999997 109.979 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 p -88.64 97.24 11.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 111.037 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.44 7.59 42.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 72.230000000000004 111.456 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -113.3 -46.46 3.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 60.310000000000002 110.83 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -92.93 1.55 57.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.381 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.59 -29.87 0.19 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.929 0.344 . . . . 74.340000000000003 111.929 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -49.78 -50.04 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 62.439999999999998 111.151 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 17.5 mt-10 -63.34 -44.03 96.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 74.530000000000001 111.103 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.57 -53.68 53.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 71.019999999999996 110.905 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' HD12 ' A' ' 44' ' ' LEU . 28.6 m -65.06 -19.85 66.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 74.349999999999994 111.383 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' LYS . 10.6 t0 -67.53 -62.03 1.62 Allowed 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.312 -0.625 . . . . 72.400000000000006 109.312 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.649 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.07 -32.82 10.28 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.844 1.307 . . . . 64.25 108.782 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HA ' HD12 ' A' ' 47' ' ' ILE . 63.7 mt -77.65 -23.29 49.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.191 -1.822 . . . . 73.420000000000002 111.903 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 17.8 ttmt -52.27 -45.17 94.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.747 -0.661 . . . . 63.109999999999999 110.083 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.1 Cg_endo -83.96 -37.54 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.628 2.219 . . . . 74.430000000000007 110.537 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 44' ' ' LEU . 60.9 mt -50.33 -21.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 116.068 -0.515 . . . . 64.109999999999999 110.196 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -110.87 -32.44 6.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.177 -0.465 . . . . 71.120000000000005 111.797 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 2.0 tm-20 -59.39 -18.15 36.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.24 0.543 . . . . 72.150000000000006 110.179 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.14 -27.98 19.25 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.42 -0.809 . . . . 60.229999999999997 109.527 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.676 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -121.48 36.07 4.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.449 -1.25 . . . . 74.319999999999993 110.814 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' ALA . 20.4 ptt-85 -67.08 -32.79 74.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.67 . . . . 72.209999999999994 111.326 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 9.61 49.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.645 -0.788 . . . . 71.439999999999998 112.83 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 14.6 p -123.78 -29.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.742 0.271 . . . . 75.319999999999993 111.581 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.411 ' CD1' ' NE2' ' A' ' 51' ' ' GLN . 32.8 mt -132.84 153.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.54 -0.3 . . . . 65.239999999999995 110.428 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -102.82 109.8 21.51 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.994 0.426 . . . . 73.319999999999993 110.728 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -70.35 125.89 28.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.412 0.625 . . . . 75.340000000000003 111.136 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.29 100.43 0.21 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.025 -0.989 . . . . 71.140000000000001 112.572 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.4 p -77.74 152.95 33.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 73.239999999999995 110.521 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.613 HG21 ' CG ' ' A' ' 30' ' ' PHE . 12.6 tt -150.14 165.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 71.430000000000007 110.87 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 28.8 t0 -88.43 120.7 30.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 112.077 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.46 3.56 35.69 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.696 0.284 . . . . 43.25 111.0 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 11.1 tttt -104.42 -32.64 8.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.492 -0.322 . . . . 73.310000000000002 111.545 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.92 -30.25 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 73.030000000000001 110.616 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -103.68 -15.72 15.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.574 -0.739 . . . . 74.209999999999994 111.236 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -32.33 -38.09 0.05 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.269 0.467 . . . . 64.5 114.269 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.53 -12.38 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.175 0.487 . . . . 74.019999999999996 110.764 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' PHE . 13.3 t-80 -103.08 -4.21 24.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.705 -0.68 . . . . 61.130000000000003 110.934 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -73.86 -53.18 10.78 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.739 0.305 . . . . 62.229999999999997 111.324 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.82 6.75 73.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 119.868 -1.158 . . . . 71.030000000000001 113.504 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -9.8 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.09 -0.707 . . . . 50.32 109.09 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -113.74 -15.04 12.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.224 -0.898 . . . . 64.209999999999994 110.376 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.468 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER 179.06 -69.92 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.355 0.598 . . . . 55.399999999999999 112.288 -178.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.508 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.5 mm? -40.96 173.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.016 -0.993 . . . . 74.439999999999998 112.594 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -101.89 -32.38 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 72.329999999999998 110.894 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p 85.01 27.34 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.808 -1.087 . . . . 74.420000000000002 108.388 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.56 -45.55 17.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.535 -1.211 . . . . 72.340000000000003 111.017 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 21.9 tttp -130.1 163.28 26.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.88 -0.6 . . . . 64.230000000000004 111.074 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -157.07 169.83 9.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.578 . . . . 73.109999999999999 111.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 18.4 Cg_endo -60.61 160.53 42.74 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 123.446 -1.481 . . . . 63.140000000000001 113.189 0.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.13 159.93 32.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.379 -0.828 . . . . 75.129999999999995 109.812 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 28' ' ' TYR . 68.4 t80 -136.76 136.83 39.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 74.340000000000003 111.748 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -134.77 148.67 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 75.540000000000006 111.172 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.462 HG22 ' CE2' ' A' ' 113' ' ' PHE . 12.9 mt -123.66 94.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.33 . . . . 70.340000000000003 110.525 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' LEU . 9.0 tm0? -77.71 136.67 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 110.89 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -107.39 116.06 31.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 110.562 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG13 ' HE1' ' A' ' 20' ' ' MET . 34.3 m -82.7 8.51 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 71.319999999999993 112.169 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.18 -40.02 3.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.813 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -105.7 -14.56 15.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 44.119999999999997 111.33 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 74.44 19.56 2.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.925 0.393 . . . . 71.239999999999995 111.092 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 6.2 tp-100 -89.12 166.53 13.78 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 110.681 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 8.6 mmtt -141.06 85.38 1.98 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.819 -0.628 . . . . 75.519999999999996 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' CE1' ' A' ' 113' ' ' PHE . 32.5 m-85 -81.31 100.73 0.77 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 75.519999999999996 110.688 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 40.6 Cg_endo -105.47 168.92 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.431 2.754 . . . . 72.109999999999999 113.294 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 36.4 t80 -102.85 165.38 11.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 64.049999999999997 110.626 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -65.51 175.06 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 72.030000000000001 110.528 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 2.4 mt-30 -116.67 -24.61 7.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 62.530000000000001 111.218 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -124.41 25.86 7.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.397 . . . . 72.430000000000007 110.825 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.5 tppt? -96.34 -72.56 0.63 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.566 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 54.7 tt0 170.46 100.48 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.96 -0.563 . . . . 74.200000000000003 110.382 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.4 mt -94.63 90.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 75.549999999999997 111.064 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 22.1 p -116.22 -150.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.413 -0.358 . . . . 72.030000000000001 110.248 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.569 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -97.35 -56.39 2.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.436 0.636 . . . . 74.200000000000003 109.495 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.528 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -61.4 -39.29 90.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.733 -1.122 . . . . 72.409999999999997 110.722 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.36 70.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 64.019999999999996 112.602 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.637 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 51.9 mm -89.49 -41.39 13.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 74.420000000000002 110.166 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 3.0 pttp -62.74 -46.23 89.03 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.479 -0.782 . . . . 71.120000000000005 109.115 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 107' ' ' LYS . . . -67.35 -49.93 61.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.985 -1.007 . . . . 73.420000000000002 110.2 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.672 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.1 t80 -51.4 -65.82 0.49 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 116.295 -0.411 . . . . 74.010000000000005 110.023 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 12.3 m -48.56 -36.16 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.486 0.66 . . . . 64.200000000000003 109.732 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -61.05 -42.97 99.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.092 -0.958 . . . . 40.149999999999999 110.062 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.731 ' OD2' HG12 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -72.39 -15.47 61.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 75.319999999999993 109.874 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.464 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.1 OUTLIER -81.46 -62.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.729 0.776 . . . . 73.219999999999999 109.345 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.464 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.8 p -62.36 -38.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.445 -1.252 . . . . 72.019999999999996 111.173 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.11 76.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.542 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.97 30.23 1.26 Allowed Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.628 -0.796 . . . . 74.530000000000001 111.731 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.99 -38.5 6.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.516 -0.342 . . . . 64.420000000000002 111.475 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.731 HG12 ' OD2' ' A' ' 112' ' ' ASP . 6.0 mt -87.23 148.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 70.430000000000007 110.518 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.25 163.88 44.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.785 -0.643 . . . . 65.140000000000001 111.328 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.344 0.337 0 C-N-CA 122.54 2.16 . . . . 73.010000000000005 112.418 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 p90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.729 0.3 . . . . 72.450000000000003 111.055 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.1 m -56.32 -26.01 50.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 72.239999999999995 110.848 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -85.64 -35.19 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.749 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.413 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 18.3 m-85 -78.47 -15.03 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.326 0.584 . . . . 72.349999999999994 109.604 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -31.34 12.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.217 -0.901 . . . . 60.310000000000002 110.16 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.29 -7.11 48.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 62.32 111.056 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -51.43 36.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 75.400000000000006 110.791 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.65 22.68 5.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 63.509999999999998 112.35 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 1.2 pt -133.38 169.52 13.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 73.340000000000003 111.341 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 15.6 Cg_exo -65.84 134.25 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.595 2.196 . . . . 52.020000000000003 112.302 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 HD13 ' CE2' ' A' ' 28' ' ' TYR . 3.4 tt -98.16 125.86 43.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 71.5 110.774 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.79 92.2 4.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.021 -0.536 . . . . 55.439999999999998 111.408 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.484 ' CE2' HD13 ' A' ' 26' ' ' LEU . 57.6 m-85 -82.17 124.58 30.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.765 -0.652 . . . . 73.0 109.909 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.4 mt -116.52 83.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.767 -0.373 . . . . 72.450000000000003 111.604 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CG ' HG23 ' A' ' 60' ' ' ILE . 4.6 m-85 -72.43 142.54 48.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.403 -0.591 . . . . 73.299999999999997 109.403 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.54 118.21 3.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.085 -0.507 . . . . 72.430000000000007 110.277 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.484 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 15.9 mt-10 -68.83 -14.02 62.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.686 -0.688 . . . . 74.299999999999997 110.144 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.38 130.29 42.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.221 0.534 . . . . 75.349999999999994 110.896 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.52 8.48 12.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.394 -0.821 . . . . 72.230000000000004 110.62 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -105.12 -49.69 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 60.310000000000002 110.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -96.08 18.96 12.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.791 -0.64 . . . . 71.430000000000007 111.011 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -28.05 37.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.763 0.316 . . . . 74.340000000000003 110.872 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -46.44 80.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -62.35 -48.11 81.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 74.530000000000001 110.662 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -59.38 -60.6 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.145 0.498 . . . . 71.019999999999996 110.733 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.7 m -61.65 -23.79 66.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.942 -0.572 . . . . 74.349999999999994 111.39 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.5 t0 -62.65 -63.41 1.23 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.235 0.54 . . . . 72.400000000000006 109.76 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.634 ' C ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -50.2 -30.15 10.9 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 123.411 1.577 . . . . 64.25 109.3 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' HA ' ' CG2' ' A' ' 47' ' ' ILE . 29.4 mt -77.05 -23.8 52.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.029 -1.896 . . . . 73.420000000000002 111.966 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.652 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 56.4 mmtt -63.9 -39.78 48.88 Favored Pre-proline 0 CA--C 1.52 -0.196 0 CA-C-N 115.926 -0.579 . . . . 63.109999999999999 111.505 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.719 ' HG2' ' H ' ' A' ' 47' ' ' ILE . 42.6 Cg_endo -76.77 -49.08 0.11 Allowed 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.249 1.966 . . . . 74.430000000000007 111.111 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.719 ' H ' ' HG2' ' A' ' 46' ' ' PRO . 1.1 tp -55.09 -27.54 19.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 119.099 -1.041 . . . . 64.109999999999999 109.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -92.4 -25.74 18.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.356 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -58.77 -23.78 60.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.357 -0.609 . . . . 72.150000000000006 109.357 178.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.95 -27.58 18.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.164 -0.926 . . . . 60.229999999999997 109.685 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 1.5 pt20 -129.45 50.55 2.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.787 -1.097 . . . . 74.319999999999993 110.586 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.2 ptt-85 -81.69 -28.01 33.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.226 -0.897 . . . . 72.209999999999994 111.087 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.56 14.1 27.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.599 -0.728 . . . . 71.439999999999998 112.399 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 8.7 p -123.05 -41.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.578 0.228 . . . . 75.319999999999993 111.089 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.3 mt -111.37 139.6 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.364 -0.236 . . . . 65.239999999999995 110.364 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 16.1 m-80 -81.77 87.99 6.31 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 110.555 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -73.59 102.78 3.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 75.340000000000003 111.193 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.33 130.41 6.02 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.928 -0.654 . . . . 71.140000000000001 112.756 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.509 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.4 p -91.1 140.79 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.239999999999995 111.137 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.612 HG23 ' CG ' ' A' ' 30' ' ' PHE . 12.4 tt -138.4 163.26 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.942 -0.572 . . . . 71.430000000000007 110.462 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' N ' HG12 ' A' ' 60' ' ' ILE . 32.8 t0 -88.34 118.83 28.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 74.299999999999997 112.103 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 79' ' ' PHE . . . -82.64 2.58 32.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.576 -0.283 . . . . 43.25 110.985 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -103.21 -32.57 9.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.482 -0.326 . . . . 73.310000000000002 111.507 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 -29.89 6.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.759 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CG ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.33 -11.22 17.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.596 -0.729 . . . . 74.209999999999994 111.263 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.2 -34.62 0.08 OUTLIER Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.49 -0.386 . . . . 64.5 113.873 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.61 -24.3 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 74.019999999999996 110.261 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -88.77 -10.43 48.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.402 -0.817 . . . . 61.130000000000003 111.216 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -72.53 -44.45 62.15 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.486 -0.325 . . . . 62.229999999999997 111.62 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -99.74 1.55 56.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.932 -1.127 . . . . 71.030000000000001 113.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -61.28 -9.39 5.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.484 -0.561 . . . . 50.32 109.484 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -116.47 -15.29 10.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.518 -0.765 . . . . 64.209999999999994 110.585 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.514 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.63 -69.55 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.99 0.424 . . . . 55.399999999999999 112.125 -178.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.519 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.8 mt -42.74 172.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.555 -0.748 . . . . 74.439999999999998 111.781 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.0 OUTLIER -110.36 -16.69 13.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.724 -0.671 . . . . 72.329999999999998 110.235 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 75' ' ' LYS . 1.7 p 79.51 41.93 0.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.259 -1.015 . . . . 74.420000000000002 108.259 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.16 -50.15 5.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.047 -1.433 . . . . 72.340000000000003 111.471 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 46.2 tttt -133.42 161.74 33.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.988 -0.551 . . . . 64.230000000000004 110.965 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.44 173.17 5.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 73.109999999999999 111.351 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.566 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 31.9 Cg_exo -58.98 163.81 25.56 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 123.596 -1.418 . . . . 63.140000000000001 112.895 0.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.32 162.69 30.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.831 -1.077 . . . . 75.129999999999995 109.485 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CE2' ' CG1' ' A' ' 84' ' ' ILE . 57.0 t80 -138.53 127.93 24.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.736 0.303 . . . . 74.340000000000003 110.411 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -122.79 120.48 33.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.252 0.464 . . . . 75.540000000000006 112.252 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.449 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 15.4 mt -103.51 95.1 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 70.340000000000003 110.56 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.64 141.38 28.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 73.209999999999994 111.034 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 113' ' ' PHE . 38.1 mm-40 -108.01 110.21 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.011 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.63 -0.65 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 71.319999999999993 110.793 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.81 -43.04 8.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.274 -0.421 . . . . 73.150000000000006 110.876 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -116.48 -8.19 11.58 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.517 -0.31 . . . . 44.119999999999997 111.328 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 69.59 60.03 0.29 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.312 0.577 . . . . 71.239999999999995 109.481 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -114.74 179.1 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.84 . . . . 71.040000000000006 111.558 -178.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.92 92.15 2.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.419 -0.81 . . . . 75.519999999999996 111.159 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 71.0 m-85 -106.4 72.05 0.27 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 111.308 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 73.7 Cg_endo -80.71 -176.78 3.34 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.442 2.094 . . . . 72.109999999999999 112.927 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 38.5 t80 -110.68 175.93 5.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.759 -0.655 . . . . 64.049999999999997 110.478 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -78.86 176.94 9.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 72.030000000000001 110.714 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -114.39 -19.09 11.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 62.530000000000001 111.326 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.1 16.94 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 110.91 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 2.5 tppp? -90.5 -14.54 32.48 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.059 -0.518 . . . . 71.049999999999997 111.376 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 23.3 tt0 88.81 112.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.283 0.563 . . . . 74.200000000000003 110.566 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.1 mt -91.5 96.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 75.549999999999997 111.357 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.08 -154.19 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 72.030000000000001 109.385 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.613 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -94.07 -72.81 0.6 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.584 -0.895 . . . . 74.200000000000003 108.584 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.539 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.68 -32.6 0.6 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.058 0.456 . . . . 72.409999999999997 111.095 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.06 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.649 -0.705 . . . . 64.019999999999996 112.335 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 102' ' ' THR . 26.1 mm -87.67 -49.09 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.66 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.6 pttt -52.78 -48.55 66.76 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.437 -0.801 . . . . 71.120000000000005 109.493 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.61 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.79 -51.95 54.79 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.913 -0.585 . . . . 73.420000000000002 110.525 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 36.9 t80 -50.53 -63.03 1.25 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.192 -0.458 . . . . 74.010000000000005 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 m -52.76 -45.02 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 64.200000000000003 110.209 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -52.06 -40.32 60.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.669 0.747 . . . . 40.149999999999999 109.113 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.7 t70 -61.33 -34.2 74.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.506 -1.225 . . . . 75.319999999999993 108.276 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.1 OUTLIER -72.85 -66.48 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 73.219999999999999 110.922 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.554 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.6 p -55.05 -44.46 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.962 -1.017 . . . . 72.019999999999996 111.864 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.86 72.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 74.230000000000004 110.898 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.73 32.79 1.83 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 110.663 -0.975 . . . . 74.530000000000001 110.663 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.886 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -104.44 -54.01 2.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.688 -0.756 . . . . 64.420000000000002 111.852 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.532 HG13 ' C ' ' A' ' 112' ' ' ASP . 54.3 mt -63.31 159.11 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.765 0.317 . . . . 70.430000000000007 110.424 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 118' ' ' ILE . 16.4 pt-20 -146.24 154.29 49.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 65.140000000000001 110.753 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 123.056 2.504 . . . . 73.010000000000005 112.474 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.1 p90 . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.805 0.336 . . . . 72.450000000000003 111.109 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -26.94 32.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 110.903 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.86 -37.09 21.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 72.5 110.64 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 8.6 m-85 -78.87 -7.81 58.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.235 0.54 . . . . 72.349999999999994 109.864 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.67 -29.74 10.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.308 -0.86 . . . . 60.310000000000002 110.259 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 t -98.54 -2.5 38.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.571 . . . . 62.32 111.166 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.42 4.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.991 0.424 . . . . 75.400000000000006 110.885 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.41 22.17 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.988 -0.625 . . . . 63.509999999999998 112.291 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.55 162.51 57.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.573 0.225 . . . . 73.340000000000003 111.006 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 20.7 Cg_exo -61.38 137.56 70.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.399 2.066 . . . . 52.020000000000003 112.569 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.471 HD12 ' CE2' ' A' ' 28' ' ' TYR . 3.3 tt -96.66 126.48 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 71.5 110.357 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.63 90.79 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.161 -0.472 . . . . 55.439999999999998 111.512 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.471 ' CE2' HD12 ' A' ' 26' ' ' LEU . 65.7 m-85 -81.88 124.92 30.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 73.0 110.033 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 2.3 mt -117.99 83.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.797 -0.361 . . . . 72.450000000000003 111.669 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.635 ' CG ' HG23 ' A' ' 60' ' ' ILE . 6.2 m-85 -70.12 151.86 44.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.476 -0.564 . . . . 73.299999999999997 109.476 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -166.52 119.81 1.05 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.111 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 19.9 mt-10 -74.51 -10.67 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.783 -0.644 . . . . 74.299999999999997 109.624 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -78.68 110.44 13.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.634 . . . . 75.349999999999994 111.215 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.37 2.15 33.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 72.230000000000004 111.073 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.78 -35.52 4.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.165 -0.471 . . . . 60.310000000000002 111.061 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.86 20.23 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 111.216 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.42 72.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.331 . . . . 74.340000000000003 110.833 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -55.66 -40.82 72.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.688 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.52 -44.74 81.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 74.530000000000001 110.589 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.09 -62.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.704 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.618 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.5 m -55.85 -26.52 47.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 74.349999999999994 111.538 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' LYS . 2.7 t70 -63.64 -59.21 4.9 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.613 0.72 . . . . 72.400000000000006 109.706 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.686 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.9 -31.32 11.96 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.746 1.26 . . . . 64.25 108.742 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -81.47 -17.79 47.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.813 -1.54 . . . . 73.420000000000002 111.964 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.628 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -54.1 -42.77 95.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.944 -0.762 . . . . 63.109999999999999 108.944 178.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.686 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 9.9 Cg_endo -84.44 -39.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.636 2.224 . . . . 74.430000000000007 110.421 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.705 HD13 ' HB ' ' A' ' 106' ' ' ILE . 45.6 mt -50.86 -20.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-N 116.173 -0.467 . . . . 64.109999999999999 109.965 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -113.44 -24.6 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 111.228 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -60.17 -20.46 58.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.17 0.51 . . . . 72.150000000000006 109.899 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.85 -27.1 17.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.791 0.805 . . . . 60.229999999999997 109.24 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -127.73 46.5 2.54 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.345 -1.298 . . . . 74.319999999999993 110.502 -178.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.1 ptt85 -80.0 -30.38 39.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.383 -0.826 . . . . 72.209999999999994 111.109 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.18 11.98 33.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.873 -0.68 . . . . 71.439999999999998 112.379 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 11.3 p -119.8 -35.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.496 0.189 . . . . 75.319999999999993 111.25 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.1 mt -123.46 146.2 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.512 -0.313 . . . . 65.239999999999995 110.696 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.426 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 8.6 m-80 -87.15 85.46 7.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.784 0.326 . . . . 73.319999999999993 110.171 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.6 m-85 -72.46 110.52 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.284 0.564 . . . . 75.340000000000003 111.552 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.92 124.35 2.67 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.304 -0.862 . . . . 71.140000000000001 112.2 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.476 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 80.0 p -83.2 155.82 23.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.029 0.443 . . . . 73.239999999999995 111.315 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.635 HG23 ' CG ' ' A' ' 30' ' ' PHE . 13.3 tt -150.98 163.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 71.430000000000007 110.206 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 60' ' ' ILE . 46.0 t0 -88.78 119.04 28.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.407 -0.361 . . . . 74.299999999999997 111.845 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' A' ' 79' ' ' PHE . . . -82.48 1.04 39.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.548 -0.296 . . . . 43.25 110.975 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.9 ttpt -101.67 -32.43 10.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.435 -0.348 . . . . 73.310000000000002 111.265 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.88 -29.96 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.105 0.478 . . . . 73.030000000000001 110.346 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.449 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -105.25 -15.02 15.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.789 . . . . 74.209999999999994 111.057 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -34.23 -36.61 0.06 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 114.1 0.4 . . . . 64.5 114.1 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.57 -19.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.582 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.41 -10.61 40.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 61.130000000000003 111.042 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -69.58 -51.53 34.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 120.858 0.361 . . . . 62.229999999999997 111.007 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.7 1.99 69.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.915 -1.135 . . . . 71.030000000000001 113.663 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.66 -10.24 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.332 0.566 . . . . 50.32 109.667 177.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' O ' ' CE ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -113.49 -17.21 12.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.631 -0.713 . . . . 64.209999999999994 109.998 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 74' ' ' LEU . 1.1 m-20 -179.85 -68.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.46 0.541 . . . . 55.399999999999999 112.46 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.1 mm? -39.85 168.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.24 -0.891 . . . . 74.439999999999998 112.241 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -110.14 -4.49 15.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.826 -0.625 . . . . 72.329999999999998 111.06 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 p 58.69 36.85 25.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.01 0.433 . . . . 74.420000000000002 110.199 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -84.13 -32.0 24.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 72.340000000000003 110.825 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -148.74 163.19 38.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 64.230000000000004 110.23 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.522 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.45 174.37 3.91 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.897 -0.592 . . . . 73.109999999999999 111.215 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 31.9 Cg_exo -58.01 166.74 15.9 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.792 -1.337 . . . . 63.140000000000001 113.019 0.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 164.82 27.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.051 -0.977 . . . . 75.129999999999995 110.143 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.8 t80 -141.98 133.81 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 74.340000000000003 111.49 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -126.41 116.17 20.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 75.540000000000006 110.949 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 22.9 mt -99.91 90.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 70.340000000000003 110.342 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' LEU . 3.0 tm0? -78.95 144.87 34.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 73.209999999999994 111.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -110.64 111.54 22.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 110.637 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.4 t -82.39 9.43 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.726 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.96 -42.86 5.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.257 -0.428 . . . . 73.150000000000006 110.314 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.9 mmtt -114.15 -12.41 12.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.278 -0.419 . . . . 44.119999999999997 110.912 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 10.5 t-20 79.53 22.83 0.52 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.356 0.598 . . . . 71.239999999999995 109.688 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -82.2 167.74 18.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.158 -0.928 . . . . 71.040000000000006 111.53 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.524 ' H ' HE21 ' A' ' 91' ' ' GLN . 0.9 OUTLIER -139.2 101.06 4.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.381 -0.827 . . . . 75.519999999999996 111.111 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.489 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 76.8 m-85 -103.55 74.33 0.2 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.928 -0.578 . . . . 75.519999999999996 110.899 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 56.5 Cg_endo -80.8 165.29 20.05 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.795 2.33 . . . . 72.109999999999999 113.126 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.411 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 35.7 t80 -95.94 173.29 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.745 -0.661 . . . . 64.049999999999997 110.573 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -75.84 177.95 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 72.030000000000001 110.986 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -112.08 -20.92 11.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.199 -0.455 . . . . 62.530000000000001 111.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.83 24.06 4.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.919 0.39 . . . . 72.430000000000007 111.069 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.495 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -94.4 -11.81 29.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.981 -0.554 . . . . 71.049999999999997 111.191 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.5 tt0 91.02 106.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.9 -0.591 . . . . 74.200000000000003 110.661 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.1 mt -91.73 96.92 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.269 -0.878 . . . . 75.549999999999997 111.495 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -121.63 -164.89 1.18 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.226 -0.657 . . . . 72.030000000000001 109.226 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.573 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -78.22 -71.43 0.43 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.471 -0.566 . . . . 74.200000000000003 109.471 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.556 ' N ' ' CD2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -42.83 -37.72 1.91 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.969 -1.014 . . . . 72.409999999999997 111.645 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -72.68 -35.84 67.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.698 -1.137 . . . . 64.019999999999996 113.202 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.705 ' HB ' HD13 ' A' ' 47' ' ' ILE . 27.8 mm -89.48 -49.07 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.674 -0.491 . . . . 74.420000000000002 109.674 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.605 ' HB3' HG12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.92 -43.91 60.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.803 -0.635 . . . . 71.120000000000005 109.633 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.95 -49.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.679 -0.691 . . . . 73.420000000000002 110.202 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 21.1 t80 -49.15 -64.13 0.9 Allowed 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.699 -0.482 . . . . 74.010000000000005 109.699 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 17.7 m -51.05 -43.09 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 64.200000000000003 109.954 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.2 t0 -50.83 -41.19 57.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.438 0.637 . . . . 40.149999999999999 109.954 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.925 ' OD1' ' N ' ' A' ' 118' ' ' ILE . 3.2 t0 -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.944 -1.025 . . . . 75.319999999999993 108.795 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.611 ' N ' HG13 ' A' ' 118' ' ' ILE . 1.3 t80 -72.6 -67.02 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.191 -0.913 . . . . 73.219999999999999 110.343 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.455 ' N ' ' CD2' ' A' ' 113' ' ' PHE . 17.5 t -49.93 -48.32 22.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.934 . . . . 72.019999999999996 111.491 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.41 -38.77 63.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 74.230000000000004 110.606 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.49 29.98 2.34 Favored Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 110.709 -0.956 . . . . 74.530000000000001 110.709 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.782 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.15 -49.21 3.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.917 -0.641 . . . . 64.420000000000002 111.661 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.925 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 29.1 mt -63.46 146.84 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.762 -0.458 . . . . 70.430000000000007 109.762 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.431 ' N ' HG21 ' A' ' 118' ' ' ILE . 1.4 mt-10 -136.02 171.0 9.53 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 65.140000000000001 110.948 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.497 2.131 . . . . 73.010000000000005 112.319 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.461 -0.256 . . . . 62.399999999999999 112.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.18 152.32 19.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.666 2.244 . . . . 75.209999999999994 112.262 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.41 30.94 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 61.530000000000001 110.898 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.54 -136.07 8.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.771 -0.728 . . . . 51.520000000000003 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.8 m -131.83 145.45 57.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.703 0.287 . . . . 54.5 110.928 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.21 134.55 19.41 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.563 2.176 . . . . 64.329999999999998 112.36 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -146.34 -74.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.887 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 57' ' ' PHE . 83.4 mt -94.93 130.86 43.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.439999999999998 110.915 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.07 -118.47 0.82 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.68 -0.771 . . . . 73.430000000000007 112.2 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.92 136.11 40.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.749 0.309 . . . . 73.310000000000002 110.651 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.696 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 65.3 mt -90.67 128.01 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 71.319999999999993 110.972 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.6 -165.01 12.06 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 74.329999999999998 112.608 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.0 -25.43 14.06 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.647 2.231 . . . . 63.399999999999999 112.534 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.54 1.4 46.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 51.210000000000001 111.504 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.414 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 11.7 p -104.23 -28.94 11.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.843 0.354 . . . . 72.420000000000002 110.744 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.15 -54.54 43.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 72.450000000000003 110.837 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 t -69.03 -23.53 64.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 72.239999999999995 111.5 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.72 -38.71 62.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.084 0.468 . . . . 72.5 110.855 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 22.0 m-85 -80.28 -22.98 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.336 0.588 . . . . 72.349999999999994 109.743 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.408 ' HA ' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.4 -33.24 22.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.287 -0.87 . . . . 60.310000000000002 110.276 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -88.81 -12.97 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 62.32 110.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.69 84.73 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.41 -0.359 . . . . 75.400000000000006 111.078 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.57 20.54 29.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.82 -0.705 . . . . 63.509999999999998 112.676 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 pt -135.38 148.62 66.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 73.340000000000003 111.02 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 55' ' ' ILE . 48.2 Cg_exo -47.07 140.17 14.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.533 2.155 . . . . 52.020000000000003 112.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 28' ' ' TYR . 2.4 tt -102.5 123.19 45.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 71.5 110.645 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.62 93.32 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.878 -0.601 . . . . 55.439999999999998 111.282 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.44 ' CE1' HD11 ' A' ' 11' ' ' ILE . 63.5 m-85 -81.98 140.17 34.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.835 -0.621 . . . . 73.0 110.485 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 2.5 mp -132.3 85.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.467 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.628 ' CG ' HG23 ' A' ' 60' ' ' ILE . 3.8 m-85 -73.08 148.6 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.671 -0.492 . . . . 73.299999999999997 109.671 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -162.95 119.84 1.9 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.118 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.87 -9.46 58.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.583 -0.735 . . . . 74.299999999999997 110.116 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -99.97 99.89 10.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.479 . . . . 75.349999999999994 111.129 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.82 12.22 22.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 72.230000000000004 111.226 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 -45.32 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.435 -0.348 . . . . 60.310000000000002 110.833 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.39 13.88 26.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.369 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -40.77 -31.54 0.17 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.529 -0.305 . . . . 74.340000000000003 111.77 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.37 85.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 62.439999999999998 111.197 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -57.31 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 74.530000000000001 111.242 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.3 -56.38 22.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.106 0.479 . . . . 71.019999999999996 110.854 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 10.3 m -58.11 -22.44 50.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.764 . . . . 74.349999999999994 112.14 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -70.18 -61.29 1.83 Allowed 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.636 0.731 . . . . 72.400000000000006 109.233 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.55 -29.41 16.93 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 122.884 1.326 . . . . 64.25 108.707 177.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 24.2 mt -77.96 -25.05 47.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.435 -1.711 . . . . 73.420000000000002 111.346 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.32 -45.87 89.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.435 -0.802 . . . . 63.109999999999999 109.835 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.624 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.2 Cg_endo -82.3 -38.7 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.516 2.144 . . . . 74.430000000000007 110.646 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 44' ' ' LEU . 57.0 mt -51.24 -21.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 116.086 -0.506 . . . . 64.109999999999999 110.48 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -112.75 -25.84 8.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 71.120000000000005 111.249 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -61.56 -19.44 62.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.215 0.531 . . . . 72.150000000000006 109.841 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.6 -27.69 17.99 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.394 -0.821 . . . . 60.229999999999997 109.461 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.639 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.2 pt20 -124.49 41.01 3.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.405 -1.27 . . . . 74.319999999999993 110.621 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptt85 -70.85 -32.79 69.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.465 -0.788 . . . . 72.209999999999994 111.06 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.47 12.22 39.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 71.439999999999998 112.738 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 14.9 p -125.67 -27.82 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.777 0.288 . . . . 75.319999999999993 111.777 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 25' ' ' PRO . 70.0 mt -133.18 140.57 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.574 0.226 . . . . 65.239999999999995 110.636 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -90.94 97.22 11.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.789 0.328 . . . . 73.319999999999993 111.012 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CD2' ' CD1' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -77.85 113.64 15.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 75.340000000000003 111.515 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.696 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -135.9 126.73 3.99 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.549 -0.75 . . . . 71.140000000000001 112.131 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.411 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 11.5 p -86.1 148.02 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 111.068 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.628 HG23 ' CG ' ' A' ' 30' ' ' PHE . 12.0 tt -145.7 163.47 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 71.430000000000007 110.653 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.9 t0 -87.05 119.79 27.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 74.299999999999997 112.014 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . . . -83.43 2.15 38.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.702 0.287 . . . . 43.25 110.903 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 18.3 tptm -102.1 -33.04 9.84 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.47 -0.332 . . . . 73.310000000000002 111.7 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 -31.98 6.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.172 0.511 . . . . 73.030000000000001 110.457 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.35 -16.06 17.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 74.209999999999994 111.07 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.96 -38.88 0.03 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 114.441 0.537 . . . . 64.5 114.441 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -52.62 -25.86 11.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.279 0.54 . . . . 74.019999999999996 110.379 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -85.78 -12.5 50.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 61.130000000000003 111.546 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.51 ' N ' ' CE2' ' A' ' 30' ' ' PHE . . . -69.89 -42.19 73.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.685 0.278 . . . . 62.229999999999997 111.269 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.06 0.17 47.89 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.084 -1.055 . . . . 71.030000000000001 113.489 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -60.0 -11.02 4.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.376 -0.601 . . . . 50.32 109.376 177.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.65 -16.01 12.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.396 -0.82 . . . . 64.209999999999994 110.441 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.513 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -177.7 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.074 0.464 . . . . 55.399999999999999 112.228 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.505 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 87.9 mt -41.43 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.405 -0.816 . . . . 74.439999999999998 112.557 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -118.85 4.48 11.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.276 -0.875 . . . . 72.329999999999998 110.467 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p 58.21 32.61 22.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.516 . . . . 74.420000000000002 110.715 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 16.0 p-10 -82.17 -31.41 30.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.327 -0.397 . . . . 72.340000000000003 111.384 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 7.2 tttt -147.61 161.61 40.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 64.230000000000004 111.256 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -157.39 170.2 9.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.544 -0.753 . . . . 73.109999999999999 111.258 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.643 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.76 160.0 44.9 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 123.538 -1.443 . . . . 63.140000000000001 113.237 0.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.32 165.59 20.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.198 -0.91 . . . . 75.129999999999995 110.006 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 5.3 t80 -139.23 128.37 23.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.797 0.332 . . . . 74.340000000000003 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . . . -120.33 145.93 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 75.540000000000006 111.702 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 57.7 mt -123.26 86.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 70.340000000000003 110.082 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.84 125.96 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 73.209999999999994 111.187 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' A' ' 93' ' ' PHE . 9.8 mp0 -95.32 117.69 30.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.841 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 20' ' ' MET . 35.1 m -84.54 4.92 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.009 -0.541 . . . . 71.319999999999993 111.328 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.37 -41.64 5.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 73.150000000000006 110.793 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -15.32 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 44.119999999999997 110.957 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 78.08 32.68 0.36 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.527 0.68 . . . . 71.239999999999995 109.559 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -95.14 166.57 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 71.040000000000006 111.254 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 6.8 mmtm -142.6 97.14 3.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.553 -0.749 . . . . 75.519999999999996 110.92 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 17.2 m-85 -102.63 75.6 0.19 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 75.519999999999996 111.002 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 84.7 Cg_endo -78.35 -176.13 3.09 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 72.109999999999999 112.638 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -107.08 169.97 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 64.049999999999997 110.789 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.32 160.02 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 72.030000000000001 111.179 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 4.1 mp0 -117.47 26.86 9.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 62.530000000000001 110.902 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -157.63 23.64 0.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 72.430000000000007 110.602 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -113.32 -68.13 0.95 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.845 -0.616 . . . . 71.049999999999997 110.954 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 1.7 tt0 159.86 118.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.902 -0.59 . . . . 74.200000000000003 109.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.23 89.2 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 75.549999999999997 111.584 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.452 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -117.14 -155.94 0.61 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.809 -0.812 . . . . 72.030000000000001 108.809 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.88 -73.65 0.51 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.755 -0.831 . . . . 74.200000000000003 108.755 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.605 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.51 -34.16 0.21 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.86 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.03 61.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 64.019999999999996 112.432 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.617 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 41.0 mm -88.14 -47.91 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.757 -0.46 . . . . 74.420000000000002 109.757 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -54.44 -45.37 73.06 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 109.695 178.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -69.8 -48.0 60.75 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 110.156 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.577 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 18.4 t80 -52.38 -67.08 0.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 74.010000000000005 110.077 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 19.3 m -47.67 -40.14 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 64.200000000000003 109.966 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -56.96 -42.34 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.381 -0.827 . . . . 40.149999999999999 110.215 178.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.746 ' OD2' HG12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -74.65 -14.58 60.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.652 -0.703 . . . . 75.319999999999993 110.014 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -81.04 -61.29 2.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.558 -0.746 . . . . 73.219999999999999 108.997 178.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.477 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 21.9 t -55.77 -46.41 79.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.658 -1.155 . . . . 72.019999999999996 110.879 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.94 64.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 74.230000000000004 110.782 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.96 30.29 1.65 Allowed Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.578 -0.82 . . . . 74.530000000000001 111.663 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -101.81 -38.65 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.397 -0.402 . . . . 64.420000000000002 111.417 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.746 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -85.75 151.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.897 0.38 . . . . 70.430000000000007 110.628 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -145.15 173.94 3.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.947 -0.57 . . . . 65.140000000000001 111.274 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -50.97 145.08 25.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.598 2.198 . . . . 73.010000000000005 112.36 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.8 t -110.05 -43.67 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 111.044 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -31.3 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 111.177 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 111.531 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.82 100.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 73.040000000000006 110.703 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -150.36 87.86 4.81 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 72.430000000000007 110.376 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 160.92 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.522 2.148 . . . . 54.229999999999997 112.566 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.8 mm -114.25 88.15 14.7 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 72.109999999999999 111.307 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 129' ' ' GLU . 53.1 Cg_exo -54.9 -158.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.89 2.393 . . . . 63.509999999999998 112.384 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER 79.27 -165.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 71.140000000000001 110.84 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -46.3 -26.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 74.349999999999994 111.761 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -91.12 160.22 15.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.645 . . . . 73.209999999999994 110.67 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 58.94 164.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 63.450000000000003 110.872 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.34 -1.256 . . . . 73.109999999999999 112.493 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.453 -0.259 . . . . 62.399999999999999 112.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.93 -61.59 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.58 2.187 . . . . 75.209999999999994 112.343 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp -151.78 -65.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 61.530000000000001 110.885 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.41 -92.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 51.520000000000003 112.471 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 1.2 m -179.12 -61.29 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.639 0.257 . . . . 54.5 110.926 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 5' ' ' SER . 58.6 Cg_endo -71.82 105.19 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.46 2.106 . . . . 64.329999999999998 112.298 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.59 -60.1 2.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 63.43 110.957 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 55.8 mt -95.98 126.36 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 74.439999999999998 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.16 -123.67 0.81 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.03 -1.081 . . . . 73.430000000000007 113.16 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.97 130.79 56.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.383 . . . . 73.310000000000002 110.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.709 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 30.2 mt -85.99 141.02 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 71.319999999999993 111.39 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.8 -178.1 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 74.329999999999998 112.416 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.44 -6.34 18.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.617 2.212 . . . . 63.399999999999999 112.71 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.59 28.62 3.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.795 0.331 . . . . 51.210000000000001 111.1 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.9 p -124.83 -38.98 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 72.420000000000002 110.939 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' SER . 17.0 p90 -52.61 -32.31 40.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 72.450000000000003 111.177 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.449 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m -53.98 -25.95 23.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.8 -38.54 18.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.02 0.438 . . . . 72.5 110.635 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 26.5 m-85 -78.08 -6.26 54.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 72.349999999999994 109.898 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.407 ' HA ' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.62 -54.42 3.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 60.310000000000002 110.045 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -17.35 64.23 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.85 -0.614 . . . . 62.32 110.919 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.74 -31.78 58.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.901 0.382 . . . . 75.400000000000006 111.021 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.38 5.99 64.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.935 -0.65 . . . . 63.509999999999998 112.596 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.62 156.41 53.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 73.340000000000003 110.989 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.95 142.74 96.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 52.020000000000003 112.594 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' CD2' ' A' ' 28' ' ' TYR . 3.2 tt -103.34 137.62 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 71.5 110.808 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.15 97.13 6.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.106 -0.497 . . . . 55.439999999999998 111.112 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.433 ' CD2' HD21 ' A' ' 26' ' ' LEU . 40.4 m-85 -85.99 127.47 34.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 73.0 109.985 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 44' ' ' LEU . 2.5 mt -121.51 83.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.13 0.419 . . . . 72.450000000000003 112.13 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.628 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.8 m-85 -71.96 144.43 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.959 -0.756 . . . . 73.299999999999997 108.959 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -155.1 117.37 4.21 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.430000000000007 111.082 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -80.17 -6.34 57.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.298 -0.865 . . . . 74.299999999999997 110.163 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.9 p -84.7 104.87 15.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 75.349999999999994 111.059 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.4 16.78 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 72.230000000000004 111.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -123.61 -42.05 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 60.310000000000002 110.778 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' ARG . 2.8 pt-20 -99.7 -8.85 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 71.430000000000007 111.574 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 36' ' ' GLU . 1.6 ptp180 -31.31 -40.47 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.366 0.506 . . . . 74.340000000000003 112.366 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -54.51 -51.5 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.965 0.412 . . . . 62.439999999999998 110.844 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.6 mt-10 -60.18 -36.75 78.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 110.963 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -63.52 -50.59 68.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 71.019999999999996 110.779 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 51.1 m -65.17 -22.51 66.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 74.349999999999994 111.242 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 45' ' ' LYS . 3.7 t70 -66.81 -61.2 2.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.582 0.706 . . . . 72.400000000000006 109.105 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.671 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -50.05 -31.69 13.65 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.662 1.22 . . . . 64.25 108.991 177.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.636 ' HB3' ' HE2' ' A' ' 57' ' ' PHE . 22.2 mt -76.48 -25.61 54.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.378 -1.737 . . . . 73.420000000000002 111.475 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 9.7 ttmm -51.6 -45.65 91.11 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.395 -0.82 . . . . 63.109999999999999 110.375 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 15.5 Cg_endo -83.76 -40.1 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.713 2.275 . . . . 74.430000000000007 111.649 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -54.92 -18.65 3.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.984 -0.686 . . . . 64.109999999999999 109.87 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.654 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -107.29 -30.82 8.5 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.813 -0.631 . . . . 71.120000000000005 111.213 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -60.83 -19.8 60.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.237 0.541 . . . . 72.150000000000006 109.888 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.2 -26.79 24.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.916 0.865 . . . . 60.229999999999997 109.029 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.654 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.7 pt20 -125.78 38.44 4.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.029 -1.441 . . . . 74.319999999999993 110.217 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -75.35 -25.21 57.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.446 -0.797 . . . . 72.209999999999994 110.992 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.78 20.16 20.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.811 -0.709 . . . . 71.439999999999998 112.137 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -133.78 -37.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.65 0.262 . . . . 75.319999999999993 111.262 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 ' CD1' ' NE2' ' A' ' 51' ' ' GLN . 43.6 mt -120.93 138.79 50.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 65.239999999999995 110.863 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -82.85 109.09 16.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.858 0.361 . . . . 73.319999999999993 110.324 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.636 ' HE2' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -80.94 119.86 24.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.644 0.735 . . . . 75.340000000000003 112.843 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.709 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -146.24 122.98 1.74 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.907 -1.042 . . . . 71.140000000000001 111.911 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -89.81 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 73.239999999999995 111.059 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.628 HG23 ' CG ' ' A' ' 30' ' ' PHE . 14.0 tt -141.9 164.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.430000000000007 110.699 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' N ' HG12 ' A' ' 60' ' ' ILE . 35.8 t0 -90.34 122.84 33.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 111.888 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . . . -85.49 6.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.71 0.291 . . . . 43.25 110.711 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 22.5 tptp -106.31 -32.82 7.99 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.349 -0.387 . . . . 73.310000000000002 111.559 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.38 -31.21 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.148 0.499 . . . . 73.030000000000001 110.731 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.77 -12.97 17.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.543 -0.753 . . . . 74.209999999999994 111.311 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -35.39 -33.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 N-CA-C 114.027 0.371 . . . . 64.5 114.027 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -12.21 4.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.061 0.458 . . . . 74.019999999999996 110.617 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -102.59 -6.79 22.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.66 -0.7 . . . . 61.130000000000003 110.971 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -71.1 -54.99 9.18 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.763 0.316 . . . . 62.229999999999997 110.963 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.39 7.5 75.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.916 -1.135 . . . . 71.030000000000001 113.738 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -8.74 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.02 -0.733 . . . . 50.32 109.02 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -114.2 -14.82 12.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.228 -0.896 . . . . 64.209999999999994 110.335 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.91 -69.91 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.261 0.553 . . . . 55.399999999999999 112.298 -178.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.506 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.2 mm? -40.31 170.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.092 -0.958 . . . . 74.439999999999998 112.419 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -110.01 -6.24 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 72.329999999999998 111.046 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 p 61.75 40.19 13.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.609 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.77 -33.01 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 72.340000000000003 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -149.51 163.25 38.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.111 -0.495 . . . . 64.230000000000004 110.427 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -153.34 177.45 1.96 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 73.109999999999999 111.126 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 35.0 Cg_exo -57.54 158.22 29.27 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.022 -1.241 . . . . 63.140000000000001 112.781 1.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.4 128.87 46.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.234 -0.894 . . . . 75.129999999999995 110.226 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 95' ' ' PHE . 49.5 t80 -108.65 117.83 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.654 -0.248 . . . . 74.340000000000003 110.437 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.18 132.85 56.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.35 0.5 . . . . 75.540000000000006 112.35 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 25.6 mm -100.88 140.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 70.340000000000003 109.973 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -128.24 129.52 46.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.985 0.421 . . . . 73.209999999999994 110.842 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.08 112.72 25.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 74.420000000000002 110.198 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 20' ' ' MET . 35.1 m -78.86 -0.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 111.708 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.73 -44.33 6.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 73.150000000000006 110.692 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.84 -7.23 14.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 44.119999999999997 111.413 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 68.96 24.87 6.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.09 0.471 . . . . 71.239999999999995 110.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -75.37 169.51 17.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.731 -0.668 . . . . 71.040000000000006 111.541 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.636 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 1.3 mptt -139.94 95.37 2.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 75.519999999999996 110.756 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 68.1 m-85 -103.52 71.41 0.15 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 75.519999999999996 111.277 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 67.4 Cg_endo -79.12 -175.5 2.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.667 2.245 . . . . 72.109999999999999 113.608 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 82' ' ' PHE . 25.0 t80 -112.02 175.16 5.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 64.049999999999997 110.578 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 3.0 m-20 -78.76 174.98 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 72.030000000000001 110.882 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -114.64 -11.99 12.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 62.530000000000001 111.297 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.63 5.25 5.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 72.430000000000007 111.041 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 1.8 tppt? -86.17 -6.05 59.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.097 -0.501 . . . . 71.049999999999997 111.294 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 32.6 tt0 81.9 132.22 0.05 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.174 0.512 . . . . 74.200000000000003 111.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.0 mp -109.02 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.41 -148.17 0.43 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 72.030000000000001 109.095 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.615 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -96.66 -70.81 0.7 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.97 -0.752 . . . . 74.200000000000003 108.97 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.594 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.11 -31.54 1.44 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.811 -0.631 . . . . 72.409999999999997 111.374 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -74.96 -33.0 61.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.688 -0.687 . . . . 64.019999999999996 111.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 102' ' ' THR . 44.2 mm -91.22 -45.71 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.39 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.594 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -60.0 -42.22 93.76 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 109.414 178.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.22 -50.73 29.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.244 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 40.6 t80 -51.72 -63.77 1.03 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.467 -0.333 . . . . 74.010000000000005 110.261 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.5 m -49.14 -44.15 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 64.200000000000003 110.042 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -54.45 -40.67 68.61 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.783 0.802 . . . . 40.149999999999999 109.009 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.9 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 16.4 t70 -61.53 -34.86 76.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.326 -1.306 . . . . 75.319999999999993 108.336 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 110' ' ' VAL . 0.7 OUTLIER -72.86 -66.86 0.61 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 73.219999999999999 110.902 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 113' ' ' PHE . 10.8 t -54.85 -45.21 74.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.22 -0.9 . . . . 72.019999999999996 111.994 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.44 70.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.856 0.36 . . . . 74.230000000000004 111.154 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.68 31.3 1.82 Allowed Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.06 -0.816 . . . . 74.530000000000001 111.06 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.9 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.43 -57.12 2.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.878 -0.661 . . . . 64.420000000000002 111.505 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.521 HG13 ' C ' ' A' ' 112' ' ' ASP . 44.7 mt -64.27 151.1 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.789 -0.448 . . . . 70.430000000000007 109.789 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.32 163.96 36.25 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.357 -0.383 . . . . 65.140000000000001 111.542 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.83 155.07 71.2 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.815 2.344 . . . . 73.010000000000005 112.519 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.37 -71.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.997 -0.547 . . . . 64.439999999999998 110.676 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.468 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -106.69 -44.07 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.420000000000002 111.014 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER 33.89 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.913 -0.585 . . . . 74.450000000000003 112.201 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -85.35 72.42 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 73.040000000000006 110.759 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -148.41 86.33 5.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 72.430000000000007 110.45 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.61 153.39 23.35 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.556 2.17 . . . . 54.229999999999997 112.517 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.17 83.38 24.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.956 -0.566 . . . . 72.109999999999999 111.003 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.95 -169.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.569 2.179 . . . . 63.509999999999998 112.039 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 60.38 69.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 71.140000000000001 110.604 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 154.03 8.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 74.349999999999994 111.18 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.32 176.35 3.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.514 . . . . 73.209999999999994 110.811 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -109.61 -45.31 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 63.450000000000003 110.95 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.308 -1.274 . . . . 73.109999999999999 112.553 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.456 -0.257 . . . . 62.399999999999999 112.456 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.48 161.85 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.586 2.191 . . . . 75.209999999999994 112.359 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.69 -70.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 61.530000000000001 110.94 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -151.74 17.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 51.520000000000003 112.563 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -103.81 93.78 5.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 54.5 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.39 161.28 45.52 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.519 2.146 . . . . 64.329999999999998 112.388 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 5.7 mp -117.02 -49.18 2.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.845 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.581 ' HB ' ' CB ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -72.36 154.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 74.439999999999998 110.949 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.39 -71.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.413 -0.898 . . . . 73.430000000000007 112.242 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -124.49 134.88 52.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.545 -0.328 . . . . 73.310000000000002 110.256 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.523 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 1.8 mt -88.7 140.0 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.766 0.317 . . . . 71.319999999999993 111.019 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.12 172.68 23.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 74.329999999999998 112.42 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.57 -20.54 57.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.692 2.261 . . . . 63.399999999999999 112.436 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.06 28.58 8.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.379 . . . . 51.210000000000001 110.859 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.438 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 6.9 p -131.21 -39.46 1.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 111.048 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 11' ' ' ILE . 17.6 m-85 -45.18 -63.57 0.91 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.056 0.455 . . . . 72.450000000000003 111.383 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -51.53 -34.44 36.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.797 -0.638 . . . . 72.239999999999995 111.422 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -70.86 -39.12 73.08 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.147 0.499 . . . . 72.5 110.725 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 15' ' ' THR . 18.0 m-85 -77.39 -9.19 58.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.634 . . . . 72.349999999999994 109.678 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -30.48 11.97 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.47 -0.787 . . . . 60.310000000000002 110.131 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -83.36 -17.93 40.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.685 -0.689 . . . . 62.32 110.572 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.7 -14.21 41.43 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.275 -0.42 . . . . 75.400000000000006 111.602 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.93 14.12 65.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 63.509999999999998 112.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.99 158.79 59.13 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.246 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HG2' HG12 ' A' ' 55' ' ' ILE . 26.7 Cg_endo -62.38 138.15 69.5 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 52.020000000000003 112.758 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 28' ' ' TYR . 1.5 tt -93.12 136.41 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.833 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.95 89.43 3.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 55.439999999999998 111.001 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' CE1' ' CD2' ' A' ' 26' ' ' LEU . 70.0 m-85 -81.19 136.6 35.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 73.0 110.404 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -131.53 89.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.855 0.359 . . . . 72.450000000000003 111.518 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.599 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.1 m-85 -70.88 149.18 47.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.303 -0.629 . . . . 73.299999999999997 109.303 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.73 119.07 2.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.233 0.54 . . . . 72.430000000000007 111.269 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' HG3' ' HB1' ' A' ' 62' ' ' ALA . 20.9 mt-10 -76.0 -7.23 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 74.299999999999997 109.972 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.6 p -76.53 123.44 26.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.209 -0.451 . . . . 75.349999999999994 110.848 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.12 9.52 18.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 72.230000000000004 111.087 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -50.43 2.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.404 -0.362 . . . . 60.310000000000002 110.735 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.69 15.04 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 111.196 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -49.1 -28.45 4.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 111.104 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.32 73.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 62.439999999999998 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 2.2 mm-40 -61.45 -48.91 79.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.736 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -58.45 -47.34 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 71.019999999999996 110.652 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 67.0 m -67.17 -20.69 65.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.349999999999994 111.218 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 15.6 t0 -67.68 -60.6 2.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 72.400000000000006 108.946 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.676 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.48 -33.64 9.76 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.65 1.214 . . . . 64.25 108.633 177.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HA ' HD13 ' A' ' 47' ' ' ILE . 25.9 mt -75.22 -25.95 58.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.317 -1.765 . . . . 73.420000000000002 112.188 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 3.4 mmpt? -51.44 -45.47 90.32 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 63.109999999999999 110.285 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.6 Cg_endo -83.26 -38.54 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.546 2.164 . . . . 74.430000000000007 111.13 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.681 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 24.0 mt -53.85 -17.35 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-N 116.367 -0.379 . . . . 64.109999999999999 110.14 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -114.98 -25.34 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.52 . . . . 71.120000000000005 111.151 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -64.91 -18.94 65.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.939 0.4 . . . . 72.150000000000006 110.669 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . . . -93.67 -9.95 36.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.81 . . . . 60.229999999999997 109.377 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.488 ' CG ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -136.67 27.62 3.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.221 -1.354 . . . . 74.319999999999993 110.885 -176.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.5 ptt180 -61.4 -33.24 73.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.586 -0.734 . . . . 72.209999999999994 111.156 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.33 9.02 45.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.811 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 51' ' ' GLN . 10.3 p -122.35 -29.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.78 0.29 . . . . 75.319999999999993 111.609 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG12 ' HG2' ' A' ' 25' ' ' PRO . 79.7 mt -131.87 141.35 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 65.239999999999995 110.807 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.409 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -94.61 94.83 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 73.319999999999993 110.063 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CB ' ' HB ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -69.23 134.76 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 75.340000000000003 111.641 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.523 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -153.87 113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.787 -1.097 . . . . 71.140000000000001 111.86 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.3 p -80.87 150.14 29.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 73.239999999999995 110.316 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.599 HG23 ' CG ' ' A' ' 30' ' ' PHE . 11.2 tt -147.4 163.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.105 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 60' ' ' ILE . 45.0 t0 -84.01 119.78 25.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.123 -0.49 . . . . 74.299999999999997 111.909 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' HB1' ' CG ' ' A' ' 79' ' ' PHE . . . -85.02 6.0 27.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.696 0.284 . . . . 43.25 110.859 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -106.25 -31.88 8.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.548 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.95 -32.27 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 73.030000000000001 110.638 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CG ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.95 -12.4 18.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.518 -0.764 . . . . 74.209999999999994 111.404 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -33.57 -36.54 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.208 0.443 . . . . 64.5 114.208 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.17 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 74.019999999999996 110.448 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -89.21 -11.63 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.482 -0.781 . . . . 61.130000000000003 111.461 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' N ' ' CE2' ' A' ' 30' ' ' PHE . . . -73.65 -44.12 57.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 111.76 0.281 . . . . 62.229999999999997 111.76 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' A' ' 74' ' ' LEU . . . -103.4 1.39 46.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.991 -1.099 . . . . 71.030000000000001 113.752 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -8.81 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.187 -0.671 . . . . 50.32 109.187 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -114.65 -15.81 11.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.325 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.504 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.36 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.155 0.502 . . . . 55.399999999999999 112.022 -178.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HB2' ' CA ' ' A' ' 70' ' ' GLY . 74.9 mt -44.88 178.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.275 -0.875 . . . . 74.439999999999998 112.168 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 5.25 8.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.61 -0.723 . . . . 72.329999999999998 110.597 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 p 59.06 36.86 24.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.694 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.75 -36.49 15.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 111.27 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 0.2 OUTLIER -137.31 161.18 36.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.123 0.487 . . . . 64.230000000000004 110.746 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CG ' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -159.44 169.04 11.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.738 -0.665 . . . . 73.109999999999999 111.607 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.613 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.8 161.87 40.47 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.395 -1.502 . . . . 63.140000000000001 113.12 0.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.12 161.17 29.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.478 -0.783 . . . . 75.129999999999995 110.038 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.4 t80 -132.3 123.39 26.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.67 0.272 . . . . 74.340000000000003 111.198 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.34 111.85 17.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 75.540000000000006 111.738 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 93' ' ' PHE . 6.8 mt -100.78 96.84 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.729 0.3 . . . . 70.340000000000003 110.822 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -89.6 147.8 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.474 -0.33 . . . . 73.209999999999994 110.584 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -106.69 114.15 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 74.420000000000002 110.851 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.8 0.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 110.968 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.46 -42.62 8.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.4 -0.364 . . . . 73.150000000000006 110.914 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.55 -7.88 10.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.487 -0.324 . . . . 44.119999999999997 111.454 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.53 62.19 0.21 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.413 -0.588 . . . . 71.239999999999995 109.413 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.468 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 1.3 tp60 -114.15 173.74 6.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.33 -0.85 . . . . 71.040000000000006 111.575 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -137.27 92.53 2.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.416 -0.811 . . . . 75.519999999999996 110.807 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 93.1 m-85 -104.77 68.7 0.16 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.638 -0.71 . . . . 75.519999999999996 111.314 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 76.5 Cg_endo -78.93 -175.58 2.83 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.263 1.975 . . . . 72.109999999999999 112.589 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -109.37 170.4 8.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.049999999999997 111.104 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.37 170.48 16.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 72.030000000000001 110.991 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 7.2 mt-30 -119.83 27.29 8.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 62.530000000000001 110.746 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.12 26.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.501 . . . . 72.430000000000007 110.662 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -112.0 0.05 15.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.996 -0.547 . . . . 71.049999999999997 111.668 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 78.31 98.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 74.200000000000003 110.325 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 5.8 mt -80.01 97.71 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 75.549999999999997 111.59 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -120.51 -151.34 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.707 -0.849 . . . . 72.030000000000001 108.707 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.59 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.43 -66.93 0.89 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.925 -0.768 . . . . 74.200000000000003 108.925 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.603 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.02 -39.0 5.24 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.669 -0.696 . . . . 72.409999999999997 111.752 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 64.019999999999996 112.28 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.681 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 50.1 mm -91.31 -48.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 74.420000000000002 110.235 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.603 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -57.09 -42.21 80.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.962 -0.755 . . . . 71.120000000000005 108.962 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.52 -51.06 31.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.038 -0.528 . . . . 73.420000000000002 110.036 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.556 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 67.5 t80 -50.4 -63.21 1.19 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 116.369 -0.378 . . . . 74.010000000000005 110.094 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 3.9 m -50.05 -41.97 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 64.200000000000003 109.494 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.1 t0 -53.61 -37.76 63.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.793 0.806 . . . . 40.149999999999999 108.959 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.3 t70 -66.84 -34.79 78.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.309 -1.314 . . . . 75.319999999999993 108.413 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.463 ' CB ' HD11 ' A' ' 118' ' ' ILE . 1.1 t80 -71.73 -68.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.244 -0.889 . . . . 73.219999999999999 110.984 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 113' ' ' PHE . 15.3 t -51.72 -46.86 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.268 -0.878 . . . . 72.019999999999996 111.996 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.66 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.230000000000004 111.018 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.56 31.01 2.06 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.575 -1.01 . . . . 74.530000000000001 110.575 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.886 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -102.92 -52.0 3.15 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.716 -0.742 . . . . 64.420000000000002 111.619 -178.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.543 HG13 ' C ' ' A' ' 112' ' ' ASP . 57.7 mt -65.75 153.05 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.49 -0.559 . . . . 70.430000000000007 109.49 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' N ' HG22 ' A' ' 118' ' ' ILE . 1.3 mt-10 -137.25 152.66 73.89 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 111.199 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 137.66 32.23 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.542 2.161 . . . . 73.010000000000005 112.552 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.3 m -102.72 -117.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.519 . . . . 64.439999999999998 110.525 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.2 pt -51.35 166.43 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 72.420000000000002 111.25 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.64 -171.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 74.450000000000003 110.564 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.81 62.19 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 73.040000000000006 110.955 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -149.01 85.06 6.08 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 72.430000000000007 110.595 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.81 153.02 19.59 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.49 2.127 . . . . 54.229999999999997 112.473 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.9 tt -149.38 79.45 8.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 72.109999999999999 111.097 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 171.4 16.94 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.525 2.15 . . . . 63.509999999999998 112.369 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.51 125.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.998 -0.546 . . . . 71.140000000000001 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -117.17 18.46 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 74.349999999999994 111.129 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.96 168.61 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 73.209999999999994 110.957 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -177.85 -72.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 63.450000000000003 110.861 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.427 -1.207 . . . . 73.109999999999999 112.452 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.533 -0.227 . . . . 62.399999999999999 112.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.09 -40.53 4.71 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.642 2.228 . . . . 75.209999999999994 112.262 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.39 -58.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 61.530000000000001 110.869 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.5 -170.25 28.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 51.520000000000003 112.517 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -118.61 63.01 5.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 54.5 110.794 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.83 -26.18 22.84 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.575 2.183 . . . . 64.329999999999998 112.457 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.86 -61.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 63.43 111.005 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 57' ' ' PHE . 46.4 mt -81.62 119.7 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 74.439999999999998 111.193 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.45 -127.32 1.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.206 -0.997 . . . . 73.430000000000007 112.355 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.46 138.52 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.189 -0.3 . . . . 73.310000000000002 110.189 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.576 HG12 ' HA3' ' A' ' 58' ' ' GLY . 6.1 mt -91.79 129.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.917 0.389 . . . . 71.319999999999993 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.89 -164.29 11.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.84 -0.695 . . . . 74.329999999999998 112.42 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.4 -0.51 10.77 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.641 2.227 . . . . 63.399999999999999 112.933 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -124.79 7.46 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.559 0.219 . . . . 51.210000000000001 111.492 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 19' ' ' TYR . 15.5 p -112.31 -27.57 8.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 72.420000000000002 110.99 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -53.35 -60.7 2.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 111.202 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -56.45 -26.61 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 72.239999999999995 111.695 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.99 -43.69 61.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.013 0.435 . . . . 72.5 111.047 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 15' ' ' THR . 9.5 m-85 -78.97 -27.14 43.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.303 0.573 . . . . 72.349999999999994 109.718 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -29.82 38.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.127 -0.942 . . . . 60.310000000000002 110.473 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -98.14 -6.51 31.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.912 -0.586 . . . . 62.32 110.624 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.39 71.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.883 0.373 . . . . 75.400000000000006 111.015 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.74 54.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 63.509999999999998 112.602 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.12 156.54 76.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.706 0.289 . . . . 73.340000000000003 110.975 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 142.17 88.07 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.813 2.342 . . . . 52.020000000000003 112.874 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 28' ' ' TYR . 2.1 tt -99.53 133.08 44.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 71.5 110.776 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.88 86.89 2.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 55.439999999999998 111.061 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.445 ' CE1' HD12 ' A' ' 11' ' ' ILE . 64.0 m-85 -75.06 141.03 43.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.606 -0.724 . . . . 73.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.505 HG12 ' CE2' ' A' ' 82' ' ' PHE . 1.9 mp -133.99 85.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.532 -0.303 . . . . 72.450000000000003 111.395 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.641 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.7 m-85 -72.15 145.42 48.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.758 -0.46 . . . . 73.299999999999997 109.758 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.74 117.3 3.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.153 0.502 . . . . 72.430000000000007 110.9 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 9.4 mt-10 -71.05 -12.43 61.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 74.299999999999997 110.396 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.26 97.54 7.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 111.218 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.94 5.9 41.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.726 -0.67 . . . . 72.230000000000004 110.986 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.72 -52.55 4.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.91 0.386 . . . . 60.310000000000002 110.508 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 13.22 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 71.430000000000007 111.108 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -46.55 -28.09 1.32 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.466 -0.334 . . . . 74.340000000000003 111.375 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.75 -45.61 78.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 110.764 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -66.73 -44.25 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.856 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.89 -57.12 12.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 110.817 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 20.4 m -63.33 -21.32 66.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.407 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 9.6 t70 -66.08 -65.39 0.68 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.546 0.688 . . . . 72.400000000000006 109.488 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.65 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.39 -31.82 6.72 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.653 1.216 . . . . 64.25 108.991 177.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 35.7 mt -77.53 -23.17 50.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.368 -1.742 . . . . 73.420000000000002 112.369 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 20.7 mttt -55.53 -43.62 99.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 63.109999999999999 110.152 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 23.9 Cg_endo -83.86 -41.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.648 2.232 . . . . 74.430000000000007 111.822 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -53.23 -22.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 C-N-CA 119.983 -0.687 . . . . 64.109999999999999 109.721 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -106.07 -27.66 10.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.549 -0.751 . . . . 71.120000000000005 111.211 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.1 tm-20 -59.43 -22.4 61.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.256 0.551 . . . . 72.150000000000006 109.921 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.43 29.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.303 -0.862 . . . . 60.229999999999997 109.464 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.644 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.8 pt20 -126.88 40.47 3.71 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.385 -1.28 . . . . 74.319999999999993 110.995 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptm180 -73.45 -32.25 64.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.662 . . . . 72.209999999999994 111.282 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.69 6.18 48.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 71.439999999999998 112.849 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 12.4 p -116.84 -31.94 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 75.319999999999993 111.259 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.406 HD13 ' NE2' ' A' ' 51' ' ' GLN . 28.4 mt -128.46 144.72 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 110.691 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.19 104.74 16.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.559 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.545 ' HE2' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -73.9 132.88 42.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.354 0.597 . . . . 75.340000000000003 112.065 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.576 ' HA3' HG12 ' A' ' 11' ' ' ILE . . . -155.71 108.26 0.36 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.196 -0.911 . . . . 71.140000000000001 112.509 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 22.1 p -75.76 152.33 37.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.701 0.286 . . . . 73.239999999999995 110.383 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.641 HG23 ' CG ' ' A' ' 30' ' ' PHE . 12.8 tt -149.97 164.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 71.430000000000007 110.856 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' N ' HG12 ' A' ' 60' ' ' ILE . 31.2 t0 -85.99 120.23 27.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 74.299999999999997 111.842 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . . . -85.2 5.29 30.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.698 0.285 . . . . 43.25 110.864 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -104.28 -33.04 8.81 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.45 -0.341 . . . . 73.310000000000002 111.543 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.32 -31.92 6.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.179 0.514 . . . . 73.030000000000001 110.684 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.04 -15.99 17.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 74.209999999999994 111.357 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -32.28 -37.46 0.04 OUTLIER Glycine 0 C--N 1.336 0.547 0 N-CA-C 114.301 0.48 . . . . 64.5 114.301 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.66 -17.27 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.43 . . . . 74.019999999999996 110.774 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -94.72 -9.24 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 61.130000000000003 111.214 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -73.24 -51.53 17.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.76 0.314 . . . . 62.229999999999997 111.434 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -91.33 1.34 76.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.861 -1.161 . . . . 71.030000000000001 113.911 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -60.87 -9.79 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.454 0.627 . . . . 50.32 109.462 177.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -115.78 -16.9 11.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 64.209999999999994 110.377 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.497 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -176.78 -71.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.24 0.459 . . . . 55.399999999999999 112.24 -178.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.509 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.8 mp -40.57 175.14 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 112.969 0.729 . . . . 74.439999999999998 112.969 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' CG ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -107.86 -21.7 12.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.105 -0.952 . . . . 72.329999999999998 110.851 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' ' CZ ' ' A' ' 79' ' ' PHE . 1.5 p 82.73 20.85 0.23 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.263 -1.014 . . . . 74.420000000000002 108.263 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -79.01 -48.76 13.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.663 -1.153 . . . . 72.340000000000003 111.51 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -118.98 158.86 24.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.207 0.527 . . . . 64.230000000000004 111.451 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.661 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -158.24 165.53 18.4 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.48 -0.782 . . . . 73.109999999999999 111.762 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.671 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 25.6 Cg_endo -61.9 157.15 59.09 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.158 -1.601 . . . . 63.140000000000001 112.915 0.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.47 164.44 15.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 75.129999999999995 109.363 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 29' ' ' ILE . 2.5 t80 -138.44 131.29 29.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 74.340000000000003 111.167 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . . . -122.6 147.42 46.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.540000000000006 111.661 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 57.5 mt -129.32 81.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 109.85 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -75.4 138.4 41.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 73.209999999999994 111.333 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.65 118.62 37.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.706 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 t -88.62 20.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 71.319999999999993 110.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.67 -38.96 2.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.057 -0.519 . . . . 73.150000000000006 110.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tttt -113.64 -15.25 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.394 -0.367 . . . . 44.119999999999997 110.922 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 34.5 t-20 79.6 21.05 0.61 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.237 0.542 . . . . 71.239999999999995 109.949 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -84.67 164.65 18.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.321 -0.854 . . . . 71.040000000000006 111.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' O ' ' CD ' ' A' ' 94' ' ' PRO . 6.2 mmtt -139.56 99.15 3.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.25 -0.886 . . . . 75.519999999999996 110.757 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 17.4 m-85 -101.14 70.99 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.656 -0.702 . . . . 75.519999999999996 111.538 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 90.8 Cg_endo -75.39 168.66 24.09 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.554 2.17 . . . . 72.109999999999999 112.384 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 106' ' ' ILE . 35.0 t80 -88.27 169.33 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.498 . . . . 64.049999999999997 110.684 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 2.9 m-20 -83.85 148.26 27.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 72.030000000000001 110.885 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 26.6 mt-30 -103.22 28.47 6.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.217 0.532 . . . . 62.530000000000001 110.381 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -155.94 18.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.73 -0.668 . . . . 72.430000000000007 110.648 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 1.5 ttmt -113.36 -7.89 13.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.137 -0.483 . . . . 71.049999999999997 111.611 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 22.3 tt0 83.97 97.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.258 0.552 . . . . 74.200000000000003 110.894 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.9 mt -72.84 93.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 75.549999999999997 111.153 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 4.8 p -111.15 -147.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.609 -0.515 . . . . 72.030000000000001 109.609 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.576 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -100.26 -59.83 1.64 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.39 -0.596 . . . . 74.200000000000003 109.39 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -56.14 -34.0 65.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.068 -0.969 . . . . 72.409999999999997 110.83 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.53 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.507 -0.77 . . . . 64.019999999999996 112.322 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.426 ' HB ' HG21 ' A' ' 47' ' ' ILE . 40.9 mm -89.93 -42.58 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 121.058 0.456 . . . . 74.420000000000002 110.552 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.704 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.8 pttt -61.79 -47.36 85.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.936 -0.764 . . . . 71.120000000000005 108.936 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.03 -51.47 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 73.420000000000002 110.324 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.6 ' CG ' HD12 ' A' ' 118' ' ' ILE . 67.9 t80 -54.63 -64.91 0.68 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.015 -0.539 . . . . 74.010000000000005 110.894 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 6.0 m -51.82 -37.4 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.127 0.489 . . . . 64.200000000000003 111.533 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.704 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -67.97 -35.79 78.96 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.694 -1.224 . . . . 40.149999999999999 107.694 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER -63.33 -37.27 86.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.347 -1.751 . . . . 75.319999999999993 108.025 177.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -63.8 -66.27 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.981 -1.009 . . . . 73.219999999999999 110.268 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 113' ' ' PHE . 10.4 t -58.09 -36.95 59.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.916 -1.038 . . . . 72.019999999999996 111.876 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.58 78.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 74.230000000000004 111.393 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.78 25.87 2.24 Favored Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 120.535 -0.84 . . . . 74.530000000000001 111.724 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -98.12 -57.78 2.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.2 -0.5 . . . . 64.420000000000002 111.014 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.6 HD12 ' CG ' ' A' ' 109' ' ' PHE . 8.9 mt -71.43 150.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.89 -0.595 . . . . 70.430000000000007 110.092 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.12 171.94 5.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.261 -0.427 . . . . 65.140000000000001 111.364 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.16 119.51 4.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.607 2.204 . . . . 73.010000000000005 112.35 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -89.06 -53.43 4.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 64.439999999999998 110.857 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.9 pt -159.07 179.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.46 32.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.852 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.3 t -75.95 152.83 36.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 110.969 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.68 85.2 6.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.501 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.43 154.02 21.14 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.51 2.14 . . . . 54.229999999999997 112.551 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.61 81.89 9.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 72.109999999999999 111.039 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.55 -178.51 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.586 2.191 . . . . 63.509999999999998 112.271 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.55 136.84 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 71.140000000000001 110.897 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -131.95 146.35 52.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 74.349999999999994 110.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.03 176.5 5.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.87 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -167.88 -44.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 63.450000000000003 110.909 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.379 -1.234 . . . . 73.109999999999999 112.527 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.494 -0.243 . . . . 62.399999999999999 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.9 144.98 33.91 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.601 2.201 . . . . 75.209999999999994 112.318 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.75 150.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 61.530000000000001 110.877 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.73 115.07 1.33 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 51.520000000000003 112.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -176.43 64.83 0.22 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 54.5 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.93 -156.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.499 2.132 . . . . 64.329999999999998 112.148 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 mt -57.92 -29.67 65.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 63.43 111.025 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 57' ' ' PHE . 3.7 mp -56.81 147.52 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 74.439999999999998 111.05 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.17 -153.32 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.128 -1.035 . . . . 73.430000000000007 112.765 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -94.47 131.54 40.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 73.310000000000002 110.367 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.719 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 58.1 mt -84.31 139.97 16.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 71.319999999999993 111.318 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.59 -172.46 12.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 74.329999999999998 112.543 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.95 -22.23 19.99 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.682 2.255 . . . . 63.399999999999999 112.667 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.55 -14.88 21.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 51.210000000000001 111.461 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.3 p -99.63 -24.21 14.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 72.420000000000002 110.838 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.477 ' CE1' ' CG2' ' A' ' 11' ' ' ILE . 1.8 m-85 -51.33 -54.99 20.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 72.450000000000003 111.191 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 t -65.88 -22.44 66.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 72.239999999999995 111.57 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 -41.47 71.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 72.5 110.92 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 13.3 m-85 -79.53 -24.31 42.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 72.349999999999994 109.746 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -42.41 29.01 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.269 -0.878 . . . . 60.310000000000002 110.359 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -85.26 -11.45 54.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 62.32 110.508 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.74 -31.4 68.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 75.400000000000006 111.069 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.27 15.9 56.51 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 63.509999999999998 112.708 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pt -133.28 158.3 76.06 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.699 0.285 . . . . 73.340000000000003 110.933 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.46 138.9 88.34 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.631 2.22 . . . . 52.020000000000003 112.6 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.7 tt -99.65 135.94 40.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 71.5 111.007 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' HB1' ' CD1' ' A' ' 57' ' ' PHE . . . -109.01 100.49 9.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 55.439999999999998 111.037 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.436 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 11.4 m-85 -85.47 132.03 34.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 73.0 110.057 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.2 mt -127.71 83.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.743 -0.383 . . . . 72.450000000000003 111.277 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CG ' HG22 ' A' ' 60' ' ' ILE . 2.7 m-85 -71.51 149.79 45.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 109.801 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.57 116.87 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.28 0.562 . . . . 72.430000000000007 111.257 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 3.4 mt-10 -75.88 -7.97 55.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.208 -0.906 . . . . 74.299999999999997 110.027 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -99.84 92.63 5.39 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.179 -0.464 . . . . 75.349999999999994 111.094 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.76 6.38 35.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 72.230000000000004 111.488 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -34.49 10.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 60.310000000000002 110.779 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.98 9.66 16.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 71.430000000000007 111.317 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.8 -29.12 1.79 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.767 0.317 . . . . 74.340000000000003 111.335 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -54.74 -45.65 74.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 62.439999999999998 110.79 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.39 -36.36 81.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.772 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.438 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -66.4 -62.11 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.019999999999996 110.697 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.592 ' HA ' HD12 ' A' ' 44' ' ' LEU . 7.2 m -57.68 -25.93 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.953 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' LYS . 15.6 t0 -62.64 -59.7 4.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.531 0.681 . . . . 72.400000000000006 109.569 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.717 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.56 -33.36 9.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.601 1.191 . . . . 64.25 108.676 177.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -80.54 -17.58 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.831 -1.531 . . . . 73.420000000000002 112.185 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 4.8 tppt? -55.13 -42.84 98.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.207 -0.664 . . . . 63.109999999999999 109.207 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.717 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 11.8 Cg_endo -84.93 -38.64 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.69 2.26 . . . . 74.430000000000007 110.31 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.74 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 55.1 mt -50.21 -22.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.507 0 CA-C-N 115.975 -0.557 . . . . 64.109999999999999 109.847 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -112.49 -25.55 9.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.621 -0.718 . . . . 71.120000000000005 111.506 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -59.8 -20.4 56.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.255 0.55 . . . . 72.150000000000006 109.771 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.37 -30.24 18.52 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.833 0.825 . . . . 60.229999999999997 108.969 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.652 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -125.34 42.27 3.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.161 -1.381 . . . . 74.319999999999993 110.061 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.5 -29.14 46.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.153 -0.93 . . . . 72.209999999999994 111.04 -178.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 11.32 52.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 71.439999999999998 112.405 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.97 -33.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.636 0.255 . . . . 75.319999999999993 111.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -123.15 142.91 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 65.239999999999995 111.166 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.415 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.3 m-80 -90.57 87.7 6.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.755 -0.461 . . . . 73.319999999999993 109.755 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.48 ' CG ' ' HB1' ' A' ' 48' ' ' ALA . 3.0 m-85 -71.89 119.22 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 75.340000000000003 111.896 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.719 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -141.9 125.17 2.64 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.052 -0.976 . . . . 71.140000000000001 112.463 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.495 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 2.3 p -82.82 153.89 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.629 HG22 ' CG ' ' A' ' 30' ' ' PHE . 12.3 tt -150.68 164.16 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.028 -0.533 . . . . 71.430000000000007 110.531 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 60' ' ' ILE . 43.0 t0 -87.13 120.26 28.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.296 -0.411 . . . . 74.299999999999997 112.072 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.485 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . . . -85.02 6.25 26.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.965 -0.294 . . . . 43.25 110.898 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 8.1 ttmt -106.04 -33.02 8.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.449 -0.341 . . . . 73.310000000000002 111.455 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.3 -30.57 6.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 73.030000000000001 110.489 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.452 ' CG ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.66 -11.64 17.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.507 -0.769 . . . . 74.209999999999994 111.276 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.03 -37.59 0.18 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 114.119 0.407 . . . . 64.5 114.119 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.71 10.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 74.019999999999996 110.483 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -93.0 -8.17 43.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 61.130000000000003 111.247 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -75.16 -46.9 31.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.656 -0.247 . . . . 62.229999999999997 111.642 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -97.67 1.41 59.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.982 -1.104 . . . . 71.030000000000001 113.784 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -8.56 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.446 -0.576 . . . . 50.32 109.446 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -115.23 -15.61 11.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.398 -0.819 . . . . 64.209999999999994 110.17 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.44 -69.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.1 0.476 . . . . 55.399999999999999 112.135 -178.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.494 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 12.6 mt -42.52 174.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.277 -0.874 . . . . 74.439999999999998 112.151 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -120.29 3.67 10.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.539 -0.755 . . . . 72.329999999999998 110.345 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p 58.4 35.15 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.698 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.5 p30 -89.2 -31.27 18.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 72.340000000000003 111.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 28.1 tttt -143.53 157.27 44.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.108 0.48 . . . . 64.230000000000004 110.707 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -154.9 170.72 8.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.731 -0.668 . . . . 73.109999999999999 111.584 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 18.2 Cg_endo -60.24 162.09 36.68 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.422 -1.491 . . . . 63.140000000000001 113.013 0.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.92 162.41 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.755 . . . . 75.129999999999995 109.812 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CZ ' ' CD1' ' A' ' 84' ' ' ILE . 42.0 t80 -138.49 124.6 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 111.132 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.63 148.43 43.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 111.499 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 93' ' ' PHE . 12.9 mm -128.58 90.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 110.346 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.74 139.19 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 73.209999999999994 110.899 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -108.34 110.38 21.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 110.76 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.33 0.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 111.153 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.42 -39.43 8.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.434 -0.348 . . . . 73.150000000000006 111.17 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 -6.51 9.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.63 -0.259 . . . . 44.119999999999997 111.525 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.6 t30 66.19 64.58 0.52 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.546 -0.538 . . . . 71.239999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.4 tp60 -122.26 169.66 10.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.5 -0.773 . . . . 71.040000000000006 111.735 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.562 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -134.96 92.01 2.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.204 -0.907 . . . . 75.519999999999996 111.602 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 70.0 m-85 -103.93 66.55 0.11 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.872 -0.603 . . . . 75.519999999999996 111.138 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 95.1 Cg_endo -77.18 -175.5 2.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.451 2.1 . . . . 72.109999999999999 112.998 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -112.66 168.61 9.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.847 -0.615 . . . . 64.049999999999997 110.943 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.469 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -72.44 176.3 5.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 72.030000000000001 110.733 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -118.18 -16.31 9.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 62.530000000000001 111.279 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -119.75 -8.13 9.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.829 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -70.96 -8.46 53.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.861 -0.609 . . . . 71.049999999999997 111.559 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.4 tt0 86.73 120.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.214 -0.448 . . . . 74.200000000000003 110.596 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.0 mt -103.94 110.01 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 111.59 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.21 -153.55 0.57 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.892 -0.781 . . . . 72.030000000000001 108.892 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.53 -66.16 0.95 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.624 -0.88 . . . . 74.200000000000003 108.624 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.659 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.19 -38.97 9.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.994 -1.003 . . . . 72.409999999999997 111.957 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -68.81 -32.88 72.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.69 0.626 . . . . 64.019999999999996 112.69 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.74 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 32.9 mm -91.24 -45.76 14.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 109.942 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.659 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -57.09 -45.77 83.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.844 -0.798 . . . . 71.120000000000005 108.844 178.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.36 36.8 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.774 -0.648 . . . . 73.420000000000002 110.125 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.528 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 48.7 t80 -49.77 -63.83 0.99 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.011 -0.366 . . . . 74.010000000000005 110.011 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 107' ' ' LYS . 8.3 m -49.17 -42.85 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.535 . . . . 64.200000000000003 109.569 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -52.97 -36.93 60.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.727 0.775 . . . . 40.149999999999999 109.204 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.893 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -69.3 -34.8 75.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 108.398 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 93' ' ' PHE . 2.0 t80 -71.75 -69.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.255 -0.884 . . . . 73.219999999999999 110.874 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.419 HG21 ' CD2' ' A' ' 113' ' ' PHE . 16.9 t -50.19 -47.46 24.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 72.019999999999996 111.987 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -36.96 67.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 74.230000000000004 111.019 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.75 29.41 2.24 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 110.864 -0.894 . . . . 74.530000000000001 110.864 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.893 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -101.76 -52.92 3.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.792 -0.704 . . . . 64.420000000000002 111.561 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.538 HG13 ' C ' ' A' ' 112' ' ' ASP . 55.9 mt -66.43 152.94 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.483 -0.562 . . . . 70.430000000000007 109.483 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.81 168.09 19.04 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.395 -0.366 . . . . 65.140000000000001 111.449 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.85 115.17 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.776 2.318 . . . . 73.010000000000005 112.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 m -73.33 132.93 43.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.017 -0.538 . . . . 64.439999999999998 110.65 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 40.96 -92.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.102 -0.499 . . . . 72.420000000000002 111.701 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.59 28.97 1.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.821 0.343 . . . . 74.450000000000003 111.171 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.0 m 53.24 44.53 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.218 0.533 . . . . 73.040000000000006 110.879 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -151.61 86.76 4.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.509 -0.769 . . . . 72.430000000000007 110.535 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.51 150.7 19.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.509 2.139 . . . . 54.229999999999997 112.65 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 mp -148.76 85.87 5.96 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 72.109999999999999 110.698 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -43.02 166.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.862 2.375 . . . . 63.509999999999998 112.695 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.49 111.16 0.67 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.585 -0.734 . . . . 71.140000000000001 110.928 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -142.16 -80.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 74.349999999999994 110.912 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -80.27 177.35 9.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.61 -0.723 . . . . 73.209999999999994 110.832 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.9 157.61 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 63.450000000000003 110.877 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.381 -1.233 . . . . 73.109999999999999 112.509 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.509 -0.237 . . . . 62.399999999999999 112.509 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.13 126.64 20.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.625 2.216 . . . . 75.209999999999994 112.311 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.18 134.82 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.530000000000001 110.812 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.64 110.62 0.45 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.608 -0.806 . . . . 51.520000000000003 112.601 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 0.7 OUTLIER -141.51 64.97 20.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 54.5 110.802 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 5' ' ' SER . 11.7 Cg_exo -70.77 139.07 35.94 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.741 2.294 . . . . 64.329999999999998 112.363 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.99 -64.46 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 63.43 110.479 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' HB ' ' CB ' ' A' ' 57' ' ' PHE . 1.6 pt -79.37 130.15 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.863 -0.608 . . . . 74.439999999999998 110.748 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.86 8.77 0.65 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 73.430000000000007 113.181 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.97 114.19 7.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.999 0.399 . . . . 73.310000000000002 110.894 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.72 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 11.9 mt -118.21 137.97 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 111.237 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.02 -170.72 12.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.777 -0.725 . . . . 74.329999999999998 112.414 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.35 4.06 7.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.728 2.285 . . . . 63.399999999999999 112.938 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.84 28.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 51.210000000000001 111.111 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 p -122.89 -36.78 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 72.420000000000002 111.068 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -55.58 -30.88 61.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 72.450000000000003 111.113 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -55.59 -24.03 30.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 72.239999999999995 111.237 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -83.04 -40.88 19.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 72.5 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 15.6 m-85 -77.13 -18.31 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.372 0.606 . . . . 72.349999999999994 109.59 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -32.17 17.23 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.091 -0.959 . . . . 60.310000000000002 110.233 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -90.9 -8.64 48.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.694 -0.685 . . . . 62.32 111.006 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.19 -56.21 10.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.935 0.397 . . . . 75.400000000000006 110.623 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.35 23.99 2.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.928 -0.653 . . . . 63.509999999999998 112.351 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.88 166.44 28.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.746 0.308 . . . . 73.340000000000003 111.296 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.25 141.49 69.09 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.607 2.205 . . . . 52.020000000000003 112.357 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.8 tt -105.46 128.04 53.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.522 . . . . 71.5 110.564 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 57' ' ' PHE . . . -100.75 86.6 3.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.093 0.473 . . . . 55.439999999999998 111.451 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.456 ' CE1' HD13 ' A' ' 26' ' ' LEU . 62.4 m-85 -75.81 136.82 40.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.573 -0.739 . . . . 73.0 110.264 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 2.8 mp -130.43 87.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.773 0.32 . . . . 72.450000000000003 111.178 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.627 ' CG ' HG23 ' A' ' 60' ' ' ILE . 2.5 m-85 -71.59 147.09 47.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.683 -0.488 . . . . 73.299999999999997 109.683 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -159.26 119.64 3.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.147 0.499 . . . . 72.430000000000007 110.828 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 12.1 mt-10 -74.32 -7.46 52.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.494 -0.776 . . . . 74.299999999999997 110.346 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -89.09 126.56 35.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 75.349999999999994 111.104 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.85 4.38 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.476 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.1 -38.33 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 60.310000000000002 110.474 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -104.34 15.96 27.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 111.074 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -59.23 -25.81 64.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 74.340000000000003 111.035 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -58.13 -44.08 87.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.365 . . . . 62.439999999999998 110.855 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.44 -42.93 82.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 74.530000000000001 110.981 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.06 -53.65 46.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 71.019999999999996 110.83 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 49.8 m -64.86 -22.84 67.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.214 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 30.3 t0 -65.29 -61.6 2.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.567 0.698 . . . . 72.400000000000006 109.244 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.643 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.41 -32.96 8.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.604 1.192 . . . . 64.25 108.746 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.637 ' HA ' HD13 ' A' ' 47' ' ' ILE . 43.3 mt -76.62 -24.04 53.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.463 -1.699 . . . . 73.420000000000002 112.388 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.0 mtpt -53.73 -44.68 98.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 63.109999999999999 110.13 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.9 Cg_endo -83.21 -38.86 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.532 2.155 . . . . 74.430000000000007 110.819 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.668 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 58.7 mt -49.78 -23.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.912 -0.585 . . . . 64.109999999999999 110.102 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.675 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -110.82 -26.19 9.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 71.120000000000005 111.465 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.62 -18.83 61.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.128 0.49 . . . . 72.150000000000006 110.04 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.96 -28.94 17.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.76 0.79 . . . . 60.229999999999997 109.409 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.675 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.1 pt20 -121.31 38.96 3.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.311 -1.313 . . . . 74.319999999999993 110.597 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.1 ptm180 -75.04 -27.05 59.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 72.209999999999994 111.406 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.03 14.97 28.59 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.903 -0.665 . . . . 71.439999999999998 112.618 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG13 ' CA ' ' A' ' 51' ' ' GLN . 7.5 p -128.81 -44.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 75.319999999999993 110.964 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.0 mt -118.06 146.24 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 65.239999999999995 110.527 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.08 102.11 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.889 0.376 . . . . 73.319999999999993 110.406 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.471 ' CD1' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -80.01 136.69 36.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.348 0.594 . . . . 75.340000000000003 111.587 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.72 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -160.6 126.71 1.65 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.148 -0.933 . . . . 71.140000000000001 111.879 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 p -88.4 153.67 21.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 73.239999999999995 110.415 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.627 HG23 ' CG ' ' A' ' 30' ' ' PHE . 10.8 tt -147.91 162.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 71.430000000000007 110.853 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.3 t0 -83.55 117.4 23.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.178 -0.465 . . . . 74.299999999999997 112.183 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.506 ' HB2' ' CG ' ' A' ' 79' ' ' PHE . . . -83.05 5.35 22.61 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.673 0.273 . . . . 43.25 110.788 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 17.6 ttmt -103.67 -33.23 9.03 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.526 -0.306 . . . . 73.310000000000002 111.622 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.54 -32.42 5.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.224 0.535 . . . . 73.030000000000001 110.57 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.33 -16.47 17.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 74.209999999999994 111.101 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.65 -39.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.442 0.537 . . . . 64.5 114.442 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -52.02 -26.71 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.25 0.548 . . . . 74.019999999999996 110.459 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -83.29 -13.48 55.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 61.130000000000003 111.611 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -71.73 -36.76 70.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.667 0.27 . . . . 62.229999999999997 111.558 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -108.07 -0.44 33.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.917 -1.135 . . . . 71.030000000000001 113.416 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -60.93 -10.68 6.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.507 -0.553 . . . . 50.32 109.507 177.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 73' ' ' ASN . 0.4 OUTLIER -113.93 -14.84 12.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.372 -0.831 . . . . 64.209999999999994 110.328 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.506 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.31 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.276 0.473 . . . . 55.399999999999999 112.276 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 73' ' ' ASN . 96.6 mt -43.14 178.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.514 -0.766 . . . . 74.439999999999998 112.913 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.94 -24.53 11.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.969 -1.014 . . . . 72.329999999999998 110.495 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 79' ' ' PHE . 1.5 p 78.95 21.54 0.68 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.206 -0.906 . . . . 74.420000000000002 108.609 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.67 -45.16 25.78 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.649 -1.159 . . . . 72.340000000000003 111.41 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -123.93 163.2 21.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.1 -0.5 . . . . 64.230000000000004 111.154 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -160.59 167.43 13.7 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 73.109999999999999 112.023 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 26.2 Cg_endo -62.34 158.1 60.37 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 123.16 -1.6 . . . . 63.140000000000001 113.05 0.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.31 167.59 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.737 . . . . 75.129999999999995 109.969 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 1.7 t80 -138.36 130.32 28.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.669 0.271 . . . . 74.340000000000003 110.778 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . . . -129.68 121.34 26.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.038 0.385 . . . . 75.540000000000006 112.038 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 HG22 ' CZ ' ' A' ' 113' ' ' PHE . 31.1 mt -103.63 93.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 110.346 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -85.05 141.77 30.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.768 0.318 . . . . 73.209999999999994 110.741 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -112.43 109.9 19.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.958 0.408 . . . . 74.420000000000002 111.072 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.2 -1.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.797 -0.638 . . . . 71.319999999999993 110.904 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.87 -42.67 11.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.919 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -118.8 -9.01 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.552 -0.294 . . . . 44.119999999999997 111.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 t30 75.46 57.05 0.06 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.353 0.597 . . . . 71.239999999999995 109.562 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.644 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -121.49 166.44 14.16 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.179 -0.919 . . . . 71.040000000000006 110.932 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.644 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 5.4 mmtt -141.42 98.19 3.31 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.413 -0.812 . . . . 75.519999999999996 110.663 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 64.1 m-85 -101.76 73.41 0.12 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.838 . . . . 75.519999999999996 110.866 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 53.7 Cg_endo -80.05 167.32 20.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 72.109999999999999 112.585 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' ' N ' ' A' ' 96' ' ' ASP . 40.5 t80 -96.08 166.15 11.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 64.049999999999997 110.828 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' N ' ' CD2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -63.67 173.81 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 72.030000000000001 110.392 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.415 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 mm-40 -117.15 -22.9 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.423 . . . . 62.530000000000001 111.369 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -127.52 25.61 6.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.378 . . . . 72.430000000000007 110.835 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.4 tppt? -93.33 -69.37 0.75 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.022 -0.536 . . . . 71.049999999999997 110.533 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 9.7 tt0 163.56 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.763 -0.653 . . . . 74.200000000000003 109.892 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 8.7 mt -91.25 88.09 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.549999999999997 111.735 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -112.25 -154.1 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.98 -67.57 0.85 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.741 -0.837 . . . . 74.200000000000003 108.741 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.632 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.82 -35.83 6.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.341 -0.845 . . . . 72.409999999999997 111.479 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -71.82 -33.38 68.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 64.019999999999996 112.426 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.668 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 50.0 mm -89.48 -46.43 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.113 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -58.47 -44.93 89.47 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.727 -0.67 . . . . 71.120000000000005 109.471 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.86 -49.01 50.77 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.696 -0.684 . . . . 73.420000000000002 110.123 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.638 ' O ' HD11 ' A' ' 118' ' ' ILE . 27.5 t80 -51.56 -67.2 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 74.010000000000005 109.822 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 21.9 m -47.16 -38.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.322 0.582 . . . . 64.200000000000003 109.869 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -57.87 -41.88 83.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.356 -0.838 . . . . 40.149999999999999 110.057 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.691 ' OD2' HG12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -77.16 -11.93 59.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.615 -0.721 . . . . 75.319999999999993 110.263 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -82.0 -61.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.74 0.781 . . . . 73.219999999999999 109.153 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.543 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 11.5 p -57.94 -37.29 60.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.302 -1.317 . . . . 72.019999999999996 110.885 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.05 86.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 74.230000000000004 110.431 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.85 1.53 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.722 -0.751 . . . . 74.530000000000001 111.558 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.46 -37.13 6.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.296 -0.452 . . . . 64.420000000000002 111.704 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.691 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.4 mt -86.54 150.0 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.16 0.505 . . . . 70.430000000000007 110.508 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.48 162.56 45.92 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.479 -0.782 . . . . 65.140000000000001 111.079 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.22 129.66 19.74 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 73.010000000000005 112.189 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 t -58.72 -41.67 86.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 64.439999999999998 110.12 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.2 pt -145.23 -165.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.738 -0.665 . . . . 72.420000000000002 109.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.14 -171.09 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.178 0.514 . . . . 74.450000000000003 111.729 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -155.84 -172.67 4.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.456 -0.793 . . . . 73.040000000000006 110.429 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.76 82.24 15.82 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.378 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.05 -171.77 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.623 2.215 . . . . 54.229999999999997 112.464 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 tt -112.06 81.11 3.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.109999999999999 110.97 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.14 -179.51 2.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.568 2.179 . . . . 63.509999999999998 112.332 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -162.89 90.3 0.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 71.140000000000001 110.945 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 163.28 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 74.349999999999994 110.985 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.62 179.11 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 73.209999999999994 110.983 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 46.27 -169.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.168 -0.469 . . . . 63.450000000000003 111.283 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.307 -1.274 . . . . 73.109999999999999 112.43 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.504 -0.239 . . . . 62.399999999999999 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -51.85 -26.76 25.2 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 75.209999999999994 112.349 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tt 61.92 103.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 61.530000000000001 110.865 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.43 85.77 0.14 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.742 -0.742 . . . . 51.520000000000003 112.6 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 152.68 27.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.668 0.27 . . . . 54.5 110.962 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.35 -79.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.203 . . . . 64.329999999999998 112.074 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.422 HD12 HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -143.33 -135.61 0.09 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.239 -0.652 . . . . 63.43 109.239 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.493 ' HB ' ' CB ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -157.89 145.13 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 110.82 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 59' ' ' THR . . . 119.59 17.4 4.76 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.684 -0.77 . . . . 73.430000000000007 112.901 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -145.06 104.74 4.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.665 0.269 . . . . 73.310000000000002 110.844 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.721 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 23.3 mt -113.0 140.3 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.972 0.415 . . . . 71.319999999999993 111.737 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.99 -150.87 6.47 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.86 -0.609 . . . . 74.329999999999998 112.311 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.54 -33.07 3.35 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.935 2.423 . . . . 63.399999999999999 112.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.84 24.67 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 51.210000000000001 111.155 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 3.1 p -136.75 -42.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 72.420000000000002 111.142 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.416 ' CE2' ' OH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -43.92 -56.5 3.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 111.374 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -64.49 -26.67 68.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 72.239999999999995 111.666 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.35 -38.39 60.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 72.5 111.015 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 23.0 m-85 -79.12 -23.44 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.362 0.601 . . . . 72.349999999999994 109.593 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -25.47 23.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.118 -0.946 . . . . 60.310000000000002 110.379 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 t -95.31 -11.23 28.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.025 -0.534 . . . . 62.32 110.521 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.01 78.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.458 -0.337 . . . . 75.400000000000006 111.175 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 17.18 39.77 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.715 . . . . 63.509999999999998 112.666 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.97 161.1 65.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.718 0.294 . . . . 73.340000000000003 110.89 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.04 139.57 88.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.624 2.216 . . . . 52.020000000000003 112.688 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' A' ' 28' ' ' TYR . 2.3 tt -98.42 140.96 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 71.5 111.145 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 57' ' ' PHE . . . -114.94 88.22 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 55.439999999999998 111.023 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.461 ' CD1' HD13 ' A' ' 11' ' ' ILE . 81.6 m-85 -76.87 133.97 39.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.69 -0.687 . . . . 73.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 3.0 mt -125.76 85.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.501 -0.318 . . . . 72.450000000000003 111.093 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.624 ' CG ' HG22 ' A' ' 60' ' ' ILE . 3.6 m-85 -73.24 148.84 43.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.299 -0.63 . . . . 73.299999999999997 109.299 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -157.18 115.13 3.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.383 0.611 . . . . 72.430000000000007 111.326 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -84.72 -1.25 55.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.022 -0.99 . . . . 74.299999999999997 109.901 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 p -106.6 112.48 25.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.974 -0.557 . . . . 75.349999999999994 110.662 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.32 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 72.230000000000004 111.375 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.36 -55.17 5.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.091 0.472 . . . . 60.310000000000002 110.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.38 -3.42 55.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 71.430000000000007 110.902 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 -44.83 -38.77 4.78 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 111.15 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.22 -56.11 9.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.676 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 7.4 pt-20 -58.2 -31.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 74.530000000000001 110.576 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.74 -57.54 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.042 0.449 . . . . 71.019999999999996 110.448 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 25.6 m -63.43 -20.26 65.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 74.349999999999994 111.329 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t0 -65.94 -63.87 0.99 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.609 0.718 . . . . 72.400000000000006 109.345 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -47.85 -33.02 6.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.703 1.24 . . . . 64.25 108.684 177.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.1 mt -76.88 -23.32 52.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.43 -1.714 . . . . 73.420000000000002 112.467 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 10.8 mtpt -54.45 -43.95 98.37 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 116.431 -0.35 . . . . 63.109999999999999 110.073 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 21.0 Cg_endo -82.37 -39.85 0.15 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 110.543 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.651 ' CD1' ' HB ' ' A' ' 106' ' ' ILE . 47.1 mt -51.25 -22.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-N 116.045 -0.525 . . . . 64.109999999999999 109.948 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.685 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -111.22 -23.99 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.775 -0.648 . . . . 71.120000000000005 111.429 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -61.47 -20.74 63.49 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.195 0.521 . . . . 72.150000000000006 109.89 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.7 -26.54 19.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.422 -0.808 . . . . 60.229999999999997 109.338 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.685 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -125.66 42.21 3.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.441 -1.254 . . . . 74.319999999999993 110.793 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -76.32 -32.54 58.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.666 -0.697 . . . . 72.209999999999994 111.056 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.4 6.69 53.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.849 -0.691 . . . . 71.439999999999998 112.641 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 13.1 p -119.09 -34.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 75.319999999999993 111.23 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.94 143.95 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 65.239999999999995 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-80 -93.61 87.0 5.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 73.319999999999993 109.927 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CB ' ' HB ' ' A' ' 8' ' ' ILE . 3.5 m-85 -69.89 136.71 50.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 75.340000000000003 111.234 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.721 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -158.63 129.63 2.32 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.389 -0.823 . . . . 71.140000000000001 111.961 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.446 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 50.0 p -89.38 151.58 21.97 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.039 0.447 . . . . 73.239999999999995 110.878 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.624 HG22 ' CG ' ' A' ' 30' ' ' PHE . 11.3 tt -148.07 163.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.503 -0.771 . . . . 71.430000000000007 110.422 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.2 t0 -87.08 120.98 28.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.379 -0.373 . . . . 74.299999999999997 111.883 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.482 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.98 5.09 23.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.788 -0.365 . . . . 43.25 111.073 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 29.2 ttmt -105.08 -34.15 8.06 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 111.735 0.272 . . . . 73.310000000000002 111.735 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.57 -30.51 7.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.218 0.532 . . . . 73.030000000000001 110.417 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' CG ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.77 -17.99 14.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.413 -0.812 . . . . 74.209999999999994 111.167 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -31.41 -39.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 114.239 0.456 . . . . 64.5 114.239 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.55 -19.03 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.058 0.429 . . . . 74.019999999999996 110.691 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -90.66 -11.83 38.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.805 -0.634 . . . . 61.130000000000003 111.183 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -69.19 -51.36 38.75 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.73 0.3 . . . . 62.229999999999997 111.048 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.52 1.75 69.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.739 -1.22 . . . . 71.030000000000001 113.778 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.61 -9.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.452 0.626 . . . . 50.32 109.668 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -114.29 -15.22 12.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.319 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.432 ' N ' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.16 -70.02 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.246 0.546 . . . . 55.399999999999999 112.264 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.554 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.6 mm? -40.86 171.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 114.89 -1.05 . . . . 74.439999999999998 112.375 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.24 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 72.329999999999998 110.832 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.0 p 53.75 38.13 27.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.383 . . . . 74.420000000000002 110.825 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.64 -29.84 33.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 72.340000000000003 110.769 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -150.69 163.81 37.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.243 -0.435 . . . . 64.230000000000004 110.36 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.482 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.61 173.15 5.23 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.915 -0.584 . . . . 73.109999999999999 111.787 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 19.1 Cg_endo -60.36 164.63 30.24 Favored 'Cis proline' 0 C--N 1.353 0.793 0 C-N-CA 123.363 -1.515 . . . . 63.140000000000001 113.076 0.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.49 167.62 16.04 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.394 -0.821 . . . . 75.129999999999995 109.532 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 2.1 t80 -143.58 112.1 6.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.645 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -109.44 126.42 53.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 75.540000000000006 111.429 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 11.8 mt -109.26 88.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.803 0.335 . . . . 70.340000000000003 110.42 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -84.92 138.5 32.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 73.209999999999994 110.6 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -100.11 115.28 29.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.922 0.391 . . . . 74.420000000000002 110.894 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 t -81.61 3.49 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.539 . . . . 71.319999999999993 110.827 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.99 -41.5 8.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.292 -0.413 . . . . 73.150000000000006 110.857 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -117.79 -15.93 10.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.637 -0.256 . . . . 44.119999999999997 111.308 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 35.4 t-20 81.18 40.75 0.05 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.324 0.583 . . . . 71.239999999999995 110.268 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.1 tp60 -91.6 -174.74 3.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.339 -0.846 . . . . 71.040000000000006 111.152 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.575 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -150.28 93.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.56 -0.745 . . . . 75.519999999999996 110.713 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 75.0 m-85 -105.18 70.07 0.2 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.835 -0.62 . . . . 75.519999999999996 111.353 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 52.0 Cg_endo -81.56 178.65 6.42 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.683 2.255 . . . . 72.109999999999999 112.968 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 37.1 t80 -113.05 164.45 13.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 64.049999999999997 110.505 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.449 ' N ' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -62.35 174.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 72.030000000000001 110.74 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.49 -23.27 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 62.530000000000001 111.21 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 24.93 6.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 110.847 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.3 tppt? -94.55 -77.3 0.47 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.019 -0.537 . . . . 71.049999999999997 110.534 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 3.8 tt0 173.74 105.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 74.200000000000003 110.4 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.0 mt -98.63 88.58 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.815 -0.63 . . . . 75.549999999999997 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -119.07 -164.68 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.28 -0.637 . . . . 72.030000000000001 109.28 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.557 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -79.76 -66.32 0.89 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.098 0.475 . . . . 74.200000000000003 110.099 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.554 ' N ' ' CD2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -48.98 -39.23 25.73 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.936 -1.029 . . . . 72.409999999999997 111.754 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -71.88 -34.94 69.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.067 -0.97 . . . . 64.019999999999996 113.412 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.651 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 46.2 mm -88.05 -44.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.0 0.429 . . . . 74.420000000000002 110.201 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB3' HG12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -54.66 -42.97 71.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.866 -0.606 . . . . 71.120000000000005 109.511 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.81 36.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.621 -0.718 . . . . 73.420000000000002 110.139 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 32.2 t80 -49.64 -64.74 0.72 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.631 -0.507 . . . . 74.010000000000005 109.631 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 16.7 m -49.97 -41.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.765 -0.458 . . . . 64.200000000000003 109.765 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -55.58 -36.96 67.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.686 0.755 . . . . 40.149999999999999 109.133 178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.906 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -68.03 -34.82 77.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.431 -1.259 . . . . 75.319999999999993 108.281 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.472 ' CB ' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -71.52 -69.05 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.099 -0.955 . . . . 73.219999999999999 111.025 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 113' ' ' PHE . 11.9 t -52.36 -46.05 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.284 -0.871 . . . . 72.019999999999996 112.101 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.66 69.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.843 0.354 . . . . 74.230000000000004 111.235 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.36 31.17 1.9 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.86 -0.896 . . . . 74.530000000000001 110.86 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.906 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -103.25 -56.22 2.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.848 -0.676 . . . . 64.420000000000002 111.373 -178.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.52 HG13 ' C ' ' A' ' 112' ' ' ASP . 50.4 mt -64.56 150.75 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.403 -0.591 . . . . 70.430000000000007 109.403 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -133.13 157.37 78.44 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 65.140000000000001 111.581 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.17 114.5 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.8 2.333 . . . . 73.010000000000005 112.611 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.466 ' O ' HG13 ' A' ' 122' ' ' ILE . 19.0 m -92.78 117.81 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 64.439999999999998 110.953 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 121' ' ' SER . 1.1 pt 41.84 -173.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.861 -0.609 . . . . 72.420000000000002 112.249 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -159.32 133.96 7.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 74.450000000000003 110.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.51 107.85 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 73.040000000000006 110.405 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -163.46 71.36 1.87 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.94 178.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.59 2.194 . . . . 54.229999999999997 112.539 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.77 84.16 0.62 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 111.667 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.98 -166.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.523 2.148 . . . . 63.509999999999998 111.954 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.38 76.91 1.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 71.140000000000001 111.059 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tptt 179.98 159.55 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 74.349999999999994 110.947 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 -168.79 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 110.839 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.74 166.46 22.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 63.450000000000003 110.863 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.378 -1.235 . . . . 73.109999999999999 112.533 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.492 -0.243 . . . . 62.399999999999999 112.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.07 93.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.573 2.182 . . . . 75.209999999999994 112.295 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.17 146.73 24.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 61.530000000000001 110.903 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.35 -155.79 23.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 51.520000000000003 112.517 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -177.66 90.26 0.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 54.5 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.12 141.47 57.62 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.504 2.136 . . . . 64.329999999999998 112.196 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.6 mt -92.3 -77.55 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 63.43 110.992 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' HB ' ' CB ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -130.83 131.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.84 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.78 -56.36 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.45 -0.881 . . . . 73.430000000000007 112.665 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -128.08 135.5 49.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.623 0.249 . . . . 73.310000000000002 110.957 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.556 HG12 ' HA3' ' A' ' 58' ' ' GLY . 1.2 mt -107.21 153.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 71.319999999999993 111.028 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.63 -159.18 9.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.737 -0.744 . . . . 74.329999999999998 112.325 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.96 10.29 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.684 2.256 . . . . 63.399999999999999 112.826 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.9 25.96 1.4 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.571 0.224 . . . . 51.210000000000001 111.512 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 p -123.32 -23.46 4.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 72.420000000000002 110.329 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -57.83 -38.7 76.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.749 -0.66 . . . . 72.450000000000003 111.616 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.7 t -55.86 -30.83 62.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.051 -0.522 . . . . 72.239999999999995 111.965 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.09 -35.86 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.899 0.38 . . . . 72.5 111.251 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 11.7 m-85 -81.53 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 72.349999999999994 110.664 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.08 -28.85 9.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 60.310000000000002 110.577 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -97.15 -5.87 36.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.982 -0.554 . . . . 62.32 110.882 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.12 76.78 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.906 0.384 . . . . 75.400000000000006 111.026 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.62 15.67 22.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.859 -0.686 . . . . 63.509999999999998 112.459 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pt -133.35 154.37 80.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.340000000000003 111.096 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.34 145.12 99.27 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.84 2.36 . . . . 52.020000000000003 112.604 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' GLN . 3.1 tt -95.97 135.7 37.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.9 -0.591 . . . . 71.5 111.143 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.72 95.27 5.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 55.439999999999998 110.793 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.486 ' CD1' HD12 ' A' ' 11' ' ' ILE . 6.5 m-85 -82.3 130.75 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 73.0 110.371 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG2' ' CD1' ' A' ' 44' ' ' LEU . 2.3 mp -124.38 83.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.81 -0.356 . . . . 72.450000000000003 111.339 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 60' ' ' ILE . 4.8 m-85 -70.28 143.97 51.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.561 -0.533 . . . . 73.299999999999997 109.561 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -158.07 118.47 3.37 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.145 0.497 . . . . 72.430000000000007 111.028 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 23.4 mt-10 -71.26 -13.25 61.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 74.299999999999997 109.979 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 p -88.64 97.24 11.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 111.037 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.44 7.59 42.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 72.230000000000004 111.456 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -113.3 -46.46 3.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 60.310000000000002 110.83 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -92.93 1.55 57.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.381 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.59 -29.87 0.19 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.929 0.344 . . . . 74.340000000000003 111.929 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -49.78 -50.04 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 62.439999999999998 111.151 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 17.5 mt-10 -63.34 -44.03 96.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 74.530000000000001 111.103 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.57 -53.68 53.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 71.019999999999996 110.905 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' HD12 ' A' ' 44' ' ' LEU . 28.6 m -65.06 -19.85 66.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 74.349999999999994 111.383 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' LYS . 10.6 t0 -67.53 -62.03 1.62 Allowed 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.312 -0.625 . . . . 72.400000000000006 109.312 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.649 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.07 -32.82 10.28 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.844 1.307 . . . . 64.25 108.782 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' HA ' HD12 ' A' ' 47' ' ' ILE . 63.7 mt -77.65 -23.29 49.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.191 -1.822 . . . . 73.420000000000002 111.903 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 17.8 ttmt -52.27 -45.17 94.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.747 -0.661 . . . . 63.109999999999999 110.083 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.1 Cg_endo -83.96 -37.54 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.628 2.219 . . . . 74.430000000000007 110.537 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 44' ' ' LEU . 60.9 mt -50.33 -21.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 116.068 -0.515 . . . . 64.109999999999999 110.196 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.676 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -110.87 -32.44 6.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.177 -0.465 . . . . 71.120000000000005 111.797 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 2.0 tm-20 -59.39 -18.15 36.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.24 0.543 . . . . 72.150000000000006 110.179 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.14 -27.98 19.25 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.42 -0.809 . . . . 60.229999999999997 109.527 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.676 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -121.48 36.07 4.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.449 -1.25 . . . . 74.319999999999993 110.814 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' ALA . 20.4 ptt-85 -67.08 -32.79 74.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.67 . . . . 72.209999999999994 111.326 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 9.61 49.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.645 -0.788 . . . . 71.439999999999998 112.83 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' A' ' 51' ' ' GLN . 14.6 p -123.78 -29.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.742 0.271 . . . . 75.319999999999993 111.581 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.411 ' CD1' ' NE2' ' A' ' 51' ' ' GLN . 32.8 mt -132.84 153.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.54 -0.3 . . . . 65.239999999999995 110.428 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -102.82 109.8 21.51 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.994 0.426 . . . . 73.319999999999993 110.728 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -70.35 125.89 28.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.412 0.625 . . . . 75.340000000000003 111.136 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' HG12 ' A' ' 11' ' ' ILE . . . -150.29 100.43 0.21 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.025 -0.989 . . . . 71.140000000000001 112.572 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.4 p -77.74 152.95 33.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 73.239999999999995 110.521 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.613 HG21 ' CG ' ' A' ' 30' ' ' PHE . 12.6 tt -150.14 165.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 71.430000000000007 110.87 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 28.8 t0 -88.43 120.7 30.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 112.077 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.46 3.56 35.69 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.696 0.284 . . . . 43.25 111.0 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 11.1 tttt -104.42 -32.64 8.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.492 -0.322 . . . . 73.310000000000002 111.545 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.92 -30.25 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 73.030000000000001 110.616 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -103.68 -15.72 15.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.574 -0.739 . . . . 74.209999999999994 111.236 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -32.33 -38.09 0.05 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.269 0.467 . . . . 64.5 114.269 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.53 -12.38 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.175 0.487 . . . . 74.019999999999996 110.764 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' PHE . 13.3 t-80 -103.08 -4.21 24.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.705 -0.68 . . . . 61.130000000000003 110.934 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -73.86 -53.18 10.78 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.739 0.305 . . . . 62.229999999999997 111.324 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.82 6.75 73.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 119.868 -1.158 . . . . 71.030000000000001 113.504 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -9.8 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.09 -0.707 . . . . 50.32 109.09 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -113.74 -15.04 12.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.224 -0.898 . . . . 64.209999999999994 110.376 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.468 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER 179.06 -69.92 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.355 0.598 . . . . 55.399999999999999 112.288 -178.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.508 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 1.5 mm? -40.96 173.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.016 -0.993 . . . . 74.439999999999998 112.594 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -101.89 -32.38 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 72.329999999999998 110.894 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.8 p 85.01 27.34 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.808 -1.087 . . . . 74.420000000000002 108.388 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.56 -45.55 17.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.535 -1.211 . . . . 72.340000000000003 111.017 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 21.9 tttp -130.1 163.28 26.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.88 -0.6 . . . . 64.230000000000004 111.074 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -157.07 169.83 9.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.578 . . . . 73.109999999999999 111.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 18.4 Cg_endo -60.61 160.53 42.74 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 123.446 -1.481 . . . . 63.140000000000001 113.189 0.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.13 159.93 32.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.379 -0.828 . . . . 75.129999999999995 109.812 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 28' ' ' TYR . 68.4 t80 -136.76 136.83 39.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 74.340000000000003 111.748 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -134.77 148.67 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 75.540000000000006 111.172 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.462 HG22 ' CE2' ' A' ' 113' ' ' PHE . 12.9 mt -123.66 94.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.33 . . . . 70.340000000000003 110.525 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' LEU . 9.0 tm0? -77.71 136.67 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 110.89 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -107.39 116.06 31.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 110.562 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG13 ' HE1' ' A' ' 20' ' ' MET . 34.3 m -82.7 8.51 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 71.319999999999993 112.169 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.18 -40.02 3.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.813 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -105.7 -14.56 15.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 44.119999999999997 111.33 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 74.44 19.56 2.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.925 0.393 . . . . 71.239999999999995 111.092 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 6.2 tp-100 -89.12 166.53 13.78 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 110.681 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 8.6 mmtt -141.06 85.38 1.98 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.819 -0.628 . . . . 75.519999999999996 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' CE1' ' A' ' 113' ' ' PHE . 32.5 m-85 -81.31 100.73 0.77 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 75.519999999999996 110.688 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 40.6 Cg_endo -105.47 168.92 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.431 2.754 . . . . 72.109999999999999 113.294 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 36.4 t80 -102.85 165.38 11.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 64.049999999999997 110.626 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -65.51 175.06 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 72.030000000000001 110.528 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 2.4 mt-30 -116.67 -24.61 7.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 62.530000000000001 111.218 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -124.41 25.86 7.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.397 . . . . 72.430000000000007 110.825 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.5 tppt? -96.34 -72.56 0.63 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.566 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 54.7 tt0 170.46 100.48 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.96 -0.563 . . . . 74.200000000000003 110.382 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.4 mt -94.63 90.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 75.549999999999997 111.064 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 22.1 p -116.22 -150.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.413 -0.358 . . . . 72.030000000000001 110.248 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.569 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -97.35 -56.39 2.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.436 0.636 . . . . 74.200000000000003 109.495 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.528 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -61.4 -39.29 90.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.733 -1.122 . . . . 72.409999999999997 110.722 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.36 70.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 64.019999999999996 112.602 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.637 ' HB ' ' CD1' ' A' ' 47' ' ' ILE . 51.9 mm -89.49 -41.39 13.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 74.420000000000002 110.166 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 3.0 pttp -62.74 -46.23 89.03 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.479 -0.782 . . . . 71.120000000000005 109.115 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 107' ' ' LYS . . . -67.35 -49.93 61.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.985 -1.007 . . . . 73.420000000000002 110.2 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.672 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.1 t80 -51.4 -65.82 0.49 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 116.295 -0.411 . . . . 74.010000000000005 110.023 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 12.3 m -48.56 -36.16 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.486 0.66 . . . . 64.200000000000003 109.732 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -61.05 -42.97 99.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.092 -0.958 . . . . 40.149999999999999 110.062 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.731 ' OD2' HG12 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -72.39 -15.47 61.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 75.319999999999993 109.874 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.464 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.1 OUTLIER -81.46 -62.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.729 0.776 . . . . 73.219999999999999 109.345 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.464 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.8 p -62.36 -38.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.445 -1.252 . . . . 72.019999999999996 111.173 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.11 76.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.542 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.97 30.23 1.26 Allowed Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.628 -0.796 . . . . 74.530000000000001 111.731 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.99 -38.5 6.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.516 -0.342 . . . . 64.420000000000002 111.475 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.731 HG12 ' OD2' ' A' ' 112' ' ' ASP . 6.0 mt -87.23 148.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 70.430000000000007 110.518 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.25 163.88 44.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.785 -0.643 . . . . 65.140000000000001 111.328 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.99 122.52 10.66 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.54 2.16 . . . . 73.010000000000005 112.418 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.5 p -86.94 -79.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 64.439999999999998 110.551 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.4 162.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.63 97.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 74.450000000000003 111.221 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.85 49.22 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 73.040000000000006 110.169 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -153.74 87.61 3.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.54 -0.755 . . . . 72.430000000000007 110.057 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 73.8 Cg_endo -73.05 -170.45 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.439 2.093 . . . . 54.229999999999997 112.483 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 pt -114.56 84.66 10.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 72.109999999999999 111.55 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -58.55 -160.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.79 2.327 . . . . 63.509999999999998 111.993 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -106.5 96.46 6.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.991 -0.55 . . . . 71.140000000000001 110.859 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -118.64 125.53 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 74.349999999999994 110.901 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.34 -168.57 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.891 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 62.39 149.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 63.450000000000003 110.889 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.32 -1.267 . . . . 73.109999999999999 112.448 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.535 -0.226 . . . . 62.399999999999999 112.535 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.45 100.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.182 . . . . 75.209999999999994 112.311 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.78 30.12 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.530000000000001 110.87 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.29 114.57 0.36 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 51.520000000000003 112.55 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.73 145.26 31.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.662 0.268 . . . . 54.5 110.901 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.52 -25.9 12.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.588 2.192 . . . . 64.329999999999998 112.488 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.39 -81.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 63.43 111.077 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 2.6 mp -136.59 145.3 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 74.439999999999998 111.118 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.57 -168.55 40.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 73.430000000000007 112.268 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -86.22 122.11 29.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.866 0.365 . . . . 73.310000000000002 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.676 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 34.4 mt -77.73 137.03 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 110.959 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.66 -170.22 12.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.757 . . . . 74.329999999999998 112.55 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.0 3.89 7.22 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.781 2.32 . . . . 63.399999999999999 112.853 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.32 26.73 2.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 51.210000000000001 111.021 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 p -123.34 -35.46 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.420000000000002 111.022 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -56.06 -31.83 63.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 72.450000000000003 111.055 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.1 m -56.32 -26.01 50.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 72.239999999999995 110.848 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -85.64 -35.19 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.749 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 18.3 m-85 -78.47 -15.03 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.326 0.584 . . . . 72.349999999999994 109.604 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -31.34 12.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.217 -0.901 . . . . 60.310000000000002 110.16 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.29 -7.11 48.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 62.32 111.056 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -51.43 36.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 75.400000000000006 110.791 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.65 22.68 5.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 63.509999999999998 112.35 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 1.2 pt -133.38 169.52 13.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 73.340000000000003 111.341 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 15.6 Cg_exo -65.84 134.25 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.595 2.196 . . . . 52.020000000000003 112.302 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD13 ' CE2' ' A' ' 28' ' ' TYR . 3.4 tt -98.16 125.86 43.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 71.5 110.774 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.79 92.2 4.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.021 -0.536 . . . . 55.439999999999998 111.408 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.484 ' CE2' HD13 ' A' ' 26' ' ' LEU . 57.6 m-85 -82.17 124.58 30.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.765 -0.652 . . . . 73.0 109.909 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.4 mt -116.52 83.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.767 -0.373 . . . . 72.450000000000003 111.604 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CG ' HG23 ' A' ' 60' ' ' ILE . 4.6 m-85 -72.43 142.54 48.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.403 -0.591 . . . . 73.299999999999997 109.403 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.54 118.21 3.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.085 -0.507 . . . . 72.430000000000007 110.277 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.484 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 15.9 mt-10 -68.83 -14.02 62.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.686 -0.688 . . . . 74.299999999999997 110.144 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.38 130.29 42.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.221 0.534 . . . . 75.349999999999994 110.896 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.52 8.48 12.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.394 -0.821 . . . . 72.230000000000004 110.62 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -105.12 -49.69 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 60.310000000000002 110.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -96.08 18.96 12.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.791 -0.64 . . . . 71.430000000000007 111.011 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -28.05 37.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.763 0.316 . . . . 74.340000000000003 110.872 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -46.44 80.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.48 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -62.35 -48.11 81.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 74.530000000000001 110.662 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -59.38 -60.6 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.145 0.498 . . . . 71.019999999999996 110.733 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.7 m -61.65 -23.79 66.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.942 -0.572 . . . . 74.349999999999994 111.39 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.5 t0 -62.65 -63.41 1.23 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.235 0.54 . . . . 72.400000000000006 109.76 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.634 ' C ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -50.2 -30.15 10.9 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 123.411 1.577 . . . . 64.25 109.3 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' HA ' ' CG2' ' A' ' 47' ' ' ILE . 29.4 mt -77.05 -23.8 52.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.029 -1.896 . . . . 73.420000000000002 111.966 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.652 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 56.4 mmtt -63.9 -39.78 48.88 Favored Pre-proline 0 CA--C 1.52 -0.196 0 CA-C-N 115.926 -0.579 . . . . 63.109999999999999 111.505 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.719 ' HG2' ' H ' ' A' ' 47' ' ' ILE . 42.6 Cg_endo -76.77 -49.08 0.11 Allowed 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.249 1.966 . . . . 74.430000000000007 111.111 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.719 ' H ' ' HG2' ' A' ' 46' ' ' PRO . 1.1 tp -55.09 -27.54 19.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 119.099 -1.041 . . . . 64.109999999999999 109.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -92.4 -25.74 18.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.356 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -58.77 -23.78 60.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.357 -0.609 . . . . 72.150000000000006 109.357 178.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.95 -27.58 18.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.164 -0.926 . . . . 60.229999999999997 109.685 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 1.5 pt20 -129.45 50.55 2.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.787 -1.097 . . . . 74.319999999999993 110.586 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.2 ptt-85 -81.69 -28.01 33.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.226 -0.897 . . . . 72.209999999999994 111.087 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.56 14.1 27.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.599 -0.728 . . . . 71.439999999999998 112.399 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 8.7 p -123.05 -41.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.578 0.228 . . . . 75.319999999999993 111.089 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 74.3 mt -111.37 139.6 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.364 -0.236 . . . . 65.239999999999995 110.364 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 16.1 m-80 -81.77 87.99 6.31 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 110.555 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -73.59 102.78 3.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 75.340000000000003 111.193 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.676 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.33 130.41 6.02 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.928 -0.654 . . . . 71.140000000000001 112.756 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.509 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.4 p -91.1 140.79 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.239999999999995 111.137 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.612 HG23 ' CG ' ' A' ' 30' ' ' PHE . 12.4 tt -138.4 163.26 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.942 -0.572 . . . . 71.430000000000007 110.462 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' N ' HG12 ' A' ' 60' ' ' ILE . 32.8 t0 -88.34 118.83 28.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 74.299999999999997 112.103 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 79' ' ' PHE . . . -82.64 2.58 32.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.576 -0.283 . . . . 43.25 110.985 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -103.21 -32.57 9.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.482 -0.326 . . . . 73.310000000000002 111.507 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 -29.89 6.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.759 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CG ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.33 -11.22 17.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.596 -0.729 . . . . 74.209999999999994 111.263 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.2 -34.62 0.08 OUTLIER Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.49 -0.386 . . . . 64.5 113.873 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.61 -24.3 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 74.019999999999996 110.261 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -88.77 -10.43 48.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.402 -0.817 . . . . 61.130000000000003 111.216 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -72.53 -44.45 62.15 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.486 -0.325 . . . . 62.229999999999997 111.62 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -99.74 1.55 56.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.932 -1.127 . . . . 71.030000000000001 113.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -61.28 -9.39 5.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.484 -0.561 . . . . 50.32 109.484 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -116.47 -15.29 10.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.518 -0.765 . . . . 64.209999999999994 110.585 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.63 -69.55 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.99 0.424 . . . . 55.399999999999999 112.125 -178.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.519 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.8 mt -42.74 172.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.555 -0.748 . . . . 74.439999999999998 111.781 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.0 OUTLIER -110.36 -16.69 13.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.724 -0.671 . . . . 72.329999999999998 110.235 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 75' ' ' LYS . 1.7 p 79.51 41.93 0.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.259 -1.015 . . . . 74.420000000000002 108.259 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.16 -50.15 5.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.047 -1.433 . . . . 72.340000000000003 111.471 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 46.2 tttt -133.42 161.74 33.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.988 -0.551 . . . . 64.230000000000004 110.965 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.44 173.17 5.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 73.109999999999999 111.351 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.566 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 31.9 Cg_exo -58.98 163.81 25.56 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 123.596 -1.418 . . . . 63.140000000000001 112.895 0.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.32 162.69 30.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.831 -1.077 . . . . 75.129999999999995 109.485 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.449 ' CE2' ' CG1' ' A' ' 84' ' ' ILE . 57.0 t80 -138.53 127.93 24.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.736 0.303 . . . . 74.340000000000003 110.411 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -122.79 120.48 33.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.252 0.464 . . . . 75.540000000000006 112.252 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.449 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 15.4 mt -103.51 95.1 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 70.340000000000003 110.56 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.64 141.38 28.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 73.209999999999994 111.034 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 113' ' ' PHE . 38.1 mm-40 -108.01 110.21 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.011 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.63 -0.65 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 71.319999999999993 110.793 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.81 -43.04 8.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.274 -0.421 . . . . 73.150000000000006 110.876 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -116.48 -8.19 11.58 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.517 -0.31 . . . . 44.119999999999997 111.328 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 69.59 60.03 0.29 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.312 0.577 . . . . 71.239999999999995 109.481 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -114.74 179.1 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.84 . . . . 71.040000000000006 111.558 -178.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.92 92.15 2.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.419 -0.81 . . . . 75.519999999999996 111.159 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.505 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 71.0 m-85 -106.4 72.05 0.27 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 111.308 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 73.7 Cg_endo -80.71 -176.78 3.34 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.442 2.094 . . . . 72.109999999999999 112.927 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 38.5 t80 -110.68 175.93 5.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.759 -0.655 . . . . 64.049999999999997 110.478 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -78.86 176.94 9.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 72.030000000000001 110.714 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -114.39 -19.09 11.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 62.530000000000001 111.326 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.1 16.94 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 110.91 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 2.5 tppp? -90.5 -14.54 32.48 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.059 -0.518 . . . . 71.049999999999997 111.376 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 23.3 tt0 88.81 112.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.283 0.563 . . . . 74.200000000000003 110.566 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.1 mt -91.5 96.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 75.549999999999997 111.357 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.08 -154.19 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 72.030000000000001 109.385 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.613 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -94.07 -72.81 0.6 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.584 -0.895 . . . . 74.200000000000003 108.584 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.539 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.68 -32.6 0.6 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.058 0.456 . . . . 72.409999999999997 111.095 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.06 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.649 -0.705 . . . . 64.019999999999996 112.335 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 102' ' ' THR . 26.1 mm -87.67 -49.09 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.66 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.6 pttt -52.78 -48.55 66.76 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.437 -0.801 . . . . 71.120000000000005 109.493 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.61 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.79 -51.95 54.79 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.913 -0.585 . . . . 73.420000000000002 110.525 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 36.9 t80 -50.53 -63.03 1.25 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.192 -0.458 . . . . 74.010000000000005 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 2.1 m -52.76 -45.02 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 64.200000000000003 110.209 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -52.06 -40.32 60.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.669 0.747 . . . . 40.149999999999999 109.113 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.7 t70 -61.33 -34.2 74.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.506 -1.225 . . . . 75.319999999999993 108.276 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 114' ' ' VAL . 0.1 OUTLIER -72.85 -66.48 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 73.219999999999999 110.922 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.554 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.6 p -55.05 -44.46 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.962 -1.017 . . . . 72.019999999999996 111.864 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.86 72.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 74.230000000000004 110.898 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.73 32.79 1.83 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 110.663 -0.975 . . . . 74.530000000000001 110.663 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.886 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -104.44 -54.01 2.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.688 -0.756 . . . . 64.420000000000002 111.852 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.532 HG13 ' C ' ' A' ' 112' ' ' ASP . 54.3 mt -63.31 159.11 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.765 0.317 . . . . 70.430000000000007 110.424 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 118' ' ' ILE . 16.4 pt-20 -146.24 154.29 49.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 65.140000000000001 110.753 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -41.26 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.056 2.504 . . . . 73.010000000000005 112.474 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.0 m -66.11 -45.94 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 64.439999999999998 110.952 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 9.7 pt -155.25 159.31 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 72.420000000000002 111.059 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.8 38.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.450000000000003 110.788 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -123.8 172.68 8.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.983 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.48 85.11 6.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.501 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.11 154.12 22.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.624 2.216 . . . . 54.229999999999997 112.485 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 pp -146.48 82.01 9.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.109999999999999 111.085 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.08 -178.03 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.551 2.168 . . . . 63.509999999999998 112.245 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.84 47.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.140000000000001 110.936 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -171.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 74.349999999999994 110.79 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -106.22 165.43 11.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.876 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -113.54 158.7 20.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.450000000000003 110.904 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.334 -1.259 . . . . 73.109999999999999 112.475 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.483 -0.247 . . . . 62.399999999999999 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.87 -174.93 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.571 2.18 . . . . 75.209999999999994 112.347 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mt 62.01 148.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.530000000000001 111.119 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.87 169.13 23.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.851 -0.69 . . . . 51.520000000000003 112.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 3.3 t 179.13 -60.68 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.498 0.19 . . . . 54.5 111.206 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 5' ' ' SER . 19.5 Cg_endo -60.56 -46.58 16.79 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.444 2.096 . . . . 64.329999999999998 112.663 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.11 -85.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 63.43 111.133 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 4.3 mp -118.69 144.88 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 74.439999999999998 111.201 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.75 -145.25 9.92 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.399 -0.905 . . . . 73.430000000000007 112.308 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.97 133.2 35.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.977 0.418 . . . . 73.310000000000002 110.669 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.702 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.3 mt -87.08 147.35 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 71.319999999999993 111.154 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.46 177.79 19.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 74.329999999999998 112.546 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.61 -8.52 23.35 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.605 2.203 . . . . 63.399999999999999 112.674 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -126.49 27.81 6.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 51.210000000000001 110.848 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.8 p -125.66 -39.4 2.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 111.002 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -53.66 -31.82 49.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 72.450000000000003 111.109 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -26.94 32.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 110.903 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -84.86 -37.09 21.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 72.5 110.64 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 8.6 m-85 -78.87 -7.81 58.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.235 0.54 . . . . 72.349999999999994 109.864 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.67 -29.74 10.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.308 -0.86 . . . . 60.310000000000002 110.259 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 t -98.54 -2.5 38.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.571 . . . . 62.32 111.166 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.42 4.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.991 0.424 . . . . 75.400000000000006 110.885 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.41 22.17 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.988 -0.625 . . . . 63.509999999999998 112.291 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.55 162.51 57.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.573 0.225 . . . . 73.340000000000003 111.006 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 20.7 Cg_exo -61.38 137.56 70.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.399 2.066 . . . . 52.020000000000003 112.569 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.471 HD12 ' CE2' ' A' ' 28' ' ' TYR . 3.3 tt -96.66 126.48 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 71.5 110.357 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.63 90.79 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.161 -0.472 . . . . 55.439999999999998 111.512 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.471 ' CE2' HD12 ' A' ' 26' ' ' LEU . 65.7 m-85 -81.88 124.92 30.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 73.0 110.033 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 2.3 mt -117.99 83.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.797 -0.361 . . . . 72.450000000000003 111.669 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.635 ' CG ' HG23 ' A' ' 60' ' ' ILE . 6.2 m-85 -70.12 151.86 44.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.476 -0.564 . . . . 73.299999999999997 109.476 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -166.52 119.81 1.05 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.111 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 19.9 mt-10 -74.51 -10.67 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.783 -0.644 . . . . 74.299999999999997 109.624 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -78.68 110.44 13.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.634 . . . . 75.349999999999994 111.215 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.37 2.15 33.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 72.230000000000004 111.073 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.78 -35.52 4.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.165 -0.471 . . . . 60.310000000000002 111.061 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.86 20.23 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 111.216 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.42 72.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.331 . . . . 74.340000000000003 110.833 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -55.66 -40.82 72.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.688 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.52 -44.74 81.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 74.530000000000001 110.589 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.09 -62.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.704 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.618 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.5 m -55.85 -26.52 47.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 74.349999999999994 111.538 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' LYS . 2.7 t70 -63.64 -59.21 4.9 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.613 0.72 . . . . 72.400000000000006 109.706 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.686 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.9 -31.32 11.96 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.746 1.26 . . . . 64.25 108.742 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -81.47 -17.79 47.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.813 -1.54 . . . . 73.420000000000002 111.964 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.628 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -54.1 -42.77 95.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.944 -0.762 . . . . 63.109999999999999 108.944 178.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.686 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 9.9 Cg_endo -84.44 -39.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.636 2.224 . . . . 74.430000000000007 110.421 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.705 HD13 ' HB ' ' A' ' 106' ' ' ILE . 45.6 mt -50.86 -20.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-N 116.173 -0.467 . . . . 64.109999999999999 109.965 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -113.44 -24.6 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 111.228 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -60.17 -20.46 58.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.17 0.51 . . . . 72.150000000000006 109.899 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.85 -27.1 17.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.791 0.805 . . . . 60.229999999999997 109.24 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -127.73 46.5 2.54 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.345 -1.298 . . . . 74.319999999999993 110.502 -178.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.1 ptt85 -80.0 -30.38 39.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.383 -0.826 . . . . 72.209999999999994 111.109 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.18 11.98 33.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.873 -0.68 . . . . 71.439999999999998 112.379 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 11.3 p -119.8 -35.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.496 0.189 . . . . 75.319999999999993 111.25 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 91.1 mt -123.46 146.2 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.512 -0.313 . . . . 65.239999999999995 110.696 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 8.6 m-80 -87.15 85.46 7.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.784 0.326 . . . . 73.319999999999993 110.171 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.6 m-85 -72.46 110.52 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.284 0.564 . . . . 75.340000000000003 111.552 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.702 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -139.92 124.35 2.67 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.304 -0.862 . . . . 71.140000000000001 112.2 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.476 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 80.0 p -83.2 155.82 23.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.029 0.443 . . . . 73.239999999999995 111.315 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.635 HG23 ' CG ' ' A' ' 30' ' ' PHE . 13.3 tt -150.98 163.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 71.430000000000007 110.206 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 60' ' ' ILE . 46.0 t0 -88.78 119.04 28.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.407 -0.361 . . . . 74.299999999999997 111.845 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' A' ' 79' ' ' PHE . . . -82.48 1.04 39.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.548 -0.296 . . . . 43.25 110.975 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.9 ttpt -101.67 -32.43 10.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.435 -0.348 . . . . 73.310000000000002 111.265 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.88 -29.96 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.105 0.478 . . . . 73.030000000000001 110.346 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.449 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -105.25 -15.02 15.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.789 . . . . 74.209999999999994 111.057 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -34.23 -36.61 0.06 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 114.1 0.4 . . . . 64.5 114.1 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.57 -19.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.582 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.41 -10.61 40.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 61.130000000000003 111.042 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . . . -69.58 -51.53 34.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 120.858 0.361 . . . . 62.229999999999997 111.007 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.7 1.99 69.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.915 -1.135 . . . . 71.030000000000001 113.663 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.66 -10.24 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.332 0.566 . . . . 50.32 109.667 177.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' O ' ' CE ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -113.49 -17.21 12.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.631 -0.713 . . . . 64.209999999999994 109.998 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 74' ' ' LEU . 1.1 m-20 -179.85 -68.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.46 0.541 . . . . 55.399999999999999 112.46 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.1 mm? -39.85 168.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.24 -0.891 . . . . 74.439999999999998 112.241 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -110.14 -4.49 15.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.826 -0.625 . . . . 72.329999999999998 111.06 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 p 58.69 36.85 25.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.01 0.433 . . . . 74.420000000000002 110.199 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -84.13 -32.0 24.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 72.340000000000003 110.825 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -148.74 163.19 38.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 64.230000000000004 110.23 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.522 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.45 174.37 3.91 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.897 -0.592 . . . . 73.109999999999999 111.215 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 31.9 Cg_exo -58.01 166.74 15.9 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.792 -1.337 . . . . 63.140000000000001 113.019 0.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 164.82 27.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.051 -0.977 . . . . 75.129999999999995 110.143 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.8 t80 -141.98 133.81 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 74.340000000000003 111.49 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -126.41 116.17 20.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 75.540000000000006 110.949 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 22.9 mt -99.91 90.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 70.340000000000003 110.342 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' LEU . 3.0 tm0? -78.95 144.87 34.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 73.209999999999994 111.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -110.64 111.54 22.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 110.637 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.4 t -82.39 9.43 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.726 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.96 -42.86 5.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.257 -0.428 . . . . 73.150000000000006 110.314 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.9 mmtt -114.15 -12.41 12.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.278 -0.419 . . . . 44.119999999999997 110.912 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 10.5 t-20 79.53 22.83 0.52 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.356 0.598 . . . . 71.239999999999995 109.688 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -82.2 167.74 18.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.158 -0.928 . . . . 71.040000000000006 111.53 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.524 ' H ' HE21 ' A' ' 91' ' ' GLN . 0.9 OUTLIER -139.2 101.06 4.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.381 -0.827 . . . . 75.519999999999996 111.111 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.489 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 76.8 m-85 -103.55 74.33 0.2 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.928 -0.578 . . . . 75.519999999999996 110.899 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 56.5 Cg_endo -80.8 165.29 20.05 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.795 2.33 . . . . 72.109999999999999 113.126 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.411 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 35.7 t80 -95.94 173.29 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.745 -0.661 . . . . 64.049999999999997 110.573 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -75.84 177.95 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 72.030000000000001 110.986 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -112.08 -20.92 11.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.199 -0.455 . . . . 62.530000000000001 111.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.83 24.06 4.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.919 0.39 . . . . 72.430000000000007 111.069 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.495 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -94.4 -11.81 29.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.981 -0.554 . . . . 71.049999999999997 111.191 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.5 tt0 91.02 106.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.9 -0.591 . . . . 74.200000000000003 110.661 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.1 mt -91.73 96.92 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.269 -0.878 . . . . 75.549999999999997 111.495 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -121.63 -164.89 1.18 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.226 -0.657 . . . . 72.030000000000001 109.226 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.573 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -78.22 -71.43 0.43 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.471 -0.566 . . . . 74.200000000000003 109.471 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.556 ' N ' ' CD2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -42.83 -37.72 1.91 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.969 -1.014 . . . . 72.409999999999997 111.645 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -72.68 -35.84 67.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.698 -1.137 . . . . 64.019999999999996 113.202 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.705 ' HB ' HD13 ' A' ' 47' ' ' ILE . 27.8 mm -89.48 -49.07 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.674 -0.491 . . . . 74.420000000000002 109.674 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.605 ' HB3' HG12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.92 -43.91 60.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.803 -0.635 . . . . 71.120000000000005 109.633 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.95 -49.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.679 -0.691 . . . . 73.420000000000002 110.202 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 21.1 t80 -49.15 -64.13 0.9 Allowed 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.699 -0.482 . . . . 74.010000000000005 109.699 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 17.7 m -51.05 -43.09 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 64.200000000000003 109.954 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.2 t0 -50.83 -41.19 57.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.438 0.637 . . . . 40.149999999999999 109.954 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.925 ' OD1' ' N ' ' A' ' 118' ' ' ILE . 3.2 t0 -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.944 -1.025 . . . . 75.319999999999993 108.795 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.611 ' N ' HG13 ' A' ' 118' ' ' ILE . 1.3 t80 -72.6 -67.02 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.191 -0.913 . . . . 73.219999999999999 110.343 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.455 ' N ' ' CD2' ' A' ' 113' ' ' PHE . 17.5 t -49.93 -48.32 22.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.934 . . . . 72.019999999999996 111.491 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.41 -38.77 63.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 74.230000000000004 110.606 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.49 29.98 2.34 Favored Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 110.709 -0.956 . . . . 74.530000000000001 110.709 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.782 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.15 -49.21 3.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.917 -0.641 . . . . 64.420000000000002 111.661 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.925 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 29.1 mt -63.46 146.84 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.762 -0.458 . . . . 70.430000000000007 109.762 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.431 ' N ' HG21 ' A' ' 118' ' ' ILE . 1.4 mt-10 -136.02 171.0 9.53 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 65.140000000000001 110.948 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.97 115.46 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.497 2.131 . . . . 73.010000000000005 112.319 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.7 t -81.97 -66.51 0.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.439999999999998 111.221 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -115.59 -30.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 72.420000000000002 111.04 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -24.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 74.450000000000003 112.112 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.0 t -60.44 -179.11 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.636 -0.711 . . . . 73.040000000000006 110.815 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -147.18 85.23 6.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 72.430000000000007 110.599 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 -173.76 1.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.577 2.184 . . . . 54.229999999999997 112.452 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 127' ' ' ILE . 27.7 mm -116.72 84.44 15.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 72.109999999999999 111.08 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.89 -161.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.829 2.353 . . . . 63.509999999999998 112.27 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.63 82.19 2.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 71.140000000000001 110.908 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -75.76 128.5 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.948 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.19 176.85 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 110.785 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 61.5 154.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 63.450000000000003 110.913 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.44 -1.2 . . . . 73.109999999999999 112.504 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.934 0.397 . . . . 71.450000000000003 110.837 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 t -69.03 -23.53 64.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 55.149999999999999 111.5 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 9.8 t70 -74.72 -38.71 62.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.084 0.468 . . . . 72.5 110.855 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 22.0 m-85 -80.28 -22.98 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.336 0.588 . . . . 72.349999999999994 109.743 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.673 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.4 -33.24 22.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.287 -0.87 . . . . 60.310000000000002 110.276 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -88.81 -12.97 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 62.32 110.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -63.79 -36.69 84.73 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.41 -0.359 . . . . 73.530000000000001 111.078 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.57 20.54 29.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.82 -0.705 . . . . 63.509999999999998 112.676 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.428 HD11 ' OD1' ' A' ' 56' ' ' ASN . 1.4 pt -135.38 148.62 66.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 73.340000000000003 111.02 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HB2' HG12 ' A' ' 55' ' ' ILE . 48.2 Cg_exo -47.07 140.17 14.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.533 2.155 . . . . 52.020000000000003 112.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 28' ' ' TYR . 2.4 tt -102.5 123.19 45.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 71.5 110.645 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -98.62 93.32 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.878 -0.601 . . . . 55.439999999999998 111.282 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 26' ' ' LEU . 63.5 m-85 -81.98 140.17 34.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.835 -0.621 . . . . 73.0 110.485 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -132.3 85.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.467 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.837 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 3.8 m-85 -73.08 148.6 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.671 -0.492 . . . . 73.299999999999997 109.671 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -162.95 119.84 1.9 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.118 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 32.2 mt-10 -73.87 -9.46 58.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.583 -0.735 . . . . 74.299999999999997 110.116 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -99.97 99.89 10.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.479 . . . . 75.349999999999994 111.129 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.82 12.22 22.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 72.230000000000004 111.226 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 -45.32 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.435 -0.348 . . . . 60.310000000000002 110.833 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.39 13.88 26.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.369 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -40.77 -31.54 0.17 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.529 -0.305 . . . . 74.340000000000003 111.77 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.37 85.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 62.439999999999998 111.197 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -57.31 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 74.530000000000001 111.242 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.3 -56.38 22.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.106 0.479 . . . . 71.019999999999996 110.854 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 10.3 m -58.11 -22.44 50.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.764 . . . . 74.349999999999994 112.14 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -70.18 -61.29 1.83 Allowed 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.636 0.731 . . . . 72.209999999999994 109.233 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.629 ' C ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.55 -29.41 16.93 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 122.884 1.326 . . . . 64.25 108.707 177.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.872 HD23 HD12 ' A' ' 47' ' ' ILE . 24.2 mt -77.96 -25.05 47.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.435 -1.711 . . . . 73.319999999999993 111.346 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.32 -45.87 89.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.435 -0.802 . . . . 63.109999999999999 109.835 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 18.2 Cg_endo -82.3 -38.7 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.516 2.144 . . . . 74.430000000000007 110.646 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 HD23 ' A' ' 44' ' ' LEU . 57.0 mt -51.24 -21.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 116.086 -0.506 . . . . 64.109999999999999 110.48 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -112.75 -25.84 8.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 71.120000000000005 111.249 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -61.56 -19.44 62.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.215 0.531 . . . . 72.150000000000006 109.841 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.6 -27.69 17.99 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.394 -0.821 . . . . 60.229999999999997 109.461 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 54' ' ' VAL . 1.2 pt20 -124.49 41.01 3.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.405 -1.27 . . . . 74.319999999999993 110.621 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptt85 -70.85 -32.79 69.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.465 -0.788 . . . . 72.209999999999994 111.06 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.47 12.22 39.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 71.439999999999998 112.738 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.9 p -125.67 -27.82 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.777 0.288 . . . . 75.319999999999993 111.777 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' CD ' ' A' ' 51' ' ' GLN . 70.0 mt -133.18 140.57 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.574 0.226 . . . . 65.239999999999995 110.636 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -90.94 97.22 11.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.789 0.328 . . . . 73.319999999999993 111.012 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.8 ' CD2' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -77.85 113.64 15.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 74.209999999999994 111.515 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.9 126.73 3.99 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.549 -0.75 . . . . 71.140000000000001 112.131 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 11.5 p -86.1 148.02 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 111.068 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.921 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.0 tt -145.7 163.47 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 71.430000000000007 110.653 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.9 t0 -87.05 119.79 27.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 74.25 112.014 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.961 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.43 2.15 38.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.702 0.287 . . . . 43.25 110.903 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 18.3 tptm -102.1 -33.04 9.84 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.47 -0.332 . . . . 73.310000000000002 111.7 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 -31.98 6.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.172 0.511 . . . . 73.030000000000001 110.457 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.921 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.35 -16.06 17.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 71.140000000000001 111.07 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.96 -38.88 0.03 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 114.441 0.537 . . . . 64.5 114.441 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.62 -25.86 11.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.279 0.54 . . . . 74.019999999999996 110.379 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -85.78 -12.5 50.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 61.109999999999999 111.546 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.89 -42.19 73.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.685 0.278 . . . . 62.229999999999997 111.269 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.06 0.17 47.89 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.084 -1.055 . . . . 71.030000000000001 113.489 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.0 -11.02 4.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.376 -0.601 . . . . 50.32 109.376 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.65 -16.01 12.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.396 -0.82 . . . . 64.209999999999994 110.441 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.746 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -177.7 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.074 0.464 . . . . 55.399999999999999 112.228 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.716 HD22 ' CD ' ' A' ' 97' ' ' GLN . 87.9 mt -41.43 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.405 -0.816 . . . . 74.439999999999998 112.557 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -118.85 4.48 11.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.276 -0.875 . . . . 72.329999999999998 110.467 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' ' 67' ' ' ALA . 5.5 p 58.21 32.61 22.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.516 . . . . 74.420000000000002 110.715 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 16.0 p-10 -82.17 -31.41 30.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.327 -0.397 . . . . 72.340000000000003 111.384 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 7.2 tttt -147.61 161.61 40.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 44.039999999999999 111.256 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.961 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -157.39 170.2 9.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.544 -0.753 . . . . 72.200000000000003 111.258 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.76 160.0 44.9 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 123.538 -1.443 . . . . 54.200000000000003 113.237 0.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.32 165.59 20.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.198 -0.91 . . . . 75.129999999999995 110.006 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 5.3 t80 -139.23 128.37 23.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.797 0.332 . . . . 64.099999999999994 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -120.33 145.93 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 75.540000000000006 111.702 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.889 HG22 ' OE2' ' A' ' 86' ' ' GLU . 57.7 mt -123.26 86.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 70.340000000000003 110.082 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.84 125.96 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 73.209999999999994 111.187 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.889 ' OE2' HG22 ' A' ' 84' ' ' ILE . 9.8 mp0 -95.32 117.69 30.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.841 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -84.54 4.92 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.009 -0.541 . . . . 71.319999999999993 111.328 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.37 -41.64 5.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 73.150000000000006 110.793 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -15.32 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 44.119999999999997 110.957 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 78.08 32.68 0.36 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.527 0.68 . . . . 71.239999999999995 109.559 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.493 ' H ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -95.14 166.57 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 63.100000000000001 111.254 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 6.8 mmtm -142.6 97.14 3.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.553 -0.749 . . . . 75.519999999999996 110.92 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.626 ' O ' HD12 ' A' ' 84' ' ' ILE . 17.2 m-85 -102.63 75.6 0.19 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 75.519999999999996 111.002 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 84.7 Cg_endo -78.35 -176.13 3.09 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 54.450000000000003 112.638 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -107.08 169.97 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 64.049999999999997 110.789 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.32 160.02 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 71.010000000000005 111.179 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.716 ' CD ' HD22 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.47 26.86 9.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 62.530000000000001 110.902 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -157.63 23.64 0.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 72.430000000000007 110.602 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -113.32 -68.13 0.95 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.845 -0.616 . . . . 71.049999999999997 110.954 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 1.7 tt0 159.86 118.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.902 -0.59 . . . . 74.200000000000003 109.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.23 89.2 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 75.549999999999997 111.584 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -117.14 -155.94 0.61 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.809 -0.812 . . . . 72.030000000000001 108.809 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -89.88 -73.65 0.51 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.755 -0.831 . . . . 72.319999999999993 108.755 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.51 -34.16 0.21 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.86 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.03 61.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 62.240000000000002 112.432 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.651 ' HB ' HD13 ' A' ' 47' ' ' ILE . 41.0 mm -88.14 -47.91 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.757 -0.46 . . . . 74.420000000000002 109.757 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -54.44 -45.37 73.06 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 109.695 178.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -69.8 -48.0 60.75 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 110.156 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 118' ' ' ILE . 18.4 t80 -52.38 -67.08 0.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.077 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.66 HG12 HD11 ' A' ' 84' ' ' ILE . 19.3 m -47.67 -40.14 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 62.439999999999998 109.966 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -56.96 -42.34 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.381 -0.827 . . . . 40.149999999999999 110.215 178.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.859 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -74.65 -14.58 60.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.652 -0.703 . . . . 75.319999999999993 110.014 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -81.04 -61.29 2.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.558 -0.746 . . . . 73.219999999999999 108.997 178.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.477 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 21.9 t -55.77 -46.41 79.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.658 -1.155 . . . . 72.019999999999996 110.879 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.94 64.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 74.230000000000004 110.782 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.96 30.29 1.65 Allowed Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.578 -0.82 . . . . 74.530000000000001 111.663 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -101.81 -38.65 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.397 -0.402 . . . . 64.420000000000002 111.417 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.976 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.2 mt -85.75 151.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.897 0.38 . . . . 61.450000000000003 110.628 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -145.15 173.94 3.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.947 -0.57 . . . . 65.140000000000001 111.274 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo . . . . . 0 C--N 1.345 0.344 0 C-N-CA 122.598 2.198 . . . . 73.010000000000005 112.36 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' SER . 17.0 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.818 0.342 . . . . 71.450000000000003 111.177 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.449 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m -53.98 -25.95 23.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 55.149999999999999 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.8 -38.54 18.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.02 0.438 . . . . 72.5 110.635 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 26.5 m-85 -78.08 -6.26 54.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 72.349999999999994 109.898 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.638 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.62 -54.42 3.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 60.310000000000002 110.045 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -17.35 64.23 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.85 -0.614 . . . . 62.32 110.919 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.74 -31.78 58.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.901 0.382 . . . . 73.530000000000001 111.021 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.38 5.99 64.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.935 -0.65 . . . . 63.509999999999998 112.596 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.62 156.41 53.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 73.340000000000003 110.989 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.95 142.74 96.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 52.020000000000003 112.594 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.2 tt -103.34 137.62 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 71.5 110.808 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -110.15 97.13 6.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.106 -0.497 . . . . 55.439999999999998 111.112 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.795 ' CD2' HD22 ' A' ' 26' ' ' LEU . 40.4 m-85 -85.99 127.47 34.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 73.0 109.985 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mt -121.51 83.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.13 0.419 . . . . 72.450000000000003 112.13 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.785 ' HA ' HG23 ' A' ' 60' ' ' ILE . 2.8 m-85 -71.96 144.43 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.959 -0.756 . . . . 73.299999999999997 108.959 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -155.1 117.37 4.21 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.430000000000007 111.082 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -80.17 -6.34 57.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.298 -0.865 . . . . 74.299999999999997 110.163 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.9 p -84.7 104.87 15.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 75.349999999999994 111.059 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.4 16.78 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 72.230000000000004 111.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -123.61 -42.05 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 60.310000000000002 110.778 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' ARG . 2.8 pt-20 -99.7 -8.85 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 71.430000000000007 111.574 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 36' ' ' GLU . 1.6 ptp180 -31.31 -40.47 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.366 0.506 . . . . 74.340000000000003 112.366 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -54.51 -51.5 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.965 0.412 . . . . 62.439999999999998 110.844 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.6 mt-10 -60.18 -36.75 78.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 110.963 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -63.52 -50.59 68.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 71.019999999999996 110.779 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' HD12 ' A' ' 44' ' ' LEU . 51.1 m -65.17 -22.51 66.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 74.349999999999994 111.242 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 3.7 t70 -66.81 -61.2 2.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.582 0.706 . . . . 72.209999999999994 109.105 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.899 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.05 -31.69 13.65 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.662 1.22 . . . . 64.25 108.991 177.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 29' ' ' ILE . 22.2 mt -76.48 -25.61 54.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.378 -1.737 . . . . 73.319999999999993 111.475 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 9.7 ttmm -51.6 -45.65 91.11 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.395 -0.82 . . . . 63.109999999999999 110.375 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 15.5 Cg_endo -83.76 -40.1 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.713 2.275 . . . . 74.430000000000007 111.649 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -54.92 -18.65 3.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.984 -0.686 . . . . 64.109999999999999 109.87 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.687 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -107.29 -30.82 8.5 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.813 -0.631 . . . . 71.120000000000005 111.213 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -60.83 -19.8 60.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.237 0.541 . . . . 72.150000000000006 109.888 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.2 -26.79 24.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.916 0.865 . . . . 60.229999999999997 109.029 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 6.9 pt20 -125.78 38.44 4.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.029 -1.441 . . . . 74.319999999999993 110.217 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -75.35 -25.21 57.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.446 -0.797 . . . . 72.209999999999994 110.992 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.78 20.16 20.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.811 -0.709 . . . . 71.439999999999998 112.137 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 51' ' ' GLN . 9.9 p -133.78 -37.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.65 0.262 . . . . 75.319999999999993 111.262 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 27' ' ' ALA . 43.6 mt -120.93 138.79 50.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 65.239999999999995 110.863 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-80 -82.85 109.09 16.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.858 0.361 . . . . 73.319999999999993 110.324 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.79 ' CE1' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -80.94 119.86 24.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.644 0.735 . . . . 74.209999999999994 112.843 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -146.24 122.98 1.74 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.907 -1.042 . . . . 71.140000000000001 111.911 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -89.81 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 73.239999999999995 111.059 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.891 HD11 ' CG ' ' A' ' 65' ' ' PHE . 14.0 tt -141.9 164.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.430000000000007 110.699 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 35.8 t0 -90.34 122.84 33.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.888 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.87 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.49 6.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.71 0.291 . . . . 43.25 110.711 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 22.5 tptp -106.31 -32.82 7.99 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.349 -0.387 . . . . 73.310000000000002 111.559 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.38 -31.21 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.148 0.499 . . . . 73.030000000000001 110.731 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.77 -12.97 17.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.543 -0.753 . . . . 71.140000000000001 111.311 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -35.39 -33.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 N-CA-C 114.027 0.371 . . . . 64.5 114.027 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -12.21 4.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.061 0.458 . . . . 74.019999999999996 110.617 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -102.59 -6.79 22.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.66 -0.7 . . . . 61.109999999999999 110.971 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.1 -54.99 9.18 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.763 0.316 . . . . 62.229999999999997 110.963 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.39 7.5 75.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.916 -1.135 . . . . 71.030000000000001 113.738 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.64 -8.74 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.02 -0.733 . . . . 50.32 109.02 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.2 -14.82 12.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.228 -0.896 . . . . 64.209999999999994 110.335 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.91 -69.91 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.261 0.553 . . . . 55.399999999999999 112.298 -178.219 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.855 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.2 mm? -40.31 170.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.092 -0.958 . . . . 74.439999999999998 112.419 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -110.01 -6.24 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 72.329999999999998 111.046 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 p 61.75 40.19 13.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.609 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.77 -33.01 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 72.340000000000003 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -149.51 163.25 38.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.111 -0.495 . . . . 44.039999999999999 110.427 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.87 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -153.34 177.45 1.96 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 72.200000000000003 111.126 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.619 ' O ' HD11 ' A' ' 101' ' ' ILE . 35.0 Cg_exo -57.54 158.22 29.27 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.022 -1.241 . . . . 54.200000000000003 112.781 1.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.4 128.87 46.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.234 -0.894 . . . . 75.129999999999995 110.226 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 84' ' ' ILE . 49.5 t80 -108.65 117.83 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.654 -0.248 . . . . 64.099999999999994 110.437 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -118.18 132.85 56.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.35 0.5 . . . . 75.540000000000006 112.35 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.715 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 25.6 mm -100.88 140.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 70.340000000000003 109.973 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -128.24 129.52 46.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.985 0.421 . . . . 73.209999999999994 110.842 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 1.2 mt-10 -105.08 112.72 25.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 74.420000000000002 110.198 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -78.86 -0.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 111.708 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.73 -44.33 6.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 73.150000000000006 110.692 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.84 -7.23 14.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 44.119999999999997 111.413 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 68.96 24.87 6.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.09 0.471 . . . . 71.239999999999995 110.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -75.37 169.51 17.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.731 -0.668 . . . . 63.100000000000001 111.541 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 1.3 mptt -139.94 95.37 2.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 75.519999999999996 110.756 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 68.1 m-85 -103.52 71.41 0.15 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 75.519999999999996 111.277 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.855 ' CB ' HD21 ' A' ' 74' ' ' LEU . 67.4 Cg_endo -79.12 -175.5 2.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.667 2.245 . . . . 54.450000000000003 113.608 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 82' ' ' PHE . 25.0 t80 -112.02 175.16 5.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 64.049999999999997 110.578 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 3.0 m-20 -78.76 174.98 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 71.010000000000005 110.882 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -114.64 -11.99 12.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 62.530000000000001 111.297 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.63 5.25 5.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 72.430000000000007 111.041 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 1.8 tppt? -86.17 -6.05 59.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.097 -0.501 . . . . 71.049999999999997 111.294 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 32.6 tt0 81.9 132.22 0.05 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.174 0.512 . . . . 74.200000000000003 111.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.619 HD11 ' O ' ' A' ' 80' ' ' PRO . 3.0 mp -109.02 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -113.41 -148.17 0.43 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 72.030000000000001 109.095 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.661 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -96.66 -70.81 0.7 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.97 -0.752 . . . . 72.319999999999993 108.97 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.624 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.11 -31.54 1.44 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.811 -0.631 . . . . 72.409999999999997 111.374 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -74.96 -33.0 61.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.688 -0.687 . . . . 62.240000000000002 111.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.815 ' O ' HG13 ' A' ' 110' ' ' VAL . 44.2 mm -91.22 -45.71 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.39 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.0 -42.22 93.76 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 109.414 178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.22 -50.73 29.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.244 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CE1' HD13 ' A' ' 118' ' ' ILE . 40.6 t80 -51.72 -63.77 1.03 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.467 -0.333 . . . . 73.219999999999999 110.261 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.5 m -49.14 -44.15 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 62.439999999999998 110.042 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -54.45 -40.67 68.61 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.783 0.802 . . . . 40.149999999999999 109.009 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.918 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 16.4 t70 -61.53 -34.86 76.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.326 -1.306 . . . . 75.319999999999993 108.336 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.796 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -72.86 -66.86 0.61 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 73.219999999999999 110.902 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.8 t -54.85 -45.21 74.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.22 -0.9 . . . . 72.019999999999996 111.994 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.44 70.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.856 0.36 . . . . 74.230000000000004 111.154 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.68 31.3 1.82 Allowed Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.06 -0.816 . . . . 74.530000000000001 111.06 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.918 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.43 -57.12 2.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.878 -0.661 . . . . 64.420000000000002 111.505 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.796 HD12 ' HB2' ' A' ' 113' ' ' PHE . 44.7 mt -64.27 151.1 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.789 -0.448 . . . . 61.450000000000003 109.789 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.32 163.96 36.25 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.357 -0.383 . . . . 65.140000000000001 111.542 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.815 2.344 . . . . 73.010000000000005 112.519 -179.544 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 17.6 m-85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.056 0.455 . . . . 71.450000000000003 111.383 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -51.53 -34.44 36.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.797 -0.638 . . . . 55.149999999999999 111.422 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -70.86 -39.12 73.08 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.147 0.499 . . . . 72.5 110.725 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 18.0 m-85 -77.39 -9.19 58.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.634 . . . . 72.349999999999994 109.678 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.768 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -99.97 -30.48 11.97 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.47 -0.787 . . . . 60.310000000000002 110.131 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -83.36 -17.93 40.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.685 -0.689 . . . . 62.32 110.572 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.7 -14.21 41.43 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.275 -0.42 . . . . 73.530000000000001 111.602 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.93 14.12 65.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 63.509999999999998 112.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 HD11 ' OD1' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -123.99 158.79 59.13 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.246 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HG2' HG12 ' A' ' 55' ' ' ILE . 26.7 Cg_endo -62.38 138.15 69.5 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 52.020000000000003 112.758 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 28' ' ' TYR . 1.5 tt -93.12 136.41 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.833 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -105.95 89.43 3.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 55.439999999999998 111.001 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.909 ' CE1' HD22 ' A' ' 26' ' ' LEU . 70.0 m-85 -81.19 136.6 35.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 73.0 110.404 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mp -131.53 89.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.855 0.359 . . . . 72.450000000000003 111.518 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.855 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.1 m-85 -70.88 149.18 47.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.303 -0.629 . . . . 73.299999999999997 109.303 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.644 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.73 119.07 2.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.233 0.54 . . . . 72.430000000000007 111.269 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 20.9 mt-10 -76.0 -7.23 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 74.299999999999997 109.972 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.6 p -76.53 123.44 26.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.209 -0.451 . . . . 75.349999999999994 110.848 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.12 9.52 18.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 72.230000000000004 111.087 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -50.43 2.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.404 -0.362 . . . . 60.310000000000002 110.735 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.69 15.04 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 111.196 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -49.1 -28.45 4.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 111.104 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.32 73.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 62.439999999999998 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 2.2 mm-40 -61.45 -48.91 79.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.736 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -58.45 -47.34 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 71.019999999999996 110.652 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 44' ' ' LEU . 67.0 m -67.17 -20.69 65.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.349999999999994 111.218 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 15.6 t0 -67.68 -60.6 2.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 72.209999999999994 108.946 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.662 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.48 -33.64 9.76 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.65 1.214 . . . . 64.25 108.633 177.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.086 HD11 HG21 ' A' ' 29' ' ' ILE . 25.9 mt -75.22 -25.95 58.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.317 -1.765 . . . . 73.319999999999993 112.188 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 3.4 mmpt? -51.44 -45.47 90.32 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 63.109999999999999 110.285 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.6 Cg_endo -83.26 -38.54 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.546 2.164 . . . . 74.430000000000007 111.13 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.062 HG21 HG22 ' A' ' 106' ' ' ILE . 24.0 mt -53.85 -17.35 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-N 116.367 -0.379 . . . . 64.109999999999999 110.14 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.784 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -114.98 -25.34 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.52 . . . . 71.120000000000005 111.151 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -64.91 -18.94 65.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.939 0.4 . . . . 72.150000000000006 110.669 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . . . -93.67 -9.95 36.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.81 . . . . 60.229999999999997 109.377 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.749 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -136.67 27.62 3.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.221 -1.354 . . . . 74.319999999999993 110.885 -176.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.5 ptt180 -61.4 -33.24 73.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.586 -0.734 . . . . 72.209999999999994 111.156 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.33 9.02 45.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.811 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 51' ' ' GLN . 10.3 p -122.35 -29.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.78 0.29 . . . . 75.319999999999993 111.609 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.813 HG21 ' HB2' ' A' ' 27' ' ' ALA . 79.7 mt -131.87 141.35 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 65.239999999999995 110.807 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -94.61 94.83 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 73.319999999999993 110.063 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.23 134.76 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 74.209999999999994 111.641 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.87 113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.787 -1.097 . . . . 71.140000000000001 111.86 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.3 p -80.87 150.14 29.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 73.239999999999995 110.316 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.901 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.2 tt -147.4 163.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.105 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 45.0 t0 -84.01 119.78 25.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.123 -0.49 . . . . 74.25 111.909 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.0 27.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.696 0.284 . . . . 43.25 110.859 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.2 ttpt -106.25 -31.88 8.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.548 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.95 -32.27 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 73.030000000000001 110.638 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.901 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.95 -12.4 18.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.518 -0.764 . . . . 71.140000000000001 111.404 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 76' ' ' THR . . . -33.57 -36.54 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.208 0.443 . . . . 64.5 114.208 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.17 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 74.019999999999996 110.448 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -89.21 -11.63 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.482 -0.781 . . . . 61.109999999999999 111.461 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.65 -44.12 57.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 111.76 0.281 . . . . 62.229999999999997 111.76 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.477 ' CA ' ' HB2' ' A' ' 74' ' ' LEU . . . -103.4 1.39 46.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.991 -1.099 . . . . 71.030000000000001 113.752 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.3 -8.81 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.187 -0.671 . . . . 50.32 109.187 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.65 -15.81 11.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.325 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.36 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.155 0.502 . . . . 55.399999999999999 112.022 -178.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.511 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 74.9 mt -44.88 178.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.275 -0.875 . . . . 74.439999999999998 112.168 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 5.25 8.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.61 -0.723 . . . . 72.329999999999998 110.597 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 66' ' ' GLY . 4.4 p 59.06 36.86 24.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.694 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.75 -36.49 15.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 111.27 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 0.2 OUTLIER -137.31 161.18 36.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.123 0.487 . . . . 44.039999999999999 110.746 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -159.44 169.04 11.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.738 -0.665 . . . . 72.200000000000003 111.607 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.8 161.87 40.47 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.395 -1.502 . . . . 54.200000000000003 113.12 0.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.12 161.17 29.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.478 -0.783 . . . . 75.129999999999995 110.038 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.4 t80 -132.3 123.39 26.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.67 0.272 . . . . 64.099999999999994 111.198 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -121.34 111.85 17.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 75.540000000000006 111.738 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 93' ' ' PHE . 6.8 mt -100.78 96.84 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.729 0.3 . . . . 70.340000000000003 110.822 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -89.6 147.8 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.474 -0.33 . . . . 73.209999999999994 110.584 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 8.7 mt-10 -106.69 114.15 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 74.420000000000002 110.851 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 20' ' ' MET . 13.1 t -79.8 0.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 110.968 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.46 -42.62 8.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.4 -0.364 . . . . 73.150000000000006 110.914 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.55 -7.88 10.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.487 -0.324 . . . . 44.119999999999997 111.454 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 70.53 62.19 0.21 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.413 -0.588 . . . . 71.239999999999995 109.413 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 1.4 tp-100 -114.15 173.74 6.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.33 -0.85 . . . . 63.100000000000001 111.575 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.638 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -137.27 92.53 2.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.416 -0.811 . . . . 75.519999999999996 110.807 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.765 ' O ' HD12 ' A' ' 84' ' ' ILE . 93.1 m-85 -104.77 68.7 0.16 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.638 -0.71 . . . . 75.519999999999996 111.314 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 76.5 Cg_endo -78.93 -175.58 2.83 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.263 1.975 . . . . 54.450000000000003 112.589 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 41.6 t80 -109.37 170.4 8.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.049999999999997 111.104 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.6 m-20 -76.37 170.48 16.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 71.010000000000005 110.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 7.2 mt-30 -119.83 27.29 8.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 62.530000000000001 110.746 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.12 26.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.501 . . . . 72.430000000000007 110.662 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 10.1 ttmt -112.0 0.05 15.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.996 -0.547 . . . . 71.049999999999997 111.668 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 78.31 98.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 74.200000000000003 110.325 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' PRO . 5.8 mt -80.01 97.71 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 75.549999999999997 111.59 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -120.51 -151.34 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.707 -0.849 . . . . 72.030000000000001 108.707 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.786 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -92.43 -66.93 0.89 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.925 -0.768 . . . . 72.319999999999993 108.925 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.02 -39.0 5.24 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.669 -0.696 . . . . 72.409999999999997 111.752 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 62.240000000000002 112.28 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HG21 ' A' ' 47' ' ' ILE . 50.1 mm -91.31 -48.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 74.420000000000002 110.235 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.878 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -42.21 80.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.962 -0.755 . . . . 71.120000000000005 108.962 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.52 -51.06 31.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.038 -0.528 . . . . 73.420000000000002 110.036 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.713 ' O ' HD11 ' A' ' 118' ' ' ILE . 67.5 t80 -50.4 -63.21 1.19 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 116.369 -0.378 . . . . 73.219999999999999 110.094 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.9 m -50.05 -41.97 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 62.439999999999998 109.494 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.1 t0 -53.61 -37.76 63.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.793 0.806 . . . . 40.149999999999999 108.959 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.911 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.3 t70 -66.84 -34.79 78.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.309 -1.314 . . . . 75.319999999999993 108.413 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.881 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -71.73 -68.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.244 -0.889 . . . . 73.219999999999999 110.984 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 55' ' ' ILE . 15.3 t -51.72 -46.86 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.268 -0.878 . . . . 72.019999999999996 111.996 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.66 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.230000000000004 111.018 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.56 31.01 2.06 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.575 -1.01 . . . . 74.530000000000001 110.575 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.911 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -102.92 -52.0 3.15 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.716 -0.742 . . . . 64.420000000000002 111.619 -178.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.881 HD12 ' HB2' ' A' ' 113' ' ' PHE . 57.7 mt -65.75 153.05 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.49 -0.559 . . . . 61.450000000000003 109.49 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.408 ' HG2' ' HD2' ' A' ' 120' ' ' PRO . 1.3 mt-10 -137.25 152.66 73.89 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 111.199 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 119' ' ' GLU . 57.1 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 122.542 2.161 . . . . 73.010000000000005 112.552 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.926 0.393 . . . . 71.450000000000003 111.202 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -56.45 -26.61 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 55.149999999999999 111.695 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.8 t0 -72.99 -43.69 61.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.013 0.435 . . . . 72.5 111.047 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 9.5 m-85 -78.97 -27.14 43.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.303 0.573 . . . . 72.349999999999994 109.718 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.588 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.33 -29.82 38.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.127 -0.942 . . . . 60.310000000000002 110.473 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -98.14 -6.51 31.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.912 -0.586 . . . . 62.32 110.624 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -64.51 -30.39 71.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.883 0.373 . . . . 73.530000000000001 111.015 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.74 54.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 63.509999999999998 112.602 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.12 156.54 76.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.706 0.289 . . . . 73.340000000000003 110.975 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' ILE . 12.1 Cg_endo -56.29 142.17 88.07 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.813 2.342 . . . . 52.020000000000003 112.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.1 tt -99.53 133.08 44.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 71.5 110.776 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -104.88 86.89 2.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 55.439999999999998 111.061 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.805 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 64.0 m-85 -75.06 141.03 43.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.606 -0.724 . . . . 73.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.851 HG21 ' CD1' ' A' ' 44' ' ' LEU . 1.9 mp -133.99 85.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.532 -0.303 . . . . 72.450000000000003 111.395 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 2.7 m-85 -72.15 145.42 48.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.758 -0.46 . . . . 73.299999999999997 109.758 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.74 117.3 3.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.153 0.502 . . . . 72.430000000000007 110.9 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 9.4 mt-10 -71.05 -12.43 61.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 74.299999999999997 110.396 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.26 97.54 7.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 111.218 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.94 5.9 41.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.726 -0.67 . . . . 72.230000000000004 110.986 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.72 -52.55 4.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.91 0.386 . . . . 60.310000000000002 110.508 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 13.22 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 71.430000000000007 111.108 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -46.55 -28.09 1.32 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.466 -0.334 . . . . 74.340000000000003 111.375 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.75 -45.61 78.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 110.764 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 6.3 mt-10 -66.73 -44.25 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.856 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.89 -57.12 12.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 110.817 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 20.4 m -63.33 -21.32 66.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.407 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 9.6 t70 -66.08 -65.39 0.68 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.546 0.688 . . . . 72.209999999999994 109.488 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.92 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -48.39 -31.82 6.72 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.653 1.216 . . . . 64.25 108.991 177.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.851 ' CD1' HG21 ' A' ' 29' ' ' ILE . 35.7 mt -77.53 -23.17 50.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.368 -1.742 . . . . 73.319999999999993 112.369 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 20.7 mttt -55.53 -43.62 99.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 63.109999999999999 110.152 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 23.9 Cg_endo -83.86 -41.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.648 2.232 . . . . 74.430000000000007 111.822 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -53.23 -22.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 C-N-CA 119.983 -0.687 . . . . 64.109999999999999 109.721 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.744 ' HB2' ' CE1' ' A' ' 57' ' ' PHE . . . -106.07 -27.66 10.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.549 -0.751 . . . . 71.120000000000005 111.211 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.1 tm-20 -59.43 -22.4 61.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.256 0.551 . . . . 72.150000000000006 109.921 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.43 29.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.303 -0.862 . . . . 60.229999999999997 109.464 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.681 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 6.9 pt20 -126.88 40.47 3.71 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.385 -1.28 . . . . 74.319999999999993 110.995 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptm180 -73.45 -32.25 64.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.662 . . . . 72.209999999999994 111.282 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.69 6.18 48.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 71.439999999999998 112.849 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 51' ' ' GLN . 12.4 p -116.84 -31.94 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 75.319999999999993 111.259 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 28.4 mt -128.46 144.72 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 110.691 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.19 104.74 16.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.559 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.83 ' CZ ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.9 132.88 42.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.354 0.597 . . . . 74.209999999999994 112.065 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.71 108.26 0.36 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.196 -0.911 . . . . 71.140000000000001 112.509 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.438 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 22.1 p -75.76 152.33 37.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.701 0.286 . . . . 73.239999999999995 110.383 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.881 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.8 tt -149.97 164.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 71.430000000000007 110.856 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 60' ' ' ILE . 31.2 t0 -85.99 120.23 27.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.842 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.912 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.2 5.29 30.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.698 0.285 . . . . 43.25 110.864 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 tttp -104.28 -33.04 8.81 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.45 -0.341 . . . . 73.310000000000002 111.543 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.32 -31.92 6.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.179 0.514 . . . . 73.030000000000001 110.684 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.04 -15.99 17.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 71.140000000000001 111.357 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -32.28 -37.46 0.04 OUTLIER Glycine 0 C--N 1.336 0.547 0 N-CA-C 114.301 0.48 . . . . 64.5 114.301 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.66 -17.27 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.43 . . . . 74.019999999999996 110.774 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -94.72 -9.24 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 61.109999999999999 111.214 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.24 -51.53 17.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.76 0.314 . . . . 62.229999999999997 111.434 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -91.33 1.34 76.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.861 -1.161 . . . . 71.030000000000001 113.911 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.87 -9.79 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.454 0.627 . . . . 50.32 109.462 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -115.78 -16.9 11.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 64.209999999999994 110.377 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.792 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -176.78 -71.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.24 0.459 . . . . 55.399999999999999 112.24 -178.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.609 HD12 HD11 ' A' ' 72' ' ' LEU . 1.8 mp -40.57 175.14 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 112.969 0.729 . . . . 74.439999999999998 112.969 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -107.86 -21.7 12.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.105 -0.952 . . . . 72.329999999999998 110.851 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 82.73 20.85 0.23 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.263 -1.014 . . . . 74.420000000000002 108.263 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -79.01 -48.76 13.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.663 -1.153 . . . . 72.340000000000003 111.51 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -118.98 158.86 24.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.207 0.527 . . . . 44.039999999999999 111.451 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.912 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -158.24 165.53 18.4 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.48 -0.782 . . . . 72.200000000000003 111.762 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 25.6 Cg_endo -61.9 157.15 59.09 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.158 -1.601 . . . . 54.200000000000003 112.915 0.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.597 ' HB1' HD22 ' A' ' 74' ' ' LEU . . . -119.47 164.44 15.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 75.129999999999995 109.363 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.533 ' CE2' HG12 ' A' ' 29' ' ' ILE . 2.5 t80 -138.44 131.29 29.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 64.099999999999994 111.167 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -122.6 147.42 46.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.540000000000006 111.661 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.644 HG21 ' CE2' ' A' ' 113' ' ' PHE . 57.5 mt -129.32 81.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 109.85 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LEU . 2.3 tt0 -75.4 138.4 41.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 73.209999999999994 111.333 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.9 mm-40 -100.65 118.62 37.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.706 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -88.62 20.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 71.319999999999993 110.345 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.67 -38.96 2.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.057 -0.519 . . . . 73.150000000000006 110.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tttt -113.64 -15.25 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.394 -0.367 . . . . 44.119999999999997 110.922 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 34.5 t-20 79.6 21.05 0.61 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.237 0.542 . . . . 71.239999999999995 109.949 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -84.67 164.65 18.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.321 -0.854 . . . . 63.100000000000001 111.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' O ' ' CD ' ' A' ' 94' ' ' PRO . 6.2 mmtt -139.56 99.15 3.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.25 -0.886 . . . . 75.519999999999996 110.757 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 17.4 m-85 -101.14 70.99 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.656 -0.702 . . . . 75.519999999999996 111.538 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 90.8 Cg_endo -75.39 168.66 24.09 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.554 2.17 . . . . 54.450000000000003 112.384 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' HD13 ' A' ' 106' ' ' ILE . 35.0 t80 -88.27 169.33 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.498 . . . . 64.049999999999997 110.684 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 2.9 m-20 -83.85 148.26 27.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 71.010000000000005 110.885 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 26.6 mt-30 -103.22 28.47 6.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.217 0.532 . . . . 62.530000000000001 110.381 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -155.94 18.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.73 -0.668 . . . . 72.430000000000007 110.648 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 1.5 ttmt -113.36 -7.89 13.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.137 -0.483 . . . . 71.049999999999997 111.611 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 22.3 tt0 83.97 97.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.258 0.552 . . . . 74.200000000000003 110.894 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.9 mt -72.84 93.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 75.549999999999997 111.153 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 4.8 p -111.15 -147.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.609 -0.515 . . . . 72.030000000000001 109.609 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.616 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.26 -59.83 1.64 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.39 -0.596 . . . . 72.319999999999993 109.39 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.581 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -56.14 -34.0 65.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.068 -0.969 . . . . 72.409999999999997 110.83 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.53 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.507 -0.77 . . . . 62.240000000000002 112.322 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.747 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.9 mm -89.93 -42.58 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 121.058 0.456 . . . . 74.420000000000002 110.552 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 10.8 pttt -61.79 -47.36 85.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.936 -0.764 . . . . 71.120000000000005 108.936 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.03 -51.47 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 73.420000000000002 110.324 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.753 ' O ' HD11 ' A' ' 118' ' ' ILE . 67.9 t80 -54.63 -64.91 0.68 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.015 -0.539 . . . . 73.219999999999999 110.894 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 106' ' ' ILE . 6.0 m -51.82 -37.4 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.127 0.489 . . . . 62.439999999999998 111.533 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.723 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -67.97 -35.79 78.96 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.694 -1.224 . . . . 40.149999999999999 107.694 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER -63.33 -37.27 86.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.347 -1.751 . . . . 75.319999999999993 108.025 177.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.806 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -63.8 -66.27 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.981 -1.009 . . . . 73.219999999999999 110.268 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.4 t -58.09 -36.95 59.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.916 -1.038 . . . . 72.019999999999996 111.876 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.58 78.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 74.230000000000004 111.393 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.78 25.87 2.24 Favored Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 120.535 -0.84 . . . . 74.530000000000001 111.724 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -98.12 -57.78 2.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.2 -0.5 . . . . 64.420000000000002 111.014 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.806 HD12 ' HB2' ' A' ' 113' ' ' PHE . 8.9 mt -71.43 150.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.89 -0.595 . . . . 61.450000000000003 110.092 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.12 171.94 5.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.261 -0.427 . . . . 65.140000000000001 111.364 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--N 1.345 0.359 0 C-N-CA 122.607 2.204 . . . . 73.010000000000005 112.35 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.011 0.434 . . . . 71.450000000000003 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 t -65.88 -22.44 66.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 55.149999999999999 111.57 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -70.77 -41.47 71.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 72.5 110.92 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 13.3 m-85 -79.53 -24.31 42.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 72.349999999999994 109.746 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.628 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.61 -42.41 29.01 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.269 -0.878 . . . . 60.310000000000002 110.359 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -85.26 -11.45 54.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 62.32 110.508 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -58.74 -31.4 68.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 73.530000000000001 111.069 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.27 15.9 56.51 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 63.509999999999998 112.708 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 87' ' ' VAL . 1.5 pt -133.28 158.3 76.06 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.699 0.285 . . . . 73.340000000000003 110.933 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.46 138.9 88.34 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.631 2.22 . . . . 52.020000000000003 112.6 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.848 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.7 tt -99.65 135.94 40.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 71.5 111.007 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.748 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -109.01 100.49 9.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 55.439999999999998 111.037 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 11.4 m-85 -85.47 132.03 34.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 73.0 110.057 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.2 mt -127.71 83.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.743 -0.383 . . . . 72.450000000000003 111.277 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.7 m-85 -71.51 149.79 45.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 109.801 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.57 116.87 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.28 0.562 . . . . 72.430000000000007 111.257 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 3.4 mt-10 -75.88 -7.97 55.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.208 -0.906 . . . . 74.299999999999997 110.027 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -99.84 92.63 5.39 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.179 -0.464 . . . . 75.349999999999994 111.094 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.76 6.38 35.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 72.230000000000004 111.488 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -34.49 10.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 60.310000000000002 110.779 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.98 9.66 16.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 71.430000000000007 111.317 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.8 -29.12 1.79 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.767 0.317 . . . . 74.340000000000003 111.335 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -54.74 -45.65 74.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 62.439999999999998 110.79 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.39 -36.36 81.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.772 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -66.4 -62.11 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.019999999999996 110.697 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.422 ' OG ' HG21 ' A' ' 59' ' ' THR . 7.2 m -57.68 -25.93 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.953 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.6 t0 -62.64 -59.7 4.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.531 0.681 . . . . 72.209999999999994 109.569 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.716 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.56 -33.36 9.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.601 1.191 . . . . 64.25 108.676 177.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -80.54 -17.58 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.831 -1.531 . . . . 73.319999999999993 112.185 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 4.8 tppt? -55.13 -42.84 98.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.207 -0.664 . . . . 63.109999999999999 109.207 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.716 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 11.8 Cg_endo -84.93 -38.64 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.69 2.26 . . . . 74.430000000000007 110.31 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 106' ' ' ILE . 55.1 mt -50.21 -22.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.507 0 CA-C-N 115.975 -0.557 . . . . 64.109999999999999 109.847 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -112.49 -25.55 9.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.621 -0.718 . . . . 71.120000000000005 111.506 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -59.8 -20.4 56.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.255 0.55 . . . . 72.150000000000006 109.771 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.37 -30.24 18.52 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.833 0.825 . . . . 60.229999999999997 108.969 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.686 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 7.0 pt20 -125.34 42.27 3.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.161 -1.381 . . . . 74.319999999999993 110.061 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.5 -29.14 46.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.153 -0.93 . . . . 72.209999999999994 111.04 -178.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 11.32 52.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 71.439999999999998 112.405 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.5 p -124.97 -33.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.636 0.255 . . . . 75.319999999999993 111.419 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 27' ' ' ALA . 72.5 mt -123.15 142.91 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 65.239999999999995 111.166 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.3 m-80 -90.57 87.7 6.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.755 -0.461 . . . . 73.319999999999993 109.755 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.836 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.0 m-85 -71.89 119.22 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 74.209999999999994 111.896 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -141.9 125.17 2.64 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.052 -0.976 . . . . 71.140000000000001 112.463 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.505 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 2.3 p -82.82 153.89 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.3 tt -150.68 164.16 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.028 -0.533 . . . . 71.430000000000007 110.531 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 43.0 t0 -87.13 120.26 28.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.296 -0.411 . . . . 74.25 112.072 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.953 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.25 26.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.965 -0.294 . . . . 43.25 110.898 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 8.1 ttmt -106.04 -33.02 8.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.449 -0.341 . . . . 73.310000000000002 111.455 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.3 -30.57 6.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 73.030000000000001 110.489 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.66 -11.64 17.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.507 -0.769 . . . . 71.140000000000001 111.276 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.03 -37.59 0.18 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 114.119 0.407 . . . . 64.5 114.119 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.71 10.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 74.019999999999996 110.483 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -93.0 -8.17 43.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 61.109999999999999 111.247 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.862 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -75.16 -46.9 31.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.656 -0.247 . . . . 62.229999999999997 111.642 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -97.67 1.41 59.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.982 -1.104 . . . . 71.030000000000001 113.784 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.61 -8.56 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.446 -0.576 . . . . 50.32 109.446 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -115.23 -15.61 11.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.398 -0.819 . . . . 64.209999999999994 110.17 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.44 -69.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.1 0.476 . . . . 55.399999999999999 112.135 -178.187 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.508 HD13 ' HB1' ' A' ' 81' ' ' ALA . 12.6 mt -42.52 174.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.277 -0.874 . . . . 74.439999999999998 112.151 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -120.29 3.67 10.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.539 -0.755 . . . . 72.329999999999998 110.345 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p 58.4 35.15 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.698 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.5 p30 -89.2 -31.27 18.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 72.340000000000003 111.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 28.1 tttt -143.53 157.27 44.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.108 0.48 . . . . 44.039999999999999 110.707 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.953 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.9 170.72 8.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.731 -0.668 . . . . 72.200000000000003 111.584 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 18.2 Cg_endo -60.24 162.09 36.68 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.422 -1.491 . . . . 54.200000000000003 113.013 0.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -123.92 162.41 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.755 . . . . 75.129999999999995 109.812 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 84' ' ' ILE . 42.0 t80 -138.49 124.6 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 64.099999999999994 111.132 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -119.63 148.43 43.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 111.499 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.853 HD11 ' CE2' ' A' ' 82' ' ' PHE . 12.9 mm -128.58 90.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 110.346 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.74 139.19 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 73.209999999999994 110.899 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.0 mt-10 -108.34 110.38 21.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 110.76 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 20' ' ' MET . 33.8 m -78.33 0.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 111.153 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.42 -39.43 8.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.434 -0.348 . . . . 73.150000000000006 111.17 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 -6.51 9.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.63 -0.259 . . . . 44.119999999999997 111.525 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.6 t30 66.19 64.58 0.52 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.546 -0.538 . . . . 71.239999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 tp-100 -122.26 169.66 10.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.5 -0.773 . . . . 63.100000000000001 111.735 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.609 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -134.96 92.01 2.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.204 -0.907 . . . . 75.519999999999996 111.602 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 70.0 m-85 -103.93 66.55 0.11 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.872 -0.603 . . . . 75.519999999999996 111.138 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 95.1 Cg_endo -77.18 -175.5 2.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.451 2.1 . . . . 54.450000000000003 112.998 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -112.66 168.61 9.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.847 -0.615 . . . . 64.049999999999997 110.943 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -72.44 176.3 5.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 71.010000000000005 110.733 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -118.18 -16.31 9.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 62.530000000000001 111.279 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -119.75 -8.13 9.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.829 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -70.96 -8.46 53.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.861 -0.609 . . . . 71.049999999999997 111.559 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.4 tt0 86.73 120.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.214 -0.448 . . . . 74.200000000000003 110.596 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.0 mt -103.94 110.01 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 111.59 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -131.21 -153.55 0.57 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.892 -0.781 . . . . 72.030000000000001 108.892 178.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.869 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.53 -66.16 0.95 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.624 -0.88 . . . . 72.319999999999993 108.624 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.703 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.19 -38.97 9.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.994 -1.003 . . . . 72.409999999999997 111.957 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -68.81 -32.88 72.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.69 0.626 . . . . 62.240000000000002 112.69 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 47' ' ' ILE . 32.9 mm -91.24 -45.76 14.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 109.942 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.841 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -45.77 83.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.844 -0.798 . . . . 71.120000000000005 108.844 178.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.36 36.8 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.774 -0.648 . . . . 73.420000000000002 110.125 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.741 ' CE1' HD13 ' A' ' 118' ' ' ILE . 48.7 t80 -49.77 -63.83 0.99 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.011 -0.366 . . . . 73.219999999999999 110.011 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 106' ' ' ILE . 8.3 m -49.17 -42.85 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.535 . . . . 62.439999999999998 109.569 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -52.97 -36.93 60.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.727 0.775 . . . . 40.149999999999999 109.204 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -69.3 -34.8 75.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 108.398 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.854 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.0 t80 -71.75 -69.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.255 -0.884 . . . . 73.219999999999999 110.874 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 55' ' ' ILE . 16.9 t -50.19 -47.46 24.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 72.019999999999996 111.987 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -36.96 67.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 74.230000000000004 111.019 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.75 29.41 2.24 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 110.864 -0.894 . . . . 74.530000000000001 110.864 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.916 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -101.76 -52.92 3.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.792 -0.704 . . . . 64.420000000000002 111.561 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.854 HD12 ' HB2' ' A' ' 113' ' ' PHE . 55.9 mt -66.43 152.94 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.483 -0.562 . . . . 61.450000000000003 109.483 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.81 168.09 19.04 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.395 -0.366 . . . . 65.140000000000001 111.449 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo . . . . . 0 C--N 1.344 0.336 0 C-N-CA 122.776 2.318 . . . . 73.010000000000005 112.728 -179.586 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.711 0.291 . . . . 71.450000000000003 111.113 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -55.59 -24.03 30.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 55.149999999999999 111.237 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -83.04 -40.88 19.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 72.5 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' HB2' HD12 ' A' ' 26' ' ' LEU . 15.6 m-85 -77.13 -18.31 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.372 0.606 . . . . 72.349999999999994 109.59 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.878 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.6 -32.17 17.23 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.091 -0.959 . . . . 60.310000000000002 110.233 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -90.9 -8.64 48.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.694 -0.685 . . . . 62.32 111.006 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.19 -56.21 10.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.935 0.397 . . . . 73.530000000000001 110.623 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.35 23.99 2.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.928 -0.653 . . . . 63.509999999999998 112.351 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.88 166.44 28.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.746 0.308 . . . . 73.340000000000003 111.296 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.1 Cg_exo -65.25 141.49 69.09 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.607 2.205 . . . . 52.020000000000003 112.357 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.922 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.8 tt -105.46 128.04 53.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.522 . . . . 71.5 110.564 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . . . -100.75 86.6 3.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.093 0.473 . . . . 55.439999999999998 111.451 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.922 ' CD1' HD22 ' A' ' 26' ' ' LEU . 62.4 m-85 -75.81 136.82 40.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.573 -0.739 . . . . 73.0 110.264 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 44' ' ' LEU . 2.8 mp -130.43 87.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.773 0.32 . . . . 72.450000000000003 111.178 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.854 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.5 m-85 -71.59 147.09 47.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.683 -0.488 . . . . 73.299999999999997 109.683 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.657 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -159.26 119.64 3.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.147 0.499 . . . . 72.430000000000007 110.828 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 12.1 mt-10 -74.32 -7.46 52.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.494 -0.776 . . . . 74.299999999999997 110.346 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -89.09 126.56 35.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 75.349999999999994 111.104 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.85 4.38 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.476 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.1 -38.33 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 60.310000000000002 110.474 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -104.34 15.96 27.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 111.074 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -59.23 -25.81 64.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 74.340000000000003 111.035 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -58.13 -44.08 87.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.365 . . . . 62.439999999999998 110.855 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.44 -42.93 82.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 74.530000000000001 110.981 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.06 -53.65 46.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 71.019999999999996 110.83 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 44' ' ' LEU . 49.8 m -64.86 -22.84 67.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.214 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 30.3 t0 -65.29 -61.6 2.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.567 0.698 . . . . 72.209999999999994 109.244 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -48.41 -32.96 8.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.604 1.192 . . . . 64.25 108.746 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.036 HD11 HG21 ' A' ' 29' ' ' ILE . 43.3 mt -76.62 -24.04 53.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.463 -1.699 . . . . 73.319999999999993 112.388 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.0 mtpt -53.73 -44.68 98.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 63.109999999999999 110.13 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.9 Cg_endo -83.21 -38.86 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.532 2.155 . . . . 74.430000000000007 110.819 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.842 ' CD1' HD23 ' A' ' 44' ' ' LEU . 58.7 mt -49.78 -23.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.912 -0.585 . . . . 64.109999999999999 110.102 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.747 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -110.82 -26.19 9.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 71.120000000000005 111.465 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.62 -18.83 61.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.128 0.49 . . . . 72.150000000000006 110.04 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.96 -28.94 17.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.76 0.79 . . . . 60.229999999999997 109.409 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.708 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 5.9 pt20 -121.31 38.96 3.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.311 -1.313 . . . . 74.319999999999993 110.597 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.1 ptm180 -75.04 -27.05 59.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 72.209999999999994 111.406 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.03 14.97 28.59 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.903 -0.665 . . . . 71.439999999999998 112.618 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 51' ' ' GLN . 7.5 p -128.81 -44.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 75.319999999999993 110.964 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 25' ' ' PRO . 30.0 mt -118.06 146.24 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 65.239999999999995 110.527 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -94.08 102.11 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.889 0.376 . . . . 73.319999999999993 110.406 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.747 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -80.01 136.69 36.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.348 0.594 . . . . 74.209999999999994 111.587 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.6 126.71 1.65 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.148 -0.933 . . . . 71.140000000000001 111.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 p -88.4 153.67 21.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 73.239999999999995 110.415 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.902 HD11 ' CG ' ' A' ' 65' ' ' PHE . 10.8 tt -147.91 162.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 71.430000000000007 110.853 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.501 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.3 t0 -83.55 117.4 23.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.178 -0.465 . . . . 74.25 112.183 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.947 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.05 5.35 22.61 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.673 0.273 . . . . 43.25 110.788 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 17.6 ttmt -103.67 -33.23 9.03 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.526 -0.306 . . . . 73.310000000000002 111.622 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.54 -32.42 5.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.224 0.535 . . . . 73.030000000000001 110.57 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.902 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.33 -16.47 17.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 71.140000000000001 111.101 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.65 -39.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.442 0.537 . . . . 64.5 114.442 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.02 -26.71 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.25 0.548 . . . . 74.019999999999996 110.459 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -83.29 -13.48 55.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 61.109999999999999 111.611 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.854 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.73 -36.76 70.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.667 0.27 . . . . 62.229999999999997 111.558 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -108.07 -0.44 33.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.917 -1.135 . . . . 71.030000000000001 113.416 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -10.68 6.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.507 -0.553 . . . . 50.32 109.507 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -113.93 -14.84 12.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.372 -0.831 . . . . 64.209999999999994 110.328 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.716 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.31 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.276 0.473 . . . . 55.399999999999999 112.276 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.549 HD13 ' HB1' ' A' ' 81' ' ' ALA . 96.6 mt -43.14 178.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.514 -0.766 . . . . 74.439999999999998 112.913 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.568 ' C ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -107.94 -24.53 11.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.969 -1.014 . . . . 72.329999999999998 110.495 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 78.95 21.54 0.68 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.206 -0.906 . . . . 74.420000000000002 108.609 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.67 -45.16 25.78 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.649 -1.159 . . . . 72.340000000000003 111.41 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -123.93 163.2 21.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.1 -0.5 . . . . 44.039999999999999 111.154 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.947 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -160.59 167.43 13.7 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 72.200000000000003 112.023 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 26.2 Cg_endo -62.34 158.1 60.37 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 123.16 -1.6 . . . . 54.200000000000003 113.05 0.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.712 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . . . -123.31 167.59 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.737 . . . . 75.129999999999995 109.969 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.7 t80 -138.36 130.32 28.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.669 0.271 . . . . 64.099999999999994 110.778 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.711 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -129.68 121.34 26.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.038 0.385 . . . . 75.540000000000006 112.038 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.684 HD11 HG12 ' A' ' 110' ' ' VAL . 31.1 mt -103.63 93.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 110.346 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 92' ' ' LYS . 50.8 tt0 -85.05 141.77 30.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.768 0.318 . . . . 73.209999999999994 110.741 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.0 mt-10 -112.43 109.9 19.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.958 0.408 . . . . 74.420000000000002 111.072 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.878 HG11 ' O ' ' A' ' 20' ' ' MET . 15.7 t -80.2 -1.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.797 -0.638 . . . . 71.319999999999993 110.904 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.87 -42.67 11.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.919 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -118.8 -9.01 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.552 -0.294 . . . . 44.119999999999997 111.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 t30 75.46 57.05 0.06 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.353 0.597 . . . . 71.239999999999995 109.562 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.645 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -121.49 166.44 14.16 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.179 -0.919 . . . . 63.100000000000001 110.932 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.645 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 5.4 mmtt -141.42 98.19 3.31 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.413 -0.812 . . . . 75.519999999999996 110.663 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.635 ' O ' HD12 ' A' ' 84' ' ' ILE . 64.1 m-85 -101.76 73.41 0.12 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.838 . . . . 75.519999999999996 110.866 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 53.7 Cg_endo -80.05 167.32 20.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 54.450000000000003 112.585 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' ' N ' ' A' ' 96' ' ' ASP . 40.5 t80 -96.08 166.15 11.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 64.049999999999997 110.828 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -63.67 173.81 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 71.010000000000005 110.392 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.712 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 7.1 mm-40 -117.15 -22.9 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.423 . . . . 62.530000000000001 111.369 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -127.52 25.61 6.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.378 . . . . 72.430000000000007 110.835 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.4 tppt? -93.33 -69.37 0.75 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.022 -0.536 . . . . 71.049999999999997 110.533 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 9.7 tt0 163.56 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.763 -0.653 . . . . 74.200000000000003 109.892 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 8.7 mt -91.25 88.09 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.549999999999997 111.735 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -112.25 -154.1 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.98 -67.57 0.85 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.741 -0.837 . . . . 72.319999999999993 108.741 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.82 -35.83 6.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.341 -0.845 . . . . 72.409999999999997 111.479 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -71.82 -33.38 68.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 62.240000000000002 112.426 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.702 ' HB ' HD13 ' A' ' 47' ' ' ILE . 50.0 mm -89.48 -46.43 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.113 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.666 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -58.47 -44.93 89.47 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.727 -0.67 . . . . 71.120000000000005 109.471 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -70.86 -49.01 50.77 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.696 -0.684 . . . . 73.420000000000002 110.123 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.79 ' O ' HD11 ' A' ' 118' ' ' ILE . 27.5 t80 -51.56 -67.2 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 109.822 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.684 HG12 HD11 ' A' ' 84' ' ' ILE . 21.9 m -47.16 -38.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.322 0.582 . . . . 62.439999999999998 109.869 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -57.87 -41.88 83.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.356 -0.838 . . . . 40.149999999999999 110.057 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.793 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -77.16 -11.93 59.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.615 -0.721 . . . . 75.319999999999993 110.263 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.941 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -82.0 -61.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.74 0.781 . . . . 73.219999999999999 109.153 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.543 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 11.5 p -57.94 -37.29 60.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.302 -1.317 . . . . 72.019999999999996 110.885 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.05 86.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 74.230000000000004 110.431 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.85 1.53 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.722 -0.751 . . . . 74.530000000000001 111.558 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.46 -37.13 6.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.296 -0.452 . . . . 64.420000000000002 111.704 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.4 mt -86.54 150.0 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.16 0.505 . . . . 61.450000000000003 110.508 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.48 162.56 45.92 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.479 -0.782 . . . . 65.140000000000001 111.079 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 91' ' ' GLN . 15.8 Cg_exo . . . . . 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 73.010000000000005 112.189 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.92 0.39 . . . . 71.450000000000003 111.374 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -64.49 -26.67 68.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 55.149999999999999 111.666 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.35 -38.39 60.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 72.5 111.015 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 23.0 m-85 -79.12 -23.44 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.362 0.601 . . . . 72.349999999999994 109.593 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.642 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -87.91 -25.47 23.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.118 -0.946 . . . . 60.310000000000002 110.379 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 t -95.31 -11.23 28.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.025 -0.534 . . . . 62.32 110.521 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.01 78.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.458 -0.337 . . . . 73.530000000000001 111.175 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 17.18 39.77 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.715 . . . . 63.509999999999998 112.666 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.97 161.1 65.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.718 0.294 . . . . 73.340000000000003 110.89 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.04 139.57 88.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.624 2.216 . . . . 52.020000000000003 112.688 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.898 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.3 tt -98.42 140.96 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 71.5 111.145 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -114.94 88.22 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 55.439999999999998 111.023 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.898 ' CD2' HD22 ' A' ' 26' ' ' LEU . 81.6 m-85 -76.87 133.97 39.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.69 -0.687 . . . . 73.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.0 mt -125.76 85.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.501 -0.318 . . . . 72.450000000000003 111.093 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.6 m-85 -73.24 148.84 43.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.299 -0.63 . . . . 73.299999999999997 109.299 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -157.18 115.13 3.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.383 0.611 . . . . 72.430000000000007 111.326 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -84.72 -1.25 55.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.022 -0.99 . . . . 74.299999999999997 109.901 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 p -106.6 112.48 25.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.974 -0.557 . . . . 75.349999999999994 110.662 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.32 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 72.230000000000004 111.375 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.36 -55.17 5.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.091 0.472 . . . . 60.310000000000002 110.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.487 ' OE2' HD23 ' A' ' 40' ' ' LEU . 3.7 pt-20 -82.38 -3.42 55.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 71.430000000000007 110.902 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 -44.83 -38.77 4.78 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 111.15 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.22 -56.11 9.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.676 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 7.4 pt-20 -58.2 -31.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 74.530000000000001 110.576 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.74 -57.54 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.042 0.449 . . . . 71.019999999999996 110.448 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HA ' HD12 ' A' ' 44' ' ' LEU . 25.6 m -63.43 -20.26 65.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 74.349999999999994 111.329 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t0 -65.94 -63.87 0.99 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.609 0.718 . . . . 72.209999999999994 109.345 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -47.85 -33.02 6.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.703 1.24 . . . . 64.25 108.684 177.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.913 HD23 HD12 ' A' ' 47' ' ' ILE . 52.1 mt -76.88 -23.32 52.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.43 -1.714 . . . . 73.319999999999993 112.467 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 10.8 mtpt -54.45 -43.95 98.37 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 116.431 -0.35 . . . . 63.109999999999999 110.073 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 21.0 Cg_endo -82.37 -39.85 0.15 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 110.543 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.993 HG21 HG22 ' A' ' 106' ' ' ILE . 47.1 mt -51.25 -22.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-N 116.045 -0.525 . . . . 64.109999999999999 109.948 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.734 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -111.22 -23.99 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.775 -0.648 . . . . 71.120000000000005 111.429 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -61.47 -20.74 63.49 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.195 0.521 . . . . 72.150000000000006 109.89 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.7 -26.54 19.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.422 -0.808 . . . . 60.229999999999997 109.338 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.718 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -125.66 42.21 3.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.441 -1.254 . . . . 74.319999999999993 110.793 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -76.32 -32.54 58.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.666 -0.697 . . . . 72.209999999999994 111.056 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.4 6.69 53.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.849 -0.691 . . . . 71.439999999999998 112.641 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 51' ' ' GLN . 13.1 p -119.09 -34.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 75.319999999999993 111.23 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.0 mt -122.94 143.95 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 65.239999999999995 111.009 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-80 -93.61 87.0 5.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 73.319999999999993 109.927 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.734 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m-85 -69.89 136.71 50.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 74.209999999999994 111.234 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.63 129.63 2.32 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.389 -0.823 . . . . 71.140000000000001 111.961 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 50.0 p -89.38 151.58 21.97 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.039 0.447 . . . . 73.239999999999995 110.878 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.951 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.3 tt -148.07 163.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.503 -0.771 . . . . 71.430000000000007 110.422 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.2 t0 -87.08 120.98 28.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.379 -0.373 . . . . 74.25 111.883 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.859 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.98 5.09 23.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.788 -0.365 . . . . 43.25 111.073 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 29.2 ttmt -105.08 -34.15 8.06 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 111.735 0.272 . . . . 73.310000000000002 111.735 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.57 -30.51 7.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.218 0.532 . . . . 73.030000000000001 110.417 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.951 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.77 -17.99 14.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.413 -0.812 . . . . 71.140000000000001 111.167 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -31.41 -39.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 114.239 0.456 . . . . 64.5 114.239 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.55 -19.03 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.058 0.429 . . . . 74.019999999999996 110.691 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -90.66 -11.83 38.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.805 -0.634 . . . . 61.109999999999999 111.183 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.19 -51.36 38.75 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.73 0.3 . . . . 62.229999999999997 111.048 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.52 1.75 69.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.739 -1.22 . . . . 71.030000000000001 113.778 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.61 -9.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.452 0.626 . . . . 50.32 109.668 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -114.29 -15.22 12.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.319 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.73 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.16 -70.02 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.246 0.546 . . . . 55.399999999999999 112.264 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.6 mm? -40.86 171.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 114.89 -1.05 . . . . 74.439999999999998 112.375 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.24 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 72.329999999999998 110.832 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 16.0 p 53.75 38.13 27.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.383 . . . . 74.420000000000002 110.825 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.64 -29.84 33.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 72.340000000000003 110.769 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -150.69 163.81 37.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.243 -0.435 . . . . 44.039999999999999 110.36 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.61 173.15 5.23 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.915 -0.584 . . . . 72.200000000000003 111.787 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.597 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 19.1 Cg_endo -60.36 164.63 30.24 Favored 'Cis proline' 0 C--N 1.353 0.793 0 C-N-CA 123.363 -1.515 . . . . 54.200000000000003 113.076 0.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.49 167.62 16.04 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.394 -0.821 . . . . 75.129999999999995 109.532 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.1 t80 -143.58 112.1 6.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 64.099999999999994 110.645 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -109.44 126.42 53.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 75.540000000000006 111.429 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 113' ' ' PHE . 11.8 mt -109.26 88.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.803 0.335 . . . . 70.340000000000003 110.42 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -84.92 138.5 32.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 73.209999999999994 110.6 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 9.7 mt-10 -100.11 115.28 29.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.922 0.391 . . . . 74.420000000000002 110.894 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -81.61 3.49 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.539 . . . . 71.319999999999993 110.827 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.99 -41.5 8.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.292 -0.413 . . . . 73.150000000000006 110.857 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -117.79 -15.93 10.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.637 -0.256 . . . . 44.119999999999997 111.308 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 35.4 t-20 81.18 40.75 0.05 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.324 0.583 . . . . 71.239999999999995 110.268 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 tp-100 -91.6 -174.74 3.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.339 -0.846 . . . . 63.100000000000001 111.152 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -150.28 93.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.56 -0.745 . . . . 75.519999999999996 110.713 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.61 ' O ' HD12 ' A' ' 84' ' ' ILE . 75.0 m-85 -105.18 70.07 0.2 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.835 -0.62 . . . . 75.519999999999996 111.353 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.889 ' CB ' HD21 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.56 178.65 6.42 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.683 2.255 . . . . 54.450000000000003 112.968 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 37.1 t80 -113.05 164.45 13.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 64.049999999999997 110.505 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -62.35 174.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 71.010000000000005 110.74 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -117.49 -23.27 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 62.530000000000001 111.21 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 24.93 6.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 110.847 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.3 tppt? -94.55 -77.3 0.47 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.019 -0.537 . . . . 71.049999999999997 110.534 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 3.8 tt0 173.74 105.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 74.200000000000003 110.4 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.0 mt -98.63 88.58 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.815 -0.63 . . . . 75.549999999999997 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -119.07 -164.68 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.28 -0.637 . . . . 72.030000000000001 109.28 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.76 -66.32 0.89 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.098 0.475 . . . . 72.319999999999993 110.099 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -48.98 -39.23 25.73 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.936 -1.029 . . . . 72.409999999999997 111.754 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -71.88 -34.94 69.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.067 -0.97 . . . . 62.240000000000002 113.412 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.993 HG22 HG21 ' A' ' 47' ' ' ILE . 46.2 mm -88.05 -44.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.0 0.429 . . . . 74.420000000000002 110.201 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -54.66 -42.97 71.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.866 -0.606 . . . . 71.120000000000005 109.511 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.81 36.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.621 -0.718 . . . . 73.420000000000002 110.139 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.722 ' O ' HD11 ' A' ' 118' ' ' ILE . 32.2 t80 -49.64 -64.74 0.72 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.631 -0.507 . . . . 73.219999999999999 109.631 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 111' ' ' ASP . 16.7 m -49.97 -41.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.765 -0.458 . . . . 62.439999999999998 109.765 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -55.58 -36.96 67.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.686 0.755 . . . . 40.149999999999999 109.133 178.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.927 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -68.03 -34.82 77.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.431 -1.259 . . . . 75.319999999999993 108.281 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.88 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -71.52 -69.05 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.099 -0.955 . . . . 73.219999999999999 111.025 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.606 ' CG2' HD11 ' A' ' 55' ' ' ILE . 11.9 t -52.36 -46.05 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.284 -0.871 . . . . 72.019999999999996 112.101 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.66 69.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.843 0.354 . . . . 74.230000000000004 111.235 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.36 31.17 1.9 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.86 -0.896 . . . . 74.530000000000001 110.86 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.927 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -103.25 -56.22 2.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.848 -0.676 . . . . 64.420000000000002 111.373 -178.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.88 HD12 ' HB2' ' A' ' 113' ' ' PHE . 50.4 mt -64.56 150.75 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.403 -0.591 . . . . 61.450000000000003 109.403 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.13 157.37 78.44 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 65.140000000000001 111.581 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.8 2.333 . . . . 73.010000000000005 112.611 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.853 0.358 . . . . 71.450000000000003 111.616 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.7 t -55.86 -30.83 62.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.051 -0.522 . . . . 55.149999999999999 111.965 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.678 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.7 t0 -87.09 -35.86 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.899 0.38 . . . . 72.5 111.251 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 11.7 m-85 -81.53 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 72.349999999999994 110.664 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.08 -28.85 9.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 60.310000000000002 110.577 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -97.15 -5.87 36.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.982 -0.554 . . . . 62.32 110.882 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.62 -40.12 76.78 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.906 0.384 . . . . 73.530000000000001 111.026 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.62 15.67 22.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.859 -0.686 . . . . 63.509999999999998 112.459 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.51 ' C ' HG22 ' A' ' 87' ' ' VAL . 2.1 pt -133.35 154.37 80.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.340000000000003 111.096 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 19.0 Cg_endo -60.34 145.12 99.27 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.84 2.36 . . . . 52.020000000000003 112.604 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 27' ' ' ALA . 3.1 tt -95.97 135.7 37.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.9 -0.591 . . . . 71.5 111.143 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' N ' HD23 ' A' ' 26' ' ' LEU . . . -104.72 95.27 5.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 55.439999999999998 110.793 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.476 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 6.5 m-85 -82.3 130.75 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 73.0 110.371 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.92 HG21 ' CD1' ' A' ' 44' ' ' LEU . 2.3 mp -124.38 83.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.81 -0.356 . . . . 72.450000000000003 111.339 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.8 m-85 -70.28 143.97 51.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.561 -0.533 . . . . 73.299999999999997 109.561 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -158.07 118.47 3.37 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.145 0.497 . . . . 72.430000000000007 111.028 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 23.4 mt-10 -71.26 -13.25 61.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 74.299999999999997 109.979 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 p -88.64 97.24 11.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 111.037 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.44 7.59 42.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 72.230000000000004 111.456 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -113.3 -46.46 3.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 60.310000000000002 110.83 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -92.93 1.55 57.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.381 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.59 -29.87 0.19 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.929 0.344 . . . . 74.340000000000003 111.929 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -49.78 -50.04 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 62.439999999999998 111.151 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 17.5 mt-10 -63.34 -44.03 96.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 74.530000000000001 111.103 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.57 -53.68 53.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 71.019999999999996 110.905 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 28.6 m -65.06 -19.85 66.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 74.349999999999994 111.383 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' LYS . 10.6 t0 -67.53 -62.03 1.62 Allowed 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.312 -0.625 . . . . 72.209999999999994 109.312 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.649 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.07 -32.82 10.28 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.844 1.307 . . . . 64.25 108.782 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.92 ' CD1' HG21 ' A' ' 29' ' ' ILE . 63.7 mt -77.65 -23.29 49.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.191 -1.822 . . . . 73.319999999999993 111.903 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 17.8 ttmt -52.27 -45.17 94.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.747 -0.661 . . . . 63.109999999999999 110.083 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.1 Cg_endo -83.96 -37.54 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.628 2.219 . . . . 74.430000000000007 110.537 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 44' ' ' LEU . 60.9 mt -50.33 -21.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 116.068 -0.515 . . . . 64.109999999999999 110.196 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -110.87 -32.44 6.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.177 -0.465 . . . . 71.120000000000005 111.797 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 2.0 tm-20 -59.39 -18.15 36.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.24 0.543 . . . . 72.150000000000006 110.179 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.14 -27.98 19.25 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.42 -0.809 . . . . 60.229999999999997 109.527 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 6.5 pt20 -121.48 36.07 4.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.449 -1.25 . . . . 74.319999999999993 110.814 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' ALA . 20.4 ptt-85 -67.08 -32.79 74.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.67 . . . . 72.209999999999994 111.326 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 9.61 49.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.645 -0.788 . . . . 71.439999999999998 112.83 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.6 p -123.78 -29.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.742 0.271 . . . . 75.319999999999993 111.581 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 27' ' ' ALA . 32.8 mt -132.84 153.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.54 -0.3 . . . . 65.239999999999995 110.428 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -102.82 109.8 21.51 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.994 0.426 . . . . 73.319999999999993 110.728 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -70.35 125.89 28.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.412 0.625 . . . . 74.209999999999994 111.136 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.29 100.43 0.21 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.025 -0.989 . . . . 71.140000000000001 112.572 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.4 p -77.74 152.95 33.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 73.239999999999995 110.521 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.969 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.6 tt -150.14 165.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 71.430000000000007 110.87 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 28.8 t0 -88.43 120.7 30.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.197 -0.456 . . . . 74.25 112.077 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.942 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -84.46 3.56 35.69 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.696 0.284 . . . . 43.25 111.0 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 11.1 tttt -104.42 -32.64 8.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.492 -0.322 . . . . 73.310000000000002 111.545 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.92 -30.25 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 73.030000000000001 110.616 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.68 -15.72 15.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.574 -0.739 . . . . 71.140000000000001 111.236 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -32.33 -38.09 0.05 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.269 0.467 . . . . 64.5 114.269 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.53 -12.38 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.175 0.487 . . . . 74.019999999999996 110.764 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' PHE . 47.9 t60 -103.08 -4.21 24.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.705 -0.68 . . . . 61.109999999999999 110.934 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.86 -53.18 10.78 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.739 0.305 . . . . 62.229999999999997 111.324 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.82 6.75 73.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 119.868 -1.158 . . . . 71.030000000000001 113.504 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.42 -9.8 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.09 -0.707 . . . . 50.32 109.09 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.74 -15.04 12.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.224 -0.898 . . . . 64.209999999999994 110.376 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.727 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER 179.06 -69.92 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.355 0.598 . . . . 55.399999999999999 112.288 -178.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 94' ' ' PRO . 1.5 mm? -40.96 173.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.016 -0.993 . . . . 74.439999999999998 112.594 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.606 ' C ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -101.89 -32.38 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 72.329999999999998 110.894 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.606 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.8 p 85.01 27.34 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.808 -1.087 . . . . 74.420000000000002 108.388 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.56 -45.55 17.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.535 -1.211 . . . . 72.340000000000003 111.017 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 21.9 tttp -130.1 163.28 26.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.88 -0.6 . . . . 44.039999999999999 111.074 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -157.07 169.83 9.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.578 . . . . 72.200000000000003 111.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 18.4 Cg_endo -60.61 160.53 42.74 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 123.446 -1.481 . . . . 54.200000000000003 113.189 0.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.13 159.93 32.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.379 -0.828 . . . . 75.129999999999995 109.812 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HG12 ' A' ' 110' ' ' VAL . 68.4 t80 -136.76 136.83 39.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 64.099999999999994 111.748 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -134.77 148.67 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 75.540000000000006 111.172 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.886 HG21 ' CE2' ' A' ' 113' ' ' PHE . 12.9 mt -123.66 94.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.33 . . . . 70.340000000000003 110.525 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.623 HE22 HG12 ' A' ' 87' ' ' VAL . 9.0 tm0? -77.71 136.67 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 110.89 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.9 mt-10 -107.39 116.06 31.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HE22 ' A' ' 85' ' ' GLN . 34.3 m -82.7 8.51 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 71.319999999999993 112.169 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.18 -40.02 3.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.813 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -105.7 -14.56 15.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 44.119999999999997 111.33 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.453 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 0.5 OUTLIER 74.44 19.56 2.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.925 0.393 . . . . 71.239999999999995 111.092 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 6.2 tp-100 -89.12 166.53 13.78 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.122 -0.49 . . . . 63.100000000000001 110.681 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 8.6 mmtt -141.06 85.38 1.98 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.819 -0.628 . . . . 75.519999999999996 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' O ' HD12 ' A' ' 84' ' ' ILE . 32.5 m-85 -81.31 100.73 0.77 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 75.519999999999996 110.688 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 74' ' ' LEU . 40.6 Cg_endo -105.47 168.92 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.431 2.754 . . . . 54.450000000000003 113.294 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 36.4 t80 -102.85 165.38 11.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 64.049999999999997 110.626 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -65.51 175.06 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 71.010000000000005 110.528 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 1.4 mt-30 -116.67 -24.61 7.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 62.530000000000001 111.218 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 9.5 pt-20 -124.41 25.86 7.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.397 . . . . 72.430000000000007 110.825 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.5 tppt? -96.34 -72.56 0.63 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.566 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 54.7 tt0 170.46 100.48 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.96 -0.563 . . . . 74.200000000000003 110.382 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.4 mt -94.63 90.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 75.549999999999997 111.064 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 22.1 p -116.22 -150.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.413 -0.358 . . . . 72.030000000000001 110.248 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.696 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -97.35 -56.39 2.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.436 0.636 . . . . 72.319999999999993 109.495 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -61.4 -39.29 90.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.733 -1.122 . . . . 72.409999999999997 110.722 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -70.75 -33.36 70.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 62.240000000000002 112.602 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.664 ' HB ' HD13 ' A' ' 47' ' ' ILE . 51.9 mm -89.49 -41.39 13.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 74.420000000000002 110.166 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.599 ' HB3' HG12 ' A' ' 47' ' ' ILE . 3.0 pttp -62.74 -46.23 89.03 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.479 -0.782 . . . . 71.120000000000005 109.115 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 107' ' ' LYS . . . -67.35 -49.93 61.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.985 -1.007 . . . . 73.420000000000002 110.2 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.672 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.1 t80 -51.4 -65.82 0.49 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 116.295 -0.411 . . . . 73.219999999999999 110.023 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 106' ' ' ILE . 12.3 m -48.56 -36.16 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.486 0.66 . . . . 62.439999999999998 109.732 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -61.05 -42.97 99.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.092 -0.958 . . . . 40.149999999999999 110.062 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.982 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -72.39 -15.47 61.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 75.319999999999993 109.874 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.952 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -81.46 -62.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.729 0.776 . . . . 73.219999999999999 109.345 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.464 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.8 p -62.36 -38.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.445 -1.252 . . . . 72.019999999999996 111.173 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.11 76.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.542 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.97 30.23 1.26 Allowed Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.628 -0.796 . . . . 74.530000000000001 111.731 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.99 -38.5 6.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.516 -0.342 . . . . 64.420000000000002 111.475 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.982 HD11 ' OD1' ' A' ' 112' ' ' ASP . 6.0 mt -87.23 148.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 61.450000000000003 110.518 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.25 163.88 44.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.785 -0.643 . . . . 65.140000000000001 111.328 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.344 0.337 0 C-N-CA 122.54 2.16 . . . . 73.010000000000005 112.418 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 p90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.729 0.3 . . . . 71.450000000000003 111.055 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.1 m -56.32 -26.01 50.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 55.149999999999999 110.848 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 25.0 m-20 -85.64 -35.19 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.749 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 18.3 m-85 -78.47 -15.03 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.326 0.584 . . . . 72.349999999999994 109.604 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.729 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.69 -31.34 12.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.217 -0.901 . . . . 60.310000000000002 110.16 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.29 -7.11 48.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 62.32 111.056 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.41 -51.43 36.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 73.530000000000001 110.791 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.65 22.68 5.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 63.509999999999998 112.35 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 1.2 pt -133.38 169.52 13.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 73.340000000000003 111.341 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 15.6 Cg_exo -65.84 134.25 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.595 2.196 . . . . 52.020000000000003 112.302 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.4 tt -98.16 125.86 43.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 71.5 110.774 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -101.79 92.2 4.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.021 -0.536 . . . . 55.439999999999998 111.408 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.885 ' CD2' HD22 ' A' ' 26' ' ' LEU . 57.6 m-85 -82.17 124.58 30.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.765 -0.652 . . . . 73.0 109.909 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.4 mt -116.52 83.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.767 -0.373 . . . . 72.450000000000003 111.604 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 4.6 m-85 -72.43 142.54 48.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.403 -0.591 . . . . 73.299999999999997 109.403 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.54 118.21 3.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.085 -0.507 . . . . 72.430000000000007 110.277 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 15.9 mt-10 -68.83 -14.02 62.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.686 -0.688 . . . . 74.299999999999997 110.144 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.38 130.29 42.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.221 0.534 . . . . 75.349999999999994 110.896 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.52 8.48 12.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.394 -0.821 . . . . 72.230000000000004 110.62 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -105.12 -49.69 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 60.310000000000002 110.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -96.08 18.96 12.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.791 -0.64 . . . . 71.430000000000007 111.011 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -28.05 37.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.763 0.316 . . . . 74.340000000000003 110.872 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -56.37 -46.44 80.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.48 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -62.35 -48.11 81.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 74.530000000000001 110.662 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.38 -60.6 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.145 0.498 . . . . 71.019999999999996 110.733 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.7 m -61.65 -23.79 66.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.942 -0.572 . . . . 74.349999999999994 111.39 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.5 t0 -62.65 -63.41 1.23 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.235 0.54 . . . . 72.209999999999994 109.76 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HZ2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -50.2 -30.15 10.9 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 123.411 1.577 . . . . 64.25 109.3 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.654 ' CD1' HG21 ' A' ' 29' ' ' ILE . 29.4 mt -77.05 -23.8 52.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.029 -1.896 . . . . 73.319999999999993 111.966 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.681 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 56.4 mmtt -63.9 -39.78 48.88 Favored Pre-proline 0 CA--C 1.52 -0.196 0 CA-C-N 115.926 -0.579 . . . . 63.109999999999999 111.505 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 42.6 Cg_endo -76.77 -49.08 0.11 Allowed 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.249 1.966 . . . . 74.430000000000007 111.111 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.739 HD11 ' CG2' ' A' ' 110' ' ' VAL . 1.1 tp -55.09 -27.54 19.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 119.099 -1.041 . . . . 64.109999999999999 109.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -92.4 -25.74 18.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.356 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -58.77 -23.78 60.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.357 -0.609 . . . . 72.150000000000006 109.357 178.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.95 -27.58 18.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.164 -0.926 . . . . 60.229999999999997 109.685 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.72 ' CD ' HD12 ' A' ' 55' ' ' ILE . 1.5 pt20 -129.45 50.55 2.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.787 -1.097 . . . . 74.319999999999993 110.586 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.2 ptt-85 -81.69 -28.01 33.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.226 -0.897 . . . . 72.209999999999994 111.087 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.56 14.1 27.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.599 -0.728 . . . . 71.439999999999998 112.399 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 51' ' ' GLN . 8.7 p -123.05 -41.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.578 0.228 . . . . 75.319999999999993 111.089 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.72 HD12 ' CD ' ' A' ' 51' ' ' GLN . 74.3 mt -111.37 139.6 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.364 -0.236 . . . . 65.239999999999995 110.364 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 10.2 m120 -81.77 87.99 6.31 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 110.555 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.639 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -73.59 102.78 3.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 111.193 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.33 130.41 6.02 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.928 -0.654 . . . . 71.140000000000001 112.756 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.4 p -91.1 140.79 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.239999999999995 111.137 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.4 tt -138.4 163.26 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.942 -0.572 . . . . 71.430000000000007 110.462 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' N ' HG12 ' A' ' 60' ' ' ILE . 32.8 t0 -88.34 118.83 28.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 74.25 112.103 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.952 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.64 2.58 32.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.576 -0.283 . . . . 43.25 110.985 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -103.21 -32.57 9.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.482 -0.326 . . . . 73.310000000000002 111.507 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 -29.89 6.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.759 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.876 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.33 -11.22 17.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.596 -0.729 . . . . 71.140000000000001 111.263 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.2 -34.62 0.08 OUTLIER Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.49 -0.386 . . . . 64.5 113.873 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.61 -24.3 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 74.019999999999996 110.261 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -88.77 -10.43 48.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.402 -0.817 . . . . 61.109999999999999 111.216 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 74' ' ' LEU . . . -72.53 -44.45 62.15 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.486 -0.325 . . . . 62.229999999999997 111.62 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -99.74 1.55 56.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.932 -1.127 . . . . 71.030000000000001 113.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -61.28 -9.39 5.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.484 -0.561 . . . . 50.32 109.484 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -116.47 -15.29 10.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.518 -0.765 . . . . 64.209999999999994 110.585 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.63 -69.55 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.99 0.424 . . . . 55.399999999999999 112.125 -178.219 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 69' ' ' ALA . 2.8 mt -42.74 172.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.555 -0.748 . . . . 74.439999999999998 111.781 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.558 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -110.36 -16.69 13.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.724 -0.671 . . . . 72.329999999999998 110.235 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.7 p 79.51 41.93 0.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.259 -1.015 . . . . 74.420000000000002 108.259 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.16 -50.15 5.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.047 -1.433 . . . . 72.340000000000003 111.471 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 46.2 tttt -133.42 161.74 33.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.988 -0.551 . . . . 44.039999999999999 110.965 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.952 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.44 173.17 5.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 72.200000000000003 111.351 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.98 163.81 25.56 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 123.596 -1.418 . . . . 54.200000000000003 112.895 0.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.32 162.69 30.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.831 -1.077 . . . . 75.129999999999995 109.485 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.495 ' HE2' HD11 ' A' ' 84' ' ' ILE . 57.0 t80 -138.53 127.93 24.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.736 0.303 . . . . 64.099999999999994 110.411 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -122.79 120.48 33.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.252 0.464 . . . . 75.540000000000006 112.252 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 93' ' ' PHE . 15.4 mt -103.51 95.1 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 70.340000000000003 110.56 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.64 141.38 28.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 73.209999999999994 111.034 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 38.1 mm-40 -108.01 110.21 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.011 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.729 HG11 ' O ' ' A' ' 20' ' ' MET . 7.3 t -79.63 -0.65 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 71.319999999999993 110.793 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.81 -43.04 8.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.274 -0.421 . . . . 73.150000000000006 110.876 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -116.48 -8.19 11.58 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.517 -0.31 . . . . 44.119999999999997 111.328 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 69.59 60.03 0.29 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.312 0.577 . . . . 71.239999999999995 109.481 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.533 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.4 tp-100 -114.74 179.1 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.84 . . . . 63.100000000000001 111.558 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.57 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.92 92.15 2.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.419 -0.81 . . . . 75.519999999999996 111.159 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 71.0 m-85 -106.4 72.05 0.27 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 111.308 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 73.7 Cg_endo -80.71 -176.78 3.34 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.442 2.094 . . . . 54.450000000000003 112.927 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' PHE . 38.5 t80 -110.68 175.93 5.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.759 -0.655 . . . . 64.049999999999997 110.478 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -78.86 176.94 9.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 71.010000000000005 110.714 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 41.0 mt-30 -114.39 -19.09 11.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 62.530000000000001 111.326 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.1 16.94 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 110.91 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 2.5 tppp? -90.5 -14.54 32.48 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.059 -0.518 . . . . 71.049999999999997 111.376 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 23.3 tt0 88.81 112.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.283 0.563 . . . . 74.200000000000003 110.566 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 80' ' ' PRO . 6.1 mt -91.5 96.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 75.549999999999997 111.357 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.663 HG22 ' HZ2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -118.08 -154.19 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 72.030000000000001 109.385 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -94.07 -72.81 0.6 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.584 -0.895 . . . . 72.319999999999993 108.584 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.547 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.68 -32.6 0.6 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.058 0.456 . . . . 72.409999999999997 111.095 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.06 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.649 -0.705 . . . . 62.240000000000002 112.335 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 110' ' ' VAL . 26.1 mm -87.67 -49.09 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.6 pttt -52.78 -48.55 66.76 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.437 -0.801 . . . . 71.120000000000005 109.493 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.631 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.79 -51.95 54.79 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.913 -0.585 . . . . 73.420000000000002 110.525 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.84 ' O ' HD11 ' A' ' 118' ' ' ILE . 36.9 t80 -50.53 -63.03 1.25 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 106' ' ' ILE . 2.1 m -52.76 -45.02 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 62.439999999999998 110.209 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -52.06 -40.32 60.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.669 0.747 . . . . 40.149999999999999 109.113 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.7 t70 -61.33 -34.2 74.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.506 -1.225 . . . . 75.319999999999993 108.276 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.789 ' CB ' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -72.85 -66.48 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 73.219999999999999 110.922 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.554 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.6 p -55.05 -44.46 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.962 -1.017 . . . . 72.019999999999996 111.864 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' N ' HG13 ' A' ' 114' ' ' VAL . . . -58.41 -35.86 72.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 74.230000000000004 110.898 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.73 32.79 1.83 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 110.663 -0.975 . . . . 74.530000000000001 110.663 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.91 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -104.44 -54.01 2.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.688 -0.756 . . . . 64.420000000000002 111.852 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 109' ' ' PHE . 54.3 mt -63.31 159.11 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.765 0.317 . . . . 61.450000000000003 110.424 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.518 ' N ' HG22 ' A' ' 118' ' ' ILE . 16.4 pt-20 -146.24 154.29 49.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 65.140000000000001 110.753 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 123.056 2.504 . . . . 73.010000000000005 112.474 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.1 p90 . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.805 0.336 . . . . 71.450000000000003 111.109 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -26.94 32.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 55.149999999999999 110.903 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 13.3 m-20 -84.86 -37.09 21.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 72.5 110.64 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' O ' HG21 ' A' ' 87' ' ' VAL . 8.6 m-85 -78.87 -7.81 58.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.235 0.54 . . . . 72.349999999999994 109.864 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.424 ' CE ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.67 -29.74 10.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.308 -0.86 . . . . 60.310000000000002 110.259 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 t -98.54 -2.5 38.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.571 . . . . 62.32 111.166 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -72.35 -57.42 4.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.991 0.424 . . . . 73.530000000000001 110.885 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.41 22.17 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.988 -0.625 . . . . 63.509999999999998 112.291 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.55 162.51 57.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.573 0.225 . . . . 73.340000000000003 111.006 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 20.7 Cg_exo -61.38 137.56 70.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.399 2.066 . . . . 52.020000000000003 112.569 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.3 tt -96.66 126.48 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 71.5 110.357 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -100.63 90.79 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.161 -0.472 . . . . 55.439999999999998 111.512 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.825 ' CD2' HD22 ' A' ' 26' ' ' LEU . 65.7 m-85 -81.88 124.92 30.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 73.0 110.033 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 2.3 mt -117.99 83.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.797 -0.361 . . . . 72.450000000000003 111.669 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.829 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.2 m-85 -70.12 151.86 44.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.476 -0.564 . . . . 73.299999999999997 109.476 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -166.52 119.81 1.05 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.111 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 19.9 mt-10 -74.51 -10.67 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.783 -0.644 . . . . 74.299999999999997 109.624 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -78.68 110.44 13.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.634 . . . . 75.349999999999994 111.215 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.37 2.15 33.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 72.230000000000004 111.073 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.78 -35.52 4.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.165 -0.471 . . . . 60.310000000000002 111.061 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.86 20.23 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 111.216 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.42 72.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.331 . . . . 74.340000000000003 110.833 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -55.66 -40.82 72.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.688 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.52 -44.74 81.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 74.530000000000001 110.589 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.013 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.09 -62.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.704 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -55.85 -26.52 47.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 74.349999999999994 111.538 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' LYS . 2.7 t70 -63.64 -59.21 4.9 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.613 0.72 . . . . 72.209999999999994 109.706 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.9 -31.32 11.96 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.746 1.26 . . . . 64.25 108.742 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -81.47 -17.79 47.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.813 -1.54 . . . . 73.319999999999993 111.964 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -54.1 -42.77 95.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.944 -0.762 . . . . 63.109999999999999 108.944 178.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 9.9 Cg_endo -84.44 -39.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.636 2.224 . . . . 74.430000000000007 110.421 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 106' ' ' ILE . 45.6 mt -50.86 -20.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-N 116.173 -0.467 . . . . 64.109999999999999 109.965 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -113.44 -24.6 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 111.228 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.17 -20.46 58.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.17 0.51 . . . . 72.150000000000006 109.899 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.85 -27.1 17.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.791 0.805 . . . . 60.229999999999997 109.24 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.688 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -127.73 46.5 2.54 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.345 -1.298 . . . . 74.319999999999993 110.502 -178.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.1 ptt85 -80.0 -30.38 39.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.383 -0.826 . . . . 72.209999999999994 111.109 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.18 11.98 33.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.873 -0.68 . . . . 71.439999999999998 112.379 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.3 p -119.8 -35.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.496 0.189 . . . . 75.319999999999993 111.25 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.1 mt -123.46 146.2 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.512 -0.313 . . . . 65.239999999999995 110.696 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.46 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 6.7 m120 -87.15 85.46 7.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.784 0.326 . . . . 73.319999999999993 110.171 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.763 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 3.6 m-85 -72.46 110.52 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.284 0.564 . . . . 74.209999999999994 111.552 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.92 124.35 2.67 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.304 -0.862 . . . . 71.140000000000001 112.2 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 80.0 p -83.2 155.82 23.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.029 0.443 . . . . 73.239999999999995 111.315 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 13.3 tt -150.98 163.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 71.430000000000007 110.206 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' N ' HG12 ' A' ' 60' ' ' ILE . 46.0 t0 -88.78 119.04 28.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.407 -0.361 . . . . 74.25 111.845 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.48 1.04 39.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.548 -0.296 . . . . 43.25 110.975 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.9 ttpt -101.67 -32.43 10.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.435 -0.348 . . . . 73.310000000000002 111.265 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.88 -29.96 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.105 0.478 . . . . 73.030000000000001 110.346 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -105.25 -15.02 15.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.789 . . . . 71.140000000000001 111.057 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -34.23 -36.61 0.06 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 114.1 0.4 . . . . 64.5 114.1 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.582 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.41 -10.61 40.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 61.109999999999999 111.042 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.58 -51.53 34.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 120.858 0.361 . . . . 62.229999999999997 111.007 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.7 1.99 69.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.915 -1.135 . . . . 71.030000000000001 113.663 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -59.66 -10.24 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.332 0.566 . . . . 50.32 109.667 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -113.49 -17.21 12.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.631 -0.713 . . . . 64.209999999999994 109.998 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.683 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.1 m-20 -179.85 -68.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.46 0.541 . . . . 55.399999999999999 112.46 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.902 HD21 ' CB ' ' A' ' 94' ' ' PRO . 2.1 mm? -39.85 168.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.24 -0.891 . . . . 74.439999999999998 112.241 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -110.14 -4.49 15.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.826 -0.625 . . . . 72.329999999999998 111.06 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 p 58.69 36.85 25.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.01 0.433 . . . . 74.420000000000002 110.199 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -84.13 -32.0 24.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 72.340000000000003 110.825 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -148.74 163.19 38.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 44.039999999999999 110.23 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.45 174.37 3.91 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.897 -0.592 . . . . 72.200000000000003 111.215 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.755 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.01 166.74 15.9 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.792 -1.337 . . . . 54.200000000000003 113.019 0.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 164.82 27.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.051 -0.977 . . . . 75.129999999999995 110.143 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HZ ' ' HB1' ' A' ' 27' ' ' ALA . 1.8 t80 -141.98 133.81 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 64.099999999999994 111.49 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -126.41 116.17 20.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 75.540000000000006 110.949 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 93' ' ' PHE . 22.9 mt -99.91 90.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 70.340000000000003 110.342 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' LEU . 3.0 tm0? -78.95 144.87 34.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 73.209999999999994 111.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.7 mt-10 -110.64 111.54 22.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 110.637 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' VAL . 26.4 t -82.39 9.43 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.726 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.96 -42.86 5.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.257 -0.428 . . . . 73.150000000000006 110.314 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.9 mmtt -114.15 -12.41 12.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.278 -0.419 . . . . 44.119999999999997 110.912 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 0.5 OUTLIER 79.53 22.83 0.52 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.356 0.598 . . . . 71.239999999999995 109.688 -179.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.484 ' NE2' ' HG3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -82.2 167.74 18.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.158 -0.928 . . . . 63.100000000000001 111.53 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 0.9 OUTLIER -139.2 101.06 4.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.381 -0.827 . . . . 75.519999999999996 111.111 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.679 ' O ' HD12 ' A' ' 84' ' ' ILE . 76.8 m-85 -103.55 74.33 0.2 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.928 -0.578 . . . . 75.519999999999996 110.899 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.902 ' CB ' HD21 ' A' ' 74' ' ' LEU . 56.5 Cg_endo -80.8 165.29 20.05 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.795 2.33 . . . . 54.450000000000003 113.126 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.431 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 35.7 t80 -95.94 173.29 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.745 -0.661 . . . . 64.049999999999997 110.573 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -75.84 177.95 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 71.010000000000005 110.986 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -112.08 -20.92 11.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.199 -0.455 . . . . 62.530000000000001 111.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.83 24.06 4.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.919 0.39 . . . . 72.430000000000007 111.069 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -94.4 -11.81 29.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.981 -0.554 . . . . 71.049999999999997 111.191 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.5 tt0 91.02 106.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.9 -0.591 . . . . 74.200000000000003 110.661 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 80' ' ' PRO . 7.1 mt -91.73 96.92 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.269 -0.878 . . . . 75.549999999999997 111.495 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -121.63 -164.89 1.18 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.226 -0.657 . . . . 72.030000000000001 109.226 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.919 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -78.22 -71.43 0.43 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.471 -0.566 . . . . 72.319999999999993 109.471 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.585 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.83 -37.72 1.91 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.969 -1.014 . . . . 72.409999999999997 111.645 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -72.68 -35.84 67.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.698 -1.137 . . . . 62.240000000000002 113.202 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 47' ' ' ILE . 27.8 mm -89.48 -49.07 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.674 -0.491 . . . . 74.420000000000002 109.674 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.834 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.92 -43.91 60.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.803 -0.635 . . . . 71.120000000000005 109.633 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.95 -49.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.679 -0.691 . . . . 73.420000000000002 110.202 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.808 ' O ' HD11 ' A' ' 118' ' ' ILE . 21.1 t80 -49.15 -64.13 0.9 Allowed 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.699 -0.482 . . . . 73.219999999999999 109.699 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 111' ' ' ASP . 17.7 m -51.05 -43.09 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 62.439999999999998 109.954 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.2 t0 -50.83 -41.19 57.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.438 0.637 . . . . 40.149999999999999 109.954 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.925 ' OD1' ' N ' ' A' ' 118' ' ' ILE . 3.2 t0 -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.944 -1.025 . . . . 75.319999999999993 108.795 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.924 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.3 t80 -72.6 -67.02 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.191 -0.913 . . . . 73.219999999999999 110.343 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.561 HG22 HD11 ' A' ' 55' ' ' ILE . 17.5 t -49.93 -48.32 22.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.934 . . . . 72.019999999999996 111.491 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.41 -38.77 63.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 74.230000000000004 110.606 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.49 29.98 2.34 Favored Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 110.709 -0.956 . . . . 74.530000000000001 110.709 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.804 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.15 -49.21 3.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.917 -0.641 . . . . 64.420000000000002 111.661 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.925 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 29.1 mt -63.46 146.84 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.762 -0.458 . . . . 61.450000000000003 109.762 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -136.02 171.0 9.53 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 65.140000000000001 110.948 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.484 ' HG3' ' NE2' ' A' ' 91' ' ' GLN . 81.6 Cg_exo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.497 2.131 . . . . 73.010000000000005 112.319 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.707 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.461 -0.256 . . . . 62.399999999999999 112.461 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.18 152.32 19.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.666 2.244 . . . . 75.209999999999994 112.262 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -148.41 30.94 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 61.530000000000001 110.898 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.54 -136.07 8.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.771 -0.728 . . . . 51.520000000000003 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.8 m -131.83 145.45 57.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.703 0.287 . . . . 54.5 110.928 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.21 134.55 19.41 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.563 2.176 . . . . 64.329999999999998 112.36 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -146.34 -74.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.887 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.812 HG23 ' HB3' ' A' ' 57' ' ' PHE . 83.4 mt -94.93 130.86 43.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.439999999999998 110.915 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.07 -118.47 0.82 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.68 -0.771 . . . . 73.430000000000007 112.2 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.92 136.11 40.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.749 0.309 . . . . 73.310000000000002 110.651 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.722 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 65.3 mt -90.67 128.01 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 71.319999999999993 110.972 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.6 -165.01 12.06 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 74.329999999999998 112.608 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.0 -25.43 14.06 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.647 2.231 . . . . 63.399999999999999 112.534 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.54 1.4 46.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 51.210000000000001 111.504 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 p -104.23 -28.94 11.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.843 0.354 . . . . 72.420000000000002 110.744 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -54.54 43.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 71.450000000000003 110.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 t -69.03 -23.53 64.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 55.149999999999999 111.5 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 9.8 t70 -74.72 -38.71 62.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.084 0.468 . . . . 72.5 110.855 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 22.0 m-85 -80.28 -22.98 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.336 0.588 . . . . 72.349999999999994 109.743 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.673 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.4 -33.24 22.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.287 -0.87 . . . . 60.310000000000002 110.276 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -88.81 -12.97 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 62.32 110.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -63.79 -36.69 84.73 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.41 -0.359 . . . . 73.530000000000001 111.078 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.57 20.54 29.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.82 -0.705 . . . . 63.509999999999998 112.676 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.428 HD11 ' OD1' ' A' ' 56' ' ' ASN . 1.4 pt -135.38 148.62 66.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 73.340000000000003 111.02 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HB2' HG12 ' A' ' 55' ' ' ILE . 48.2 Cg_exo -47.07 140.17 14.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.533 2.155 . . . . 52.020000000000003 112.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 28' ' ' TYR . 2.4 tt -102.5 123.19 45.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 71.5 110.645 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -98.62 93.32 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.878 -0.601 . . . . 55.439999999999998 111.282 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 26' ' ' LEU . 63.5 m-85 -81.98 140.17 34.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.835 -0.621 . . . . 73.0 110.485 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -132.3 85.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.468 -0.333 . . . . 72.450000000000003 111.467 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.837 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 3.8 m-85 -73.08 148.6 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.671 -0.492 . . . . 73.299999999999997 109.671 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -162.95 119.84 1.9 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.118 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 32.2 mt-10 -73.87 -9.46 58.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.583 -0.735 . . . . 74.299999999999997 110.116 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -99.97 99.89 10.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.479 . . . . 75.349999999999994 111.129 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.82 12.22 22.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 72.230000000000004 111.226 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 -45.32 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.435 -0.348 . . . . 60.310000000000002 110.833 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.39 13.88 26.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.369 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -40.77 -31.54 0.17 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.529 -0.305 . . . . 74.340000000000003 111.77 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.37 85.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 62.439999999999998 111.197 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -57.31 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 74.530000000000001 111.242 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.3 -56.38 22.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.106 0.479 . . . . 71.019999999999996 110.854 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 10.3 m -58.11 -22.44 50.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.764 . . . . 74.349999999999994 112.14 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -70.18 -61.29 1.83 Allowed 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.636 0.731 . . . . 72.209999999999994 109.233 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' C ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.55 -29.41 16.93 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 122.884 1.326 . . . . 64.25 108.707 177.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.872 HD23 HD12 ' A' ' 47' ' ' ILE . 24.2 mt -77.96 -25.05 47.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.435 -1.711 . . . . 73.319999999999993 111.346 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.32 -45.87 89.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.435 -0.802 . . . . 63.109999999999999 109.835 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 18.2 Cg_endo -82.3 -38.7 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.516 2.144 . . . . 74.430000000000007 110.646 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 HD23 ' A' ' 44' ' ' LEU . 57.0 mt -51.24 -21.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 116.086 -0.506 . . . . 64.109999999999999 110.48 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -112.75 -25.84 8.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 71.120000000000005 111.249 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -61.56 -19.44 62.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.215 0.531 . . . . 72.150000000000006 109.841 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.6 -27.69 17.99 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.394 -0.821 . . . . 60.229999999999997 109.461 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 54' ' ' VAL . 1.2 pt20 -124.49 41.01 3.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.405 -1.27 . . . . 74.319999999999993 110.621 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptt85 -70.85 -32.79 69.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.465 -0.788 . . . . 72.209999999999994 111.06 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.47 12.22 39.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 71.439999999999998 112.738 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.9 p -125.67 -27.82 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.777 0.288 . . . . 75.319999999999993 111.777 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' CD ' ' A' ' 51' ' ' GLN . 70.0 mt -133.18 140.57 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.574 0.226 . . . . 65.239999999999995 110.636 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -90.94 97.22 11.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.789 0.328 . . . . 73.319999999999993 111.012 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.812 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -77.85 113.64 15.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 74.209999999999994 111.515 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.722 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -135.9 126.73 3.99 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.549 -0.75 . . . . 71.140000000000001 112.131 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 11.5 p -86.1 148.02 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 111.068 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.921 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.0 tt -145.7 163.47 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 71.430000000000007 110.653 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.9 t0 -87.05 119.79 27.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 74.25 112.014 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.961 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.43 2.15 38.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.702 0.287 . . . . 43.25 110.903 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 18.3 tptm -102.1 -33.04 9.84 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.47 -0.332 . . . . 73.310000000000002 111.7 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 -31.98 6.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.172 0.511 . . . . 73.030000000000001 110.457 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.921 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.35 -16.06 17.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 71.140000000000001 111.07 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.96 -38.88 0.03 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 114.441 0.537 . . . . 64.5 114.441 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.62 -25.86 11.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.279 0.54 . . . . 74.019999999999996 110.379 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -85.78 -12.5 50.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 61.109999999999999 111.546 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.89 -42.19 73.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.685 0.278 . . . . 62.229999999999997 111.269 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.06 0.17 47.89 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.084 -1.055 . . . . 71.030000000000001 113.489 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.0 -11.02 4.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.376 -0.601 . . . . 50.32 109.376 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.65 -16.01 12.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.396 -0.82 . . . . 64.209999999999994 110.441 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.746 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -177.7 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.074 0.464 . . . . 55.399999999999999 112.228 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.716 HD22 ' CD ' ' A' ' 97' ' ' GLN . 87.9 mt -41.43 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.405 -0.816 . . . . 74.439999999999998 112.557 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -118.85 4.48 11.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.276 -0.875 . . . . 72.329999999999998 110.467 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' ' 67' ' ' ALA . 5.5 p 58.21 32.61 22.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.516 . . . . 74.420000000000002 110.715 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 16.0 p-10 -82.17 -31.41 30.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.327 -0.397 . . . . 72.340000000000003 111.384 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 7.2 tttt -147.61 161.61 40.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 44.039999999999999 111.256 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.961 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -157.39 170.2 9.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.544 -0.753 . . . . 72.200000000000003 111.258 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.76 160.0 44.9 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 123.538 -1.443 . . . . 54.200000000000003 113.237 0.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.32 165.59 20.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.198 -0.91 . . . . 75.129999999999995 110.006 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 5.3 t80 -139.23 128.37 23.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.797 0.332 . . . . 64.099999999999994 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -120.33 145.93 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 75.540000000000006 111.702 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.889 HG22 ' OE2' ' A' ' 86' ' ' GLU . 57.7 mt -123.26 86.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 70.340000000000003 110.082 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.84 125.96 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 73.209999999999994 111.187 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.889 ' OE2' HG22 ' A' ' 84' ' ' ILE . 9.8 mp0 -95.32 117.69 30.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.841 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -84.54 4.92 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.009 -0.541 . . . . 71.319999999999993 111.328 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.37 -41.64 5.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 73.150000000000006 110.793 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -15.32 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 44.119999999999997 110.957 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 78.08 32.68 0.36 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.527 0.68 . . . . 71.239999999999995 109.559 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.493 ' H ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -95.14 166.57 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 63.100000000000001 111.254 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 6.8 mmtm -142.6 97.14 3.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.553 -0.749 . . . . 75.519999999999996 110.92 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.626 ' O ' HD12 ' A' ' 84' ' ' ILE . 17.2 m-85 -102.63 75.6 0.19 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 75.519999999999996 111.002 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 84.7 Cg_endo -78.35 -176.13 3.09 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 54.450000000000003 112.638 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -107.08 169.97 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 64.049999999999997 110.789 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.32 160.02 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 71.010000000000005 111.179 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.716 ' CD ' HD22 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -117.47 26.86 9.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 62.530000000000001 110.902 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -157.63 23.64 0.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 72.430000000000007 110.602 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -113.32 -68.13 0.95 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.845 -0.616 . . . . 71.049999999999997 110.954 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 1.7 tt0 159.86 118.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.902 -0.59 . . . . 74.200000000000003 109.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.23 89.2 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 75.549999999999997 111.584 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -117.14 -155.94 0.61 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.809 -0.812 . . . . 72.030000000000001 108.809 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -89.88 -73.65 0.51 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.755 -0.831 . . . . 72.319999999999993 108.755 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.51 -34.16 0.21 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.86 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.03 61.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 62.240000000000002 112.432 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.651 ' HB ' HD13 ' A' ' 47' ' ' ILE . 41.0 mm -88.14 -47.91 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.757 -0.46 . . . . 74.420000000000002 109.757 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -54.44 -45.37 73.06 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 109.695 178.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -69.8 -48.0 60.75 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.953 -0.567 . . . . 73.420000000000002 110.156 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 118' ' ' ILE . 18.4 t80 -52.38 -67.08 0.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.077 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.66 HG12 HD11 ' A' ' 84' ' ' ILE . 19.3 m -47.67 -40.14 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 62.439999999999998 109.966 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -56.96 -42.34 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.381 -0.827 . . . . 40.149999999999999 110.215 178.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.859 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -74.65 -14.58 60.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.652 -0.703 . . . . 75.319999999999993 110.014 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -81.04 -61.29 2.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.558 -0.746 . . . . 73.219999999999999 108.997 178.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.477 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 21.9 t -55.77 -46.41 79.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.658 -1.155 . . . . 72.019999999999996 110.879 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.94 64.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 74.230000000000004 110.782 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.96 30.29 1.65 Allowed Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.578 -0.82 . . . . 74.530000000000001 111.663 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -101.81 -38.65 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.397 -0.402 . . . . 64.420000000000002 111.417 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.976 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.2 mt -85.75 151.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.897 0.38 . . . . 61.450000000000003 110.628 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -145.15 173.94 3.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.947 -0.57 . . . . 65.140000000000001 111.274 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -50.97 145.08 25.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.598 2.198 . . . . 73.010000000000005 112.36 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.8 t -110.05 -43.67 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 111.044 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -31.3 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 111.177 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 111.531 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.82 100.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 73.040000000000006 110.703 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -150.36 87.86 4.81 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 72.430000000000007 110.376 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 160.92 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.522 2.148 . . . . 54.229999999999997 112.566 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.8 mm -114.25 88.15 14.7 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 72.109999999999999 111.307 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 129' ' ' GLU . 53.1 Cg_exo -54.9 -158.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.89 2.393 . . . . 63.509999999999998 112.384 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER 79.27 -165.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 71.140000000000001 110.84 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -46.3 -26.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 74.349999999999994 111.761 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -91.12 160.22 15.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.645 . . . . 73.209999999999994 110.67 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 58.94 164.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 63.450000000000003 110.872 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.34 -1.256 . . . . 73.109999999999999 112.493 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.453 -0.259 . . . . 62.399999999999999 112.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.511 ' C ' HD12 ' A' ' 3' ' ' LEU . 54.1 Cg_exo -51.93 -61.59 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.58 2.187 . . . . 75.209999999999994 112.343 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 2' ' ' PRO . 3.2 mp -151.78 -65.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 61.530000000000001 110.885 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.41 -92.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 51.520000000000003 112.471 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 1.2 m -179.12 -61.29 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.639 0.257 . . . . 54.5 110.926 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 5' ' ' SER . 58.6 Cg_endo -71.82 105.19 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.46 2.106 . . . . 64.329999999999998 112.298 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.59 -60.1 2.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 63.43 110.957 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 57' ' ' PHE . 55.8 mt -95.98 126.36 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 74.439999999999998 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.16 -123.67 0.81 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.03 -1.081 . . . . 73.430000000000007 113.16 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.97 130.79 56.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.383 . . . . 73.310000000000002 110.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.736 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 30.2 mt -85.99 141.02 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 71.319999999999993 111.39 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.8 -178.1 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 74.329999999999998 112.416 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.44 -6.34 18.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.617 2.212 . . . . 63.399999999999999 112.71 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.59 28.62 3.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.795 0.331 . . . . 51.210000000000001 111.1 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.9 p -124.83 -38.98 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 72.420000000000002 110.939 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' SER . 17.0 p90 -52.61 -32.31 40.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 71.450000000000003 111.177 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.449 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m -53.98 -25.95 23.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 55.149999999999999 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.8 -38.54 18.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.02 0.438 . . . . 72.5 110.635 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 26.5 m-85 -78.08 -6.26 54.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 72.349999999999994 109.898 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.638 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.62 -54.42 3.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 60.310000000000002 110.045 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -17.35 64.23 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.85 -0.614 . . . . 62.32 110.919 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.74 -31.78 58.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.901 0.382 . . . . 73.530000000000001 111.021 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.38 5.99 64.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.935 -0.65 . . . . 63.509999999999998 112.596 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.62 156.41 53.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 73.340000000000003 110.989 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.95 142.74 96.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 52.020000000000003 112.594 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.2 tt -103.34 137.62 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 71.5 110.808 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -110.15 97.13 6.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.106 -0.497 . . . . 55.439999999999998 111.112 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.795 ' CD2' HD22 ' A' ' 26' ' ' LEU . 40.4 m-85 -85.99 127.47 34.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 73.0 109.985 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mt -121.51 83.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.13 0.419 . . . . 72.450000000000003 112.13 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.785 ' HA ' HG23 ' A' ' 60' ' ' ILE . 2.8 m-85 -71.96 144.43 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.959 -0.756 . . . . 73.299999999999997 108.959 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -155.1 117.37 4.21 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.430000000000007 111.082 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -80.17 -6.34 57.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.298 -0.865 . . . . 74.299999999999997 110.163 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.9 p -84.7 104.87 15.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 75.349999999999994 111.059 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.4 16.78 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 72.230000000000004 111.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -123.61 -42.05 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 60.310000000000002 110.778 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' ARG . 2.8 pt-20 -99.7 -8.85 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 71.430000000000007 111.574 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 36' ' ' GLU . 1.6 ptp180 -31.31 -40.47 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.366 0.506 . . . . 74.340000000000003 112.366 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -54.51 -51.5 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.965 0.412 . . . . 62.439999999999998 110.844 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.6 mt-10 -60.18 -36.75 78.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 74.530000000000001 110.963 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -63.52 -50.59 68.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 71.019999999999996 110.779 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' HD12 ' A' ' 44' ' ' LEU . 51.1 m -65.17 -22.51 66.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 74.349999999999994 111.242 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 3.7 t70 -66.81 -61.2 2.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.582 0.706 . . . . 72.209999999999994 109.105 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.899 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.05 -31.69 13.65 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.662 1.22 . . . . 64.25 108.991 177.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 29' ' ' ILE . 22.2 mt -76.48 -25.61 54.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.378 -1.737 . . . . 73.319999999999993 111.475 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 9.7 ttmm -51.6 -45.65 91.11 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.395 -0.82 . . . . 63.109999999999999 110.375 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 15.5 Cg_endo -83.76 -40.1 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.713 2.275 . . . . 74.430000000000007 111.649 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -54.92 -18.65 3.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.984 -0.686 . . . . 64.109999999999999 109.87 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.687 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -107.29 -30.82 8.5 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.813 -0.631 . . . . 71.120000000000005 111.213 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -60.83 -19.8 60.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.237 0.541 . . . . 72.150000000000006 109.888 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.2 -26.79 24.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.916 0.865 . . . . 60.229999999999997 109.029 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 6.9 pt20 -125.78 38.44 4.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.029 -1.441 . . . . 74.319999999999993 110.217 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -75.35 -25.21 57.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.446 -0.797 . . . . 72.209999999999994 110.992 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.78 20.16 20.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.811 -0.709 . . . . 71.439999999999998 112.137 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 51' ' ' GLN . 9.9 p -133.78 -37.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.65 0.262 . . . . 75.319999999999993 111.262 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 27' ' ' ALA . 43.6 mt -120.93 138.79 50.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 65.239999999999995 110.863 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-80 -82.85 109.09 16.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.858 0.361 . . . . 73.319999999999993 110.324 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.834 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -80.94 119.86 24.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.644 0.735 . . . . 74.209999999999994 112.843 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.736 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -146.24 122.98 1.74 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.907 -1.042 . . . . 71.140000000000001 111.911 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -89.81 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 73.239999999999995 111.059 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.891 HD11 ' CG ' ' A' ' 65' ' ' PHE . 14.0 tt -141.9 164.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.430000000000007 110.699 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 35.8 t0 -90.34 122.84 33.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.888 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.87 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.49 6.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.71 0.291 . . . . 43.25 110.711 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 22.5 tptp -106.31 -32.82 7.99 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.349 -0.387 . . . . 73.310000000000002 111.559 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.38 -31.21 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.148 0.499 . . . . 73.030000000000001 110.731 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.77 -12.97 17.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.543 -0.753 . . . . 71.140000000000001 111.311 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -35.39 -33.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 N-CA-C 114.027 0.371 . . . . 64.5 114.027 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -12.21 4.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.061 0.458 . . . . 74.019999999999996 110.617 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -102.59 -6.79 22.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.66 -0.7 . . . . 61.109999999999999 110.971 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.1 -54.99 9.18 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.763 0.316 . . . . 62.229999999999997 110.963 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.39 7.5 75.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.916 -1.135 . . . . 71.030000000000001 113.738 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.64 -8.74 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.02 -0.733 . . . . 50.32 109.02 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.2 -14.82 12.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.228 -0.896 . . . . 64.209999999999994 110.335 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.91 -69.91 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.261 0.553 . . . . 55.399999999999999 112.298 -178.219 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.855 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.2 mm? -40.31 170.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.092 -0.958 . . . . 74.439999999999998 112.419 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -110.01 -6.24 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 72.329999999999998 111.046 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 p 61.75 40.19 13.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.609 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.77 -33.01 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 72.340000000000003 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -149.51 163.25 38.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.111 -0.495 . . . . 44.039999999999999 110.427 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.87 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -153.34 177.45 1.96 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 72.200000000000003 111.126 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.619 ' O ' HD11 ' A' ' 101' ' ' ILE . 35.0 Cg_exo -57.54 158.22 29.27 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.022 -1.241 . . . . 54.200000000000003 112.781 1.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.4 128.87 46.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.234 -0.894 . . . . 75.129999999999995 110.226 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 84' ' ' ILE . 49.5 t80 -108.65 117.83 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.654 -0.248 . . . . 64.099999999999994 110.437 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -118.18 132.85 56.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.35 0.5 . . . . 75.540000000000006 112.35 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.715 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 25.6 mm -100.88 140.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 70.340000000000003 109.973 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -128.24 129.52 46.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.985 0.421 . . . . 73.209999999999994 110.842 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 1.2 mt-10 -105.08 112.72 25.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 74.420000000000002 110.198 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -78.86 -0.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 111.708 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.73 -44.33 6.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 73.150000000000006 110.692 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.84 -7.23 14.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 44.119999999999997 111.413 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 68.96 24.87 6.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.09 0.471 . . . . 71.239999999999995 110.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -75.37 169.51 17.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.731 -0.668 . . . . 63.100000000000001 111.541 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 1.3 mptt -139.94 95.37 2.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 75.519999999999996 110.756 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 68.1 m-85 -103.52 71.41 0.15 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 75.519999999999996 111.277 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.855 ' CB ' HD21 ' A' ' 74' ' ' LEU . 67.4 Cg_endo -79.12 -175.5 2.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.667 2.245 . . . . 54.450000000000003 113.608 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 82' ' ' PHE . 25.0 t80 -112.02 175.16 5.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 64.049999999999997 110.578 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 3.0 m-20 -78.76 174.98 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 71.010000000000005 110.882 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -114.64 -11.99 12.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 62.530000000000001 111.297 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.63 5.25 5.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 72.430000000000007 111.041 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 1.8 tppt? -86.17 -6.05 59.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.097 -0.501 . . . . 71.049999999999997 111.294 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 32.6 tt0 81.9 132.22 0.05 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.174 0.512 . . . . 74.200000000000003 111.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.619 HD11 ' O ' ' A' ' 80' ' ' PRO . 3.0 mp -109.02 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 75.549999999999997 110.905 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -113.41 -148.17 0.43 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 72.030000000000001 109.095 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.661 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -96.66 -70.81 0.7 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.97 -0.752 . . . . 72.319999999999993 108.97 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.624 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.11 -31.54 1.44 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.811 -0.631 . . . . 72.409999999999997 111.374 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -74.96 -33.0 61.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.688 -0.687 . . . . 62.240000000000002 111.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.815 ' O ' HG13 ' A' ' 110' ' ' VAL . 44.2 mm -91.22 -45.71 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.39 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.0 -42.22 93.76 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 109.414 178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.22 -50.73 29.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 73.420000000000002 110.244 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CE1' HD13 ' A' ' 118' ' ' ILE . 40.6 t80 -51.72 -63.77 1.03 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.467 -0.333 . . . . 73.219999999999999 110.261 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.5 m -49.14 -44.15 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 62.439999999999998 110.042 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -54.45 -40.67 68.61 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.783 0.802 . . . . 40.149999999999999 109.009 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.918 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 16.4 t70 -61.53 -34.86 76.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.326 -1.306 . . . . 75.319999999999993 108.336 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.796 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -72.86 -66.86 0.61 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 73.219999999999999 110.902 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.8 t -54.85 -45.21 74.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.22 -0.9 . . . . 72.019999999999996 111.994 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.44 70.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.856 0.36 . . . . 74.230000000000004 111.154 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.68 31.3 1.82 Allowed Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.06 -0.816 . . . . 74.530000000000001 111.06 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.918 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.43 -57.12 2.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.878 -0.661 . . . . 64.420000000000002 111.505 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.796 HD12 ' HB2' ' A' ' 113' ' ' PHE . 44.7 mt -64.27 151.1 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.789 -0.448 . . . . 61.450000000000003 109.789 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.32 163.96 36.25 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.357 -0.383 . . . . 65.140000000000001 111.542 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.83 155.07 71.2 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.815 2.344 . . . . 73.010000000000005 112.519 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.37 -71.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.997 -0.547 . . . . 64.439999999999998 110.676 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -106.69 -44.07 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.420000000000002 111.014 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER 33.89 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.913 -0.585 . . . . 74.340000000000003 112.201 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -85.35 72.42 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 73.040000000000006 110.759 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -148.41 86.33 5.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 72.430000000000007 110.45 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.61 153.39 23.35 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.556 2.17 . . . . 54.229999999999997 112.517 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.17 83.38 24.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.956 -0.566 . . . . 72.109999999999999 111.003 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.95 -169.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.569 2.179 . . . . 63.509999999999998 112.039 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 60.38 69.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 71.140000000000001 110.604 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 154.03 8.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 74.349999999999994 111.18 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.32 176.35 3.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.514 . . . . 73.209999999999994 110.811 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -109.61 -45.31 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 63.450000000000003 110.95 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.308 -1.274 . . . . 73.109999999999999 112.553 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.456 -0.257 . . . . 62.399999999999999 112.456 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.48 161.85 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.586 2.191 . . . . 75.209999999999994 112.359 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.69 -70.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 61.530000000000001 110.94 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -151.74 17.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 51.520000000000003 112.563 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -103.81 93.78 5.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 54.5 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.61 ' C ' HD12 ' A' ' 7' ' ' LEU . 46.1 Cg_endo -68.39 161.28 45.52 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.519 2.146 . . . . 64.329999999999998 112.388 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 6' ' ' PRO . 5.7 mp -117.02 -49.18 2.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.845 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.608 ' HB ' ' CB ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -72.36 154.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 74.439999999999998 110.949 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' O ' HG23 ' A' ' 59' ' ' THR . . . 156.39 -71.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.413 -0.898 . . . . 73.430000000000007 112.242 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -124.49 134.88 52.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.545 -0.328 . . . . 73.310000000000002 110.256 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.846 HD11 ' O ' ' A' ' 58' ' ' GLY . 1.8 mt -88.7 140.0 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.766 0.317 . . . . 71.319999999999993 111.019 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.12 172.68 23.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 74.329999999999998 112.42 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.57 -20.54 57.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.692 2.261 . . . . 63.399999999999999 112.436 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.06 28.58 8.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.379 . . . . 51.210000000000001 110.859 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.405 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 6.9 p -131.21 -39.46 1.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 111.048 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 17.6 m-85 -45.18 -63.57 0.91 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.056 0.455 . . . . 71.450000000000003 111.383 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -51.53 -34.44 36.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.797 -0.638 . . . . 55.149999999999999 111.422 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -70.86 -39.12 73.08 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.147 0.499 . . . . 72.5 110.725 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 18.0 m-85 -77.39 -9.19 58.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.634 . . . . 72.349999999999994 109.678 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.768 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -99.97 -30.48 11.97 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.47 -0.787 . . . . 60.310000000000002 110.131 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -83.36 -17.93 40.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.685 -0.689 . . . . 62.32 110.572 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.7 -14.21 41.43 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.275 -0.42 . . . . 73.530000000000001 111.602 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.93 14.12 65.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 63.509999999999998 112.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 HD11 ' OD1' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -123.99 158.79 59.13 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.246 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HG2' HG12 ' A' ' 55' ' ' ILE . 26.7 Cg_endo -62.38 138.15 69.5 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 52.020000000000003 112.758 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 28' ' ' TYR . 1.5 tt -93.12 136.41 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.833 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -105.95 89.43 3.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 55.439999999999998 111.001 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.909 ' CE1' HD22 ' A' ' 26' ' ' LEU . 70.0 m-85 -81.19 136.6 35.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 73.0 110.404 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mp -131.53 89.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.855 0.359 . . . . 72.450000000000003 111.518 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.855 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.1 m-85 -70.88 149.18 47.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.303 -0.629 . . . . 73.299999999999997 109.303 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.644 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.73 119.07 2.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.233 0.54 . . . . 72.430000000000007 111.269 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 20.9 mt-10 -76.0 -7.23 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 74.299999999999997 109.972 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.6 p -76.53 123.44 26.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.209 -0.451 . . . . 75.349999999999994 110.848 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.12 9.52 18.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 72.230000000000004 111.087 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -50.43 2.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.404 -0.362 . . . . 60.310000000000002 110.735 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.69 15.04 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 71.430000000000007 111.196 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -49.1 -28.45 4.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 111.104 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.32 73.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 62.439999999999998 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 2.2 mm-40 -61.45 -48.91 79.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.736 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -58.45 -47.34 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 71.019999999999996 110.652 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 44' ' ' LEU . 67.0 m -67.17 -20.69 65.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.349999999999994 111.218 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 15.6 t0 -67.68 -60.6 2.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 72.209999999999994 108.946 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.662 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.48 -33.64 9.76 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.65 1.214 . . . . 64.25 108.633 177.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.086 HD11 HG21 ' A' ' 29' ' ' ILE . 25.9 mt -75.22 -25.95 58.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.317 -1.765 . . . . 73.319999999999993 112.188 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 3.4 mmpt? -51.44 -45.47 90.32 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 63.109999999999999 110.285 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.6 Cg_endo -83.26 -38.54 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.546 2.164 . . . . 74.430000000000007 111.13 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.062 HG21 HG22 ' A' ' 106' ' ' ILE . 24.0 mt -53.85 -17.35 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-N 116.367 -0.379 . . . . 64.109999999999999 110.14 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.784 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -114.98 -25.34 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.52 . . . . 71.120000000000005 111.151 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -64.91 -18.94 65.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.939 0.4 . . . . 72.150000000000006 110.669 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . . . -93.67 -9.95 36.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.81 . . . . 60.229999999999997 109.377 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.749 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -136.67 27.62 3.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.221 -1.354 . . . . 74.319999999999993 110.885 -176.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.5 ptt180 -61.4 -33.24 73.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.586 -0.734 . . . . 72.209999999999994 111.156 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.33 9.02 45.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.811 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 51' ' ' GLN . 10.3 p -122.35 -29.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.78 0.29 . . . . 75.319999999999993 111.609 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.813 HG21 ' HB2' ' A' ' 27' ' ' ALA . 79.7 mt -131.87 141.35 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 65.239999999999995 110.807 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -94.61 94.83 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 73.319999999999993 110.063 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.23 134.76 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 74.209999999999994 111.641 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.846 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -153.87 113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.787 -1.097 . . . . 71.140000000000001 111.86 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 9' ' ' GLY . 81.3 p -80.87 150.14 29.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 73.239999999999995 110.316 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.901 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.2 tt -147.4 163.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 111.105 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 45.0 t0 -84.01 119.78 25.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.123 -0.49 . . . . 74.25 111.909 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.0 27.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.696 0.284 . . . . 43.25 110.859 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.2 ttpt -106.25 -31.88 8.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.548 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.95 -32.27 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 73.030000000000001 110.638 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.901 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.95 -12.4 18.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.518 -0.764 . . . . 71.140000000000001 111.404 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 76' ' ' THR . . . -33.57 -36.54 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.208 0.443 . . . . 64.5 114.208 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.17 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 74.019999999999996 110.448 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -89.21 -11.63 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.482 -0.781 . . . . 61.109999999999999 111.461 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.65 -44.12 57.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 111.76 0.281 . . . . 62.229999999999997 111.76 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.477 ' CA ' ' HB2' ' A' ' 74' ' ' LEU . . . -103.4 1.39 46.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.991 -1.099 . . . . 71.030000000000001 113.752 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.3 -8.81 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.187 -0.671 . . . . 50.32 109.187 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.65 -15.81 11.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.325 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.36 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.155 0.502 . . . . 55.399999999999999 112.022 -178.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.511 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 74.9 mt -44.88 178.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.275 -0.875 . . . . 74.439999999999998 112.168 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 5.25 8.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.61 -0.723 . . . . 72.329999999999998 110.597 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 66' ' ' GLY . 4.4 p 59.06 36.86 24.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.694 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.75 -36.49 15.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 111.27 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 0.2 OUTLIER -137.31 161.18 36.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.123 0.487 . . . . 44.039999999999999 110.746 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -159.44 169.04 11.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.738 -0.665 . . . . 72.200000000000003 111.607 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.8 161.87 40.47 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.395 -1.502 . . . . 54.200000000000003 113.12 0.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.12 161.17 29.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.478 -0.783 . . . . 75.129999999999995 110.038 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.4 t80 -132.3 123.39 26.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.67 0.272 . . . . 64.099999999999994 111.198 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -121.34 111.85 17.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 75.540000000000006 111.738 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 93' ' ' PHE . 6.8 mt -100.78 96.84 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.729 0.3 . . . . 70.340000000000003 110.822 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -89.6 147.8 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.474 -0.33 . . . . 73.209999999999994 110.584 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 8.7 mt-10 -106.69 114.15 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 74.420000000000002 110.851 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 20' ' ' MET . 13.1 t -79.8 0.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 110.968 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.46 -42.62 8.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.4 -0.364 . . . . 73.150000000000006 110.914 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.55 -7.88 10.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.487 -0.324 . . . . 44.119999999999997 111.454 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 70.53 62.19 0.21 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.413 -0.588 . . . . 71.239999999999995 109.413 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 1.4 tp-100 -114.15 173.74 6.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.33 -0.85 . . . . 63.100000000000001 111.575 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.638 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -137.27 92.53 2.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.416 -0.811 . . . . 75.519999999999996 110.807 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.765 ' O ' HD12 ' A' ' 84' ' ' ILE . 93.1 m-85 -104.77 68.7 0.16 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.638 -0.71 . . . . 75.519999999999996 111.314 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 76.5 Cg_endo -78.93 -175.58 2.83 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.263 1.975 . . . . 54.450000000000003 112.589 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 41.6 t80 -109.37 170.4 8.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.049999999999997 111.104 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.6 m-20 -76.37 170.48 16.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 71.010000000000005 110.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 7.2 mt-30 -119.83 27.29 8.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 62.530000000000001 110.746 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.12 26.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.501 . . . . 72.430000000000007 110.662 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 10.1 ttmt -112.0 0.05 15.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.996 -0.547 . . . . 71.049999999999997 111.668 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 78.31 98.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 74.200000000000003 110.325 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' PRO . 5.8 mt -80.01 97.71 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 75.549999999999997 111.59 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -120.51 -151.34 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.707 -0.849 . . . . 72.030000000000001 108.707 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.786 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -92.43 -66.93 0.89 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.925 -0.768 . . . . 72.319999999999993 108.925 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.02 -39.0 5.24 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.669 -0.696 . . . . 72.409999999999997 111.752 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 62.240000000000002 112.28 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HG21 ' A' ' 47' ' ' ILE . 50.1 mm -91.31 -48.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 74.420000000000002 110.235 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.878 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -42.21 80.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.962 -0.755 . . . . 71.120000000000005 108.962 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.52 -51.06 31.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.038 -0.528 . . . . 73.420000000000002 110.036 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.713 ' O ' HD11 ' A' ' 118' ' ' ILE . 67.5 t80 -50.4 -63.21 1.19 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 116.369 -0.378 . . . . 73.219999999999999 110.094 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.9 m -50.05 -41.97 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 62.439999999999998 109.494 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.1 t0 -53.61 -37.76 63.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.793 0.806 . . . . 40.149999999999999 108.959 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.911 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.3 t70 -66.84 -34.79 78.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.309 -1.314 . . . . 75.319999999999993 108.413 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.881 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -71.73 -68.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.244 -0.889 . . . . 73.219999999999999 110.984 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 55' ' ' ILE . 15.3 t -51.72 -46.86 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.268 -0.878 . . . . 72.019999999999996 111.996 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.66 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.230000000000004 111.018 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.56 31.01 2.06 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.575 -1.01 . . . . 74.530000000000001 110.575 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.911 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -102.92 -52.0 3.15 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.716 -0.742 . . . . 64.420000000000002 111.619 -178.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.881 HD12 ' HB2' ' A' ' 113' ' ' PHE . 57.7 mt -65.75 153.05 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.49 -0.559 . . . . 61.450000000000003 109.49 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.408 ' HG2' ' HD2' ' A' ' 120' ' ' PRO . 1.3 mt-10 -137.25 152.66 73.89 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.254 -0.43 . . . . 65.140000000000001 111.199 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 119' ' ' GLU . 57.1 Cg_endo -71.02 137.66 32.23 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.542 2.161 . . . . 73.010000000000005 112.552 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.3 m -102.72 -117.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.519 . . . . 64.439999999999998 110.525 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.703 HD11 ' HA ' ' A' ' 73' ' ' ASN . 36.2 pt -51.35 166.43 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 72.420000000000002 111.25 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.64 -171.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 110.564 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.81 62.19 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 73.040000000000006 110.955 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -149.01 85.06 6.08 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 72.430000000000007 110.595 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.81 153.02 19.59 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.49 2.127 . . . . 54.229999999999997 112.473 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 127' ' ' ILE . 1.9 tt -149.38 79.45 8.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 72.109999999999999 111.097 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 171.4 16.94 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.525 2.15 . . . . 63.509999999999998 112.369 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.51 125.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.998 -0.546 . . . . 71.140000000000001 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -117.17 18.46 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 74.349999999999994 111.129 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.96 168.61 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 73.209999999999994 110.957 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -177.85 -72.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 63.450000000000003 110.861 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.427 -1.207 . . . . 73.109999999999999 112.452 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.533 -0.227 . . . . 62.399999999999999 112.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.09 -40.53 4.71 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.642 2.228 . . . . 75.209999999999994 112.262 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.39 -58.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 61.530000000000001 110.869 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.5 -170.25 28.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 51.520000000000003 112.517 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -118.61 63.01 5.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 54.5 110.794 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.83 -26.18 22.84 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.575 2.183 . . . . 64.329999999999998 112.457 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.522 HD23 ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -149.86 -61.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 63.43 111.005 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.967 HG23 ' HB3' ' A' ' 57' ' ' PHE . 46.4 mt -81.62 119.7 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 74.439999999999998 111.193 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.45 -127.32 1.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.206 -0.997 . . . . 73.430000000000007 112.355 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.46 138.52 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.189 -0.3 . . . . 73.310000000000002 110.189 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 58' ' ' GLY . 6.1 mt -91.79 129.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.917 0.389 . . . . 71.319999999999993 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.89 -164.29 11.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.84 -0.695 . . . . 74.329999999999998 112.42 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.4 -0.51 10.77 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.641 2.227 . . . . 63.399999999999999 112.933 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -124.79 7.46 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.559 0.219 . . . . 51.210000000000001 111.492 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 19' ' ' TYR . 15.5 p -112.31 -27.57 8.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 72.420000000000002 110.99 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -60.7 2.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 71.450000000000003 111.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -56.45 -26.61 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 55.149999999999999 111.695 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.8 t0 -72.99 -43.69 61.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.013 0.435 . . . . 72.5 111.047 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CE1' HD23 ' A' ' 7' ' ' LEU . 9.5 m-85 -78.97 -27.14 43.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.303 0.573 . . . . 72.349999999999994 109.718 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.588 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.33 -29.82 38.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.127 -0.942 . . . . 60.310000000000002 110.473 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -98.14 -6.51 31.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.912 -0.586 . . . . 62.32 110.624 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -64.51 -30.39 71.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.883 0.373 . . . . 73.530000000000001 111.015 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.74 54.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 63.509999999999998 112.602 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.12 156.54 76.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.706 0.289 . . . . 73.340000000000003 110.975 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' ILE . 12.1 Cg_endo -56.29 142.17 88.07 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.813 2.342 . . . . 52.020000000000003 112.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.1 tt -99.53 133.08 44.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 71.5 110.776 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -104.88 86.89 2.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 55.439999999999998 111.061 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.805 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 64.0 m-85 -75.06 141.03 43.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.606 -0.724 . . . . 73.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.851 HG21 ' CD1' ' A' ' 44' ' ' LEU . 1.9 mp -133.99 85.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.532 -0.303 . . . . 72.450000000000003 111.395 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 2.7 m-85 -72.15 145.42 48.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.758 -0.46 . . . . 73.299999999999997 109.758 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.74 117.3 3.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.153 0.502 . . . . 72.430000000000007 110.9 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 9.4 mt-10 -71.05 -12.43 61.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 74.299999999999997 110.396 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.26 97.54 7.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 111.218 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.94 5.9 41.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.726 -0.67 . . . . 72.230000000000004 110.986 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.72 -52.55 4.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.91 0.386 . . . . 60.310000000000002 110.508 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 13.22 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 71.430000000000007 111.108 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -46.55 -28.09 1.32 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.466 -0.334 . . . . 74.340000000000003 111.375 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.75 -45.61 78.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 110.764 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 6.3 mt-10 -66.73 -44.25 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.856 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.89 -57.12 12.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 110.817 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 20.4 m -63.33 -21.32 66.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.407 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 9.6 t70 -66.08 -65.39 0.68 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.546 0.688 . . . . 72.209999999999994 109.488 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.92 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -48.39 -31.82 6.72 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.653 1.216 . . . . 64.25 108.991 177.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.851 ' CD1' HG21 ' A' ' 29' ' ' ILE . 35.7 mt -77.53 -23.17 50.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.368 -1.742 . . . . 73.319999999999993 112.369 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 20.7 mttt -55.53 -43.62 99.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 63.109999999999999 110.152 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 23.9 Cg_endo -83.86 -41.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.648 2.232 . . . . 74.430000000000007 111.822 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -53.23 -22.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 C-N-CA 119.983 -0.687 . . . . 64.109999999999999 109.721 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.744 ' HB2' ' CE1' ' A' ' 57' ' ' PHE . . . -106.07 -27.66 10.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.549 -0.751 . . . . 71.120000000000005 111.211 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.1 tm-20 -59.43 -22.4 61.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.256 0.551 . . . . 72.150000000000006 109.921 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.43 29.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.303 -0.862 . . . . 60.229999999999997 109.464 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.681 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 6.9 pt20 -126.88 40.47 3.71 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.385 -1.28 . . . . 74.319999999999993 110.995 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 8' ' ' ILE . 1.6 ptm180 -73.45 -32.25 64.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.662 . . . . 72.209999999999994 111.282 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.69 6.18 48.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 71.439999999999998 112.849 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 51' ' ' GLN . 12.4 p -116.84 -31.94 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 75.319999999999993 111.259 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 28.4 mt -128.46 144.72 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 110.691 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.19 104.74 16.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.559 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.967 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -73.9 132.88 42.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.354 0.597 . . . . 74.209999999999994 112.065 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.754 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -155.71 108.26 0.36 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.196 -0.911 . . . . 71.140000000000001 112.509 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.438 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 22.1 p -75.76 152.33 37.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.701 0.286 . . . . 73.239999999999995 110.383 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.881 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.8 tt -149.97 164.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 71.430000000000007 110.856 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 60' ' ' ILE . 31.2 t0 -85.99 120.23 27.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.842 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.912 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.2 5.29 30.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.698 0.285 . . . . 43.25 110.864 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 tttp -104.28 -33.04 8.81 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.45 -0.341 . . . . 73.310000000000002 111.543 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.32 -31.92 6.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.179 0.514 . . . . 73.030000000000001 110.684 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.04 -15.99 17.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 71.140000000000001 111.357 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -32.28 -37.46 0.04 OUTLIER Glycine 0 C--N 1.336 0.547 0 N-CA-C 114.301 0.48 . . . . 64.5 114.301 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.66 -17.27 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.43 . . . . 74.019999999999996 110.774 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -94.72 -9.24 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 61.109999999999999 111.214 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.24 -51.53 17.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.76 0.314 . . . . 62.229999999999997 111.434 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -91.33 1.34 76.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.861 -1.161 . . . . 71.030000000000001 113.911 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.87 -9.79 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.454 0.627 . . . . 50.32 109.462 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -115.78 -16.9 11.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 64.209999999999994 110.377 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.792 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -176.78 -71.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.24 0.459 . . . . 55.399999999999999 112.24 -178.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.609 HD12 HD11 ' A' ' 72' ' ' LEU . 1.8 mp -40.57 175.14 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 112.969 0.729 . . . . 74.439999999999998 112.969 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -107.86 -21.7 12.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.105 -0.952 . . . . 72.329999999999998 110.851 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 82.73 20.85 0.23 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.263 -1.014 . . . . 74.420000000000002 108.263 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -79.01 -48.76 13.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.663 -1.153 . . . . 72.340000000000003 111.51 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -118.98 158.86 24.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.207 0.527 . . . . 44.039999999999999 111.451 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.912 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -158.24 165.53 18.4 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.48 -0.782 . . . . 72.200000000000003 111.762 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 25.6 Cg_endo -61.9 157.15 59.09 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.158 -1.601 . . . . 54.200000000000003 112.915 0.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.597 ' HB1' HD22 ' A' ' 74' ' ' LEU . . . -119.47 164.44 15.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 75.129999999999995 109.363 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.533 ' CE2' HG12 ' A' ' 29' ' ' ILE . 2.5 t80 -138.44 131.29 29.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 64.099999999999994 111.167 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -122.6 147.42 46.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.540000000000006 111.661 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.644 HG21 ' CE2' ' A' ' 113' ' ' PHE . 57.5 mt -129.32 81.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 109.85 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LEU . 2.3 tt0 -75.4 138.4 41.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 73.209999999999994 111.333 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.9 mm-40 -100.65 118.62 37.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.706 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -88.62 20.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 71.319999999999993 110.345 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.67 -38.96 2.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.057 -0.519 . . . . 73.150000000000006 110.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tttt -113.64 -15.25 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.394 -0.367 . . . . 44.119999999999997 110.922 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 34.5 t-20 79.6 21.05 0.61 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.237 0.542 . . . . 71.239999999999995 109.949 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -84.67 164.65 18.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.321 -0.854 . . . . 63.100000000000001 111.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' O ' ' CD ' ' A' ' 94' ' ' PRO . 6.2 mmtt -139.56 99.15 3.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.25 -0.886 . . . . 75.519999999999996 110.757 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 17.4 m-85 -101.14 70.99 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.656 -0.702 . . . . 75.519999999999996 111.538 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 90.8 Cg_endo -75.39 168.66 24.09 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.554 2.17 . . . . 54.450000000000003 112.384 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' HD13 ' A' ' 106' ' ' ILE . 35.0 t80 -88.27 169.33 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.498 . . . . 64.049999999999997 110.684 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 2.9 m-20 -83.85 148.26 27.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 71.010000000000005 110.885 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 26.6 mt-30 -103.22 28.47 6.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.217 0.532 . . . . 62.530000000000001 110.381 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -155.94 18.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.73 -0.668 . . . . 72.430000000000007 110.648 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 1.5 ttmt -113.36 -7.89 13.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.137 -0.483 . . . . 71.049999999999997 111.611 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 22.3 tt0 83.97 97.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.258 0.552 . . . . 74.200000000000003 110.894 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.9 mt -72.84 93.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 75.549999999999997 111.153 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 4.8 p -111.15 -147.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.609 -0.515 . . . . 72.030000000000001 109.609 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.616 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.26 -59.83 1.64 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.39 -0.596 . . . . 72.319999999999993 109.39 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.581 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -56.14 -34.0 65.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.068 -0.969 . . . . 72.409999999999997 110.83 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.53 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.507 -0.77 . . . . 62.240000000000002 112.322 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.747 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.9 mm -89.93 -42.58 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 121.058 0.456 . . . . 74.420000000000002 110.552 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 10.8 pttt -61.79 -47.36 85.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.936 -0.764 . . . . 71.120000000000005 108.936 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.03 -51.47 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 73.420000000000002 110.324 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.753 ' O ' HD11 ' A' ' 118' ' ' ILE . 67.9 t80 -54.63 -64.91 0.68 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.015 -0.539 . . . . 73.219999999999999 110.894 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 106' ' ' ILE . 6.0 m -51.82 -37.4 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.127 0.489 . . . . 62.439999999999998 111.533 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.723 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -67.97 -35.79 78.96 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.694 -1.224 . . . . 40.149999999999999 107.694 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER -63.33 -37.27 86.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.347 -1.751 . . . . 75.319999999999993 108.025 177.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.806 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -63.8 -66.27 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.981 -1.009 . . . . 73.219999999999999 110.268 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.4 t -58.09 -36.95 59.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.916 -1.038 . . . . 72.019999999999996 111.876 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.58 78.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 74.230000000000004 111.393 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.78 25.87 2.24 Favored Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 120.535 -0.84 . . . . 74.530000000000001 111.724 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -98.12 -57.78 2.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.2 -0.5 . . . . 64.420000000000002 111.014 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.806 HD12 ' HB2' ' A' ' 113' ' ' PHE . 8.9 mt -71.43 150.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.89 -0.595 . . . . 61.450000000000003 110.092 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.12 171.94 5.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.261 -0.427 . . . . 65.140000000000001 111.364 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.16 119.51 4.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.607 2.204 . . . . 73.010000000000005 112.35 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 122' ' ' ILE . 4.8 p -89.06 -53.43 4.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 64.439999999999998 110.857 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 121' ' ' SER . 1.9 pt -159.07 179.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 111.133 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.46 32.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.852 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.3 t -75.95 152.83 36.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 110.969 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.68 85.2 6.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.501 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.43 154.02 21.14 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.51 2.14 . . . . 54.229999999999997 112.551 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.61 81.89 9.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 72.109999999999999 111.039 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.55 -178.51 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.586 2.191 . . . . 63.509999999999998 112.271 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.55 136.84 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 71.140000000000001 110.897 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -131.95 146.35 52.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 74.349999999999994 110.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.03 176.5 5.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.87 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -167.88 -44.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 63.450000000000003 110.909 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.379 -1.234 . . . . 73.109999999999999 112.527 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.494 -0.243 . . . . 62.399999999999999 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.9 144.98 33.91 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.601 2.201 . . . . 75.209999999999994 112.318 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.75 150.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 61.530000000000001 110.877 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.73 115.07 1.33 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 51.520000000000003 112.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 1.1 m -176.43 64.83 0.22 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 54.5 110.903 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.68 ' HB2' HD12 ' A' ' 8' ' ' ILE . 38.6 Cg_exo -59.93 -156.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.499 2.132 . . . . 64.329999999999998 112.148 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 mt -57.92 -29.67 65.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 63.43 111.025 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.779 HG23 ' HB3' ' A' ' 57' ' ' PHE . 3.7 mp -56.81 147.52 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 74.439999999999998 111.05 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.17 -153.32 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.128 -1.035 . . . . 73.430000000000007 112.765 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -94.47 131.54 40.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 73.310000000000002 110.367 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.739 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 58.1 mt -84.31 139.97 16.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 71.319999999999993 111.318 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.59 -172.46 12.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 74.329999999999998 112.543 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.95 -22.23 19.99 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.682 2.255 . . . . 63.399999999999999 112.667 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.55 -14.88 21.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 51.210000000000001 111.461 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.3 p -99.63 -24.21 14.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 72.420000000000002 110.838 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CE1' HG21 ' A' ' 11' ' ' ILE . 1.8 m-85 -51.33 -54.99 20.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 71.450000000000003 111.191 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 t -65.88 -22.44 66.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 55.149999999999999 111.57 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -70.77 -41.47 71.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 72.5 110.92 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 13.3 m-85 -79.53 -24.31 42.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 72.349999999999994 109.746 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.628 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.61 -42.41 29.01 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.269 -0.878 . . . . 60.310000000000002 110.359 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -85.26 -11.45 54.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 62.32 110.508 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -58.74 -31.4 68.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 73.530000000000001 111.069 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.27 15.9 56.51 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 63.509999999999998 112.708 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 87' ' ' VAL . 1.5 pt -133.28 158.3 76.06 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.699 0.285 . . . . 73.340000000000003 110.933 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.46 138.9 88.34 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.631 2.22 . . . . 52.020000000000003 112.6 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.848 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.7 tt -99.65 135.94 40.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 71.5 111.007 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.748 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -109.01 100.49 9.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 55.439999999999998 111.037 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 11.4 m-85 -85.47 132.03 34.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 73.0 110.057 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.2 mt -127.71 83.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.743 -0.383 . . . . 72.450000000000003 111.277 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.7 m-85 -71.51 149.79 45.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 109.801 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.57 116.87 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.28 0.562 . . . . 72.430000000000007 111.257 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 3.4 mt-10 -75.88 -7.97 55.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.208 -0.906 . . . . 74.299999999999997 110.027 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -99.84 92.63 5.39 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.179 -0.464 . . . . 75.349999999999994 111.094 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.76 6.38 35.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 72.230000000000004 111.488 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -34.49 10.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 60.310000000000002 110.779 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.98 9.66 16.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 71.430000000000007 111.317 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.8 -29.12 1.79 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.767 0.317 . . . . 74.340000000000003 111.335 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -54.74 -45.65 74.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 62.439999999999998 110.79 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.39 -36.36 81.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.772 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -66.4 -62.11 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.019999999999996 110.697 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.422 ' OG ' HG21 ' A' ' 59' ' ' THR . 7.2 m -57.68 -25.93 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.953 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.6 t0 -62.64 -59.7 4.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.531 0.681 . . . . 72.209999999999994 109.569 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.56 -33.36 9.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.601 1.191 . . . . 64.25 108.676 177.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -80.54 -17.58 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.831 -1.531 . . . . 73.319999999999993 112.185 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 4.8 tppt? -55.13 -42.84 98.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.207 -0.664 . . . . 63.109999999999999 109.207 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.716 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 11.8 Cg_endo -84.93 -38.64 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.69 2.26 . . . . 74.430000000000007 110.31 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 106' ' ' ILE . 55.1 mt -50.21 -22.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.507 0 CA-C-N 115.975 -0.557 . . . . 64.109999999999999 109.847 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -112.49 -25.55 9.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.621 -0.718 . . . . 71.120000000000005 111.506 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -59.8 -20.4 56.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.255 0.55 . . . . 72.150000000000006 109.771 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.37 -30.24 18.52 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.833 0.825 . . . . 60.229999999999997 108.969 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.686 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 7.0 pt20 -125.34 42.27 3.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.161 -1.381 . . . . 74.319999999999993 110.061 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.5 -29.14 46.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.153 -0.93 . . . . 72.209999999999994 111.04 -178.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 11.32 52.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 71.439999999999998 112.405 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.5 p -124.97 -33.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.636 0.255 . . . . 75.319999999999993 111.419 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 27' ' ' ALA . 72.5 mt -123.15 142.91 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 65.239999999999995 111.166 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.3 m-80 -90.57 87.7 6.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.755 -0.461 . . . . 73.319999999999993 109.755 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.836 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.0 m-85 -71.89 119.22 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 74.209999999999994 111.896 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.739 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -141.9 125.17 2.64 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.052 -0.976 . . . . 71.140000000000001 112.463 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.505 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 2.3 p -82.82 153.89 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.3 tt -150.68 164.16 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.028 -0.533 . . . . 71.430000000000007 110.531 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 43.0 t0 -87.13 120.26 28.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.296 -0.411 . . . . 74.25 112.072 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.953 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.25 26.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.965 -0.294 . . . . 43.25 110.898 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 8.1 ttmt -106.04 -33.02 8.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.449 -0.341 . . . . 73.310000000000002 111.455 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.3 -30.57 6.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 73.030000000000001 110.489 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.66 -11.64 17.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.507 -0.769 . . . . 71.140000000000001 111.276 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.03 -37.59 0.18 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 114.119 0.407 . . . . 64.5 114.119 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.71 10.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 74.019999999999996 110.483 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -93.0 -8.17 43.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 61.109999999999999 111.247 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.862 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -75.16 -46.9 31.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.656 -0.247 . . . . 62.229999999999997 111.642 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -97.67 1.41 59.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.982 -1.104 . . . . 71.030000000000001 113.784 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.61 -8.56 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.446 -0.576 . . . . 50.32 109.446 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -115.23 -15.61 11.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.398 -0.819 . . . . 64.209999999999994 110.17 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.44 -69.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.1 0.476 . . . . 55.399999999999999 112.135 -178.187 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.508 HD13 ' HB1' ' A' ' 81' ' ' ALA . 12.6 mt -42.52 174.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.277 -0.874 . . . . 74.439999999999998 112.151 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -120.29 3.67 10.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.539 -0.755 . . . . 72.329999999999998 110.345 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p 58.4 35.15 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.698 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.5 p30 -89.2 -31.27 18.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 72.340000000000003 111.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 28.1 tttt -143.53 157.27 44.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.108 0.48 . . . . 44.039999999999999 110.707 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.953 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.9 170.72 8.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.731 -0.668 . . . . 72.200000000000003 111.584 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 18.2 Cg_endo -60.24 162.09 36.68 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.422 -1.491 . . . . 54.200000000000003 113.013 0.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -123.92 162.41 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.755 . . . . 75.129999999999995 109.812 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 84' ' ' ILE . 42.0 t80 -138.49 124.6 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 64.099999999999994 111.132 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -119.63 148.43 43.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 111.499 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.853 HD11 ' CE2' ' A' ' 82' ' ' PHE . 12.9 mm -128.58 90.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 110.346 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.74 139.19 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 73.209999999999994 110.899 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.0 mt-10 -108.34 110.38 21.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 110.76 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 20' ' ' MET . 33.8 m -78.33 0.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 111.153 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.42 -39.43 8.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.434 -0.348 . . . . 73.150000000000006 111.17 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 -6.51 9.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.63 -0.259 . . . . 44.119999999999997 111.525 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.6 t30 66.19 64.58 0.52 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.546 -0.538 . . . . 71.239999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 tp-100 -122.26 169.66 10.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.5 -0.773 . . . . 63.100000000000001 111.735 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.609 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -134.96 92.01 2.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.204 -0.907 . . . . 75.519999999999996 111.602 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 70.0 m-85 -103.93 66.55 0.11 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.872 -0.603 . . . . 75.519999999999996 111.138 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 95.1 Cg_endo -77.18 -175.5 2.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.451 2.1 . . . . 54.450000000000003 112.998 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -112.66 168.61 9.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.847 -0.615 . . . . 64.049999999999997 110.943 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -72.44 176.3 5.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 71.010000000000005 110.733 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -118.18 -16.31 9.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 62.530000000000001 111.279 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -119.75 -8.13 9.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.829 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -70.96 -8.46 53.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.861 -0.609 . . . . 71.049999999999997 111.559 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.4 tt0 86.73 120.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.214 -0.448 . . . . 74.200000000000003 110.596 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.0 mt -103.94 110.01 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 111.59 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -131.21 -153.55 0.57 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.892 -0.781 . . . . 72.030000000000001 108.892 178.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.869 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.53 -66.16 0.95 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.624 -0.88 . . . . 72.319999999999993 108.624 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.703 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.19 -38.97 9.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.994 -1.003 . . . . 72.409999999999997 111.957 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -68.81 -32.88 72.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.69 0.626 . . . . 62.240000000000002 112.69 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 47' ' ' ILE . 32.9 mm -91.24 -45.76 14.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 109.942 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.841 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -45.77 83.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.844 -0.798 . . . . 71.120000000000005 108.844 178.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.36 36.8 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.774 -0.648 . . . . 73.420000000000002 110.125 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.741 ' CE1' HD13 ' A' ' 118' ' ' ILE . 48.7 t80 -49.77 -63.83 0.99 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.011 -0.366 . . . . 73.219999999999999 110.011 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 106' ' ' ILE . 8.3 m -49.17 -42.85 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.535 . . . . 62.439999999999998 109.569 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -52.97 -36.93 60.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.727 0.775 . . . . 40.149999999999999 109.204 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -69.3 -34.8 75.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 108.398 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.854 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.0 t80 -71.75 -69.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.255 -0.884 . . . . 73.219999999999999 110.874 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 55' ' ' ILE . 16.9 t -50.19 -47.46 24.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 72.019999999999996 111.987 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -36.96 67.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 74.230000000000004 111.019 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.75 29.41 2.24 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 110.864 -0.894 . . . . 74.530000000000001 110.864 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.916 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -101.76 -52.92 3.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.792 -0.704 . . . . 64.420000000000002 111.561 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.854 HD12 ' HB2' ' A' ' 113' ' ' PHE . 55.9 mt -66.43 152.94 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.483 -0.562 . . . . 61.450000000000003 109.483 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.81 168.09 19.04 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.395 -0.366 . . . . 65.140000000000001 111.449 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.85 115.17 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.776 2.318 . . . . 73.010000000000005 112.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 m -73.33 132.93 43.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.017 -0.538 . . . . 64.439999999999998 110.65 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 40.96 -92.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.102 -0.499 . . . . 72.420000000000002 111.701 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.59 28.97 1.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.821 0.343 . . . . 74.340000000000003 111.171 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.0 m 53.24 44.53 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.218 0.533 . . . . 73.040000000000006 110.879 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 127' ' ' ILE . 5.8 tp10 -151.61 86.76 4.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.509 -0.769 . . . . 72.430000000000007 110.535 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.622 ' C ' HD12 ' A' ' 127' ' ' ILE . 91.9 Cg_endo -80.51 150.7 19.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.509 2.139 . . . . 54.229999999999997 112.65 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.622 HD12 ' C ' ' A' ' 126' ' ' PRO . 5.1 mp -148.76 85.87 5.96 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 72.109999999999999 110.698 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -43.02 166.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.862 2.375 . . . . 63.509999999999998 112.695 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.49 111.16 0.67 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.585 -0.734 . . . . 71.140000000000001 110.928 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -142.16 -80.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 74.349999999999994 110.912 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -80.27 177.35 9.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.61 -0.723 . . . . 73.209999999999994 110.832 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.9 157.61 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 63.450000000000003 110.877 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.381 -1.233 . . . . 73.109999999999999 112.509 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.509 -0.237 . . . . 62.399999999999999 112.509 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.13 126.64 20.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.625 2.216 . . . . 75.209999999999994 112.311 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -121.18 134.82 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.530000000000001 110.812 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' N ' HD13 ' A' ' 3' ' ' LEU . . . -156.64 110.62 0.45 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.608 -0.806 . . . . 51.520000000000003 112.601 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.429 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 0.7 OUTLIER -141.51 64.97 20.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 54.5 110.802 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 5' ' ' SER . 11.7 Cg_exo -70.77 139.07 35.94 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.741 2.294 . . . . 64.329999999999998 112.363 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.99 -64.46 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 63.43 110.479 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.744 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.6 pt -79.37 130.15 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.863 -0.608 . . . . 74.439999999999998 110.748 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.86 8.77 0.65 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 73.430000000000007 113.181 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.97 114.19 7.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.999 0.399 . . . . 73.310000000000002 110.894 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.739 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 11.9 mt -118.21 137.97 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 111.237 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.02 -170.72 12.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.777 -0.725 . . . . 74.329999999999998 112.414 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.35 4.06 7.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.728 2.285 . . . . 63.399999999999999 112.938 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.84 28.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 51.210000000000001 111.111 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 p -122.89 -36.78 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 72.420000000000002 111.068 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -55.58 -30.88 61.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 71.450000000000003 111.113 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -55.59 -24.03 30.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 55.149999999999999 111.237 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -83.04 -40.88 19.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 72.5 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' HB2' HD12 ' A' ' 26' ' ' LEU . 15.6 m-85 -77.13 -18.31 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.372 0.606 . . . . 72.349999999999994 109.59 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.878 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.6 -32.17 17.23 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.091 -0.959 . . . . 60.310000000000002 110.233 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -90.9 -8.64 48.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.694 -0.685 . . . . 62.32 111.006 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.19 -56.21 10.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.935 0.397 . . . . 73.530000000000001 110.623 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.35 23.99 2.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.928 -0.653 . . . . 63.509999999999998 112.351 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.88 166.44 28.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.746 0.308 . . . . 73.340000000000003 111.296 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.1 Cg_exo -65.25 141.49 69.09 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.607 2.205 . . . . 52.020000000000003 112.357 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.922 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.8 tt -105.46 128.04 53.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.522 . . . . 71.5 110.564 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . . . -100.75 86.6 3.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.093 0.473 . . . . 55.439999999999998 111.451 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.922 ' CD1' HD22 ' A' ' 26' ' ' LEU . 62.4 m-85 -75.81 136.82 40.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.573 -0.739 . . . . 73.0 110.264 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 44' ' ' LEU . 2.8 mp -130.43 87.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.773 0.32 . . . . 72.450000000000003 111.178 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.854 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.5 m-85 -71.59 147.09 47.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.683 -0.488 . . . . 73.299999999999997 109.683 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.657 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -159.26 119.64 3.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.147 0.499 . . . . 72.430000000000007 110.828 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 12.1 mt-10 -74.32 -7.46 52.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.494 -0.776 . . . . 74.299999999999997 110.346 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -89.09 126.56 35.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 75.349999999999994 111.104 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.85 4.38 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.476 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.1 -38.33 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 60.310000000000002 110.474 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -104.34 15.96 27.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 111.074 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -59.23 -25.81 64.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 74.340000000000003 111.035 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -58.13 -44.08 87.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.365 . . . . 62.439999999999998 110.855 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.44 -42.93 82.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 74.530000000000001 110.981 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.06 -53.65 46.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 71.019999999999996 110.83 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 44' ' ' LEU . 49.8 m -64.86 -22.84 67.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.214 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 30.3 t0 -65.29 -61.6 2.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.567 0.698 . . . . 72.209999999999994 109.244 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -48.41 -32.96 8.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.604 1.192 . . . . 64.25 108.746 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.036 HD11 HG21 ' A' ' 29' ' ' ILE . 43.3 mt -76.62 -24.04 53.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.463 -1.699 . . . . 73.319999999999993 112.388 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.0 mtpt -53.73 -44.68 98.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 63.109999999999999 110.13 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.9 Cg_endo -83.21 -38.86 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.532 2.155 . . . . 74.430000000000007 110.819 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.842 ' CD1' HD23 ' A' ' 44' ' ' LEU . 58.7 mt -49.78 -23.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.912 -0.585 . . . . 64.109999999999999 110.102 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.747 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -110.82 -26.19 9.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 71.120000000000005 111.465 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.62 -18.83 61.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.128 0.49 . . . . 72.150000000000006 110.04 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.96 -28.94 17.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.76 0.79 . . . . 60.229999999999997 109.409 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.708 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 5.9 pt20 -121.31 38.96 3.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.311 -1.313 . . . . 74.319999999999993 110.597 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.1 ptm180 -75.04 -27.05 59.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 72.209999999999994 111.406 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.03 14.97 28.59 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.903 -0.665 . . . . 71.439999999999998 112.618 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 51' ' ' GLN . 7.5 p -128.81 -44.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 75.319999999999993 110.964 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 25' ' ' PRO . 30.0 mt -118.06 146.24 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 65.239999999999995 110.527 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -94.08 102.11 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.889 0.376 . . . . 73.319999999999993 110.406 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.747 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -80.01 136.69 36.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.348 0.594 . . . . 74.209999999999994 111.587 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.739 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -160.6 126.71 1.65 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.148 -0.933 . . . . 71.140000000000001 111.879 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 p -88.4 153.67 21.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 73.239999999999995 110.415 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.902 HD11 ' CG ' ' A' ' 65' ' ' PHE . 10.8 tt -147.91 162.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 71.430000000000007 110.853 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.3 t0 -83.55 117.4 23.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.178 -0.465 . . . . 74.25 112.183 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.947 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.05 5.35 22.61 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.673 0.273 . . . . 43.25 110.788 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 17.6 ttmt -103.67 -33.23 9.03 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.526 -0.306 . . . . 73.310000000000002 111.622 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.54 -32.42 5.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.224 0.535 . . . . 73.030000000000001 110.57 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.902 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.33 -16.47 17.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 71.140000000000001 111.101 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.65 -39.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.442 0.537 . . . . 64.5 114.442 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.02 -26.71 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.25 0.548 . . . . 74.019999999999996 110.459 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -83.29 -13.48 55.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 61.109999999999999 111.611 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.854 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.73 -36.76 70.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.667 0.27 . . . . 62.229999999999997 111.558 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -108.07 -0.44 33.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.917 -1.135 . . . . 71.030000000000001 113.416 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -10.68 6.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.507 -0.553 . . . . 50.32 109.507 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -113.93 -14.84 12.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.372 -0.831 . . . . 64.209999999999994 110.328 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.716 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.31 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.276 0.473 . . . . 55.399999999999999 112.276 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.549 HD13 ' HB1' ' A' ' 81' ' ' ALA . 96.6 mt -43.14 178.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.514 -0.766 . . . . 74.439999999999998 112.913 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' C ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -107.94 -24.53 11.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.969 -1.014 . . . . 72.329999999999998 110.495 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 78.95 21.54 0.68 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.206 -0.906 . . . . 74.420000000000002 108.609 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.67 -45.16 25.78 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.649 -1.159 . . . . 72.340000000000003 111.41 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -123.93 163.2 21.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.1 -0.5 . . . . 44.039999999999999 111.154 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.947 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -160.59 167.43 13.7 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 72.200000000000003 112.023 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 26.2 Cg_endo -62.34 158.1 60.37 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 123.16 -1.6 . . . . 54.200000000000003 113.05 0.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.712 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . . . -123.31 167.59 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.737 . . . . 75.129999999999995 109.969 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.7 t80 -138.36 130.32 28.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.669 0.271 . . . . 64.099999999999994 110.778 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.711 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -129.68 121.34 26.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.038 0.385 . . . . 75.540000000000006 112.038 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.684 HD11 HG12 ' A' ' 110' ' ' VAL . 31.1 mt -103.63 93.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 110.346 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 92' ' ' LYS . 50.8 tt0 -85.05 141.77 30.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.768 0.318 . . . . 73.209999999999994 110.741 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.0 mt-10 -112.43 109.9 19.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.958 0.408 . . . . 74.420000000000002 111.072 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.878 HG11 ' O ' ' A' ' 20' ' ' MET . 15.7 t -80.2 -1.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.797 -0.638 . . . . 71.319999999999993 110.904 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.87 -42.67 11.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.919 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -118.8 -9.01 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.552 -0.294 . . . . 44.119999999999997 111.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 t30 75.46 57.05 0.06 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.353 0.597 . . . . 71.239999999999995 109.562 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.645 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -121.49 166.44 14.16 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.179 -0.919 . . . . 63.100000000000001 110.932 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.645 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 5.4 mmtt -141.42 98.19 3.31 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.413 -0.812 . . . . 75.519999999999996 110.663 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.635 ' O ' HD12 ' A' ' 84' ' ' ILE . 64.1 m-85 -101.76 73.41 0.12 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.838 . . . . 75.519999999999996 110.866 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 53.7 Cg_endo -80.05 167.32 20.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 54.450000000000003 112.585 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' ' N ' ' A' ' 96' ' ' ASP . 40.5 t80 -96.08 166.15 11.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 64.049999999999997 110.828 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -63.67 173.81 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 71.010000000000005 110.392 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.712 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 7.1 mm-40 -117.15 -22.9 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.423 . . . . 62.530000000000001 111.369 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -127.52 25.61 6.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.378 . . . . 72.430000000000007 110.835 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.4 tppt? -93.33 -69.37 0.75 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.022 -0.536 . . . . 71.049999999999997 110.533 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 9.7 tt0 163.56 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.763 -0.653 . . . . 74.200000000000003 109.892 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 8.7 mt -91.25 88.09 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.549999999999997 111.735 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -112.25 -154.1 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.98 -67.57 0.85 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.741 -0.837 . . . . 72.319999999999993 108.741 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.82 -35.83 6.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.341 -0.845 . . . . 72.409999999999997 111.479 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -71.82 -33.38 68.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 62.240000000000002 112.426 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.702 ' HB ' HD13 ' A' ' 47' ' ' ILE . 50.0 mm -89.48 -46.43 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.113 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.666 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -58.47 -44.93 89.47 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.727 -0.67 . . . . 71.120000000000005 109.471 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -70.86 -49.01 50.77 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.696 -0.684 . . . . 73.420000000000002 110.123 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.79 ' O ' HD11 ' A' ' 118' ' ' ILE . 27.5 t80 -51.56 -67.2 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 109.822 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.684 HG12 HD11 ' A' ' 84' ' ' ILE . 21.9 m -47.16 -38.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.322 0.582 . . . . 62.439999999999998 109.869 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -57.87 -41.88 83.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.356 -0.838 . . . . 40.149999999999999 110.057 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.793 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -77.16 -11.93 59.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.615 -0.721 . . . . 75.319999999999993 110.263 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.941 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -82.0 -61.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.74 0.781 . . . . 73.219999999999999 109.153 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.543 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 11.5 p -57.94 -37.29 60.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.302 -1.317 . . . . 72.019999999999996 110.885 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.05 86.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 74.230000000000004 110.431 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.85 1.53 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.722 -0.751 . . . . 74.530000000000001 111.558 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.46 -37.13 6.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.296 -0.452 . . . . 64.420000000000002 111.704 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.4 mt -86.54 150.0 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.16 0.505 . . . . 61.450000000000003 110.508 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.48 162.56 45.92 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.479 -0.782 . . . . 65.140000000000001 111.079 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 91' ' ' GLN . 15.8 Cg_exo -68.22 129.66 19.74 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 73.010000000000005 112.189 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 t -58.72 -41.67 86.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 64.439999999999998 110.12 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.2 pt -145.23 -165.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.738 -0.665 . . . . 72.420000000000002 109.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.14 -171.09 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.178 0.514 . . . . 74.340000000000003 111.729 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -155.84 -172.67 4.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.456 -0.793 . . . . 73.040000000000006 110.429 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.76 82.24 15.82 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.378 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.05 -171.77 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.623 2.215 . . . . 54.229999999999997 112.464 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 127' ' ' ILE . 15.0 tt -112.06 81.11 3.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.109999999999999 110.97 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.14 -179.51 2.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.568 2.179 . . . . 63.509999999999998 112.332 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -162.89 90.3 0.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 71.140000000000001 110.945 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 163.28 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 74.349999999999994 110.985 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.62 179.11 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 73.209999999999994 110.983 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 46.27 -169.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.168 -0.469 . . . . 63.450000000000003 111.283 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.307 -1.274 . . . . 73.109999999999999 112.43 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.504 -0.239 . . . . 62.399999999999999 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -51.85 -26.76 25.2 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 75.209999999999994 112.349 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 3' ' ' LEU . 8.1 tt 61.92 103.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 61.530000000000001 110.865 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.43 85.77 0.14 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.742 -0.742 . . . . 51.520000000000003 112.6 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 152.68 27.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.668 0.27 . . . . 54.5 110.962 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.35 -79.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.203 . . . . 64.329999999999998 112.074 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.803 ' CD1' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -143.33 -135.61 0.09 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.239 -0.652 . . . . 63.43 109.239 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.803 HD13 ' CD1' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -157.89 145.13 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 110.82 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 59' ' ' THR . . . 119.59 17.4 4.76 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.684 -0.77 . . . . 73.430000000000007 112.901 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -145.06 104.74 4.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.665 0.269 . . . . 73.310000000000002 110.844 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.739 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 23.3 mt -113.0 140.3 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.972 0.415 . . . . 71.319999999999993 111.737 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.99 -150.87 6.47 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.86 -0.609 . . . . 74.329999999999998 112.311 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.54 -33.07 3.35 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.935 2.423 . . . . 63.399999999999999 112.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.84 24.67 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 51.210000000000001 111.155 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 p -136.75 -42.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 72.420000000000002 111.142 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -43.92 -56.5 3.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.216 -0.447 . . . . 71.450000000000003 111.374 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -64.49 -26.67 68.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 55.149999999999999 111.666 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.35 -38.39 60.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 72.5 111.015 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 23.0 m-85 -79.12 -23.44 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.362 0.601 . . . . 72.349999999999994 109.593 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.642 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -87.91 -25.47 23.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.118 -0.946 . . . . 60.310000000000002 110.379 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 t -95.31 -11.23 28.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.025 -0.534 . . . . 62.32 110.521 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.01 78.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.458 -0.337 . . . . 73.530000000000001 111.175 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 17.18 39.77 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.715 . . . . 63.509999999999998 112.666 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.97 161.1 65.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.718 0.294 . . . . 73.340000000000003 110.89 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.04 139.57 88.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.624 2.216 . . . . 52.020000000000003 112.688 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.898 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.3 tt -98.42 140.96 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 71.5 111.145 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -114.94 88.22 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 55.439999999999998 111.023 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.898 ' CD2' HD22 ' A' ' 26' ' ' LEU . 81.6 m-85 -76.87 133.97 39.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.69 -0.687 . . . . 73.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.0 mt -125.76 85.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.501 -0.318 . . . . 72.450000000000003 111.093 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.6 m-85 -73.24 148.84 43.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.299 -0.63 . . . . 73.299999999999997 109.299 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -157.18 115.13 3.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.383 0.611 . . . . 72.430000000000007 111.326 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -84.72 -1.25 55.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.022 -0.99 . . . . 74.299999999999997 109.901 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 p -106.6 112.48 25.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.974 -0.557 . . . . 75.349999999999994 110.662 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.32 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 72.230000000000004 111.375 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.36 -55.17 5.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.091 0.472 . . . . 60.310000000000002 110.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' OE2' HD23 ' A' ' 40' ' ' LEU . 3.7 pt-20 -82.38 -3.42 55.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 71.430000000000007 110.902 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 -44.83 -38.77 4.78 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 111.15 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.22 -56.11 9.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.676 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 7.4 pt-20 -58.2 -31.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 74.530000000000001 110.576 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.74 -57.54 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.042 0.449 . . . . 71.019999999999996 110.448 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HA ' HD12 ' A' ' 44' ' ' LEU . 25.6 m -63.43 -20.26 65.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 74.349999999999994 111.329 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t0 -65.94 -63.87 0.99 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.609 0.718 . . . . 72.209999999999994 109.345 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -47.85 -33.02 6.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.703 1.24 . . . . 64.25 108.684 177.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.913 HD23 HD12 ' A' ' 47' ' ' ILE . 52.1 mt -76.88 -23.32 52.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.43 -1.714 . . . . 73.319999999999993 112.467 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 10.8 mtpt -54.45 -43.95 98.37 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 116.431 -0.35 . . . . 63.109999999999999 110.073 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 21.0 Cg_endo -82.37 -39.85 0.15 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 110.543 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.993 HG21 HG22 ' A' ' 106' ' ' ILE . 47.1 mt -51.25 -22.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-N 116.045 -0.525 . . . . 64.109999999999999 109.948 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.734 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -111.22 -23.99 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.775 -0.648 . . . . 71.120000000000005 111.429 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -61.47 -20.74 63.49 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.195 0.521 . . . . 72.150000000000006 109.89 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.7 -26.54 19.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.422 -0.808 . . . . 60.229999999999997 109.338 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.718 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -125.66 42.21 3.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.441 -1.254 . . . . 74.319999999999993 110.793 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -76.32 -32.54 58.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.666 -0.697 . . . . 72.209999999999994 111.056 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.4 6.69 53.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.849 -0.691 . . . . 71.439999999999998 112.641 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 51' ' ' GLN . 13.1 p -119.09 -34.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 75.319999999999993 111.23 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.0 mt -122.94 143.95 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 65.239999999999995 111.009 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-80 -93.61 87.0 5.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 73.319999999999993 109.927 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.734 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m-85 -69.89 136.71 50.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 74.209999999999994 111.234 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.739 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -158.63 129.63 2.32 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.389 -0.823 . . . . 71.140000000000001 111.961 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 9' ' ' GLY . 50.0 p -89.38 151.58 21.97 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.039 0.447 . . . . 73.239999999999995 110.878 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.951 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.3 tt -148.07 163.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.503 -0.771 . . . . 71.430000000000007 110.422 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.2 t0 -87.08 120.98 28.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.379 -0.373 . . . . 74.25 111.883 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.859 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.98 5.09 23.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.788 -0.365 . . . . 43.25 111.073 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 29.2 ttmt -105.08 -34.15 8.06 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 111.735 0.272 . . . . 73.310000000000002 111.735 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.57 -30.51 7.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.218 0.532 . . . . 73.030000000000001 110.417 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.951 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.77 -17.99 14.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.413 -0.812 . . . . 71.140000000000001 111.167 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -31.41 -39.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 114.239 0.456 . . . . 64.5 114.239 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.55 -19.03 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.058 0.429 . . . . 74.019999999999996 110.691 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -90.66 -11.83 38.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.805 -0.634 . . . . 61.109999999999999 111.183 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.19 -51.36 38.75 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.73 0.3 . . . . 62.229999999999997 111.048 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.52 1.75 69.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.739 -1.22 . . . . 71.030000000000001 113.778 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.61 -9.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.452 0.626 . . . . 50.32 109.668 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -114.29 -15.22 12.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.405 -0.816 . . . . 64.209999999999994 110.319 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.73 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.0 OUTLIER 178.16 -70.02 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.246 0.546 . . . . 55.399999999999999 112.264 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.6 mm? -40.86 171.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 114.89 -1.05 . . . . 74.439999999999998 112.375 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.24 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 72.329999999999998 110.832 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 16.0 p 53.75 38.13 27.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.383 . . . . 74.420000000000002 110.825 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.64 -29.84 33.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 72.340000000000003 110.769 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -150.69 163.81 37.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.243 -0.435 . . . . 44.039999999999999 110.36 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.61 173.15 5.23 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.915 -0.584 . . . . 72.200000000000003 111.787 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.597 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 19.1 Cg_endo -60.36 164.63 30.24 Favored 'Cis proline' 0 C--N 1.353 0.793 0 C-N-CA 123.363 -1.515 . . . . 54.200000000000003 113.076 0.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.49 167.62 16.04 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.394 -0.821 . . . . 75.129999999999995 109.532 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.1 t80 -143.58 112.1 6.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 64.099999999999994 110.645 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -109.44 126.42 53.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 75.540000000000006 111.429 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 113' ' ' PHE . 11.8 mt -109.26 88.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.803 0.335 . . . . 70.340000000000003 110.42 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -84.92 138.5 32.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 73.209999999999994 110.6 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 9.7 mt-10 -100.11 115.28 29.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.922 0.391 . . . . 74.420000000000002 110.894 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -81.61 3.49 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.539 . . . . 71.319999999999993 110.827 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.99 -41.5 8.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.292 -0.413 . . . . 73.150000000000006 110.857 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -117.79 -15.93 10.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.637 -0.256 . . . . 44.119999999999997 111.308 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 35.4 t-20 81.18 40.75 0.05 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.324 0.583 . . . . 71.239999999999995 110.268 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 tp-100 -91.6 -174.74 3.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.339 -0.846 . . . . 63.100000000000001 111.152 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -150.28 93.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.56 -0.745 . . . . 75.519999999999996 110.713 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.61 ' O ' HD12 ' A' ' 84' ' ' ILE . 75.0 m-85 -105.18 70.07 0.2 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.835 -0.62 . . . . 75.519999999999996 111.353 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.889 ' CB ' HD21 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.56 178.65 6.42 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.683 2.255 . . . . 54.450000000000003 112.968 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 37.1 t80 -113.05 164.45 13.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 64.049999999999997 110.505 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -62.35 174.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 71.010000000000005 110.74 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -117.49 -23.27 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 62.530000000000001 111.21 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 24.93 6.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 110.847 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.3 tppt? -94.55 -77.3 0.47 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.019 -0.537 . . . . 71.049999999999997 110.534 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 3.8 tt0 173.74 105.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 74.200000000000003 110.4 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.0 mt -98.63 88.58 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.815 -0.63 . . . . 75.549999999999997 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -119.07 -164.68 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.28 -0.637 . . . . 72.030000000000001 109.28 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.76 -66.32 0.89 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.098 0.475 . . . . 72.319999999999993 110.099 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -48.98 -39.23 25.73 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.936 -1.029 . . . . 72.409999999999997 111.754 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -71.88 -34.94 69.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.067 -0.97 . . . . 62.240000000000002 113.412 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.993 HG22 HG21 ' A' ' 47' ' ' ILE . 46.2 mm -88.05 -44.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.0 0.429 . . . . 74.420000000000002 110.201 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -54.66 -42.97 71.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.866 -0.606 . . . . 71.120000000000005 109.511 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.81 36.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.621 -0.718 . . . . 73.420000000000002 110.139 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.722 ' O ' HD11 ' A' ' 118' ' ' ILE . 32.2 t80 -49.64 -64.74 0.72 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.631 -0.507 . . . . 73.219999999999999 109.631 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 111' ' ' ASP . 16.7 m -49.97 -41.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.765 -0.458 . . . . 62.439999999999998 109.765 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -55.58 -36.96 67.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.686 0.755 . . . . 40.149999999999999 109.133 178.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.927 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -68.03 -34.82 77.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.431 -1.259 . . . . 75.319999999999993 108.281 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.88 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -71.52 -69.05 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.099 -0.955 . . . . 73.219999999999999 111.025 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.606 ' CG2' HD11 ' A' ' 55' ' ' ILE . 11.9 t -52.36 -46.05 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.284 -0.871 . . . . 72.019999999999996 112.101 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.66 69.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.843 0.354 . . . . 74.230000000000004 111.235 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.36 31.17 1.9 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.86 -0.896 . . . . 74.530000000000001 110.86 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.927 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -103.25 -56.22 2.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.848 -0.676 . . . . 64.420000000000002 111.373 -178.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.88 HD12 ' HB2' ' A' ' 113' ' ' PHE . 50.4 mt -64.56 150.75 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.403 -0.591 . . . . 61.450000000000003 109.403 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.13 157.37 78.44 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 65.140000000000001 111.581 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.17 114.5 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.8 2.333 . . . . 73.010000000000005 112.611 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.491 ' O ' HG13 ' A' ' 122' ' ' ILE . 19.0 m -92.78 117.81 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 64.439999999999998 110.953 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 121' ' ' SER . 1.1 pt 41.84 -173.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.861 -0.609 . . . . 72.420000000000002 112.249 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -159.32 133.96 7.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 74.340000000000003 110.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.51 107.85 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 73.040000000000006 110.405 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -163.46 71.36 1.87 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.94 178.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.59 2.194 . . . . 54.229999999999997 112.539 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.77 84.16 0.62 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 111.667 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.98 -166.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.523 2.148 . . . . 63.509999999999998 111.954 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.38 76.91 1.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 71.140000000000001 111.059 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tptt 179.98 159.55 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 74.349999999999994 110.947 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 -168.79 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 110.839 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.74 166.46 22.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 63.450000000000003 110.863 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.378 -1.235 . . . . 73.109999999999999 112.533 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.492 -0.243 . . . . 62.399999999999999 112.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.07 93.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.573 2.182 . . . . 75.209999999999994 112.295 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 4' ' ' GLY . 4.3 pp -96.17 146.73 24.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 61.530000000000001 110.903 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.472 ' O ' HD12 ' A' ' 3' ' ' LEU . . . -84.35 -155.79 23.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 51.520000000000003 112.517 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -177.66 90.26 0.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 54.5 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.12 141.47 57.62 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.504 2.136 . . . . 64.329999999999998 112.196 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.6 mt -92.3 -77.55 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 63.43 110.992 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -130.83 131.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.84 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 59' ' ' THR . . . 164.78 -56.36 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.45 -0.881 . . . . 73.430000000000007 112.665 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -128.08 135.5 49.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.623 0.249 . . . . 73.310000000000002 110.957 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.777 HD11 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -107.21 153.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 71.319999999999993 111.028 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.63 -159.18 9.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.737 -0.744 . . . . 74.329999999999998 112.325 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.96 10.29 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.684 2.256 . . . . 63.399999999999999 112.826 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.9 25.96 1.4 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.571 0.224 . . . . 51.210000000000001 111.512 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 p -123.32 -23.46 4.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 72.420000000000002 110.329 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -57.83 -38.7 76.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.749 -0.66 . . . . 71.450000000000003 111.616 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.7 t -55.86 -30.83 62.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.051 -0.522 . . . . 55.149999999999999 111.965 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.678 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.7 t0 -87.09 -35.86 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.899 0.38 . . . . 72.5 111.251 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 11.7 m-85 -81.53 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 72.349999999999994 110.664 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.08 -28.85 9.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 60.310000000000002 110.577 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -97.15 -5.87 36.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.982 -0.554 . . . . 62.32 110.882 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.62 -40.12 76.78 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.906 0.384 . . . . 73.530000000000001 111.026 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.62 15.67 22.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.859 -0.686 . . . . 63.509999999999998 112.459 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.51 ' C ' HG22 ' A' ' 87' ' ' VAL . 2.1 pt -133.35 154.37 80.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.340000000000003 111.096 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 19.0 Cg_endo -60.34 145.12 99.27 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.84 2.36 . . . . 52.020000000000003 112.604 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 27' ' ' ALA . 3.1 tt -95.97 135.7 37.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.9 -0.591 . . . . 71.5 111.143 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' N ' HD23 ' A' ' 26' ' ' LEU . . . -104.72 95.27 5.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 55.439999999999998 110.793 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.659 ' CE1' HD12 ' A' ' 11' ' ' ILE . 6.5 m-85 -82.3 130.75 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 73.0 110.371 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.92 HG21 ' CD1' ' A' ' 44' ' ' LEU . 2.3 mp -124.38 83.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.81 -0.356 . . . . 72.450000000000003 111.339 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.8 m-85 -70.28 143.97 51.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.561 -0.533 . . . . 73.299999999999997 109.561 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -158.07 118.47 3.37 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.145 0.497 . . . . 72.430000000000007 111.028 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 23.4 mt-10 -71.26 -13.25 61.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 74.299999999999997 109.979 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 p -88.64 97.24 11.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 111.037 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.44 7.59 42.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 72.230000000000004 111.456 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -113.3 -46.46 3.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 60.310000000000002 110.83 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -92.93 1.55 57.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.381 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.59 -29.87 0.19 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.929 0.344 . . . . 74.340000000000003 111.929 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -49.78 -50.04 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 62.439999999999998 111.151 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 17.5 mt-10 -63.34 -44.03 96.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 74.530000000000001 111.103 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.57 -53.68 53.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 71.019999999999996 110.905 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 28.6 m -65.06 -19.85 66.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 74.349999999999994 111.383 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' LYS . 10.6 t0 -67.53 -62.03 1.62 Allowed 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.312 -0.625 . . . . 72.209999999999994 109.312 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.649 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.07 -32.82 10.28 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.844 1.307 . . . . 64.25 108.782 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.92 ' CD1' HG21 ' A' ' 29' ' ' ILE . 63.7 mt -77.65 -23.29 49.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.191 -1.822 . . . . 73.319999999999993 111.903 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 17.8 ttmt -52.27 -45.17 94.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.747 -0.661 . . . . 63.109999999999999 110.083 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.1 Cg_endo -83.96 -37.54 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.628 2.219 . . . . 74.430000000000007 110.537 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 44' ' ' LEU . 60.9 mt -50.33 -21.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 116.068 -0.515 . . . . 64.109999999999999 110.196 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -110.87 -32.44 6.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.177 -0.465 . . . . 71.120000000000005 111.797 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 2.0 tm-20 -59.39 -18.15 36.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.24 0.543 . . . . 72.150000000000006 110.179 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.14 -27.98 19.25 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.42 -0.809 . . . . 60.229999999999997 109.527 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 6.5 pt20 -121.48 36.07 4.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.449 -1.25 . . . . 74.319999999999993 110.814 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' ALA . 20.4 ptt-85 -67.08 -32.79 74.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.67 . . . . 72.209999999999994 111.326 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 9.61 49.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.645 -0.788 . . . . 71.439999999999998 112.83 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.6 p -123.78 -29.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.742 0.271 . . . . 75.319999999999993 111.581 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 27' ' ' ALA . 32.8 mt -132.84 153.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.54 -0.3 . . . . 65.239999999999995 110.428 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -102.82 109.8 21.51 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.994 0.426 . . . . 73.319999999999993 110.728 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -70.35 125.89 28.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.412 0.625 . . . . 74.209999999999994 111.136 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.777 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -150.29 100.43 0.21 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.025 -0.989 . . . . 71.140000000000001 112.572 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 9' ' ' GLY . 33.4 p -77.74 152.95 33.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 73.239999999999995 110.521 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.969 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.6 tt -150.14 165.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 71.430000000000007 110.87 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 28.8 t0 -88.43 120.7 30.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.197 -0.456 . . . . 74.25 112.077 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.942 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -84.46 3.56 35.69 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.696 0.284 . . . . 43.25 111.0 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 11.1 tttt -104.42 -32.64 8.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.492 -0.322 . . . . 73.310000000000002 111.545 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.92 -30.25 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 73.030000000000001 110.616 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.68 -15.72 15.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.574 -0.739 . . . . 71.140000000000001 111.236 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -32.33 -38.09 0.05 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.269 0.467 . . . . 64.5 114.269 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.53 -12.38 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.175 0.487 . . . . 74.019999999999996 110.764 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' PHE . 47.9 t60 -103.08 -4.21 24.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.705 -0.68 . . . . 61.109999999999999 110.934 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.86 -53.18 10.78 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.739 0.305 . . . . 62.229999999999997 111.324 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.82 6.75 73.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 119.868 -1.158 . . . . 71.030000000000001 113.504 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.42 -9.8 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.09 -0.707 . . . . 50.32 109.09 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.74 -15.04 12.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.224 -0.898 . . . . 64.209999999999994 110.376 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.727 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER 179.06 -69.92 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.355 0.598 . . . . 55.399999999999999 112.288 -178.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 94' ' ' PRO . 1.5 mm? -40.96 173.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.016 -0.993 . . . . 74.439999999999998 112.594 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.606 ' C ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -101.89 -32.38 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 72.329999999999998 110.894 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.606 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.8 p 85.01 27.34 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.808 -1.087 . . . . 74.420000000000002 108.388 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.56 -45.55 17.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.535 -1.211 . . . . 72.340000000000003 111.017 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 21.9 tttp -130.1 163.28 26.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.88 -0.6 . . . . 44.039999999999999 111.074 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -157.07 169.83 9.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.578 . . . . 72.200000000000003 111.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 18.4 Cg_endo -60.61 160.53 42.74 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 123.446 -1.481 . . . . 54.200000000000003 113.189 0.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.13 159.93 32.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.379 -0.828 . . . . 75.129999999999995 109.812 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HG12 ' A' ' 110' ' ' VAL . 68.4 t80 -136.76 136.83 39.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 64.099999999999994 111.748 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -134.77 148.67 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 75.540000000000006 111.172 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.886 HG21 ' CE2' ' A' ' 113' ' ' PHE . 12.9 mt -123.66 94.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.33 . . . . 70.340000000000003 110.525 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.623 HE22 HG12 ' A' ' 87' ' ' VAL . 9.0 tm0? -77.71 136.67 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 110.89 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.9 mt-10 -107.39 116.06 31.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HE22 ' A' ' 85' ' ' GLN . 34.3 m -82.7 8.51 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 71.319999999999993 112.169 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.18 -40.02 3.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.813 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -105.7 -14.56 15.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 44.119999999999997 111.33 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.453 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 0.5 OUTLIER 74.44 19.56 2.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.925 0.393 . . . . 71.239999999999995 111.092 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 6.2 tp-100 -89.12 166.53 13.78 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.122 -0.49 . . . . 63.100000000000001 110.681 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 8.6 mmtt -141.06 85.38 1.98 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.819 -0.628 . . . . 75.519999999999996 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' O ' HD12 ' A' ' 84' ' ' ILE . 32.5 m-85 -81.31 100.73 0.77 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 75.519999999999996 110.688 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 74' ' ' LEU . 40.6 Cg_endo -105.47 168.92 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.431 2.754 . . . . 54.450000000000003 113.294 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 36.4 t80 -102.85 165.38 11.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 64.049999999999997 110.626 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -65.51 175.06 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 71.010000000000005 110.528 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 1.4 mt-30 -116.67 -24.61 7.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 62.530000000000001 111.218 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 9.5 pt-20 -124.41 25.86 7.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.397 . . . . 72.430000000000007 110.825 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.5 tppt? -96.34 -72.56 0.63 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.566 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 54.7 tt0 170.46 100.48 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.96 -0.563 . . . . 74.200000000000003 110.382 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.4 mt -94.63 90.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 75.549999999999997 111.064 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 22.1 p -116.22 -150.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.413 -0.358 . . . . 72.030000000000001 110.248 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.696 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -97.35 -56.39 2.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.436 0.636 . . . . 72.319999999999993 109.495 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -61.4 -39.29 90.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.733 -1.122 . . . . 72.409999999999997 110.722 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -70.75 -33.36 70.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 62.240000000000002 112.602 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.664 ' HB ' HD13 ' A' ' 47' ' ' ILE . 51.9 mm -89.49 -41.39 13.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 74.420000000000002 110.166 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.599 ' HB3' HG12 ' A' ' 47' ' ' ILE . 3.0 pttp -62.74 -46.23 89.03 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.479 -0.782 . . . . 71.120000000000005 109.115 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 107' ' ' LYS . . . -67.35 -49.93 61.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.985 -1.007 . . . . 73.420000000000002 110.2 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.672 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.1 t80 -51.4 -65.82 0.49 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 116.295 -0.411 . . . . 73.219999999999999 110.023 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 106' ' ' ILE . 12.3 m -48.56 -36.16 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.486 0.66 . . . . 62.439999999999998 109.732 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -61.05 -42.97 99.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.092 -0.958 . . . . 40.149999999999999 110.062 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.982 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -72.39 -15.47 61.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 75.319999999999993 109.874 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.952 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -81.46 -62.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.729 0.776 . . . . 73.219999999999999 109.345 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.464 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.8 p -62.36 -38.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.445 -1.252 . . . . 72.019999999999996 111.173 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.11 76.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.542 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.97 30.23 1.26 Allowed Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.628 -0.796 . . . . 74.530000000000001 111.731 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.99 -38.5 6.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.516 -0.342 . . . . 64.420000000000002 111.475 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.982 HD11 ' OD1' ' A' ' 112' ' ' ASP . 6.0 mt -87.23 148.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 61.450000000000003 110.518 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.25 163.88 44.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.785 -0.643 . . . . 65.140000000000001 111.328 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.99 122.52 10.66 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.54 2.16 . . . . 73.010000000000005 112.418 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.5 p -86.94 -79.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 64.439999999999998 110.551 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.4 162.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.63 97.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 74.340000000000003 111.221 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.85 49.22 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 73.040000000000006 110.169 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -153.74 87.61 3.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.54 -0.755 . . . . 72.430000000000007 110.057 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.436 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 73.8 Cg_endo -73.05 -170.45 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.439 2.093 . . . . 54.229999999999997 112.483 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 pt -114.56 84.66 10.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 72.109999999999999 111.55 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -58.55 -160.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.79 2.327 . . . . 63.509999999999998 111.993 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -106.5 96.46 6.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.991 -0.55 . . . . 71.140000000000001 110.859 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -118.64 125.53 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 74.349999999999994 110.901 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.34 -168.57 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.891 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 62.39 149.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 63.450000000000003 110.889 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.32 -1.267 . . . . 73.109999999999999 112.448 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.535 -0.226 . . . . 62.399999999999999 112.535 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.45 100.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.182 . . . . 75.209999999999994 112.311 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.78 30.12 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.530000000000001 110.87 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.29 114.57 0.36 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 51.520000000000003 112.55 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.73 145.26 31.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.662 0.268 . . . . 54.5 110.901 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.52 -25.9 12.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.588 2.192 . . . . 64.329999999999998 112.488 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.39 -81.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 63.43 111.077 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG23 ' HB3' ' A' ' 57' ' ' PHE . 2.6 mp -136.59 145.3 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 74.439999999999998 111.118 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' ' HA2' ' A' ' 58' ' ' GLY . . . 176.57 -168.55 40.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 73.430000000000007 112.268 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -86.22 122.11 29.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.866 0.365 . . . . 73.310000000000002 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.7 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 34.4 mt -77.73 137.03 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 71.319999999999993 110.959 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.66 -170.22 12.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.757 . . . . 74.329999999999998 112.55 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.0 3.89 7.22 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.781 2.32 . . . . 63.399999999999999 112.853 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.32 26.73 2.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 51.210000000000001 111.021 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 p -123.34 -35.46 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.420000000000002 111.022 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -56.06 -31.83 63.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 71.450000000000003 111.055 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.1 m -56.32 -26.01 50.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 55.149999999999999 110.848 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 25.0 m-20 -85.64 -35.19 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.749 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 18.3 m-85 -78.47 -15.03 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.326 0.584 . . . . 72.349999999999994 109.604 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.729 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.69 -31.34 12.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.217 -0.901 . . . . 60.310000000000002 110.16 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.29 -7.11 48.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 62.32 111.056 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.41 -51.43 36.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 73.530000000000001 110.791 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.65 22.68 5.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 63.509999999999998 112.35 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 1.2 pt -133.38 169.52 13.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 73.340000000000003 111.341 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 15.6 Cg_exo -65.84 134.25 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.595 2.196 . . . . 52.020000000000003 112.302 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.4 tt -98.16 125.86 43.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 71.5 110.774 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -101.79 92.2 4.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.021 -0.536 . . . . 55.439999999999998 111.408 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.885 ' CD2' HD22 ' A' ' 26' ' ' LEU . 57.6 m-85 -82.17 124.58 30.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.765 -0.652 . . . . 73.0 109.909 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.4 mt -116.52 83.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.767 -0.373 . . . . 72.450000000000003 111.604 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 4.6 m-85 -72.43 142.54 48.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.403 -0.591 . . . . 73.299999999999997 109.403 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.54 118.21 3.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.085 -0.507 . . . . 72.430000000000007 110.277 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 15.9 mt-10 -68.83 -14.02 62.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.686 -0.688 . . . . 74.299999999999997 110.144 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.38 130.29 42.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.221 0.534 . . . . 75.349999999999994 110.896 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.52 8.48 12.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.394 -0.821 . . . . 72.230000000000004 110.62 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -105.12 -49.69 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 60.310000000000002 110.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -96.08 18.96 12.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.791 -0.64 . . . . 71.430000000000007 111.011 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -28.05 37.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.763 0.316 . . . . 74.340000000000003 110.872 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -56.37 -46.44 80.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.48 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -62.35 -48.11 81.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 74.530000000000001 110.662 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.38 -60.6 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.145 0.498 . . . . 71.019999999999996 110.733 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.7 m -61.65 -23.79 66.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.942 -0.572 . . . . 74.349999999999994 111.39 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.5 t0 -62.65 -63.41 1.23 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.235 0.54 . . . . 72.209999999999994 109.76 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HZ2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -50.2 -30.15 10.9 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 123.411 1.577 . . . . 64.25 109.3 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.654 ' CD1' HG21 ' A' ' 29' ' ' ILE . 29.4 mt -77.05 -23.8 52.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.029 -1.896 . . . . 73.319999999999993 111.966 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.681 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 56.4 mmtt -63.9 -39.78 48.88 Favored Pre-proline 0 CA--C 1.52 -0.196 0 CA-C-N 115.926 -0.579 . . . . 63.109999999999999 111.505 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 42.6 Cg_endo -76.77 -49.08 0.11 Allowed 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.249 1.966 . . . . 74.430000000000007 111.111 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.739 HD11 ' CG2' ' A' ' 110' ' ' VAL . 1.1 tp -55.09 -27.54 19.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 119.099 -1.041 . . . . 64.109999999999999 109.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -92.4 -25.74 18.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.356 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -58.77 -23.78 60.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.357 -0.609 . . . . 72.150000000000006 109.357 178.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.95 -27.58 18.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.164 -0.926 . . . . 60.229999999999997 109.685 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.72 ' CD ' HD12 ' A' ' 55' ' ' ILE . 1.5 pt20 -129.45 50.55 2.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.787 -1.097 . . . . 74.319999999999993 110.586 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.2 ptt-85 -81.69 -28.01 33.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.226 -0.897 . . . . 72.209999999999994 111.087 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.56 14.1 27.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.599 -0.728 . . . . 71.439999999999998 112.399 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 51' ' ' GLN . 8.7 p -123.05 -41.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.578 0.228 . . . . 75.319999999999993 111.089 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.72 HD12 ' CD ' ' A' ' 51' ' ' GLN . 74.3 mt -111.37 139.6 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.364 -0.236 . . . . 65.239999999999995 110.364 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 10.2 m120 -81.77 87.99 6.31 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.909 0.385 . . . . 73.319999999999993 110.555 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.639 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -73.59 102.78 3.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 111.193 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.7 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.33 130.41 6.02 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.928 -0.654 . . . . 71.140000000000001 112.756 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.4 p -91.1 140.79 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.239999999999995 111.137 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.4 tt -138.4 163.26 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.942 -0.572 . . . . 71.430000000000007 110.462 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' N ' HG12 ' A' ' 60' ' ' ILE . 32.8 t0 -88.34 118.83 28.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 74.25 112.103 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.952 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.64 2.58 32.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.576 -0.283 . . . . 43.25 110.985 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -103.21 -32.57 9.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.482 -0.326 . . . . 73.310000000000002 111.507 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 -29.89 6.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.759 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.876 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.33 -11.22 17.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.596 -0.729 . . . . 71.140000000000001 111.263 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.2 -34.62 0.08 OUTLIER Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.49 -0.386 . . . . 64.5 113.873 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.61 -24.3 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 74.019999999999996 110.261 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -88.77 -10.43 48.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.402 -0.817 . . . . 61.109999999999999 111.216 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 74' ' ' LEU . . . -72.53 -44.45 62.15 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.486 -0.325 . . . . 62.229999999999997 111.62 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -99.74 1.55 56.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.932 -1.127 . . . . 71.030000000000001 113.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -61.28 -9.39 5.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.484 -0.561 . . . . 50.32 109.484 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -116.47 -15.29 10.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.518 -0.765 . . . . 64.209999999999994 110.585 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.63 -69.55 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.99 0.424 . . . . 55.399999999999999 112.125 -178.219 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 69' ' ' ALA . 2.8 mt -42.74 172.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.555 -0.748 . . . . 74.439999999999998 111.781 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.558 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -110.36 -16.69 13.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.724 -0.671 . . . . 72.329999999999998 110.235 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.7 p 79.51 41.93 0.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.259 -1.015 . . . . 74.420000000000002 108.259 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.16 -50.15 5.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.047 -1.433 . . . . 72.340000000000003 111.471 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 46.2 tttt -133.42 161.74 33.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.988 -0.551 . . . . 44.039999999999999 110.965 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.952 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.44 173.17 5.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 72.200000000000003 111.351 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.98 163.81 25.56 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 123.596 -1.418 . . . . 54.200000000000003 112.895 0.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.32 162.69 30.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.831 -1.077 . . . . 75.129999999999995 109.485 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.495 ' HE2' HD11 ' A' ' 84' ' ' ILE . 57.0 t80 -138.53 127.93 24.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.736 0.303 . . . . 64.099999999999994 110.411 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -122.79 120.48 33.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.252 0.464 . . . . 75.540000000000006 112.252 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 93' ' ' PHE . 15.4 mt -103.51 95.1 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 70.340000000000003 110.56 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.64 141.38 28.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 73.209999999999994 111.034 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 38.1 mm-40 -108.01 110.21 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.011 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.729 HG11 ' O ' ' A' ' 20' ' ' MET . 7.3 t -79.63 -0.65 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 71.319999999999993 110.793 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.81 -43.04 8.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.274 -0.421 . . . . 73.150000000000006 110.876 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -116.48 -8.19 11.58 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.517 -0.31 . . . . 44.119999999999997 111.328 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 69.59 60.03 0.29 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.312 0.577 . . . . 71.239999999999995 109.481 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.533 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.4 tp-100 -114.74 179.1 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.84 . . . . 63.100000000000001 111.558 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.57 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.92 92.15 2.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.419 -0.81 . . . . 75.519999999999996 111.159 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 71.0 m-85 -106.4 72.05 0.27 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 111.308 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 73.7 Cg_endo -80.71 -176.78 3.34 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.442 2.094 . . . . 54.450000000000003 112.927 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' PHE . 38.5 t80 -110.68 175.93 5.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.759 -0.655 . . . . 64.049999999999997 110.478 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -78.86 176.94 9.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 71.010000000000005 110.714 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 41.0 mt-30 -114.39 -19.09 11.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 62.530000000000001 111.326 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.1 16.94 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 110.91 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 2.5 tppp? -90.5 -14.54 32.48 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.059 -0.518 . . . . 71.049999999999997 111.376 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 23.3 tt0 88.81 112.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.283 0.563 . . . . 74.200000000000003 110.566 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 80' ' ' PRO . 6.1 mt -91.5 96.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 75.549999999999997 111.357 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.663 HG22 ' HZ2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -118.08 -154.19 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 72.030000000000001 109.385 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -94.07 -72.81 0.6 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.584 -0.895 . . . . 72.319999999999993 108.584 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.547 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.68 -32.6 0.6 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.058 0.456 . . . . 72.409999999999997 111.095 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.06 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.649 -0.705 . . . . 62.240000000000002 112.335 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 110' ' ' VAL . 26.1 mm -87.67 -49.09 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.6 pttt -52.78 -48.55 66.76 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.437 -0.801 . . . . 71.120000000000005 109.493 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.631 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.79 -51.95 54.79 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.913 -0.585 . . . . 73.420000000000002 110.525 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.84 ' O ' HD11 ' A' ' 118' ' ' ILE . 36.9 t80 -50.53 -63.03 1.25 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 106' ' ' ILE . 2.1 m -52.76 -45.02 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 62.439999999999998 110.209 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -52.06 -40.32 60.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.669 0.747 . . . . 40.149999999999999 109.113 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.7 t70 -61.33 -34.2 74.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.506 -1.225 . . . . 75.319999999999993 108.276 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.789 ' CB ' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -72.85 -66.48 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 73.219999999999999 110.922 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.554 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.6 p -55.05 -44.46 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.962 -1.017 . . . . 72.019999999999996 111.864 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' N ' HG13 ' A' ' 114' ' ' VAL . . . -58.41 -35.86 72.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 74.230000000000004 110.898 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.73 32.79 1.83 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 110.663 -0.975 . . . . 74.530000000000001 110.663 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.91 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -104.44 -54.01 2.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.688 -0.756 . . . . 64.420000000000002 111.852 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 109' ' ' PHE . 54.3 mt -63.31 159.11 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.765 0.317 . . . . 61.450000000000003 110.424 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.518 ' N ' HG22 ' A' ' 118' ' ' ILE . 16.4 pt-20 -146.24 154.29 49.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 65.140000000000001 110.753 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -41.26 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.056 2.504 . . . . 73.010000000000005 112.474 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.0 m -66.11 -45.94 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 64.439999999999998 110.952 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.412 HG13 ' ND2' ' A' ' 73' ' ' ASN . 9.7 pt -155.25 159.31 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 72.420000000000002 111.059 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER 179.8 38.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.788 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -123.8 172.68 8.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.983 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.48 85.11 6.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.501 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.11 154.12 22.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.624 2.216 . . . . 54.229999999999997 112.485 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 127' ' ' ILE . 1.4 pp -146.48 82.01 9.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.109999999999999 111.085 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.08 -178.03 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.551 2.168 . . . . 63.509999999999998 112.245 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.84 47.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.140000000000001 110.936 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -171.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 74.349999999999994 110.79 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -106.22 165.43 11.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.876 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -113.54 158.7 20.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.450000000000003 110.904 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.334 -1.259 . . . . 73.109999999999999 112.475 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.483 -0.247 . . . . 62.399999999999999 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.87 -174.93 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.571 2.18 . . . . 75.209999999999994 112.347 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mt 62.01 148.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.530000000000001 111.119 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.87 169.13 23.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.851 -0.69 . . . . 51.520000000000003 112.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.458 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 3.3 t 179.13 -60.68 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.498 0.19 . . . . 54.5 111.206 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 5' ' ' SER . 19.5 Cg_endo -60.56 -46.58 16.79 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.444 2.096 . . . . 64.329999999999998 112.663 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.704 ' HB2' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -108.11 -85.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 63.43 111.133 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 57' ' ' PHE . 4.3 mp -118.69 144.88 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 74.439999999999998 111.201 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.75 -145.25 9.92 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.399 -0.905 . . . . 73.430000000000007 112.308 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.97 133.2 35.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.977 0.418 . . . . 73.310000000000002 110.669 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.725 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.3 mt -87.08 147.35 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 71.319999999999993 111.154 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.46 177.79 19.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 74.329999999999998 112.546 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.61 -8.52 23.35 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.605 2.203 . . . . 63.399999999999999 112.674 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -126.49 27.81 6.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 51.210000000000001 110.848 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.8 p -125.66 -39.4 2.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 111.002 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -53.66 -31.82 49.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 71.450000000000003 111.109 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -26.94 32.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 55.149999999999999 110.903 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 13.3 m-20 -84.86 -37.09 21.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 72.5 110.64 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' O ' HG21 ' A' ' 87' ' ' VAL . 8.6 m-85 -78.87 -7.81 58.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.235 0.54 . . . . 72.349999999999994 109.864 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.424 ' CE ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.67 -29.74 10.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.308 -0.86 . . . . 60.310000000000002 110.259 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 t -98.54 -2.5 38.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.571 . . . . 62.32 111.166 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -72.35 -57.42 4.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.991 0.424 . . . . 73.530000000000001 110.885 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.41 22.17 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.988 -0.625 . . . . 63.509999999999998 112.291 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.55 162.51 57.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.573 0.225 . . . . 73.340000000000003 111.006 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 20.7 Cg_exo -61.38 137.56 70.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.399 2.066 . . . . 52.020000000000003 112.569 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.3 tt -96.66 126.48 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 71.5 110.357 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -100.63 90.79 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.161 -0.472 . . . . 55.439999999999998 111.512 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.825 ' CD2' HD22 ' A' ' 26' ' ' LEU . 65.7 m-85 -81.88 124.92 30.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 73.0 110.033 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 2.3 mt -117.99 83.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.797 -0.361 . . . . 72.450000000000003 111.669 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.829 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.2 m-85 -70.12 151.86 44.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.476 -0.564 . . . . 73.299999999999997 109.476 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -166.52 119.81 1.05 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.15 -0.477 . . . . 72.430000000000007 111.111 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 19.9 mt-10 -74.51 -10.67 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.783 -0.644 . . . . 74.299999999999997 109.624 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -78.68 110.44 13.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.634 . . . . 75.349999999999994 111.215 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.37 2.15 33.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 72.230000000000004 111.073 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.78 -35.52 4.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.165 -0.471 . . . . 60.310000000000002 111.061 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.86 20.23 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 111.216 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.42 72.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.331 . . . . 74.340000000000003 110.833 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -55.66 -40.82 72.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.688 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.52 -44.74 81.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 74.530000000000001 110.589 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.013 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.09 -62.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.704 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -55.85 -26.52 47.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 74.349999999999994 111.538 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' LYS . 2.7 t70 -63.64 -59.21 4.9 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.613 0.72 . . . . 72.209999999999994 109.706 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.9 -31.32 11.96 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.746 1.26 . . . . 64.25 108.742 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -81.47 -17.79 47.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.813 -1.54 . . . . 73.319999999999993 111.964 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -54.1 -42.77 95.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.944 -0.762 . . . . 63.109999999999999 108.944 178.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 9.9 Cg_endo -84.44 -39.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.636 2.224 . . . . 74.430000000000007 110.421 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 106' ' ' ILE . 45.6 mt -50.86 -20.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-N 116.173 -0.467 . . . . 64.109999999999999 109.965 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -113.44 -24.6 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.86 -0.609 . . . . 71.120000000000005 111.228 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.17 -20.46 58.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.17 0.51 . . . . 72.150000000000006 109.899 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.85 -27.1 17.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.791 0.805 . . . . 60.229999999999997 109.24 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.688 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -127.73 46.5 2.54 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.345 -1.298 . . . . 74.319999999999993 110.502 -178.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.1 ptt85 -80.0 -30.38 39.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.383 -0.826 . . . . 72.209999999999994 111.109 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.18 11.98 33.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.873 -0.68 . . . . 71.439999999999998 112.379 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.3 p -119.8 -35.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.496 0.189 . . . . 75.319999999999993 111.25 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.1 mt -123.46 146.2 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.512 -0.313 . . . . 65.239999999999995 110.696 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.46 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 6.7 m120 -87.15 85.46 7.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.784 0.326 . . . . 73.319999999999993 110.171 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.763 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 3.6 m-85 -72.46 110.52 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.284 0.564 . . . . 74.209999999999994 111.552 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.725 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -139.92 124.35 2.67 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.304 -0.862 . . . . 71.140000000000001 112.2 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 80.0 p -83.2 155.82 23.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.029 0.443 . . . . 73.239999999999995 111.315 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 13.3 tt -150.98 163.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 71.430000000000007 110.206 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' N ' HG12 ' A' ' 60' ' ' ILE . 46.0 t0 -88.78 119.04 28.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.407 -0.361 . . . . 74.25 111.845 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.48 1.04 39.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.548 -0.296 . . . . 43.25 110.975 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.9 ttpt -101.67 -32.43 10.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.435 -0.348 . . . . 73.310000000000002 111.265 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.88 -29.96 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.105 0.478 . . . . 73.030000000000001 110.346 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -105.25 -15.02 15.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.789 . . . . 71.140000000000001 111.057 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -34.23 -36.61 0.06 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 114.1 0.4 . . . . 64.5 114.1 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.582 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.41 -10.61 40.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 61.109999999999999 111.042 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.58 -51.53 34.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 120.858 0.361 . . . . 62.229999999999997 111.007 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.7 1.99 69.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.915 -1.135 . . . . 71.030000000000001 113.663 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -59.66 -10.24 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.332 0.566 . . . . 50.32 109.667 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -113.49 -17.21 12.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.631 -0.713 . . . . 64.209999999999994 109.998 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.683 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.1 m-20 -179.85 -68.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.46 0.541 . . . . 55.399999999999999 112.46 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.902 HD21 ' CB ' ' A' ' 94' ' ' PRO . 2.1 mm? -39.85 168.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.24 -0.891 . . . . 74.439999999999998 112.241 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -110.14 -4.49 15.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.826 -0.625 . . . . 72.329999999999998 111.06 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 p 58.69 36.85 25.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.01 0.433 . . . . 74.420000000000002 110.199 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -84.13 -32.0 24.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 72.340000000000003 110.825 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -148.74 163.19 38.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 44.039999999999999 110.23 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.45 174.37 3.91 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.897 -0.592 . . . . 72.200000000000003 111.215 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.755 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.01 166.74 15.9 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.792 -1.337 . . . . 54.200000000000003 113.019 0.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 164.82 27.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.051 -0.977 . . . . 75.129999999999995 110.143 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HZ ' ' HB1' ' A' ' 27' ' ' ALA . 1.8 t80 -141.98 133.81 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 64.099999999999994 111.49 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -126.41 116.17 20.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 75.540000000000006 110.949 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 93' ' ' PHE . 22.9 mt -99.91 90.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 70.340000000000003 110.342 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' LEU . 3.0 tm0? -78.95 144.87 34.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 73.209999999999994 111.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.7 mt-10 -110.64 111.54 22.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 110.637 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 87' ' ' VAL . 26.4 t -82.39 9.43 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.726 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.96 -42.86 5.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.257 -0.428 . . . . 73.150000000000006 110.314 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.9 mmtt -114.15 -12.41 12.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.278 -0.419 . . . . 44.119999999999997 110.912 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 0.5 OUTLIER 79.53 22.83 0.52 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.356 0.598 . . . . 71.239999999999995 109.688 -179.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.484 ' NE2' ' HG3' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -82.2 167.74 18.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.158 -0.928 . . . . 63.100000000000001 111.53 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 0.9 OUTLIER -139.2 101.06 4.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.381 -0.827 . . . . 75.519999999999996 111.111 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.679 ' O ' HD12 ' A' ' 84' ' ' ILE . 76.8 m-85 -103.55 74.33 0.2 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.928 -0.578 . . . . 75.519999999999996 110.899 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.902 ' CB ' HD21 ' A' ' 74' ' ' LEU . 56.5 Cg_endo -80.8 165.29 20.05 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.795 2.33 . . . . 54.450000000000003 113.126 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.431 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 35.7 t80 -95.94 173.29 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.745 -0.661 . . . . 64.049999999999997 110.573 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -75.84 177.95 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 71.010000000000005 110.986 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -112.08 -20.92 11.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.199 -0.455 . . . . 62.530000000000001 111.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.83 24.06 4.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.919 0.39 . . . . 72.430000000000007 111.069 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -94.4 -11.81 29.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.981 -0.554 . . . . 71.049999999999997 111.191 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.5 tt0 91.02 106.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.9 -0.591 . . . . 74.200000000000003 110.661 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 80' ' ' PRO . 7.1 mt -91.73 96.92 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.269 -0.878 . . . . 75.549999999999997 111.495 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -121.63 -164.89 1.18 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.226 -0.657 . . . . 72.030000000000001 109.226 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.919 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -78.22 -71.43 0.43 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.471 -0.566 . . . . 72.319999999999993 109.471 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.585 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.83 -37.72 1.91 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.969 -1.014 . . . . 72.409999999999997 111.645 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -72.68 -35.84 67.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.698 -1.137 . . . . 62.240000000000002 113.202 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 47' ' ' ILE . 27.8 mm -89.48 -49.07 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.674 -0.491 . . . . 74.420000000000002 109.674 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.834 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.92 -43.91 60.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.803 -0.635 . . . . 71.120000000000005 109.633 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.95 -49.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.679 -0.691 . . . . 73.420000000000002 110.202 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.808 ' O ' HD11 ' A' ' 118' ' ' ILE . 21.1 t80 -49.15 -64.13 0.9 Allowed 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.699 -0.482 . . . . 73.219999999999999 109.699 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 111' ' ' ASP . 17.7 m -51.05 -43.09 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 62.439999999999998 109.954 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.2 t0 -50.83 -41.19 57.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.438 0.637 . . . . 40.149999999999999 109.954 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.925 ' OD1' ' N ' ' A' ' 118' ' ' ILE . 3.2 t0 -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.944 -1.025 . . . . 75.319999999999993 108.795 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.924 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.3 t80 -72.6 -67.02 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.191 -0.913 . . . . 73.219999999999999 110.343 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.561 HG22 HD11 ' A' ' 55' ' ' ILE . 17.5 t -49.93 -48.32 22.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.934 . . . . 72.019999999999996 111.491 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.41 -38.77 63.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 74.230000000000004 110.606 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.49 29.98 2.34 Favored Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 110.709 -0.956 . . . . 74.530000000000001 110.709 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.804 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.15 -49.21 3.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.917 -0.641 . . . . 64.420000000000002 111.661 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.925 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 29.1 mt -63.46 146.84 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.762 -0.458 . . . . 61.450000000000003 109.762 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -136.02 171.0 9.53 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 65.140000000000001 110.948 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.484 ' HG3' ' NE2' ' A' ' 91' ' ' GLN . 81.6 Cg_exo -43.97 115.46 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.497 2.131 . . . . 73.010000000000005 112.319 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.583 ' OG ' HD13 ' A' ' 122' ' ' ILE . 32.7 t -81.97 -66.51 0.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.439999999999998 111.221 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -115.59 -30.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 72.420000000000002 111.04 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -24.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 74.340000000000003 112.112 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.0 t -60.44 -179.11 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.636 -0.711 . . . . 73.040000000000006 110.815 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -147.18 85.23 6.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 72.430000000000007 110.599 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 -173.76 1.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.577 2.184 . . . . 54.229999999999997 112.452 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.72 84.44 15.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 72.109999999999999 111.08 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.89 -161.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.829 2.353 . . . . 63.509999999999998 112.27 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.63 82.19 2.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 71.140000000000001 110.908 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -75.76 128.5 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.948 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.19 176.85 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 110.785 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 61.5 154.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 63.450000000000003 110.913 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.44 -1.2 . . . . 73.109999999999999 112.504 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.934 0.397 . . . . 71.45 110.837 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 t -69.03 -23.53 64.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 55.15 111.5 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 9.8 t70 -74.72 -38.71 62.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.084 0.468 . . . . 72.5 110.855 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 22.0 m-85 -80.28 -22.98 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.336 0.588 . . . . 72.35 109.743 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.673 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.4 -33.24 22.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.287 -0.87 . . . . 60.31 110.276 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -88.81 -12.97 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 62.32 110.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -63.79 -36.69 84.73 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.41 -0.359 . . . . 73.53 111.078 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.57 20.54 29.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.82 -0.705 . . . . 63.51 112.676 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.428 HD11 ' OD1' ' A' ' 56' ' ' ASN . 1.4 pt -135.38 148.62 66.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 73.34 111.02 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HB2' HG12 ' A' ' 55' ' ' ILE . 48.2 Cg_exo -47.07 140.17 14.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.533 2.155 . . . . 52.02 112.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 28' ' ' TYR . 2.4 tt -102.5 123.19 45.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 71.5 110.645 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -98.62 93.32 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.878 -0.601 . . . . 55.44 111.282 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 26' ' ' LEU . 63.5 m-85 -81.98 140.17 34.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.835 -0.621 . . . . 73.0 110.485 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -132.3 85.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.468 -0.333 . . . . 72.45 111.467 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.837 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 3.8 m-85 -73.08 148.6 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.671 -0.492 . . . . 73.3 109.671 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -162.95 119.84 1.9 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.179 -0.464 . . . . 72.43 111.118 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 32.2 mt-10 -73.87 -9.46 58.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.583 -0.735 . . . . 74.3 110.116 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -99.97 99.89 10.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.479 . . . . 75.35 111.129 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.82 12.22 22.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 72.23 111.226 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 -45.32 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.435 -0.348 . . . . 60.31 110.833 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.39 13.88 26.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.369 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -40.77 -31.54 0.17 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.529 -0.305 . . . . 74.34 111.77 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.37 85.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 62.44 111.197 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -57.31 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 74.53 111.242 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.3 -56.38 22.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.106 0.479 . . . . 71.02 110.854 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 10.3 m -58.11 -22.44 50.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.764 . . . . 74.35 112.14 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -70.18 -61.29 1.83 Allowed 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.636 0.731 . . . . 72.21 109.233 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.629 ' C ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.55 -29.41 16.93 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 122.884 1.326 . . . . 64.25 108.707 177.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.872 HD23 HD12 ' A' ' 47' ' ' ILE . 24.2 mt -77.96 -25.05 47.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.435 -1.711 . . . . 73.32 111.346 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.32 -45.87 89.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.435 -0.802 . . . . 63.11 109.835 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 18.2 Cg_endo -82.3 -38.7 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.516 2.144 . . . . 74.43 110.646 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 HD23 ' A' ' 44' ' ' LEU . 57.0 mt -51.24 -21.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 116.086 -0.506 . . . . 64.11 110.48 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -112.75 -25.84 8.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 71.12 111.249 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -61.56 -19.44 62.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.215 0.531 . . . . 72.15 109.841 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.6 -27.69 17.99 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.394 -0.821 . . . . 60.23 109.461 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 54' ' ' VAL . 1.2 pt20 -124.49 41.01 3.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.405 -1.27 . . . . 74.32 110.621 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptt85 -70.85 -32.79 69.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.465 -0.788 . . . . 72.21 111.06 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.47 12.22 39.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 71.44 112.738 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.9 p -125.67 -27.82 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.777 0.288 . . . . 75.32 111.777 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' CD ' ' A' ' 51' ' ' GLN . 70.0 mt -133.18 140.57 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.574 0.226 . . . . 65.24 110.636 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -90.94 97.22 11.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.789 0.328 . . . . 73.32 111.012 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.8 ' CD2' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -77.85 113.64 15.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 74.21 111.515 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.9 126.73 3.99 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.549 -0.75 . . . . 71.14 112.131 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 11.5 p -86.1 148.02 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 73.24 111.068 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.921 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.0 tt -145.7 163.47 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 71.43 110.653 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.9 t0 -87.05 119.79 27.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 74.25 112.014 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.961 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.43 2.15 38.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.702 0.287 . . . . 43.25 110.903 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 18.3 tptm -102.1 -33.04 9.84 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.47 -0.332 . . . . 73.31 111.7 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 -31.98 6.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.172 0.511 . . . . 73.03 110.457 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.921 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.35 -16.06 17.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 71.14 111.07 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.96 -38.88 0.03 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 114.441 0.537 . . . . 64.5 114.441 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.62 -25.86 11.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.279 0.54 . . . . 74.02 110.379 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -85.78 -12.5 50.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 61.11 111.546 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.89 -42.19 73.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.685 0.278 . . . . 62.23 111.269 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.06 0.17 47.89 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.084 -1.055 . . . . 71.03 113.489 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -60.0 -11.02 4.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.376 -0.601 . . . . 50.32 109.376 177.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.65 -16.01 12.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.396 -0.82 . . . . 64.21 110.441 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.746 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -177.7 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.074 0.464 . . . . 55.4 112.228 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.716 HD22 ' CD ' ' A' ' 97' ' ' GLN . 87.9 mt -41.43 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.405 -0.816 . . . . 74.44 112.557 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -118.85 4.48 11.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.276 -0.875 . . . . 72.33 110.467 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' ' 67' ' ' ALA . 5.5 p 58.21 32.61 22.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.516 . . . . 74.42 110.715 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 16.0 p-10 -82.17 -31.41 30.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.327 -0.397 . . . . 72.34 111.384 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 7.2 tttt -147.61 161.61 40.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 44.04 111.256 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.961 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -157.39 170.2 9.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.544 -0.753 . . . . 72.2 111.258 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.76 160.0 44.9 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 123.538 -1.443 . . . . 54.2 113.237 0.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.32 165.59 20.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.198 -0.91 . . . . 75.13 110.006 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 5.3 t80 -139.23 128.37 23.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.797 0.332 . . . . 64.1 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -120.33 145.93 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 75.54 111.702 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.889 HG22 ' OE2' ' A' ' 86' ' ' GLU . 57.7 mt -123.26 86.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 70.34 110.082 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.84 125.96 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 73.21 111.187 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.889 ' OE2' HG22 ' A' ' 84' ' ' ILE . 9.8 mp0 -95.32 117.69 30.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.479 . . . . 74.42 110.841 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -84.54 4.92 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.009 -0.541 . . . . 71.32 111.328 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.37 -41.64 5.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 73.15 110.793 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -15.32 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 44.12 110.957 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 78.08 32.68 0.36 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.527 0.68 . . . . 71.24 109.559 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.493 ' H ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -95.14 166.57 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 63.1 111.254 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 6.8 mmtm -142.6 97.14 3.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.553 -0.749 . . . . 75.52 110.92 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.626 ' O ' HD12 ' A' ' 84' ' ' ILE . 17.2 m-85 -102.63 75.6 0.19 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 75.52 111.002 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 84.7 Cg_endo -78.35 -176.13 3.09 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 54.45 112.638 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -107.08 169.97 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 64.05 110.789 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.32 160.02 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 71.01 111.179 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.716 ' CD ' HD22 ' A' ' 74' ' ' LEU . 4.1 mp0 -117.47 26.86 9.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 62.53 110.902 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -157.63 23.64 0.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 72.43 110.602 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -113.32 -68.13 0.95 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.845 -0.616 . . . . 71.05 110.954 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 1.7 tt0 159.86 118.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.902 -0.59 . . . . 74.2 109.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.23 89.2 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 75.55 111.584 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -117.14 -155.94 0.61 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.809 -0.812 . . . . 72.03 108.809 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -89.88 -73.65 0.51 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.755 -0.831 . . . . 72.32 108.755 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.51 -34.16 0.21 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 72.41 111.86 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.03 61.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 62.24 112.432 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.651 ' HB ' HD13 ' A' ' 47' ' ' ILE . 41.0 mm -88.14 -47.91 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.757 -0.46 . . . . 74.42 109.757 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -54.44 -45.37 73.06 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.739 -0.664 . . . . 71.12 109.695 178.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -69.8 -48.0 60.75 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.953 -0.567 . . . . 73.42 110.156 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 118' ' ' ILE . 18.4 t80 -52.38 -67.08 0.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.077 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.66 HG12 HD11 ' A' ' 84' ' ' ILE . 19.3 m -47.67 -40.14 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 62.44 109.966 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -56.96 -42.34 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.381 -0.827 . . . . 40.15 110.215 178.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.859 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -74.65 -14.58 60.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.652 -0.703 . . . . 75.32 110.014 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -81.04 -61.29 2.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.558 -0.746 . . . . 73.22 108.997 178.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.477 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 21.9 t -55.77 -46.41 79.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.658 -1.155 . . . . 72.02 110.879 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.94 64.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 74.23 110.782 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.96 30.29 1.65 Allowed Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.578 -0.82 . . . . 74.53 111.663 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -101.81 -38.65 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.397 -0.402 . . . . 64.42 111.417 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.976 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.2 mt -85.75 151.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.897 0.38 . . . . 61.45 110.628 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -145.15 173.94 3.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.947 -0.57 . . . . 65.14 111.274 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo . . . . . 0 C--N 1.345 0.344 0 C-N-CA 122.598 2.198 . . . . 73.01 112.36 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' SER . 17.0 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.818 0.342 . . . . 71.45 111.177 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.449 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m -53.98 -25.95 23.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 55.15 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.8 -38.54 18.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.02 0.438 . . . . 72.5 110.635 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 26.5 m-85 -78.08 -6.26 54.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 72.35 109.898 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.638 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.62 -54.42 3.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 60.31 110.045 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -17.35 64.23 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.85 -0.614 . . . . 62.32 110.919 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.74 -31.78 58.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.901 0.382 . . . . 73.53 111.021 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.38 5.99 64.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.935 -0.65 . . . . 63.51 112.596 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.62 156.41 53.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 73.34 110.989 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.95 142.74 96.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 52.02 112.594 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.2 tt -103.34 137.62 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 71.5 110.808 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -110.15 97.13 6.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.106 -0.497 . . . . 55.44 111.112 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.795 ' CD2' HD22 ' A' ' 26' ' ' LEU . 40.4 m-85 -85.99 127.47 34.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 73.0 109.985 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mt -121.51 83.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.13 0.419 . . . . 72.45 112.13 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.785 ' HA ' HG23 ' A' ' 60' ' ' ILE . 2.8 m-85 -71.96 144.43 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.959 -0.756 . . . . 73.3 108.959 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -155.1 117.37 4.21 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.43 111.082 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -80.17 -6.34 57.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.298 -0.865 . . . . 74.3 110.163 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.9 p -84.7 104.87 15.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 75.35 111.059 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.4 16.78 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 72.23 111.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -123.61 -42.05 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 60.31 110.778 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' ARG . 2.8 pt-20 -99.7 -8.85 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 71.43 111.574 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 36' ' ' GLU . 1.6 ptp180 -31.31 -40.47 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.366 0.506 . . . . 74.34 112.366 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -54.51 -51.5 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.965 0.412 . . . . 62.44 110.844 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.6 mt-10 -60.18 -36.75 78.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 74.53 110.963 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -63.52 -50.59 68.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 71.02 110.779 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' HD12 ' A' ' 44' ' ' LEU . 51.1 m -65.17 -22.51 66.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 74.35 111.242 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 3.7 t70 -66.81 -61.2 2.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.582 0.706 . . . . 72.21 109.105 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.899 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.05 -31.69 13.65 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.662 1.22 . . . . 64.25 108.991 177.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 29' ' ' ILE . 22.2 mt -76.48 -25.61 54.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.378 -1.737 . . . . 73.32 111.475 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 9.7 ttmm -51.6 -45.65 91.11 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.395 -0.82 . . . . 63.11 110.375 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 15.5 Cg_endo -83.76 -40.1 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.713 2.275 . . . . 74.43 111.649 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -54.92 -18.65 3.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.984 -0.686 . . . . 64.11 109.87 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.687 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -107.29 -30.82 8.5 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.813 -0.631 . . . . 71.12 111.213 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -60.83 -19.8 60.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.237 0.541 . . . . 72.15 109.888 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.2 -26.79 24.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.916 0.865 . . . . 60.23 109.029 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.7 pt20 -125.78 38.44 4.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.029 -1.441 . . . . 74.32 110.217 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -75.35 -25.21 57.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.446 -0.797 . . . . 72.21 110.992 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.78 20.16 20.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.811 -0.709 . . . . 71.44 112.137 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 51' ' ' GLN . 9.9 p -133.78 -37.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.65 0.262 . . . . 75.32 111.262 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 27' ' ' ALA . 43.6 mt -120.93 138.79 50.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 65.24 110.863 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-80 -82.85 109.09 16.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.858 0.361 . . . . 73.32 110.324 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.79 ' CE1' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -80.94 119.86 24.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.644 0.735 . . . . 74.21 112.843 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -146.24 122.98 1.74 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.907 -1.042 . . . . 71.14 111.911 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -89.81 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 73.24 111.059 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.891 HD11 ' CG ' ' A' ' 65' ' ' PHE . 14.0 tt -141.9 164.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.43 110.699 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 35.8 t0 -90.34 122.84 33.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.888 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.87 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.49 6.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.71 0.291 . . . . 43.25 110.711 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 22.5 tptp -106.31 -32.82 7.99 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.349 -0.387 . . . . 73.31 111.559 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.38 -31.21 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.148 0.499 . . . . 73.03 110.731 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.77 -12.97 17.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.543 -0.753 . . . . 71.14 111.311 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -35.39 -33.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 N-CA-C 114.027 0.371 . . . . 64.5 114.027 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -12.21 4.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.061 0.458 . . . . 74.02 110.617 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -102.59 -6.79 22.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.66 -0.7 . . . . 61.11 110.971 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.1 -54.99 9.18 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.763 0.316 . . . . 62.23 110.963 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.39 7.5 75.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.916 -1.135 . . . . 71.03 113.738 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -8.74 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.02 -0.733 . . . . 50.32 109.02 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.2 -14.82 12.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.228 -0.896 . . . . 64.21 110.335 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.91 -69.91 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.261 0.553 . . . . 55.4 112.298 -178.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.855 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.2 mm? -40.31 170.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.092 -0.958 . . . . 74.44 112.419 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -110.01 -6.24 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 72.33 111.046 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 p 61.75 40.19 13.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.609 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.77 -33.01 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 72.34 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -149.51 163.25 38.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.111 -0.495 . . . . 44.04 110.427 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.87 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -153.34 177.45 1.96 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 72.2 111.126 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.619 ' O ' HD11 ' A' ' 101' ' ' ILE . 35.0 Cg_exo -57.54 158.22 29.27 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.022 -1.241 . . . . 54.2 112.781 1.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.4 128.87 46.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.234 -0.894 . . . . 75.13 110.226 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 84' ' ' ILE . 49.5 t80 -108.65 117.83 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.654 -0.248 . . . . 64.1 110.437 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -118.18 132.85 56.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.35 0.5 . . . . 75.54 112.35 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.715 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 25.6 mm -100.88 140.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 70.34 109.973 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -128.24 129.52 46.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.985 0.421 . . . . 73.21 110.842 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 1.2 mt-10 -105.08 112.72 25.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 74.42 110.198 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -78.86 -0.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 71.32 111.708 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.73 -44.33 6.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 73.15 110.692 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.84 -7.23 14.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 44.12 111.413 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 68.96 24.87 6.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.09 0.471 . . . . 71.24 110.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -75.37 169.51 17.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.731 -0.668 . . . . 63.1 111.541 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 1.3 mptt -139.94 95.37 2.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 75.52 110.756 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 68.1 m-85 -103.52 71.41 0.15 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 75.52 111.277 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.855 ' CB ' HD21 ' A' ' 74' ' ' LEU . 67.4 Cg_endo -79.12 -175.5 2.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.667 2.245 . . . . 54.45 113.608 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 82' ' ' PHE . 25.0 t80 -112.02 175.16 5.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 64.05 110.578 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 3.0 m-20 -78.76 174.98 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 71.01 110.882 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 3.5 mt-30 -114.64 -11.99 12.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 62.53 111.297 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.63 5.25 5.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 72.43 111.041 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 1.8 tppt? -86.17 -6.05 59.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.097 -0.501 . . . . 71.05 111.294 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 32.6 tt0 81.9 132.22 0.05 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.174 0.512 . . . . 74.2 111.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.619 HD11 ' O ' ' A' ' 80' ' ' PRO . 3.0 mp -109.02 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 75.55 110.905 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -113.41 -148.17 0.43 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 72.03 109.095 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.661 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -96.66 -70.81 0.7 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.97 -0.752 . . . . 72.32 108.97 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.624 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.11 -31.54 1.44 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.811 -0.631 . . . . 72.41 111.374 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -74.96 -33.0 61.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.688 -0.687 . . . . 62.24 111.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.815 ' O ' HG13 ' A' ' 110' ' ' VAL . 44.2 mm -91.22 -45.71 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.965 0.412 . . . . 74.42 110.39 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.0 -42.22 93.76 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.86 -0.609 . . . . 71.12 109.414 178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.22 -50.73 29.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 73.42 110.244 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CE1' HD13 ' A' ' 118' ' ' ILE . 40.6 t80 -51.72 -63.77 1.03 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.467 -0.333 . . . . 73.22 110.261 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.5 m -49.14 -44.15 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 62.44 110.042 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -54.45 -40.67 68.61 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.783 0.802 . . . . 40.15 109.009 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.918 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 16.4 t70 -61.53 -34.86 76.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.326 -1.306 . . . . 75.32 108.336 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.796 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -72.86 -66.86 0.61 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 73.22 110.902 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.8 t -54.85 -45.21 74.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.22 -0.9 . . . . 72.02 111.994 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.44 70.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.856 0.36 . . . . 74.23 111.154 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.68 31.3 1.82 Allowed Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.06 -0.816 . . . . 74.53 111.06 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.918 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.43 -57.12 2.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.878 -0.661 . . . . 64.42 111.505 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.796 HD12 ' HB2' ' A' ' 113' ' ' PHE . 44.7 mt -64.27 151.1 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.789 -0.448 . . . . 61.45 109.789 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.32 163.96 36.25 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.357 -0.383 . . . . 65.14 111.542 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.815 2.344 . . . . 73.01 112.519 -179.544 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 17.6 m-85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.056 0.455 . . . . 71.45 111.383 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -51.53 -34.44 36.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.797 -0.638 . . . . 55.15 111.422 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -70.86 -39.12 73.08 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.147 0.499 . . . . 72.5 110.725 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 18.0 m-85 -77.39 -9.19 58.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.634 . . . . 72.35 109.678 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.768 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -99.97 -30.48 11.97 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.47 -0.787 . . . . 60.31 110.131 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -83.36 -17.93 40.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.685 -0.689 . . . . 62.32 110.572 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.7 -14.21 41.43 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.275 -0.42 . . . . 73.53 111.602 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.93 14.12 65.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 63.51 112.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 HD11 ' OD1' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -123.99 158.79 59.13 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.772 0.32 . . . . 73.34 111.246 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HG2' HG12 ' A' ' 55' ' ' ILE . 26.7 Cg_endo -62.38 138.15 69.5 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 52.02 112.758 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 28' ' ' TYR . 1.5 tt -93.12 136.41 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.833 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -105.95 89.43 3.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 55.44 111.001 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.909 ' CE1' HD22 ' A' ' 26' ' ' LEU . 70.0 m-85 -81.19 136.6 35.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 73.0 110.404 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mp -131.53 89.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.855 0.359 . . . . 72.45 111.518 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.855 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.1 m-85 -70.88 149.18 47.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.303 -0.629 . . . . 73.3 109.303 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.644 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.73 119.07 2.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.233 0.54 . . . . 72.43 111.269 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 20.9 mt-10 -76.0 -7.23 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 74.3 109.972 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.6 p -76.53 123.44 26.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.209 -0.451 . . . . 75.35 110.848 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.12 9.52 18.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 72.23 111.087 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -50.43 2.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.404 -0.362 . . . . 60.31 110.735 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.69 15.04 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 71.43 111.196 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -49.1 -28.45 4.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.813 0.34 . . . . 74.34 111.104 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.32 73.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 62.44 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 2.2 mm-40 -61.45 -48.91 79.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.736 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -58.45 -47.34 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 71.02 110.652 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 44' ' ' LEU . 67.0 m -67.17 -20.69 65.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.35 111.218 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 15.6 t0 -67.68 -60.6 2.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 72.21 108.946 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.662 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.48 -33.64 9.76 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.65 1.214 . . . . 64.25 108.633 177.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.086 HD11 HG21 ' A' ' 29' ' ' ILE . 25.9 mt -75.22 -25.95 58.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.317 -1.765 . . . . 73.32 112.188 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 3.4 mmpt? -51.44 -45.47 90.32 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 63.11 110.285 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.6 Cg_endo -83.26 -38.54 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.546 2.164 . . . . 74.43 111.13 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.062 HG21 HG22 ' A' ' 106' ' ' ILE . 24.0 mt -53.85 -17.35 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-N 116.367 -0.379 . . . . 64.11 110.14 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.784 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -114.98 -25.34 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.52 . . . . 71.12 111.151 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -64.91 -18.94 65.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.939 0.4 . . . . 72.15 110.669 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . . . -93.67 -9.95 36.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.81 . . . . 60.23 109.377 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.749 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -136.67 27.62 3.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.221 -1.354 . . . . 74.32 110.885 -176.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.5 ptt180 -61.4 -33.24 73.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.586 -0.734 . . . . 72.21 111.156 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.33 9.02 45.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.738 -0.744 . . . . 71.44 112.811 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 51' ' ' GLN . 10.3 p -122.35 -29.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.78 0.29 . . . . 75.32 111.609 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.813 HG21 ' HB2' ' A' ' 27' ' ' ALA . 79.7 mt -131.87 141.35 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 65.24 110.807 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -94.61 94.83 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 73.32 110.063 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.23 134.76 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 74.21 111.641 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.87 113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.787 -1.097 . . . . 71.14 111.86 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.3 p -80.87 150.14 29.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 73.24 110.316 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.901 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.2 tt -147.4 163.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.105 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 45.0 t0 -84.01 119.78 25.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.123 -0.49 . . . . 74.25 111.909 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.0 27.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.696 0.284 . . . . 43.25 110.859 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.2 ttpt -106.25 -31.88 8.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.548 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.95 -32.27 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 73.03 110.638 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.901 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.95 -12.4 18.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.518 -0.764 . . . . 71.14 111.404 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 76' ' ' THR . . . -33.57 -36.54 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.208 0.443 . . . . 64.5 114.208 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.17 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 74.02 110.448 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -89.21 -11.63 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.482 -0.781 . . . . 61.11 111.461 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.65 -44.12 57.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 111.76 0.281 . . . . 62.23 111.76 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.477 ' CA ' ' HB2' ' A' ' 74' ' ' LEU . . . -103.4 1.39 46.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.991 -1.099 . . . . 71.03 113.752 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -8.81 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.187 -0.671 . . . . 50.32 109.187 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.65 -15.81 11.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.405 -0.816 . . . . 64.21 110.325 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.36 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.155 0.502 . . . . 55.4 112.022 -178.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.511 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 74.9 mt -44.88 178.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.275 -0.875 . . . . 74.44 112.168 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 5.25 8.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.61 -0.723 . . . . 72.33 110.597 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 66' ' ' GLY . 4.4 p 59.06 36.86 24.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.694 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.75 -36.49 15.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 72.34 111.27 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 0.2 OUTLIER -137.31 161.18 36.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.123 0.487 . . . . 44.04 110.746 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -159.44 169.04 11.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.738 -0.665 . . . . 72.2 111.607 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.8 161.87 40.47 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.395 -1.502 . . . . 54.2 113.12 0.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.12 161.17 29.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.478 -0.783 . . . . 75.13 110.038 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.4 t80 -132.3 123.39 26.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.67 0.272 . . . . 64.1 111.198 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -121.34 111.85 17.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 75.54 111.738 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 93' ' ' PHE . 6.8 mt -100.78 96.84 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.729 0.3 . . . . 70.34 110.822 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -89.6 147.8 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.474 -0.33 . . . . 73.21 110.584 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 8.7 mt-10 -106.69 114.15 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 74.42 110.851 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 20' ' ' MET . 13.1 t -79.8 0.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 71.32 110.968 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.46 -42.62 8.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.4 -0.364 . . . . 73.15 110.914 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.55 -7.88 10.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.487 -0.324 . . . . 44.12 111.454 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.53 62.19 0.21 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.413 -0.588 . . . . 71.24 109.413 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 1.3 tp60 -114.15 173.74 6.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.33 -0.85 . . . . 63.1 111.575 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.638 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -137.27 92.53 2.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.416 -0.811 . . . . 75.52 110.807 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.765 ' O ' HD12 ' A' ' 84' ' ' ILE . 93.1 m-85 -104.77 68.7 0.16 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.638 -0.71 . . . . 75.52 111.314 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 76.5 Cg_endo -78.93 -175.58 2.83 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.263 1.975 . . . . 54.45 112.589 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 41.6 t80 -109.37 170.4 8.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.104 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.6 m-20 -76.37 170.48 16.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 71.01 110.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 7.2 mt-30 -119.83 27.29 8.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 62.53 110.746 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.12 26.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.501 . . . . 72.43 110.662 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 10.1 ttmt -112.0 0.05 15.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.996 -0.547 . . . . 71.05 111.668 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 78.31 98.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 74.2 110.325 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' PRO . 5.8 mt -80.01 97.71 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 75.55 111.59 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -120.51 -151.34 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.707 -0.849 . . . . 72.03 108.707 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.786 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -92.43 -66.93 0.89 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.925 -0.768 . . . . 72.32 108.925 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.02 -39.0 5.24 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.669 -0.696 . . . . 72.41 111.752 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 62.24 112.28 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HG21 ' A' ' 47' ' ' ILE . 50.1 mm -91.31 -48.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 74.42 110.235 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.878 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -42.21 80.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.962 -0.755 . . . . 71.12 108.962 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.52 -51.06 31.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.038 -0.528 . . . . 73.42 110.036 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.713 ' O ' HD11 ' A' ' 118' ' ' ILE . 67.5 t80 -50.4 -63.21 1.19 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 116.369 -0.378 . . . . 73.22 110.094 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.9 m -50.05 -41.97 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 62.44 109.494 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.1 t0 -53.61 -37.76 63.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.793 0.806 . . . . 40.15 108.959 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.911 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.3 t70 -66.84 -34.79 78.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.309 -1.314 . . . . 75.32 108.413 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.881 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -71.73 -68.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.244 -0.889 . . . . 73.22 110.984 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 55' ' ' ILE . 15.3 t -51.72 -46.86 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.268 -0.878 . . . . 72.02 111.996 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.66 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.23 111.018 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.56 31.01 2.06 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.575 -1.01 . . . . 74.53 110.575 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.911 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -102.92 -52.0 3.15 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.716 -0.742 . . . . 64.42 111.619 -178.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.881 HD12 ' HB2' ' A' ' 113' ' ' PHE . 57.7 mt -65.75 153.05 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.49 -0.559 . . . . 61.45 109.49 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.408 ' HG2' ' HD2' ' A' ' 120' ' ' PRO . 1.3 mt-10 -137.25 152.66 73.89 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.254 -0.43 . . . . 65.14 111.199 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 119' ' ' GLU . 57.1 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 122.542 2.161 . . . . 73.01 112.552 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.926 0.393 . . . . 71.45 111.202 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -56.45 -26.61 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 55.15 111.695 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.8 t0 -72.99 -43.69 61.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.013 0.435 . . . . 72.5 111.047 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 9.5 m-85 -78.97 -27.14 43.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.303 0.573 . . . . 72.35 109.718 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.588 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.33 -29.82 38.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.127 -0.942 . . . . 60.31 110.473 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -98.14 -6.51 31.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.912 -0.586 . . . . 62.32 110.624 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -64.51 -30.39 71.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.883 0.373 . . . . 73.53 111.015 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.74 54.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 63.51 112.602 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.12 156.54 76.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.706 0.289 . . . . 73.34 110.975 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' ILE . 12.1 Cg_endo -56.29 142.17 88.07 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.813 2.342 . . . . 52.02 112.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.1 tt -99.53 133.08 44.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 71.5 110.776 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -104.88 86.89 2.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 55.44 111.061 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.805 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 64.0 m-85 -75.06 141.03 43.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.606 -0.724 . . . . 73.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.851 HG21 ' CD1' ' A' ' 44' ' ' LEU . 1.9 mp -133.99 85.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.532 -0.303 . . . . 72.45 111.395 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 2.7 m-85 -72.15 145.42 48.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.758 -0.46 . . . . 73.3 109.758 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.74 117.3 3.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.153 0.502 . . . . 72.43 110.9 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 9.4 mt-10 -71.05 -12.43 61.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 74.3 110.396 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.26 97.54 7.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 75.35 111.218 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.94 5.9 41.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.726 -0.67 . . . . 72.23 110.986 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.72 -52.55 4.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.91 0.386 . . . . 60.31 110.508 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 13.22 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 71.43 111.108 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -46.55 -28.09 1.32 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.466 -0.334 . . . . 74.34 111.375 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.75 -45.61 78.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 62.44 110.764 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 6.3 mt-10 -66.73 -44.25 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.856 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.89 -57.12 12.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 71.02 110.817 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 20.4 m -63.33 -21.32 66.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 74.35 111.407 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 9.6 t70 -66.08 -65.39 0.68 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.546 0.688 . . . . 72.21 109.488 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.92 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -48.39 -31.82 6.72 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.653 1.216 . . . . 64.25 108.991 177.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.851 ' CD1' HG21 ' A' ' 29' ' ' ILE . 35.7 mt -77.53 -23.17 50.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.368 -1.742 . . . . 73.32 112.369 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 20.7 mttt -55.53 -43.62 99.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 63.11 110.152 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 23.9 Cg_endo -83.86 -41.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.648 2.232 . . . . 74.43 111.822 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -53.23 -22.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 C-N-CA 119.983 -0.687 . . . . 64.11 109.721 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.744 ' HB2' ' CE1' ' A' ' 57' ' ' PHE . . . -106.07 -27.66 10.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.549 -0.751 . . . . 71.12 111.211 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.1 tm-20 -59.43 -22.4 61.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.256 0.551 . . . . 72.15 109.921 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.43 29.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.303 -0.862 . . . . 60.23 109.464 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.681 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.8 pt20 -126.88 40.47 3.71 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.385 -1.28 . . . . 74.32 110.995 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptm180 -73.45 -32.25 64.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.662 . . . . 72.21 111.282 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.69 6.18 48.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 71.44 112.849 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 51' ' ' GLN . 12.4 p -116.84 -31.94 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 75.32 111.259 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 28.4 mt -128.46 144.72 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 65.24 110.691 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.19 104.74 16.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.893 0.378 . . . . 73.32 110.559 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.83 ' CZ ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.9 132.88 42.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.354 0.597 . . . . 74.21 112.065 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.71 108.26 0.36 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.196 -0.911 . . . . 71.14 112.509 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.438 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 22.1 p -75.76 152.33 37.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.701 0.286 . . . . 73.24 110.383 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.881 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.8 tt -149.97 164.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 71.43 110.856 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 60' ' ' ILE . 31.2 t0 -85.99 120.23 27.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.842 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.912 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.2 5.29 30.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.698 0.285 . . . . 43.25 110.864 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 tttp -104.28 -33.04 8.81 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.45 -0.341 . . . . 73.31 111.543 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.32 -31.92 6.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.179 0.514 . . . . 73.03 110.684 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.04 -15.99 17.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 71.14 111.357 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -32.28 -37.46 0.04 OUTLIER Glycine 0 C--N 1.336 0.547 0 N-CA-C 114.301 0.48 . . . . 64.5 114.301 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.66 -17.27 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.43 . . . . 74.02 110.774 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -94.72 -9.24 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 61.11 111.214 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.24 -51.53 17.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.76 0.314 . . . . 62.23 111.434 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -91.33 1.34 76.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.861 -1.161 . . . . 71.03 113.911 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -60.87 -9.79 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.454 0.627 . . . . 50.32 109.462 177.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -115.78 -16.9 11.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 64.21 110.377 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.792 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -176.78 -71.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.24 0.459 . . . . 55.4 112.24 -178.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.609 HD12 HD11 ' A' ' 72' ' ' LEU . 1.8 mp -40.57 175.14 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 112.969 0.729 . . . . 74.44 112.969 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -107.86 -21.7 12.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.105 -0.952 . . . . 72.33 110.851 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 82.73 20.85 0.23 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.263 -1.014 . . . . 74.42 108.263 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -79.01 -48.76 13.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.663 -1.153 . . . . 72.34 111.51 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -118.98 158.86 24.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.207 0.527 . . . . 44.04 111.451 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.912 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -158.24 165.53 18.4 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.48 -0.782 . . . . 72.2 111.762 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 25.6 Cg_endo -61.9 157.15 59.09 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.158 -1.601 . . . . 54.2 112.915 0.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.597 ' HB1' HD22 ' A' ' 74' ' ' LEU . . . -119.47 164.44 15.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 75.13 109.363 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.533 ' CE2' HG12 ' A' ' 29' ' ' ILE . 2.5 t80 -138.44 131.29 29.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 64.1 111.167 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -122.6 147.42 46.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.54 111.661 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.644 HG21 ' CE2' ' A' ' 113' ' ' PHE . 57.5 mt -129.32 81.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.966 -0.561 . . . . 70.34 109.85 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LEU . 2.3 tt0 -75.4 138.4 41.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 73.21 111.333 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.9 mm-40 -100.65 118.62 37.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.706 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -88.62 20.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 71.32 110.345 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.67 -38.96 2.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.057 -0.519 . . . . 73.15 110.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tttt -113.64 -15.25 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.394 -0.367 . . . . 44.12 110.922 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 34.5 t-20 79.6 21.05 0.61 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.237 0.542 . . . . 71.24 109.949 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -84.67 164.65 18.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.321 -0.854 . . . . 63.1 111.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' O ' ' CD ' ' A' ' 94' ' ' PRO . 6.2 mmtt -139.56 99.15 3.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.25 -0.886 . . . . 75.52 110.757 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 17.4 m-85 -101.14 70.99 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.656 -0.702 . . . . 75.52 111.538 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 90.8 Cg_endo -75.39 168.66 24.09 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.554 2.17 . . . . 54.45 112.384 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' HD13 ' A' ' 106' ' ' ILE . 35.0 t80 -88.27 169.33 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.498 . . . . 64.05 110.684 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 2.9 m-20 -83.85 148.26 27.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 71.01 110.885 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 26.6 mt-30 -103.22 28.47 6.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.217 0.532 . . . . 62.53 110.381 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -155.94 18.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.73 -0.668 . . . . 72.43 110.648 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 1.5 ttmt -113.36 -7.89 13.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.137 -0.483 . . . . 71.05 111.611 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 22.3 tt0 83.97 97.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.258 0.552 . . . . 74.2 110.894 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.9 mt -72.84 93.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 75.55 111.153 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 4.8 p -111.15 -147.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.609 -0.515 . . . . 72.03 109.609 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.616 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.26 -59.83 1.64 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.39 -0.596 . . . . 72.32 109.39 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.581 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -56.14 -34.0 65.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.068 -0.969 . . . . 72.41 110.83 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.53 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.507 -0.77 . . . . 62.24 112.322 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.747 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.9 mm -89.93 -42.58 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 121.058 0.456 . . . . 74.42 110.552 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 10.8 pttt -61.79 -47.36 85.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.936 -0.764 . . . . 71.12 108.936 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.03 -51.47 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 73.42 110.324 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.753 ' CZ ' HD13 ' A' ' 118' ' ' ILE . 67.9 t80 -54.63 -64.91 0.68 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.015 -0.539 . . . . 73.22 110.894 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 106' ' ' ILE . 6.0 m -51.82 -37.4 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.127 0.489 . . . . 62.44 111.533 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.723 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -67.97 -35.79 78.96 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.694 -1.224 . . . . 40.15 107.694 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER -63.33 -37.27 86.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.347 -1.751 . . . . 75.32 108.025 177.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.806 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -63.8 -66.27 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.981 -1.009 . . . . 73.22 110.268 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.4 t -58.09 -36.95 59.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.916 -1.038 . . . . 72.02 111.876 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.58 78.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 74.23 111.393 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.78 25.87 2.24 Favored Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 120.535 -0.84 . . . . 74.53 111.724 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -98.12 -57.78 2.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.2 -0.5 . . . . 64.42 111.014 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.806 HD12 ' HB2' ' A' ' 113' ' ' PHE . 8.9 mt -71.43 150.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.89 -0.595 . . . . 61.45 110.092 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.12 171.94 5.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.261 -0.427 . . . . 65.14 111.364 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--N 1.345 0.359 0 C-N-CA 122.607 2.204 . . . . 73.01 112.35 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.011 0.434 . . . . 71.45 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 t -65.88 -22.44 66.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 55.15 111.57 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -70.77 -41.47 71.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 72.5 110.92 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 13.3 m-85 -79.53 -24.31 42.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 72.35 109.746 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.628 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.61 -42.41 29.01 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.269 -0.878 . . . . 60.31 110.359 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -85.26 -11.45 54.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 62.32 110.508 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -58.74 -31.4 68.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 73.53 111.069 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.27 15.9 56.51 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 63.51 112.708 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 87' ' ' VAL . 1.5 pt -133.28 158.3 76.06 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.699 0.285 . . . . 73.34 110.933 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.46 138.9 88.34 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.631 2.22 . . . . 52.02 112.6 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.848 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.7 tt -99.65 135.94 40.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 71.5 111.007 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.748 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -109.01 100.49 9.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 55.44 111.037 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 11.4 m-85 -85.47 132.03 34.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 73.0 110.057 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.2 mt -127.71 83.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.743 -0.383 . . . . 72.45 111.277 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.7 m-85 -71.51 149.79 45.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.195 -0.457 . . . . 73.3 109.801 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.57 116.87 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.28 0.562 . . . . 72.43 111.257 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 3.4 mt-10 -75.88 -7.97 55.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.208 -0.906 . . . . 74.3 110.027 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -99.84 92.63 5.39 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.179 -0.464 . . . . 75.35 111.094 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.76 6.38 35.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 72.23 111.488 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -34.49 10.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 60.31 110.779 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.98 9.66 16.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 71.43 111.317 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.8 -29.12 1.79 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.767 0.317 . . . . 74.34 111.335 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -54.74 -45.65 74.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 62.44 110.79 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.39 -36.36 81.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.53 110.772 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -66.4 -62.11 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.02 110.697 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.422 ' OG ' HG21 ' A' ' 59' ' ' THR . 7.2 m -57.68 -25.93 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 74.35 110.953 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.6 t0 -62.64 -59.7 4.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.531 0.681 . . . . 72.21 109.569 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.716 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.56 -33.36 9.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.601 1.191 . . . . 64.25 108.676 177.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -80.54 -17.58 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.831 -1.531 . . . . 73.32 112.185 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 4.8 tppt? -55.13 -42.84 98.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.207 -0.664 . . . . 63.11 109.207 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.716 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 11.8 Cg_endo -84.93 -38.64 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.69 2.26 . . . . 74.43 110.31 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 106' ' ' ILE . 55.1 mt -50.21 -22.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.507 0 CA-C-N 115.975 -0.557 . . . . 64.11 109.847 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -112.49 -25.55 9.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.621 -0.718 . . . . 71.12 111.506 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -59.8 -20.4 56.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.255 0.55 . . . . 72.15 109.771 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.37 -30.24 18.52 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.833 0.825 . . . . 60.23 108.969 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.686 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -125.34 42.27 3.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.161 -1.381 . . . . 74.32 110.061 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.5 -29.14 46.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.153 -0.93 . . . . 72.21 111.04 -178.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 11.32 52.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 71.44 112.405 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.5 p -124.97 -33.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.636 0.255 . . . . 75.32 111.419 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 27' ' ' ALA . 72.5 mt -123.15 142.91 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 65.24 111.166 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.3 m-80 -90.57 87.7 6.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.755 -0.461 . . . . 73.32 109.755 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.836 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.0 m-85 -71.89 119.22 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 74.21 111.896 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -141.9 125.17 2.64 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.052 -0.976 . . . . 71.14 112.463 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.505 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 2.3 p -82.82 153.89 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.382 . . . . 73.24 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.3 tt -150.68 164.16 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.028 -0.533 . . . . 71.43 110.531 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 43.0 t0 -87.13 120.26 28.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.296 -0.411 . . . . 74.25 112.072 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.953 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.25 26.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.965 -0.294 . . . . 43.25 110.898 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 8.1 ttmt -106.04 -33.02 8.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.449 -0.341 . . . . 73.31 111.455 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.3 -30.57 6.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 73.03 110.489 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.66 -11.64 17.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.507 -0.769 . . . . 71.14 111.276 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.03 -37.59 0.18 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 114.119 0.407 . . . . 64.5 114.119 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.71 10.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 74.02 110.483 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -93.0 -8.17 43.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 61.11 111.247 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.862 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -75.16 -46.9 31.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.656 -0.247 . . . . 62.23 111.642 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -97.67 1.41 59.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.982 -1.104 . . . . 71.03 113.784 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -8.56 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.446 -0.576 . . . . 50.32 109.446 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -115.23 -15.61 11.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.398 -0.819 . . . . 64.21 110.17 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.44 -69.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.1 0.476 . . . . 55.4 112.135 -178.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.508 HD13 ' HB1' ' A' ' 81' ' ' ALA . 12.6 mt -42.52 174.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.277 -0.874 . . . . 74.44 112.151 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -120.29 3.67 10.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.539 -0.755 . . . . 72.33 110.345 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p 58.4 35.15 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.698 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.5 p30 -89.2 -31.27 18.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 72.34 111.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 28.1 tttt -143.53 157.27 44.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.108 0.48 . . . . 44.04 110.707 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.953 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.9 170.72 8.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.731 -0.668 . . . . 72.2 111.584 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 18.2 Cg_endo -60.24 162.09 36.68 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.422 -1.491 . . . . 54.2 113.013 0.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -123.92 162.41 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.755 . . . . 75.13 109.812 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 84' ' ' ILE . 42.0 t80 -138.49 124.6 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 64.1 111.132 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -119.63 148.43 43.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 75.54 111.499 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.853 HD11 ' CE2' ' A' ' 82' ' ' PHE . 12.9 mm -128.58 90.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 70.34 110.346 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.74 139.19 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 73.21 110.899 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.0 mt-10 -108.34 110.38 21.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.269 -0.423 . . . . 74.42 110.76 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 20' ' ' MET . 33.8 m -78.33 0.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.153 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.42 -39.43 8.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.434 -0.348 . . . . 73.15 111.17 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 -6.51 9.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.63 -0.259 . . . . 44.12 111.525 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.6 t30 66.19 64.58 0.52 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.546 -0.538 . . . . 71.24 109.546 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.4 tp60 -122.26 169.66 10.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.5 -0.773 . . . . 63.1 111.735 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.609 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -134.96 92.01 2.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.204 -0.907 . . . . 75.52 111.602 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 70.0 m-85 -103.93 66.55 0.11 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.872 -0.603 . . . . 75.52 111.138 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 95.1 Cg_endo -77.18 -175.5 2.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.451 2.1 . . . . 54.45 112.998 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -112.66 168.61 9.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.847 -0.615 . . . . 64.05 110.943 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -72.44 176.3 5.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 71.01 110.733 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -118.18 -16.31 9.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 62.53 111.279 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -119.75 -8.13 9.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 72.43 110.829 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -70.96 -8.46 53.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.861 -0.609 . . . . 71.05 111.559 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.4 tt0 86.73 120.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.214 -0.448 . . . . 74.2 110.596 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.0 mt -103.94 110.01 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 75.55 111.59 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -131.21 -153.55 0.57 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.892 -0.781 . . . . 72.03 108.892 178.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.869 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.53 -66.16 0.95 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.624 -0.88 . . . . 72.32 108.624 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.703 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.19 -38.97 9.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.994 -1.003 . . . . 72.41 111.957 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -68.81 -32.88 72.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.69 0.626 . . . . 62.24 112.69 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 47' ' ' ILE . 32.9 mm -91.24 -45.76 14.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 74.42 109.942 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.841 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -45.77 83.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.844 -0.798 . . . . 71.12 108.844 178.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.36 36.8 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.774 -0.648 . . . . 73.42 110.125 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.741 ' CE1' HD13 ' A' ' 118' ' ' ILE . 48.7 t80 -49.77 -63.83 0.99 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.011 -0.366 . . . . 73.22 110.011 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 106' ' ' ILE . 8.3 m -49.17 -42.85 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.535 . . . . 62.44 109.569 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -52.97 -36.93 60.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.727 0.775 . . . . 40.15 109.204 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -69.3 -34.8 75.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.357 -1.292 . . . . 75.32 108.398 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.854 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.0 t80 -71.75 -69.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.255 -0.884 . . . . 73.22 110.874 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 55' ' ' ILE . 16.9 t -50.19 -47.46 24.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 72.02 111.987 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -36.96 67.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 74.23 111.019 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.75 29.41 2.24 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 110.864 -0.894 . . . . 74.53 110.864 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.916 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -101.76 -52.92 3.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.792 -0.704 . . . . 64.42 111.561 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.854 HD12 ' HB2' ' A' ' 113' ' ' PHE . 55.9 mt -66.43 152.94 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.483 -0.562 . . . . 61.45 109.483 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.81 168.09 19.04 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.395 -0.366 . . . . 65.14 111.449 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo . . . . . 0 C--N 1.344 0.336 0 C-N-CA 122.776 2.318 . . . . 73.01 112.728 -179.586 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.711 0.291 . . . . 71.45 111.113 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -55.59 -24.03 30.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 55.15 111.237 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -83.04 -40.88 19.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 72.5 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' HB2' HD12 ' A' ' 26' ' ' LEU . 15.6 m-85 -77.13 -18.31 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.372 0.606 . . . . 72.35 109.59 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.878 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.6 -32.17 17.23 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.091 -0.959 . . . . 60.31 110.233 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -90.9 -8.64 48.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.694 -0.685 . . . . 62.32 111.006 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.19 -56.21 10.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.935 0.397 . . . . 73.53 110.623 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.35 23.99 2.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.928 -0.653 . . . . 63.51 112.351 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.88 166.44 28.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.746 0.308 . . . . 73.34 111.296 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.1 Cg_exo -65.25 141.49 69.09 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.607 2.205 . . . . 52.02 112.357 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.922 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.8 tt -105.46 128.04 53.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.522 . . . . 71.5 110.564 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . . . -100.75 86.6 3.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.093 0.473 . . . . 55.44 111.451 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.922 ' CD1' HD22 ' A' ' 26' ' ' LEU . 62.4 m-85 -75.81 136.82 40.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.573 -0.739 . . . . 73.0 110.264 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 44' ' ' LEU . 2.8 mp -130.43 87.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.773 0.32 . . . . 72.45 111.178 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.854 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.5 m-85 -71.59 147.09 47.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.683 -0.488 . . . . 73.3 109.683 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.657 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -159.26 119.64 3.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.147 0.499 . . . . 72.43 110.828 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 12.1 mt-10 -74.32 -7.46 52.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.494 -0.776 . . . . 74.3 110.346 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -89.09 126.56 35.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 75.35 111.104 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.85 4.38 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.972 -0.558 . . . . 72.23 110.476 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.1 -38.33 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 60.31 110.474 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -104.34 15.96 27.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 71.43 111.074 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -59.23 -25.81 64.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 74.34 111.035 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -58.13 -44.08 87.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.365 . . . . 62.44 110.855 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.44 -42.93 82.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 74.53 110.981 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.06 -53.65 46.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 71.02 110.83 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 44' ' ' LEU . 49.8 m -64.86 -22.84 67.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 74.35 111.214 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 30.3 t0 -65.29 -61.6 2.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.567 0.698 . . . . 72.21 109.244 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -48.41 -32.96 8.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.604 1.192 . . . . 64.25 108.746 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.036 HD11 HG21 ' A' ' 29' ' ' ILE . 43.3 mt -76.62 -24.04 53.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.463 -1.699 . . . . 73.32 112.388 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.0 mtpt -53.73 -44.68 98.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 63.11 110.13 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.9 Cg_endo -83.21 -38.86 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.532 2.155 . . . . 74.43 110.819 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.842 ' CD1' HD23 ' A' ' 44' ' ' LEU . 58.7 mt -49.78 -23.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.912 -0.585 . . . . 64.11 110.102 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.747 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -110.82 -26.19 9.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 71.12 111.465 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.62 -18.83 61.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.128 0.49 . . . . 72.15 110.04 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.96 -28.94 17.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.76 0.79 . . . . 60.23 109.409 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.708 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.1 pt20 -121.31 38.96 3.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.311 -1.313 . . . . 74.32 110.597 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.1 ptm180 -75.04 -27.05 59.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 72.21 111.406 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.03 14.97 28.59 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.903 -0.665 . . . . 71.44 112.618 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 51' ' ' GLN . 7.5 p -128.81 -44.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 75.32 110.964 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.505 HD12 ' NE2' ' A' ' 51' ' ' GLN . 30.0 mt -118.06 146.24 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 65.24 110.527 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -94.08 102.11 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.889 0.376 . . . . 73.32 110.406 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.747 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -80.01 136.69 36.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.348 0.594 . . . . 74.21 111.587 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.6 126.71 1.65 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.148 -0.933 . . . . 71.14 111.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 p -88.4 153.67 21.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 73.24 110.415 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.902 HD11 ' CG ' ' A' ' 65' ' ' PHE . 10.8 tt -147.91 162.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 71.43 110.853 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.501 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.3 t0 -83.55 117.4 23.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.178 -0.465 . . . . 74.25 112.183 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.947 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.05 5.35 22.61 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.673 0.273 . . . . 43.25 110.788 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 17.6 ttmt -103.67 -33.23 9.03 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.526 -0.306 . . . . 73.31 111.622 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.54 -32.42 5.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.224 0.535 . . . . 73.03 110.57 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.902 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.33 -16.47 17.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 71.14 111.101 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.65 -39.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.442 0.537 . . . . 64.5 114.442 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.02 -26.71 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.25 0.548 . . . . 74.02 110.459 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -83.29 -13.48 55.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 61.11 111.611 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.854 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.73 -36.76 70.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.667 0.27 . . . . 62.23 111.558 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -108.07 -0.44 33.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.917 -1.135 . . . . 71.03 113.416 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -60.93 -10.68 6.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.507 -0.553 . . . . 50.32 109.507 177.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -113.93 -14.84 12.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.372 -0.831 . . . . 64.21 110.328 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.716 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.31 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.276 0.473 . . . . 55.4 112.276 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.549 HD13 ' HB1' ' A' ' 81' ' ' ALA . 96.6 mt -43.14 178.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.514 -0.766 . . . . 74.44 112.913 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.568 ' C ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -107.94 -24.53 11.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.969 -1.014 . . . . 72.33 110.495 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 78.95 21.54 0.68 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.206 -0.906 . . . . 74.42 108.609 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.67 -45.16 25.78 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.649 -1.159 . . . . 72.34 111.41 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -123.93 163.2 21.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.1 -0.5 . . . . 44.04 111.154 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.947 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -160.59 167.43 13.7 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 72.2 112.023 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 26.2 Cg_endo -62.34 158.1 60.37 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 123.16 -1.6 . . . . 54.2 113.05 0.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.712 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . . . -123.31 167.59 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.737 . . . . 75.13 109.969 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.7 t80 -138.36 130.32 28.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.669 0.271 . . . . 64.1 110.778 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.711 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -129.68 121.34 26.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.038 0.385 . . . . 75.54 112.038 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.684 HD11 HG12 ' A' ' 110' ' ' VAL . 31.1 mt -103.63 93.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 70.34 110.346 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 92' ' ' LYS . 50.8 tt0 -85.05 141.77 30.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.768 0.318 . . . . 73.21 110.741 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.0 mt-10 -112.43 109.9 19.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.958 0.408 . . . . 74.42 111.072 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.878 HG11 ' O ' ' A' ' 20' ' ' MET . 15.7 t -80.2 -1.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.797 -0.638 . . . . 71.32 110.904 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.87 -42.67 11.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.372 -0.376 . . . . 73.15 110.919 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -118.8 -9.01 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.552 -0.294 . . . . 44.12 111.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 t30 75.46 57.05 0.06 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.353 0.597 . . . . 71.24 109.562 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.645 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -121.49 166.44 14.16 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.179 -0.919 . . . . 63.1 110.932 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.645 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 5.4 mmtt -141.42 98.19 3.31 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.413 -0.812 . . . . 75.52 110.663 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.635 ' O ' HD12 ' A' ' 84' ' ' ILE . 64.1 m-85 -101.76 73.41 0.12 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.838 . . . . 75.52 110.866 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 53.7 Cg_endo -80.05 167.32 20.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 54.45 112.585 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' ' N ' ' A' ' 96' ' ' ASP . 40.5 t80 -96.08 166.15 11.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 64.05 110.828 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -63.67 173.81 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 71.01 110.392 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.712 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 7.1 mm-40 -117.15 -22.9 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.423 . . . . 62.53 111.369 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -127.52 25.61 6.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.378 . . . . 72.43 110.835 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.4 tppt? -93.33 -69.37 0.75 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.022 -0.536 . . . . 71.05 110.533 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 9.7 tt0 163.56 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.763 -0.653 . . . . 74.2 109.892 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 8.7 mt -91.25 88.09 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.55 111.735 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -112.25 -154.1 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.574 -0.899 . . . . 72.03 108.574 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.98 -67.57 0.85 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.741 -0.837 . . . . 72.32 108.741 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.82 -35.83 6.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.341 -0.845 . . . . 72.41 111.479 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -71.82 -33.38 68.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 62.24 112.426 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.702 ' HB ' HD13 ' A' ' 47' ' ' ILE . 50.0 mm -89.48 -46.43 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 74.42 110.113 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.666 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -58.47 -44.93 89.47 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.727 -0.67 . . . . 71.12 109.471 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -70.86 -49.01 50.77 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.696 -0.684 . . . . 73.42 110.123 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.79 ' O ' HD11 ' A' ' 118' ' ' ILE . 27.5 t80 -51.56 -67.2 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 73.22 109.822 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.684 HG12 HD11 ' A' ' 84' ' ' ILE . 21.9 m -47.16 -38.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.322 0.582 . . . . 62.44 109.869 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -57.87 -41.88 83.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.356 -0.838 . . . . 40.15 110.057 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.793 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -77.16 -11.93 59.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.615 -0.721 . . . . 75.32 110.263 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.941 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -82.0 -61.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.74 0.781 . . . . 73.22 109.153 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.543 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 11.5 p -57.94 -37.29 60.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.302 -1.317 . . . . 72.02 110.885 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.05 86.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 74.23 110.431 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.85 1.53 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.722 -0.751 . . . . 74.53 111.558 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.46 -37.13 6.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.296 -0.452 . . . . 64.42 111.704 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.4 mt -86.54 150.0 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.16 0.505 . . . . 61.45 110.508 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.48 162.56 45.92 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.479 -0.782 . . . . 65.14 111.079 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 91' ' ' GLN . 15.8 Cg_exo . . . . . 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 73.01 112.189 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.92 0.39 . . . . 71.45 111.374 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -64.49 -26.67 68.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 55.15 111.666 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.35 -38.39 60.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 72.5 111.015 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 23.0 m-85 -79.12 -23.44 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.362 0.601 . . . . 72.35 109.593 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.642 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -87.91 -25.47 23.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.118 -0.946 . . . . 60.31 110.379 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 t -95.31 -11.23 28.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.025 -0.534 . . . . 62.32 110.521 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.01 78.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.458 -0.337 . . . . 73.53 111.175 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 17.18 39.77 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.715 . . . . 63.51 112.666 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.97 161.1 65.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.718 0.294 . . . . 73.34 110.89 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.04 139.57 88.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.624 2.216 . . . . 52.02 112.688 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.898 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.3 tt -98.42 140.96 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 71.5 111.145 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -114.94 88.22 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 55.44 111.023 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.898 ' CD2' HD22 ' A' ' 26' ' ' LEU . 81.6 m-85 -76.87 133.97 39.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.69 -0.687 . . . . 73.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.0 mt -125.76 85.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.501 -0.318 . . . . 72.45 111.093 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.6 m-85 -73.24 148.84 43.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.299 -0.63 . . . . 73.3 109.299 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -157.18 115.13 3.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.383 0.611 . . . . 72.43 111.326 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -84.72 -1.25 55.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.022 -0.99 . . . . 74.3 109.901 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 p -106.6 112.48 25.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.974 -0.557 . . . . 75.35 110.662 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.32 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 72.23 111.375 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.36 -55.17 5.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.091 0.472 . . . . 60.31 110.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.487 ' OE2' HD23 ' A' ' 40' ' ' LEU . 3.7 pt-20 -82.38 -3.42 55.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 71.43 110.902 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 -44.83 -38.77 4.78 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.185 -0.461 . . . . 74.34 111.15 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.22 -56.11 9.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 62.44 110.676 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 7.4 pt-20 -58.2 -31.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.576 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.74 -57.54 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.042 0.449 . . . . 71.02 110.448 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HA ' HD12 ' A' ' 44' ' ' LEU . 25.6 m -63.43 -20.26 65.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 74.35 111.329 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t0 -65.94 -63.87 0.99 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.609 0.718 . . . . 72.21 109.345 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -47.85 -33.02 6.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.703 1.24 . . . . 64.25 108.684 177.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.913 HD23 HD12 ' A' ' 47' ' ' ILE . 52.1 mt -76.88 -23.32 52.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.43 -1.714 . . . . 73.32 112.467 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 10.8 mtpt -54.45 -43.95 98.37 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 116.431 -0.35 . . . . 63.11 110.073 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 21.0 Cg_endo -82.37 -39.85 0.15 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.428 2.085 . . . . 74.43 110.543 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.993 HG21 HG22 ' A' ' 106' ' ' ILE . 47.1 mt -51.25 -22.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-N 116.045 -0.525 . . . . 64.11 109.948 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.734 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -111.22 -23.99 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.775 -0.648 . . . . 71.12 111.429 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -61.47 -20.74 63.49 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.195 0.521 . . . . 72.15 109.89 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.7 -26.54 19.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.422 -0.808 . . . . 60.23 109.338 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.718 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -125.66 42.21 3.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.441 -1.254 . . . . 74.32 110.793 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -76.32 -32.54 58.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.666 -0.697 . . . . 72.21 111.056 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.4 6.69 53.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.849 -0.691 . . . . 71.44 112.641 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 51' ' ' GLN . 13.1 p -119.09 -34.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 75.32 111.23 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.0 mt -122.94 143.95 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 65.24 111.009 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-80 -93.61 87.0 5.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 73.32 109.927 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.734 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m-85 -69.89 136.71 50.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 74.21 111.234 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.63 129.63 2.32 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.389 -0.823 . . . . 71.14 111.961 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 50.0 p -89.38 151.58 21.97 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.039 0.447 . . . . 73.24 110.878 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.951 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.3 tt -148.07 163.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.503 -0.771 . . . . 71.43 110.422 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.2 t0 -87.08 120.98 28.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.379 -0.373 . . . . 74.25 111.883 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.859 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.98 5.09 23.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.788 -0.365 . . . . 43.25 111.073 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 29.2 ttmt -105.08 -34.15 8.06 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 111.735 0.272 . . . . 73.31 111.735 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.57 -30.51 7.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.218 0.532 . . . . 73.03 110.417 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.951 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.77 -17.99 14.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.413 -0.812 . . . . 71.14 111.167 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -31.41 -39.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 114.239 0.456 . . . . 64.5 114.239 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.55 -19.03 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.058 0.429 . . . . 74.02 110.691 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -90.66 -11.83 38.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.805 -0.634 . . . . 61.11 111.183 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.19 -51.36 38.75 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.73 0.3 . . . . 62.23 111.048 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.52 1.75 69.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.739 -1.22 . . . . 71.03 113.778 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.61 -9.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.452 0.626 . . . . 50.32 109.668 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -114.29 -15.22 12.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.405 -0.816 . . . . 64.21 110.319 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.73 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.16 -70.02 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.246 0.546 . . . . 55.4 112.264 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.6 mm? -40.86 171.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 114.89 -1.05 . . . . 74.44 112.375 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.24 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 72.33 110.832 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 16.0 p 53.75 38.13 27.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.383 . . . . 74.42 110.825 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.64 -29.84 33.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 72.34 110.769 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -150.69 163.81 37.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.243 -0.435 . . . . 44.04 110.36 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.61 173.15 5.23 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.915 -0.584 . . . . 72.2 111.787 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.597 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 19.1 Cg_endo -60.36 164.63 30.24 Favored 'Cis proline' 0 C--N 1.353 0.793 0 C-N-CA 123.363 -1.515 . . . . 54.2 113.076 0.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.49 167.62 16.04 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.394 -0.821 . . . . 75.13 109.532 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.1 t80 -143.58 112.1 6.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 64.1 110.645 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -109.44 126.42 53.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 75.54 111.429 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 113' ' ' PHE . 11.8 mt -109.26 88.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.803 0.335 . . . . 70.34 110.42 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -84.92 138.5 32.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 73.21 110.6 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 9.7 mt-10 -100.11 115.28 29.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.922 0.391 . . . . 74.42 110.894 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -81.61 3.49 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.539 . . . . 71.32 110.827 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.99 -41.5 8.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.292 -0.413 . . . . 73.15 110.857 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -117.79 -15.93 10.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.637 -0.256 . . . . 44.12 111.308 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 35.4 t-20 81.18 40.75 0.05 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.324 0.583 . . . . 71.24 110.268 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.1 tp60 -91.6 -174.74 3.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.339 -0.846 . . . . 63.1 111.152 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -150.28 93.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.56 -0.745 . . . . 75.52 110.713 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.61 ' O ' HD12 ' A' ' 84' ' ' ILE . 75.0 m-85 -105.18 70.07 0.2 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.835 -0.62 . . . . 75.52 111.353 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.889 ' CB ' HD21 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.56 178.65 6.42 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.683 2.255 . . . . 54.45 112.968 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 37.1 t80 -113.05 164.45 13.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 64.05 110.505 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -62.35 174.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 71.01 110.74 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 3.3 mp0 -117.49 -23.27 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 62.53 111.21 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 24.93 6.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 72.43 110.847 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.3 tppt? -94.55 -77.3 0.47 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.019 -0.537 . . . . 71.05 110.534 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 3.8 tt0 173.74 105.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 74.2 110.4 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.0 mt -98.63 88.58 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.815 -0.63 . . . . 75.55 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -119.07 -164.68 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.28 -0.637 . . . . 72.03 109.28 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.76 -66.32 0.89 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.098 0.475 . . . . 72.32 110.099 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -48.98 -39.23 25.73 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.936 -1.029 . . . . 72.41 111.754 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -71.88 -34.94 69.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.067 -0.97 . . . . 62.24 113.412 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.993 HG22 HG21 ' A' ' 47' ' ' ILE . 46.2 mm -88.05 -44.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.0 0.429 . . . . 74.42 110.201 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -54.66 -42.97 71.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.866 -0.606 . . . . 71.12 109.511 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.81 36.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.621 -0.718 . . . . 73.42 110.139 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.722 ' O ' HD11 ' A' ' 118' ' ' ILE . 32.2 t80 -49.64 -64.74 0.72 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.631 -0.507 . . . . 73.22 109.631 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 111' ' ' ASP . 16.7 m -49.97 -41.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.765 -0.458 . . . . 62.44 109.765 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -55.58 -36.96 67.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.686 0.755 . . . . 40.15 109.133 178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.927 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -68.03 -34.82 77.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.431 -1.259 . . . . 75.32 108.281 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.88 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -71.52 -69.05 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.099 -0.955 . . . . 73.22 111.025 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.606 ' CG2' HD11 ' A' ' 55' ' ' ILE . 11.9 t -52.36 -46.05 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.284 -0.871 . . . . 72.02 112.101 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.66 69.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.843 0.354 . . . . 74.23 111.235 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.36 31.17 1.9 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.86 -0.896 . . . . 74.53 110.86 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.927 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -103.25 -56.22 2.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.848 -0.676 . . . . 64.42 111.373 -178.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.88 HD12 ' HB2' ' A' ' 113' ' ' PHE . 50.4 mt -64.56 150.75 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.403 -0.591 . . . . 61.45 109.403 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.13 157.37 78.44 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 65.14 111.581 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.8 2.333 . . . . 73.01 112.611 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.853 0.358 . . . . 71.45 111.616 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.7 t -55.86 -30.83 62.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.051 -0.522 . . . . 55.15 111.965 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.678 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.7 t0 -87.09 -35.86 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.899 0.38 . . . . 72.5 111.251 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 11.7 m-85 -81.53 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 72.35 110.664 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.08 -28.85 9.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 60.31 110.577 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -97.15 -5.87 36.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.982 -0.554 . . . . 62.32 110.882 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.62 -40.12 76.78 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.906 0.384 . . . . 73.53 111.026 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.62 15.67 22.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.859 -0.686 . . . . 63.51 112.459 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.51 ' C ' HG22 ' A' ' 87' ' ' VAL . 2.1 pt -133.35 154.37 80.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.34 111.096 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 19.0 Cg_endo -60.34 145.12 99.27 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.84 2.36 . . . . 52.02 112.604 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 27' ' ' ALA . 3.1 tt -95.97 135.7 37.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.9 -0.591 . . . . 71.5 111.143 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' N ' HD23 ' A' ' 26' ' ' LEU . . . -104.72 95.27 5.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 55.44 110.793 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.476 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 6.5 m-85 -82.3 130.75 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 73.0 110.371 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.92 HG21 ' CD1' ' A' ' 44' ' ' LEU . 2.3 mp -124.38 83.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.81 -0.356 . . . . 72.45 111.339 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.8 m-85 -70.28 143.97 51.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.561 -0.533 . . . . 73.3 109.561 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -158.07 118.47 3.37 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.145 0.497 . . . . 72.43 111.028 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 23.4 mt-10 -71.26 -13.25 61.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 74.3 109.979 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 p -88.64 97.24 11.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.943 -0.571 . . . . 75.35 111.037 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.44 7.59 42.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 72.23 111.456 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -113.3 -46.46 3.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 60.31 110.83 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -92.93 1.55 57.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 71.43 111.381 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.59 -29.87 0.19 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.929 0.344 . . . . 74.34 111.929 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -49.78 -50.04 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 62.44 111.151 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 17.5 mt-10 -63.34 -44.03 96.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 74.53 111.103 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.57 -53.68 53.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 71.02 110.905 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 28.6 m -65.06 -19.85 66.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.383 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' LYS . 10.6 t0 -67.53 -62.03 1.62 Allowed 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.312 -0.625 . . . . 72.21 109.312 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.649 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.07 -32.82 10.28 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.844 1.307 . . . . 64.25 108.782 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.92 ' CD1' HG21 ' A' ' 29' ' ' ILE . 63.7 mt -77.65 -23.29 49.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.191 -1.822 . . . . 73.32 111.903 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 17.8 ttmt -52.27 -45.17 94.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.747 -0.661 . . . . 63.11 110.083 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.1 Cg_endo -83.96 -37.54 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.628 2.219 . . . . 74.43 110.537 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 44' ' ' LEU . 60.9 mt -50.33 -21.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 116.068 -0.515 . . . . 64.11 110.196 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -110.87 -32.44 6.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.797 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 2.0 tm-20 -59.39 -18.15 36.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.24 0.543 . . . . 72.15 110.179 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.14 -27.98 19.25 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.42 -0.809 . . . . 60.23 109.527 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -121.48 36.07 4.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.449 -1.25 . . . . 74.32 110.814 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' ALA . 20.4 ptt-85 -67.08 -32.79 74.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.67 . . . . 72.21 111.326 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 9.61 49.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.645 -0.788 . . . . 71.44 112.83 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.6 p -123.78 -29.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.742 0.271 . . . . 75.32 111.581 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 27' ' ' ALA . 32.8 mt -132.84 153.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.54 -0.3 . . . . 65.24 110.428 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -102.82 109.8 21.51 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.994 0.426 . . . . 73.32 110.728 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -70.35 125.89 28.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.412 0.625 . . . . 74.21 111.136 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.29 100.43 0.21 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.025 -0.989 . . . . 71.14 112.572 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.4 p -77.74 152.95 33.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 73.24 110.521 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.969 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.6 tt -150.14 165.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 71.43 110.87 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 28.8 t0 -88.43 120.7 30.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.197 -0.456 . . . . 74.25 112.077 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.942 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -84.46 3.56 35.69 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.696 0.284 . . . . 43.25 111.0 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 11.1 tttt -104.42 -32.64 8.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.492 -0.322 . . . . 73.31 111.545 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.92 -30.25 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 73.03 110.616 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.68 -15.72 15.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.574 -0.739 . . . . 71.14 111.236 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -32.33 -38.09 0.05 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.269 0.467 . . . . 64.5 114.269 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.53 -12.38 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.175 0.487 . . . . 74.02 110.764 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' PHE . 13.3 t-80 -103.08 -4.21 24.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.705 -0.68 . . . . 61.11 110.934 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.86 -53.18 10.78 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.739 0.305 . . . . 62.23 111.324 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.82 6.75 73.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 119.868 -1.158 . . . . 71.03 113.504 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -9.8 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.09 -0.707 . . . . 50.32 109.09 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.74 -15.04 12.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.224 -0.898 . . . . 64.21 110.376 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.727 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER 179.06 -69.92 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.355 0.598 . . . . 55.4 112.288 -178.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 94' ' ' PRO . 1.5 mm? -40.96 173.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.016 -0.993 . . . . 74.44 112.594 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.606 ' C ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -101.89 -32.38 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 72.33 110.894 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.606 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.8 p 85.01 27.34 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.808 -1.087 . . . . 74.42 108.388 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.56 -45.55 17.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.535 -1.211 . . . . 72.34 111.017 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 21.9 tttp -130.1 163.28 26.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.88 -0.6 . . . . 44.04 111.074 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -157.07 169.83 9.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.578 . . . . 72.2 111.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 18.4 Cg_endo -60.61 160.53 42.74 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 123.446 -1.481 . . . . 54.2 113.189 0.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.13 159.93 32.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.379 -0.828 . . . . 75.13 109.812 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HG12 ' A' ' 110' ' ' VAL . 68.4 t80 -136.76 136.83 39.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 64.1 111.748 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -134.77 148.67 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 75.54 111.172 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.886 HG21 ' CE2' ' A' ' 113' ' ' PHE . 12.9 mt -123.66 94.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.33 . . . . 70.34 110.525 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.623 HE22 HG12 ' A' ' 87' ' ' VAL . 9.0 tm0? -77.71 136.67 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.21 110.89 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.9 mt-10 -107.39 116.06 31.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.948 0.404 . . . . 74.42 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HE22 ' A' ' 85' ' ' GLN . 34.3 m -82.7 8.51 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 71.32 112.169 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.18 -40.02 3.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 73.15 110.813 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -105.7 -14.56 15.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 44.12 111.33 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 74.44 19.56 2.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.925 0.393 . . . . 71.24 111.092 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 6.2 tp-100 -89.12 166.53 13.78 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.122 -0.49 . . . . 63.1 110.681 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 8.6 mmtt -141.06 85.38 1.98 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.819 -0.628 . . . . 75.52 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' O ' HD12 ' A' ' 84' ' ' ILE . 32.5 m-85 -81.31 100.73 0.77 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 75.52 110.688 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 74' ' ' LEU . 40.6 Cg_endo -105.47 168.92 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.431 2.754 . . . . 54.45 113.294 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 36.4 t80 -102.85 165.38 11.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 64.05 110.626 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -65.51 175.06 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 71.01 110.528 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 2.4 mt-30 -116.67 -24.61 7.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 62.53 111.218 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 9.5 pt-20 -124.41 25.86 7.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.397 . . . . 72.43 110.825 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.5 tppt? -96.34 -72.56 0.63 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.992 -0.549 . . . . 71.05 110.566 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 54.7 tt0 170.46 100.48 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.96 -0.563 . . . . 74.2 110.382 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.4 mt -94.63 90.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 75.55 111.064 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 22.1 p -116.22 -150.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.413 -0.358 . . . . 72.03 110.248 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.696 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -97.35 -56.39 2.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.436 0.636 . . . . 72.32 109.495 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -61.4 -39.29 90.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.733 -1.122 . . . . 72.41 110.722 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -70.75 -33.36 70.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 62.24 112.602 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.664 ' HB ' HD13 ' A' ' 47' ' ' ILE . 51.9 mm -89.49 -41.39 13.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 74.42 110.166 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.599 ' HB3' HG12 ' A' ' 47' ' ' ILE . 3.0 pttp -62.74 -46.23 89.03 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.479 -0.782 . . . . 71.12 109.115 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 107' ' ' LYS . . . -67.35 -49.93 61.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.985 -1.007 . . . . 73.42 110.2 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.672 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.1 t80 -51.4 -65.82 0.49 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 116.295 -0.411 . . . . 73.22 110.023 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 106' ' ' ILE . 12.3 m -48.56 -36.16 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.486 0.66 . . . . 62.44 109.732 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -61.05 -42.97 99.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.092 -0.958 . . . . 40.15 110.062 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.982 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -72.39 -15.47 61.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 75.32 109.874 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.952 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -81.46 -62.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.729 0.776 . . . . 73.22 109.345 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.464 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.8 p -62.36 -38.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.445 -1.252 . . . . 72.02 111.173 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.11 76.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.542 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.97 30.23 1.26 Allowed Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.628 -0.796 . . . . 74.53 111.731 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.99 -38.5 6.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.516 -0.342 . . . . 64.42 111.475 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.982 HD11 ' OD1' ' A' ' 112' ' ' ASP . 6.0 mt -87.23 148.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 61.45 110.518 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.25 163.88 44.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.785 -0.643 . . . . 65.14 111.328 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.344 0.337 0 C-N-CA 122.54 2.16 . . . . 73.01 112.418 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 p90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.729 0.3 . . . . 71.45 111.055 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.1 m -56.32 -26.01 50.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 55.15 110.848 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 25.0 m-20 -85.64 -35.19 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.749 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 18.3 m-85 -78.47 -15.03 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.326 0.584 . . . . 72.35 109.604 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.729 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.69 -31.34 12.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.217 -0.901 . . . . 60.31 110.16 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.29 -7.11 48.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 62.32 111.056 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.41 -51.43 36.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 73.53 110.791 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.65 22.68 5.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 63.51 112.35 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 1.2 pt -133.38 169.52 13.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 73.34 111.341 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 15.6 Cg_exo -65.84 134.25 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.595 2.196 . . . . 52.02 112.302 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.4 tt -98.16 125.86 43.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 71.5 110.774 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -101.79 92.2 4.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.021 -0.536 . . . . 55.44 111.408 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.885 ' CD2' HD22 ' A' ' 26' ' ' LEU . 57.6 m-85 -82.17 124.58 30.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.765 -0.652 . . . . 73.0 109.909 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.4 mt -116.52 83.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.767 -0.373 . . . . 72.45 111.604 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 4.6 m-85 -72.43 142.54 48.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.403 -0.591 . . . . 73.3 109.403 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.54 118.21 3.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.085 -0.507 . . . . 72.43 110.277 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 15.9 mt-10 -68.83 -14.02 62.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.686 -0.688 . . . . 74.3 110.144 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.38 130.29 42.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.221 0.534 . . . . 75.35 110.896 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.52 8.48 12.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.394 -0.821 . . . . 72.23 110.62 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -105.12 -49.69 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 60.31 110.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -96.08 18.96 12.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.791 -0.64 . . . . 71.43 111.011 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -28.05 37.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.763 0.316 . . . . 74.34 110.872 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -56.37 -46.44 80.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.44 110.48 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -62.35 -48.11 81.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 74.53 110.662 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.38 -60.6 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.145 0.498 . . . . 71.02 110.733 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.7 m -61.65 -23.79 66.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.942 -0.572 . . . . 74.35 111.39 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.5 t0 -62.65 -63.41 1.23 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.235 0.54 . . . . 72.21 109.76 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HZ2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -50.2 -30.15 10.9 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 123.411 1.577 . . . . 64.25 109.3 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.654 ' CD1' HG21 ' A' ' 29' ' ' ILE . 29.4 mt -77.05 -23.8 52.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.029 -1.896 . . . . 73.32 111.966 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.681 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 56.4 mmtt -63.9 -39.78 48.88 Favored Pre-proline 0 CA--C 1.52 -0.196 0 CA-C-N 115.926 -0.579 . . . . 63.11 111.505 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 42.6 Cg_endo -76.77 -49.08 0.11 Allowed 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.249 1.966 . . . . 74.43 111.111 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.739 HD11 ' CG2' ' A' ' 110' ' ' VAL . 1.1 tp -55.09 -27.54 19.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 119.099 -1.041 . . . . 64.11 109.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -92.4 -25.74 18.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.23 -0.441 . . . . 71.12 110.356 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -58.77 -23.78 60.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.357 -0.609 . . . . 72.15 109.357 178.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.95 -27.58 18.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.164 -0.926 . . . . 60.23 109.685 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.72 ' CD ' HD12 ' A' ' 55' ' ' ILE . 1.5 pt20 -129.45 50.55 2.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.787 -1.097 . . . . 74.32 110.586 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.2 ptt-85 -81.69 -28.01 33.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.226 -0.897 . . . . 72.21 111.087 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.56 14.1 27.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.599 -0.728 . . . . 71.44 112.399 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 51' ' ' GLN . 8.7 p -123.05 -41.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.578 0.228 . . . . 75.32 111.089 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.72 HD12 ' CD ' ' A' ' 51' ' ' GLN . 74.3 mt -111.37 139.6 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.364 -0.236 . . . . 65.24 110.364 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 16.1 m-80 -81.77 87.99 6.31 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.909 0.385 . . . . 73.32 110.555 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.639 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -73.59 102.78 3.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 74.21 111.193 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.33 130.41 6.02 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.928 -0.654 . . . . 71.14 112.756 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.4 p -91.1 140.79 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.24 111.137 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.4 tt -138.4 163.26 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.942 -0.572 . . . . 71.43 110.462 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' N ' HG12 ' A' ' 60' ' ' ILE . 32.8 t0 -88.34 118.83 28.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 74.25 112.103 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.952 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.64 2.58 32.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.576 -0.283 . . . . 43.25 110.985 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -103.21 -32.57 9.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.482 -0.326 . . . . 73.31 111.507 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 -29.89 6.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 73.03 110.759 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.876 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.33 -11.22 17.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.596 -0.729 . . . . 71.14 111.263 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.2 -34.62 0.08 OUTLIER Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.49 -0.386 . . . . 64.5 113.873 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.61 -24.3 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 74.02 110.261 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -88.77 -10.43 48.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.402 -0.817 . . . . 61.11 111.216 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 74' ' ' LEU . . . -72.53 -44.45 62.15 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.486 -0.325 . . . . 62.23 111.62 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -99.74 1.55 56.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.932 -1.127 . . . . 71.03 113.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -61.28 -9.39 5.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.484 -0.561 . . . . 50.32 109.484 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -116.47 -15.29 10.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.518 -0.765 . . . . 64.21 110.585 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.63 -69.55 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.99 0.424 . . . . 55.4 112.125 -178.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 69' ' ' ALA . 2.8 mt -42.74 172.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.555 -0.748 . . . . 74.44 111.781 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.558 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -110.36 -16.69 13.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.724 -0.671 . . . . 72.33 110.235 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.7 p 79.51 41.93 0.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.259 -1.015 . . . . 74.42 108.259 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.16 -50.15 5.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.047 -1.433 . . . . 72.34 111.471 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 46.2 tttt -133.42 161.74 33.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.988 -0.551 . . . . 44.04 110.965 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.952 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.44 173.17 5.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 72.2 111.351 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.98 163.81 25.56 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 123.596 -1.418 . . . . 54.2 112.895 0.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.32 162.69 30.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.831 -1.077 . . . . 75.13 109.485 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.495 ' HE2' HD11 ' A' ' 84' ' ' ILE . 57.0 t80 -138.53 127.93 24.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.736 0.303 . . . . 64.1 110.411 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -122.79 120.48 33.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.252 0.464 . . . . 75.54 112.252 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 93' ' ' PHE . 15.4 mt -103.51 95.1 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 70.34 110.56 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.64 141.38 28.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 73.21 111.034 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 38.1 mm-40 -108.01 110.21 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.42 111.011 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.729 HG11 ' O ' ' A' ' 20' ' ' MET . 7.3 t -79.63 -0.65 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 71.32 110.793 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.81 -43.04 8.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.274 -0.421 . . . . 73.15 110.876 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -116.48 -8.19 11.58 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.517 -0.31 . . . . 44.12 111.328 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 69.59 60.03 0.29 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.312 0.577 . . . . 71.24 109.481 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.533 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -114.74 179.1 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.84 . . . . 63.1 111.558 -178.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.57 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.92 92.15 2.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.419 -0.81 . . . . 75.52 111.159 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 71.0 m-85 -106.4 72.05 0.27 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.837 -0.62 . . . . 75.52 111.308 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 73.7 Cg_endo -80.71 -176.78 3.34 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.442 2.094 . . . . 54.45 112.927 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' PHE . 38.5 t80 -110.68 175.93 5.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.759 -0.655 . . . . 64.05 110.478 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -78.86 176.94 9.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 71.01 110.714 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 41.0 mt-30 -114.39 -19.09 11.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 62.53 111.326 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.1 16.94 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 72.43 110.91 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 2.5 tppp? -90.5 -14.54 32.48 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.059 -0.518 . . . . 71.05 111.376 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 23.3 tt0 88.81 112.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.283 0.563 . . . . 74.2 110.566 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 80' ' ' PRO . 6.1 mt -91.5 96.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 75.55 111.357 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.663 HG22 ' HZ2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -118.08 -154.19 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 72.03 109.385 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -94.07 -72.81 0.6 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.584 -0.895 . . . . 72.32 108.584 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.547 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.68 -32.6 0.6 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.058 0.456 . . . . 72.41 111.095 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.06 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.649 -0.705 . . . . 62.24 112.335 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 110' ' ' VAL . 26.1 mm -87.67 -49.09 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.559 -0.534 . . . . 74.42 109.559 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.6 pttt -52.78 -48.55 66.76 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.437 -0.801 . . . . 71.12 109.493 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.631 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.79 -51.95 54.79 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.913 -0.585 . . . . 73.42 110.525 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.84 ' O ' HD11 ' A' ' 118' ' ' ILE . 36.9 t80 -50.53 -63.03 1.25 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.192 -0.458 . . . . 73.22 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 106' ' ' ILE . 2.1 m -52.76 -45.02 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 62.44 110.209 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -52.06 -40.32 60.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.669 0.747 . . . . 40.15 109.113 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.7 t70 -61.33 -34.2 74.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.506 -1.225 . . . . 75.32 108.276 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.789 ' CB ' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -72.85 -66.48 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 73.22 110.922 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.554 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.6 p -55.05 -44.46 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.962 -1.017 . . . . 72.02 111.864 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' N ' HG13 ' A' ' 114' ' ' VAL . . . -58.41 -35.86 72.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 74.23 110.898 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.73 32.79 1.83 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 110.663 -0.975 . . . . 74.53 110.663 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.91 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -104.44 -54.01 2.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.688 -0.756 . . . . 64.42 111.852 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 109' ' ' PHE . 54.3 mt -63.31 159.11 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.765 0.317 . . . . 61.45 110.424 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.518 ' N ' HG22 ' A' ' 118' ' ' ILE . 16.4 pt-20 -146.24 154.29 49.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 65.14 110.753 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 123.056 2.504 . . . . 73.01 112.474 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.1 p90 . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.805 0.336 . . . . 71.45 111.109 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -26.94 32.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 55.15 110.903 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 13.3 m-20 -84.86 -37.09 21.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 72.5 110.64 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' O ' HG21 ' A' ' 87' ' ' VAL . 8.6 m-85 -78.87 -7.81 58.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.235 0.54 . . . . 72.35 109.864 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.424 ' CE ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.67 -29.74 10.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.308 -0.86 . . . . 60.31 110.259 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 t -98.54 -2.5 38.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.571 . . . . 62.32 111.166 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -72.35 -57.42 4.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.991 0.424 . . . . 73.53 110.885 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.41 22.17 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.988 -0.625 . . . . 63.51 112.291 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.55 162.51 57.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.573 0.225 . . . . 73.34 111.006 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 20.7 Cg_exo -61.38 137.56 70.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.399 2.066 . . . . 52.02 112.569 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.3 tt -96.66 126.48 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 71.5 110.357 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -100.63 90.79 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.161 -0.472 . . . . 55.44 111.512 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.825 ' CD2' HD22 ' A' ' 26' ' ' LEU . 65.7 m-85 -81.88 124.92 30.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 73.0 110.033 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 2.3 mt -117.99 83.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.797 -0.361 . . . . 72.45 111.669 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.829 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.2 m-85 -70.12 151.86 44.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.476 -0.564 . . . . 73.3 109.476 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -166.52 119.81 1.05 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.15 -0.477 . . . . 72.43 111.111 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 19.9 mt-10 -74.51 -10.67 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.783 -0.644 . . . . 74.3 109.624 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -78.68 110.44 13.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.634 . . . . 75.35 111.215 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.37 2.15 33.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 72.23 111.073 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.78 -35.52 4.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.165 -0.471 . . . . 60.31 111.061 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.86 20.23 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.43 111.216 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.42 72.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.331 . . . . 74.34 110.833 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -55.66 -40.82 72.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 62.44 110.688 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.52 -44.74 81.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 74.53 110.589 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.013 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.09 -62.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.704 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -55.85 -26.52 47.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 74.35 111.538 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' LYS . 2.7 t70 -63.64 -59.21 4.9 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.613 0.72 . . . . 72.21 109.706 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.9 -31.32 11.96 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.746 1.26 . . . . 64.25 108.742 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -81.47 -17.79 47.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.813 -1.54 . . . . 73.32 111.964 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -54.1 -42.77 95.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.944 -0.762 . . . . 63.11 108.944 178.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 9.9 Cg_endo -84.44 -39.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.636 2.224 . . . . 74.43 110.421 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 106' ' ' ILE . 45.6 mt -50.86 -20.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-N 116.173 -0.467 . . . . 64.11 109.965 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -113.44 -24.6 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.86 -0.609 . . . . 71.12 111.228 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.17 -20.46 58.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.17 0.51 . . . . 72.15 109.899 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.85 -27.1 17.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.791 0.805 . . . . 60.23 109.24 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.688 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -127.73 46.5 2.54 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.345 -1.298 . . . . 74.32 110.502 -178.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.1 ptt85 -80.0 -30.38 39.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.383 -0.826 . . . . 72.21 111.109 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.18 11.98 33.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.873 -0.68 . . . . 71.44 112.379 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.3 p -119.8 -35.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.496 0.189 . . . . 75.32 111.25 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.1 mt -123.46 146.2 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.512 -0.313 . . . . 65.24 110.696 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.46 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 8.6 m-80 -87.15 85.46 7.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.784 0.326 . . . . 73.32 110.171 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.763 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 3.6 m-85 -72.46 110.52 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.284 0.564 . . . . 74.21 111.552 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.92 124.35 2.67 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.304 -0.862 . . . . 71.14 112.2 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 80.0 p -83.2 155.82 23.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.029 0.443 . . . . 73.24 111.315 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 13.3 tt -150.98 163.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 71.43 110.206 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' N ' HG12 ' A' ' 60' ' ' ILE . 46.0 t0 -88.78 119.04 28.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.407 -0.361 . . . . 74.25 111.845 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.48 1.04 39.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.548 -0.296 . . . . 43.25 110.975 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.9 ttpt -101.67 -32.43 10.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.435 -0.348 . . . . 73.31 111.265 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.88 -29.96 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.105 0.478 . . . . 73.03 110.346 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -105.25 -15.02 15.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.789 . . . . 71.14 111.057 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -34.23 -36.61 0.06 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 114.1 0.4 . . . . 64.5 114.1 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.57 -19.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 74.02 110.582 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.41 -10.61 40.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 61.11 111.042 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.58 -51.53 34.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 120.858 0.361 . . . . 62.23 111.007 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.7 1.99 69.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.915 -1.135 . . . . 71.03 113.663 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.66 -10.24 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.332 0.566 . . . . 50.32 109.667 177.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -113.49 -17.21 12.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.631 -0.713 . . . . 64.21 109.998 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.683 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.1 m-20 -179.85 -68.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.46 0.541 . . . . 55.4 112.46 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.902 HD21 ' CB ' ' A' ' 94' ' ' PRO . 2.1 mm? -39.85 168.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.24 -0.891 . . . . 74.44 112.241 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -110.14 -4.49 15.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.826 -0.625 . . . . 72.33 111.06 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 p 58.69 36.85 25.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.01 0.433 . . . . 74.42 110.199 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -84.13 -32.0 24.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.825 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -148.74 163.19 38.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 44.04 110.23 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.45 174.37 3.91 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.897 -0.592 . . . . 72.2 111.215 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.755 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.01 166.74 15.9 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.792 -1.337 . . . . 54.2 113.019 0.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 164.82 27.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.051 -0.977 . . . . 75.13 110.143 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HZ ' ' HB1' ' A' ' 27' ' ' ALA . 1.8 t80 -141.98 133.81 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 64.1 111.49 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -126.41 116.17 20.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 75.54 110.949 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 93' ' ' PHE . 22.9 mt -99.91 90.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 70.34 110.342 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' LEU . 3.0 tm0? -78.95 144.87 34.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 73.21 111.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.7 mt-10 -110.64 111.54 22.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.065 -0.516 . . . . 74.42 110.637 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' VAL . 26.4 t -82.39 9.43 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.726 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.96 -42.86 5.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.257 -0.428 . . . . 73.15 110.314 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.9 mmtt -114.15 -12.41 12.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.278 -0.419 . . . . 44.12 110.912 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 10.5 t-20 79.53 22.83 0.52 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.356 0.598 . . . . 71.24 109.688 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.575 HE21 ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -82.2 167.74 18.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.158 -0.928 . . . . 63.1 111.53 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.575 ' H ' HE21 ' A' ' 91' ' ' GLN . 0.9 OUTLIER -139.2 101.06 4.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.381 -0.827 . . . . 75.52 111.111 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.679 ' O ' HD12 ' A' ' 84' ' ' ILE . 76.8 m-85 -103.55 74.33 0.2 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.928 -0.578 . . . . 75.52 110.899 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.902 ' CB ' HD21 ' A' ' 74' ' ' LEU . 56.5 Cg_endo -80.8 165.29 20.05 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.795 2.33 . . . . 54.45 113.126 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.431 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 35.7 t80 -95.94 173.29 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.745 -0.661 . . . . 64.05 110.573 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -75.84 177.95 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 71.01 110.986 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -112.08 -20.92 11.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.199 -0.455 . . . . 62.53 111.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.83 24.06 4.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.919 0.39 . . . . 72.43 111.069 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -94.4 -11.81 29.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.981 -0.554 . . . . 71.05 111.191 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.5 tt0 91.02 106.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.9 -0.591 . . . . 74.2 110.661 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 80' ' ' PRO . 7.1 mt -91.73 96.92 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.269 -0.878 . . . . 75.55 111.495 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -121.63 -164.89 1.18 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.226 -0.657 . . . . 72.03 109.226 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.919 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -78.22 -71.43 0.43 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.471 -0.566 . . . . 72.32 109.471 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.585 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.83 -37.72 1.91 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.969 -1.014 . . . . 72.41 111.645 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -72.68 -35.84 67.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.698 -1.137 . . . . 62.24 113.202 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 47' ' ' ILE . 27.8 mm -89.48 -49.07 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.674 -0.491 . . . . 74.42 109.674 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.834 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.92 -43.91 60.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.803 -0.635 . . . . 71.12 109.633 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.95 -49.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.679 -0.691 . . . . 73.42 110.202 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.808 ' O ' HD11 ' A' ' 118' ' ' ILE . 21.1 t80 -49.15 -64.13 0.9 Allowed 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.699 -0.482 . . . . 73.22 109.699 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 111' ' ' ASP . 17.7 m -51.05 -43.09 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 62.44 109.954 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.2 t0 -50.83 -41.19 57.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.438 0.637 . . . . 40.15 109.954 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.925 ' OD1' ' N ' ' A' ' 118' ' ' ILE . 3.2 t0 -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.944 -1.025 . . . . 75.32 108.795 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.924 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.3 t80 -72.6 -67.02 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.191 -0.913 . . . . 73.22 110.343 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.561 HG22 HD11 ' A' ' 55' ' ' ILE . 17.5 t -49.93 -48.32 22.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.934 . . . . 72.02 111.491 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.41 -38.77 63.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 74.23 110.606 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.49 29.98 2.34 Favored Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 110.709 -0.956 . . . . 74.53 110.709 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.804 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.15 -49.21 3.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.917 -0.641 . . . . 64.42 111.661 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.925 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 29.1 mt -63.46 146.84 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.762 -0.458 . . . . 61.45 109.762 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -136.02 171.0 9.53 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 65.14 110.948 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 C--N 1.345 0.348 0 C-N-CA 122.497 2.131 . . . . 73.01 112.319 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.707 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.461 -0.256 . . . . 62.4 112.461 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.18 152.32 19.44 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.666 2.244 . . . . 75.21 112.262 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -148.41 30.94 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 61.53 110.898 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.54 -136.07 8.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.771 -0.728 . . . . 51.52 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.8 m -131.83 145.45 57.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.703 0.287 . . . . 54.5 110.928 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.21 134.55 19.41 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.563 2.176 . . . . 64.33 112.36 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -146.34 -74.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.887 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.812 HG23 ' HB3' ' A' ' 57' ' ' PHE . 83.4 mt -94.93 130.86 43.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.915 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.07 -118.47 0.82 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.68 -0.771 . . . . 73.43 112.2 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.92 136.11 40.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.749 0.309 . . . . 73.31 110.651 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.722 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 65.3 mt -90.67 128.01 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 71.32 110.972 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.6 -165.01 12.06 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 74.33 112.608 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.0 -25.43 14.06 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.647 2.231 . . . . 63.4 112.534 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.54 1.4 46.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 51.21 111.504 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 p -104.23 -28.94 11.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.843 0.354 . . . . 72.42 110.744 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -54.54 43.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 71.45 110.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 t -69.03 -23.53 64.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 55.15 111.5 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 9.8 t70 -74.72 -38.71 62.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.084 0.468 . . . . 72.5 110.855 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 22.0 m-85 -80.28 -22.98 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.336 0.588 . . . . 72.35 109.743 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.673 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.4 -33.24 22.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.287 -0.87 . . . . 60.31 110.276 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -88.81 -12.97 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 62.32 110.617 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -63.79 -36.69 84.73 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.41 -0.359 . . . . 73.53 111.078 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.57 20.54 29.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.82 -0.705 . . . . 63.51 112.676 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.428 HD11 ' OD1' ' A' ' 56' ' ' ASN . 1.4 pt -135.38 148.62 66.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 73.34 111.02 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HB2' HG12 ' A' ' 55' ' ' ILE . 48.2 Cg_exo -47.07 140.17 14.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.533 2.155 . . . . 52.02 112.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' CE2' ' A' ' 28' ' ' TYR . 2.4 tt -102.5 123.19 45.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 71.5 110.645 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -98.62 93.32 6.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.878 -0.601 . . . . 55.44 111.282 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.75 ' CE2' HD22 ' A' ' 26' ' ' LEU . 63.5 m-85 -81.98 140.17 34.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.835 -0.621 . . . . 73.0 110.485 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -132.3 85.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.468 -0.333 . . . . 72.45 111.467 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.837 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 3.8 m-85 -73.08 148.6 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.671 -0.492 . . . . 73.3 109.671 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -162.95 119.84 1.9 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.179 -0.464 . . . . 72.43 111.118 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 32.2 mt-10 -73.87 -9.46 58.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.583 -0.735 . . . . 74.3 110.116 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -99.97 99.89 10.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.479 . . . . 75.35 111.129 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.82 12.22 22.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 72.23 111.226 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 -45.32 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.435 -0.348 . . . . 60.31 110.833 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -96.39 13.88 26.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.369 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -40.77 -31.54 0.17 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.529 -0.305 . . . . 74.34 111.77 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.37 85.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 62.44 111.197 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -57.31 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 74.53 111.242 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -58.3 -56.38 22.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.106 0.479 . . . . 71.02 110.854 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 10.3 m -58.11 -22.44 50.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.764 . . . . 74.35 112.14 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -70.18 -61.29 1.83 Allowed 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.636 0.731 . . . . 72.21 109.233 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' C ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.55 -29.41 16.93 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 122.884 1.326 . . . . 64.25 108.707 177.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.872 HD23 HD12 ' A' ' 47' ' ' ILE . 24.2 mt -77.96 -25.05 47.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.435 -1.711 . . . . 73.32 111.346 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -51.32 -45.87 89.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.435 -0.802 . . . . 63.11 109.835 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 18.2 Cg_endo -82.3 -38.7 0.18 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.516 2.144 . . . . 74.43 110.646 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 HD23 ' A' ' 44' ' ' LEU . 57.0 mt -51.24 -21.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.426 0 CA-C-N 116.086 -0.506 . . . . 64.11 110.48 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -112.75 -25.84 8.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 71.12 111.249 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -61.56 -19.44 62.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.215 0.531 . . . . 72.15 109.841 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.6 -27.69 17.99 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.394 -0.821 . . . . 60.23 109.461 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.71 ' HA ' HG12 ' A' ' 54' ' ' VAL . 1.2 pt20 -124.49 41.01 3.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.405 -1.27 . . . . 74.32 110.621 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.6 ptt85 -70.85 -32.79 69.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.465 -0.788 . . . . 72.21 111.06 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.47 12.22 39.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 71.44 112.738 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.9 p -125.67 -27.82 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.777 0.288 . . . . 75.32 111.777 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' CD ' ' A' ' 51' ' ' GLN . 70.0 mt -133.18 140.57 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.574 0.226 . . . . 65.24 110.636 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -90.94 97.22 11.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.789 0.328 . . . . 73.32 111.012 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.812 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -77.85 113.64 15.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 74.21 111.515 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.722 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -135.9 126.73 3.99 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.549 -0.75 . . . . 71.14 112.131 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 11.5 p -86.1 148.02 25.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 73.24 111.068 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.921 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.0 tt -145.7 163.47 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 71.43 110.653 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.9 t0 -87.05 119.79 27.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 74.25 112.014 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.961 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.43 2.15 38.02 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.702 0.287 . . . . 43.25 110.903 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 18.3 tptm -102.1 -33.04 9.84 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.47 -0.332 . . . . 73.31 111.7 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.32 -31.98 6.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.172 0.511 . . . . 73.03 110.457 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.921 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.35 -16.06 17.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 71.14 111.07 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.96 -38.88 0.03 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 114.441 0.537 . . . . 64.5 114.441 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.62 -25.86 11.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.279 0.54 . . . . 74.02 110.379 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -85.78 -12.5 50.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 61.11 111.546 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.89 -42.19 73.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.685 0.278 . . . . 62.23 111.269 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.06 0.17 47.89 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.084 -1.055 . . . . 71.03 113.489 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -60.0 -11.02 4.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.376 -0.601 . . . . 50.32 109.376 177.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.65 -16.01 12.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.396 -0.82 . . . . 64.21 110.441 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.746 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -177.7 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.074 0.464 . . . . 55.4 112.228 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.716 HD22 ' CD ' ' A' ' 97' ' ' GLN . 87.9 mt -41.43 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.405 -0.816 . . . . 74.44 112.557 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -118.85 4.48 11.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.276 -0.875 . . . . 72.33 110.467 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' ' 67' ' ' ALA . 5.5 p 58.21 32.61 22.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.516 . . . . 74.42 110.715 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 16.0 p-10 -82.17 -31.41 30.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.327 -0.397 . . . . 72.34 111.384 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 7.2 tttt -147.61 161.61 40.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 44.04 111.256 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.961 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -157.39 170.2 9.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.544 -0.753 . . . . 72.2 111.258 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.76 160.0 44.9 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 123.538 -1.443 . . . . 54.2 113.237 0.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.32 165.59 20.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.198 -0.91 . . . . 75.13 110.006 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 29' ' ' ILE . 5.3 t80 -139.23 128.37 23.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.797 0.332 . . . . 64.1 110.878 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -120.33 145.93 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 75.54 111.702 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.889 HG22 ' OE2' ' A' ' 86' ' ' GLU . 57.7 mt -123.26 86.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 70.34 110.082 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.84 125.96 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 73.21 111.187 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.889 ' OE2' HG22 ' A' ' 84' ' ' ILE . 9.8 mp0 -95.32 117.69 30.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.479 . . . . 74.42 110.841 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -84.54 4.92 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.009 -0.541 . . . . 71.32 111.328 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.37 -41.64 5.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 73.15 110.793 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -15.32 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 44.12 110.957 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 78.08 32.68 0.36 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.527 0.68 . . . . 71.24 109.559 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.493 ' H ' ' HB2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -95.14 166.57 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.928 -1.033 . . . . 63.1 111.254 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 6.8 mmtm -142.6 97.14 3.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.553 -0.749 . . . . 75.52 110.92 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.626 ' O ' HD12 ' A' ' 84' ' ' ILE . 17.2 m-85 -102.63 75.6 0.19 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.593 -0.73 . . . . 75.52 111.002 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 84.7 Cg_endo -78.35 -176.13 3.09 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 54.45 112.638 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -107.08 169.97 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 64.05 110.789 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.32 160.02 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 71.01 111.179 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.716 ' CD ' HD22 ' A' ' 74' ' ' LEU . 4.1 mp0 -117.47 26.86 9.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 62.53 110.902 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -157.63 23.64 0.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 72.43 110.602 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -113.32 -68.13 0.95 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.845 -0.616 . . . . 71.05 110.954 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 1.7 tt0 159.86 118.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.902 -0.59 . . . . 74.2 109.808 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.23 89.2 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 75.55 111.584 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -117.14 -155.94 0.61 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.809 -0.812 . . . . 72.03 108.809 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -89.88 -73.65 0.51 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.755 -0.831 . . . . 72.32 108.755 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.51 -34.16 0.21 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 72.41 111.86 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.97 -38.03 61.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 62.24 112.432 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.651 ' HB ' HD13 ' A' ' 47' ' ' ILE . 41.0 mm -88.14 -47.91 15.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.757 -0.46 . . . . 74.42 109.757 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -54.44 -45.37 73.06 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.739 -0.664 . . . . 71.12 109.695 178.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -69.8 -48.0 60.75 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.953 -0.567 . . . . 73.42 110.156 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 118' ' ' ILE . 18.4 t80 -52.38 -67.08 0.28 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.077 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.66 HG12 HD11 ' A' ' 84' ' ' ILE . 19.3 m -47.67 -40.14 7.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 62.44 109.966 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -56.96 -42.34 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.381 -0.827 . . . . 40.15 110.215 178.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.859 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -74.65 -14.58 60.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.652 -0.703 . . . . 75.32 110.014 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -81.04 -61.29 2.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.558 -0.746 . . . . 73.22 108.997 178.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.477 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 21.9 t -55.77 -46.41 79.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.658 -1.155 . . . . 72.02 110.879 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.94 64.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 74.23 110.782 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.96 30.29 1.65 Allowed Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.578 -0.82 . . . . 74.53 111.663 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -101.81 -38.65 7.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.397 -0.402 . . . . 64.42 111.417 -179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.976 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.2 mt -85.75 151.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.897 0.38 . . . . 61.45 110.628 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -145.15 173.94 3.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.947 -0.57 . . . . 65.14 111.274 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -50.97 145.08 25.75 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.598 2.198 . . . . 73.01 112.36 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.8 t -110.05 -43.67 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.44 111.044 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -31.3 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.177 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.531 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.82 100.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 73.04 110.703 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -150.36 87.86 4.81 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 72.43 110.376 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 160.92 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.522 2.148 . . . . 54.23 112.566 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.8 mm -114.25 88.15 14.7 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.492 . . . . 72.11 111.307 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 129' ' ' GLU . 53.1 Cg_exo -54.9 -158.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.89 2.393 . . . . 63.51 112.384 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER 79.27 -165.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.022 -0.536 . . . . 71.14 110.84 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -46.3 -26.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 74.35 111.761 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -91.12 160.22 15.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.645 . . . . 73.21 110.67 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 58.94 164.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 63.45 110.872 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.34 -1.256 . . . . 73.11 112.493 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.453 -0.259 . . . . 62.4 112.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.511 ' C ' HD12 ' A' ' 3' ' ' LEU . 54.1 Cg_exo -51.93 -61.59 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.58 2.187 . . . . 75.21 112.343 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 2' ' ' PRO . 3.2 mp -151.78 -65.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 61.53 110.885 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.41 -92.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 51.52 112.471 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 1.2 m -179.12 -61.29 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.639 0.257 . . . . 54.5 110.926 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 5' ' ' SER . 58.6 Cg_endo -71.82 105.19 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.46 2.106 . . . . 64.33 112.298 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.59 -60.1 2.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 63.43 110.957 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 57' ' ' PHE . 55.8 mt -95.98 126.36 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 74.44 111.091 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.16 -123.67 0.81 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.03 -1.081 . . . . 73.43 113.16 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.97 130.79 56.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.383 . . . . 73.31 110.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.736 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 30.2 mt -85.99 141.02 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.02 -0.536 . . . . 71.32 111.39 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.8 -178.1 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 74.33 112.416 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.44 -6.34 18.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.617 2.212 . . . . 63.4 112.71 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.59 28.62 3.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.795 0.331 . . . . 51.21 111.1 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.9 p -124.83 -38.98 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 72.42 110.939 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 17' ' ' SER . 17.0 p90 -52.61 -32.31 40.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 71.45 111.177 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.449 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m -53.98 -25.95 23.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 55.15 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.8 -38.54 18.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.02 0.438 . . . . 72.5 110.635 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 26.5 m-85 -78.08 -6.26 54.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 72.35 109.898 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.638 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.62 -54.42 3.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 60.31 110.045 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -17.35 64.23 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.85 -0.614 . . . . 62.32 110.919 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.74 -31.78 58.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.901 0.382 . . . . 73.53 111.021 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.38 5.99 64.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.935 -0.65 . . . . 63.51 112.596 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.62 156.41 53.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 73.34 110.989 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.95 142.74 96.73 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 52.02 112.594 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.2 tt -103.34 137.62 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 71.5 110.808 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -110.15 97.13 6.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.106 -0.497 . . . . 55.44 111.112 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.795 ' CD2' HD22 ' A' ' 26' ' ' LEU . 40.4 m-85 -85.99 127.47 34.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 73.0 109.985 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mt -121.51 83.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.13 0.419 . . . . 72.45 112.13 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.785 ' HA ' HG23 ' A' ' 60' ' ' ILE . 2.8 m-85 -71.96 144.43 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.959 -0.756 . . . . 73.3 108.959 177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -155.1 117.37 4.21 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.43 111.082 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -80.17 -6.34 57.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.298 -0.865 . . . . 74.3 110.163 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.9 p -84.7 104.87 15.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 75.35 111.059 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.4 16.78 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 72.23 111.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -123.61 -42.05 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 60.31 110.778 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' ARG . 2.8 pt-20 -99.7 -8.85 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 71.43 111.574 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 36' ' ' GLU . 1.6 ptp180 -31.31 -40.47 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.366 0.506 . . . . 74.34 112.366 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -54.51 -51.5 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.965 0.412 . . . . 62.44 110.844 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.6 mt-10 -60.18 -36.75 78.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 74.53 110.963 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -63.52 -50.59 68.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 71.02 110.779 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' HD12 ' A' ' 44' ' ' LEU . 51.1 m -65.17 -22.51 66.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 74.35 111.242 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 3.7 t70 -66.81 -61.2 2.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.582 0.706 . . . . 72.21 109.105 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.899 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.05 -31.69 13.65 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.662 1.22 . . . . 64.25 108.991 177.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 29' ' ' ILE . 22.2 mt -76.48 -25.61 54.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.378 -1.737 . . . . 73.32 111.475 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 9.7 ttmm -51.6 -45.65 91.11 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.395 -0.82 . . . . 63.11 110.375 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 15.5 Cg_endo -83.76 -40.1 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.713 2.275 . . . . 74.43 111.649 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -54.92 -18.65 3.41 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.984 -0.686 . . . . 64.11 109.87 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.687 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -107.29 -30.82 8.5 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.813 -0.631 . . . . 71.12 111.213 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -60.83 -19.8 60.47 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.237 0.541 . . . . 72.15 109.888 178.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.2 -26.79 24.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.916 0.865 . . . . 60.23 109.029 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.7 pt20 -125.78 38.44 4.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.029 -1.441 . . . . 74.32 110.217 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -75.35 -25.21 57.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.446 -0.797 . . . . 72.21 110.992 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.78 20.16 20.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.811 -0.709 . . . . 71.44 112.137 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 51' ' ' GLN . 9.9 p -133.78 -37.51 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.65 0.262 . . . . 75.32 111.262 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 27' ' ' ALA . 43.6 mt -120.93 138.79 50.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 65.24 110.863 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-80 -82.85 109.09 16.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.858 0.361 . . . . 73.32 110.324 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.834 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -80.94 119.86 24.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.644 0.735 . . . . 74.21 112.843 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.736 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -146.24 122.98 1.74 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.907 -1.042 . . . . 71.14 111.911 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -89.81 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 73.24 111.059 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.891 HD11 ' CG ' ' A' ' 65' ' ' PHE . 14.0 tt -141.9 164.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.43 110.699 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 60' ' ' ILE . 35.8 t0 -90.34 122.84 33.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.888 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.87 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.49 6.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.71 0.291 . . . . 43.25 110.711 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 22.5 tptp -106.31 -32.82 7.99 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.349 -0.387 . . . . 73.31 111.559 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.38 -31.21 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.148 0.499 . . . . 73.03 110.731 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.77 -12.97 17.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.543 -0.753 . . . . 71.14 111.311 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -35.39 -33.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 N-CA-C 114.027 0.371 . . . . 64.5 114.027 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -12.21 4.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.061 0.458 . . . . 74.02 110.617 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -102.59 -6.79 22.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.66 -0.7 . . . . 61.11 110.971 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.1 -54.99 9.18 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.763 0.316 . . . . 62.23 110.963 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.39 7.5 75.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.916 -1.135 . . . . 71.03 113.738 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -8.74 15.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.02 -0.733 . . . . 50.32 109.02 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.2 -14.82 12.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.228 -0.896 . . . . 64.21 110.335 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.91 -69.91 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.261 0.553 . . . . 55.4 112.298 -178.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.855 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.2 mm? -40.31 170.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.092 -0.958 . . . . 74.44 112.419 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -110.01 -6.24 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 72.33 111.046 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 p 61.75 40.19 13.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.609 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.77 -33.01 16.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 72.34 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -149.51 163.25 38.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.111 -0.495 . . . . 44.04 110.427 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.87 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -153.34 177.45 1.96 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 72.2 111.126 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.619 ' O ' HD11 ' A' ' 101' ' ' ILE . 35.0 Cg_exo -57.54 158.22 29.27 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.022 -1.241 . . . . 54.2 112.781 1.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.4 128.87 46.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.234 -0.894 . . . . 75.13 110.226 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 84' ' ' ILE . 49.5 t80 -108.65 117.83 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.654 -0.248 . . . . 64.1 110.437 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -118.18 132.85 56.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.35 0.5 . . . . 75.54 112.35 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.715 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 25.6 mm -100.88 140.6 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 70.34 109.973 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -128.24 129.52 46.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.985 0.421 . . . . 73.21 110.842 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 1.2 mt-10 -105.08 112.72 25.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 74.42 110.198 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 20' ' ' MET . 35.1 m -78.86 -0.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 71.32 111.708 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.73 -44.33 6.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 73.15 110.692 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.84 -7.23 14.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 44.12 111.413 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 68.96 24.87 6.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.09 0.471 . . . . 71.24 110.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -75.37 169.51 17.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.731 -0.668 . . . . 63.1 111.541 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 1.3 mptt -139.94 95.37 2.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.179 -0.919 . . . . 75.52 110.756 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 68.1 m-85 -103.52 71.41 0.15 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.685 -0.689 . . . . 75.52 111.277 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.855 ' CB ' HD21 ' A' ' 74' ' ' LEU . 67.4 Cg_endo -79.12 -175.5 2.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.667 2.245 . . . . 54.45 113.608 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 82' ' ' PHE . 25.0 t80 -112.02 175.16 5.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 64.05 110.578 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.502 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 3.0 m-20 -78.76 174.98 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 71.01 110.882 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 3.5 mt-30 -114.64 -11.99 12.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 62.53 111.297 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.63 5.25 5.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 72.43 111.041 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 1.8 tppt? -86.17 -6.05 59.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.097 -0.501 . . . . 71.05 111.294 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 32.6 tt0 81.9 132.22 0.05 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.174 0.512 . . . . 74.2 111.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.619 HD11 ' O ' ' A' ' 80' ' ' PRO . 3.0 mp -109.02 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 75.55 110.905 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -113.41 -148.17 0.43 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 72.03 109.095 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.661 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -96.66 -70.81 0.7 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.97 -0.752 . . . . 72.32 108.97 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.624 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.11 -31.54 1.44 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.811 -0.631 . . . . 72.41 111.374 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -74.96 -33.0 61.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.688 -0.687 . . . . 62.24 111.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.815 ' O ' HG13 ' A' ' 110' ' ' VAL . 44.2 mm -91.22 -45.71 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.965 0.412 . . . . 74.42 110.39 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.0 -42.22 93.76 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.86 -0.609 . . . . 71.12 109.414 178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -71.22 -50.73 29.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 73.42 110.244 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.727 ' CE1' HD13 ' A' ' 118' ' ' ILE . 40.6 t80 -51.72 -63.77 1.03 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.467 -0.333 . . . . 73.22 110.261 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.5 m -49.14 -44.15 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 62.44 110.042 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -54.45 -40.67 68.61 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.783 0.802 . . . . 40.15 109.009 178.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.918 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 16.4 t70 -61.53 -34.86 76.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.326 -1.306 . . . . 75.32 108.336 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.796 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -72.86 -66.86 0.61 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 73.22 110.902 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.558 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.8 t -54.85 -45.21 74.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.22 -0.9 . . . . 72.02 111.994 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.44 70.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.856 0.36 . . . . 74.23 111.154 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.68 31.3 1.82 Allowed Glycine 0 CA--C 1.507 -0.425 0 N-CA-C 111.06 -0.816 . . . . 74.53 111.06 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.918 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.43 -57.12 2.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.878 -0.661 . . . . 64.42 111.505 -178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.796 HD12 ' HB2' ' A' ' 113' ' ' PHE . 44.7 mt -64.27 151.1 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.789 -0.448 . . . . 61.45 109.789 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.32 163.96 36.25 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.357 -0.383 . . . . 65.14 111.542 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.83 155.07 71.2 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.815 2.344 . . . . 73.01 112.519 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.37 -71.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.997 -0.547 . . . . 64.44 110.676 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -106.69 -44.07 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.42 111.014 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER 33.89 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.913 -0.585 . . . . 74.34 112.201 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -85.35 72.42 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.759 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -148.41 86.33 5.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 72.43 110.45 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.61 153.39 23.35 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.556 2.17 . . . . 54.23 112.517 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.17 83.38 24.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.956 -0.566 . . . . 72.11 111.003 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.95 -169.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.569 2.179 . . . . 63.51 112.039 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 60.38 69.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 71.14 110.604 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 154.03 8.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 74.35 111.18 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.32 176.35 3.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.514 . . . . 73.21 110.811 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -109.61 -45.31 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.335 -0.393 . . . . 63.45 110.95 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.308 -1.274 . . . . 73.11 112.553 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.456 -0.257 . . . . 62.4 112.456 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -51.48 161.85 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.586 2.191 . . . . 75.21 112.359 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.69 -70.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 61.53 110.94 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -151.74 17.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 51.52 112.563 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p -103.81 93.78 5.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.663 0.268 . . . . 54.5 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.61 ' C ' HD12 ' A' ' 7' ' ' LEU . 46.1 Cg_endo -68.39 161.28 45.52 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.519 2.146 . . . . 64.33 112.388 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 6' ' ' PRO . 5.7 mp -117.02 -49.18 2.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.845 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.608 ' HB ' ' CB ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -72.36 154.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 74.44 110.949 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' O ' HG23 ' A' ' 59' ' ' THR . . . 156.39 -71.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.413 -0.898 . . . . 73.43 112.242 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -124.49 134.88 52.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.545 -0.328 . . . . 73.31 110.256 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.846 HD11 ' O ' ' A' ' 58' ' ' GLY . 1.8 mt -88.7 140.0 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.766 0.317 . . . . 71.32 111.019 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.12 172.68 23.64 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.42 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.57 -20.54 57.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.692 2.261 . . . . 63.4 112.436 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.06 28.58 8.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.379 . . . . 51.21 110.859 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.405 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 6.9 p -131.21 -39.46 1.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 72.42 111.048 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 17.6 m-85 -45.18 -63.57 0.91 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.056 0.455 . . . . 71.45 111.383 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -51.53 -34.44 36.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.797 -0.638 . . . . 55.15 111.422 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -70.86 -39.12 73.08 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.147 0.499 . . . . 72.5 110.725 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 18.0 m-85 -77.39 -9.19 58.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.804 -0.634 . . . . 72.35 109.678 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.768 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -99.97 -30.48 11.97 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.47 -0.787 . . . . 60.31 110.131 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 p -83.36 -17.93 40.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.685 -0.689 . . . . 62.32 110.572 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.7 -14.21 41.43 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.275 -0.42 . . . . 73.53 111.602 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.93 14.12 65.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.737 -0.744 . . . . 63.51 112.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 HD11 ' OD1' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -123.99 158.79 59.13 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.772 0.32 . . . . 73.34 111.246 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HG2' HG12 ' A' ' 55' ' ' ILE . 26.7 Cg_endo -62.38 138.15 69.5 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 52.02 112.758 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 28' ' ' TYR . 1.5 tt -93.12 136.41 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 71.5 110.833 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.813 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -105.95 89.43 3.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 55.44 111.001 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.909 ' CE1' HD22 ' A' ' 26' ' ' LEU . 70.0 m-85 -81.19 136.6 35.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 73.0 110.404 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 44' ' ' LEU . 2.5 mp -131.53 89.39 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.855 0.359 . . . . 72.45 111.518 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.855 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.1 m-85 -70.88 149.18 47.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.303 -0.629 . . . . 73.3 109.303 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.644 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.73 119.07 2.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.233 0.54 . . . . 72.43 111.269 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 20.9 mt-10 -76.0 -7.23 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 74.3 109.972 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.6 p -76.53 123.44 26.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.209 -0.451 . . . . 75.35 110.848 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.12 9.52 18.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 72.23 111.087 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -50.43 2.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.404 -0.362 . . . . 60.31 110.735 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.69 15.04 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 71.43 111.196 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -49.1 -28.45 4.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.813 0.34 . . . . 74.34 111.104 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.32 73.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.419 . . . . 62.44 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 2.2 mm-40 -61.45 -48.91 79.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.736 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -58.45 -47.34 84.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 71.02 110.652 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 44' ' ' LEU . 67.0 m -67.17 -20.69 65.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.35 111.218 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 15.6 t0 -67.68 -60.6 2.41 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 72.21 108.946 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.662 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.48 -33.64 9.76 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.65 1.214 . . . . 64.25 108.633 177.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.086 HD11 HG21 ' A' ' 29' ' ' ILE . 25.9 mt -75.22 -25.95 58.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.317 -1.765 . . . . 73.32 112.188 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 3.4 mmpt? -51.44 -45.47 90.32 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 63.11 110.285 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.6 Cg_endo -83.26 -38.54 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.546 2.164 . . . . 74.43 111.13 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.062 HG21 HG22 ' A' ' 106' ' ' ILE . 24.0 mt -53.85 -17.35 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.396 0 CA-C-N 116.367 -0.379 . . . . 64.11 110.14 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.784 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -114.98 -25.34 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.52 . . . . 71.12 111.151 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -64.91 -18.94 65.65 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.939 0.4 . . . . 72.15 110.669 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . . . -93.67 -9.95 36.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.8 0.81 . . . . 60.23 109.377 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.749 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -136.67 27.62 3.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.221 -1.354 . . . . 74.32 110.885 -176.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.5 ptt180 -61.4 -33.24 73.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.586 -0.734 . . . . 72.21 111.156 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.33 9.02 45.22 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.738 -0.744 . . . . 71.44 112.811 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 51' ' ' GLN . 10.3 p -122.35 -29.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.78 0.29 . . . . 75.32 111.609 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.813 HG21 ' HB2' ' A' ' 27' ' ' ALA . 79.7 mt -131.87 141.35 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 65.24 110.807 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -94.61 94.83 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 73.32 110.063 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.23 134.76 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 74.21 111.641 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.846 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -153.87 113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.787 -1.097 . . . . 71.14 111.86 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 9' ' ' GLY . 81.3 p -80.87 150.14 29.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 73.24 110.316 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.901 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.2 tt -147.4 163.27 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.105 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 45.0 t0 -84.01 119.78 25.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.123 -0.49 . . . . 74.25 111.909 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.0 27.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.696 0.284 . . . . 43.25 110.859 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.2 ttpt -106.25 -31.88 8.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.548 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.95 -32.27 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 73.03 110.638 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.901 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.95 -12.4 18.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.518 -0.764 . . . . 71.14 111.404 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 76' ' ' THR . . . -33.57 -36.54 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.208 0.443 . . . . 64.5 114.208 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.17 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 74.02 110.448 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -89.21 -11.63 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.482 -0.781 . . . . 61.11 111.461 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.65 -44.12 57.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 111.76 0.281 . . . . 62.23 111.76 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.477 ' CA ' ' HB2' ' A' ' 74' ' ' LEU . . . -103.4 1.39 46.47 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.991 -1.099 . . . . 71.03 113.752 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -8.81 9.44 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.187 -0.671 . . . . 50.32 109.187 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -114.65 -15.81 11.91 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.405 -0.816 . . . . 64.21 110.325 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.36 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.155 0.502 . . . . 55.4 112.022 -178.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.511 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 74.9 mt -44.88 178.82 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.275 -0.875 . . . . 74.44 112.168 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 5.25 8.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.61 -0.723 . . . . 72.33 110.597 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 66' ' ' GLY . 4.4 p 59.06 36.86 24.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.694 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.75 -36.49 15.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 72.34 111.27 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 97' ' ' GLN . 0.2 OUTLIER -137.31 161.18 36.96 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.123 0.487 . . . . 44.04 110.746 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -159.44 169.04 11.09 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.738 -0.665 . . . . 72.2 111.607 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 19.6 Cg_endo -60.8 161.87 40.47 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.395 -1.502 . . . . 54.2 113.12 0.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -128.12 161.17 29.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.478 -0.783 . . . . 75.13 110.038 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.4 t80 -132.3 123.39 26.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.67 0.272 . . . . 64.1 111.198 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -121.34 111.85 17.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 75.54 111.738 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 93' ' ' PHE . 6.8 mt -100.78 96.84 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.729 0.3 . . . . 70.34 110.822 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -89.6 147.8 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.474 -0.33 . . . . 73.21 110.584 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 8.7 mt-10 -106.69 114.15 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.361 -0.381 . . . . 74.42 110.851 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 20' ' ' MET . 13.1 t -79.8 0.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 71.32 110.968 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.46 -42.62 8.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.4 -0.364 . . . . 73.15 110.914 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.55 -7.88 10.54 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.487 -0.324 . . . . 44.12 111.454 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.53 62.19 0.21 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.413 -0.588 . . . . 71.24 109.413 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 1.3 tp60 -114.15 173.74 6.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.33 -0.85 . . . . 63.1 111.575 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.638 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -137.27 92.53 2.72 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.416 -0.811 . . . . 75.52 110.807 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.765 ' O ' HD12 ' A' ' 84' ' ' ILE . 93.1 m-85 -104.77 68.7 0.16 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.638 -0.71 . . . . 75.52 111.314 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 76.5 Cg_endo -78.93 -175.58 2.83 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.263 1.975 . . . . 54.45 112.589 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 41.6 t80 -109.37 170.4 8.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.05 111.104 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.6 m-20 -76.37 170.48 16.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 71.01 110.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 7.2 mt-30 -119.83 27.29 8.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 62.53 110.746 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -165.12 26.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.501 . . . . 72.43 110.662 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 10.1 ttmt -112.0 0.05 15.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.996 -0.547 . . . . 71.05 111.668 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 78.31 98.65 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 74.2 110.325 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' PRO . 5.8 mt -80.01 97.71 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 75.55 111.59 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -120.51 -151.34 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.707 -0.849 . . . . 72.03 108.707 178.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.786 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -92.43 -66.93 0.89 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.925 -0.768 . . . . 72.32 108.925 178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -45.02 -39.0 5.24 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.669 -0.696 . . . . 72.41 111.752 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 62.24 112.28 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HG21 ' A' ' 47' ' ' ILE . 50.1 mm -91.31 -48.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 74.42 110.235 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.878 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -42.21 80.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.962 -0.755 . . . . 71.12 108.962 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -70.52 -51.06 31.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.038 -0.528 . . . . 73.42 110.036 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.713 ' O ' HD11 ' A' ' 118' ' ' ILE . 67.5 t80 -50.4 -63.21 1.19 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 116.369 -0.378 . . . . 73.22 110.094 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 106' ' ' ILE . 3.9 m -50.05 -41.97 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 62.44 109.494 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.1 t0 -53.61 -37.76 63.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.793 0.806 . . . . 40.15 108.959 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.911 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.3 t70 -66.84 -34.79 78.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.309 -1.314 . . . . 75.32 108.413 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.881 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -71.73 -68.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.244 -0.889 . . . . 73.22 110.984 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 55' ' ' ILE . 15.3 t -51.72 -46.86 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.268 -0.878 . . . . 72.02 111.996 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.66 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.978 0.418 . . . . 74.23 111.018 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.56 31.01 2.06 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.575 -1.01 . . . . 74.53 110.575 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.911 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -102.92 -52.0 3.15 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.716 -0.742 . . . . 64.42 111.619 -178.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.881 HD12 ' HB2' ' A' ' 113' ' ' PHE . 57.7 mt -65.75 153.05 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.49 -0.559 . . . . 61.45 109.49 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.408 ' HG2' ' HD2' ' A' ' 120' ' ' PRO . 1.3 mt-10 -137.25 152.66 73.89 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.254 -0.43 . . . . 65.14 111.199 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 119' ' ' GLU . 57.1 Cg_endo -71.02 137.66 32.23 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.542 2.161 . . . . 73.01 112.552 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.3 m -102.72 -117.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.519 . . . . 64.44 110.525 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.703 HD11 ' HA ' ' A' ' 73' ' ' ASN . 36.2 pt -51.35 166.43 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 72.42 111.25 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.64 -171.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 74.34 110.564 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.81 62.19 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 73.04 110.955 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -149.01 85.06 6.08 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 72.43 110.595 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.81 153.02 19.59 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.49 2.127 . . . . 54.23 112.473 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.9 tt -149.38 79.45 8.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 72.11 111.097 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 171.4 16.94 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.525 2.15 . . . . 63.51 112.369 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.51 125.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.998 -0.546 . . . . 71.14 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -117.17 18.46 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 74.35 111.129 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.96 168.61 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 73.21 110.957 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -177.85 -72.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 63.45 110.861 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.427 -1.207 . . . . 73.11 112.452 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.533 -0.227 . . . . 62.4 112.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.09 -40.53 4.71 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.642 2.228 . . . . 75.21 112.262 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.39 -58.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 61.53 110.869 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.5 -170.25 28.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 51.52 112.517 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -118.61 63.01 5.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 54.5 110.794 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.83 -26.18 22.84 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.575 2.183 . . . . 64.33 112.457 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.522 HD23 ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -149.86 -61.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 63.43 111.005 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.967 HG23 ' HB3' ' A' ' 57' ' ' PHE . 46.4 mt -81.62 119.7 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 74.44 111.193 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.45 -127.32 1.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.206 -0.997 . . . . 73.43 112.355 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.46 138.52 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.189 -0.3 . . . . 73.31 110.189 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 58' ' ' GLY . 6.1 mt -91.79 129.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.917 0.389 . . . . 71.32 111.378 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.89 -164.29 11.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.84 -0.695 . . . . 74.33 112.42 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.4 -0.51 10.77 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.641 2.227 . . . . 63.4 112.933 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -124.79 7.46 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.559 0.219 . . . . 51.21 111.492 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 19' ' ' TYR . 15.5 p -112.31 -27.57 8.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 72.42 110.99 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -60.7 2.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 71.45 111.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -56.45 -26.61 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 55.15 111.695 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.8 t0 -72.99 -43.69 61.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.013 0.435 . . . . 72.5 111.047 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CE1' HD23 ' A' ' 7' ' ' LEU . 9.5 m-85 -78.97 -27.14 43.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.303 0.573 . . . . 72.35 109.718 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.588 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.33 -29.82 38.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.127 -0.942 . . . . 60.31 110.473 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -98.14 -6.51 31.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.912 -0.586 . . . . 62.32 110.624 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -64.51 -30.39 71.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.883 0.373 . . . . 73.53 111.015 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.74 54.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 63.51 112.602 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.12 156.54 76.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.706 0.289 . . . . 73.34 110.975 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 55' ' ' ILE . 12.1 Cg_endo -56.29 142.17 88.07 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.813 2.342 . . . . 52.02 112.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.786 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.1 tt -99.53 133.08 44.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 71.5 110.776 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -104.88 86.89 2.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 55.44 111.061 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.805 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 64.0 m-85 -75.06 141.03 43.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.606 -0.724 . . . . 73.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.851 HG21 ' CD1' ' A' ' 44' ' ' LEU . 1.9 mp -133.99 85.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.532 -0.303 . . . . 72.45 111.395 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 2.7 m-85 -72.15 145.42 48.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.758 -0.46 . . . . 73.3 109.758 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.74 117.3 3.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.153 0.502 . . . . 72.43 110.9 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 9.4 mt-10 -71.05 -12.43 61.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 74.3 110.396 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.26 97.54 7.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 75.35 111.218 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.94 5.9 41.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.726 -0.67 . . . . 72.23 110.986 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.72 -52.55 4.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.91 0.386 . . . . 60.31 110.508 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 13.22 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 71.43 111.108 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -46.55 -28.09 1.32 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.466 -0.334 . . . . 74.34 111.375 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.75 -45.61 78.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 62.44 110.764 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 6.3 mt-10 -66.73 -44.25 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.856 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.89 -57.12 12.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 71.02 110.817 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 20.4 m -63.33 -21.32 66.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 74.35 111.407 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 9.6 t70 -66.08 -65.39 0.68 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.546 0.688 . . . . 72.21 109.488 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.92 ' O ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -48.39 -31.82 6.72 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 122.653 1.216 . . . . 64.25 108.991 177.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.851 ' CD1' HG21 ' A' ' 29' ' ' ILE . 35.7 mt -77.53 -23.17 50.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.368 -1.742 . . . . 73.32 112.369 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 20.7 mttt -55.53 -43.62 99.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 63.11 110.152 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 23.9 Cg_endo -83.86 -41.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.648 2.232 . . . . 74.43 111.822 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.92 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -53.23 -22.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 C-N-CA 119.983 -0.687 . . . . 64.11 109.721 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.744 ' HB2' ' CE1' ' A' ' 57' ' ' PHE . . . -106.07 -27.66 10.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.549 -0.751 . . . . 71.12 111.211 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.1 tm-20 -59.43 -22.4 61.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.256 0.551 . . . . 72.15 109.921 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.43 29.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.303 -0.862 . . . . 60.23 109.464 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.681 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.8 pt20 -126.88 40.47 3.71 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.385 -1.28 . . . . 74.32 110.995 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 8' ' ' ILE . 1.6 ptm180 -73.45 -32.25 64.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.662 . . . . 72.21 111.282 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.69 6.18 48.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 71.44 112.849 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 51' ' ' GLN . 12.4 p -116.84 -31.94 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 75.32 111.259 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 28.4 mt -128.46 144.72 37.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 65.24 110.691 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.19 104.74 16.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.893 0.378 . . . . 73.32 110.559 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.967 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -73.9 132.88 42.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.354 0.597 . . . . 74.21 112.065 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.754 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -155.71 108.26 0.36 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.196 -0.911 . . . . 71.14 112.509 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.438 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 22.1 p -75.76 152.33 37.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.701 0.286 . . . . 73.24 110.383 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.881 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.8 tt -149.97 164.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 71.43 110.856 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 60' ' ' ILE . 31.2 t0 -85.99 120.23 27.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.842 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.912 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.2 5.29 30.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.698 0.285 . . . . 43.25 110.864 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 tttp -104.28 -33.04 8.81 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.45 -0.341 . . . . 73.31 111.543 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.32 -31.92 6.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.179 0.514 . . . . 73.03 110.684 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -101.04 -15.99 17.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 71.14 111.357 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -32.28 -37.46 0.04 OUTLIER Glycine 0 C--N 1.336 0.547 0 N-CA-C 114.301 0.48 . . . . 64.5 114.301 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.66 -17.27 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.004 0.43 . . . . 74.02 110.774 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -94.72 -9.24 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 61.11 111.214 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.24 -51.53 17.34 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.76 0.314 . . . . 62.23 111.434 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -91.33 1.34 76.43 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.861 -1.161 . . . . 71.03 113.911 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -60.87 -9.79 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.454 0.627 . . . . 50.32 109.462 177.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -115.78 -16.9 11.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 64.21 110.377 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.792 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -176.78 -71.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.24 0.459 . . . . 55.4 112.24 -178.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.609 HD12 HD11 ' A' ' 72' ' ' LEU . 1.8 mp -40.57 175.14 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 112.969 0.729 . . . . 74.44 112.969 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -107.86 -21.7 12.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.105 -0.952 . . . . 72.33 110.851 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 82.73 20.85 0.23 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.263 -1.014 . . . . 74.42 108.263 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -79.01 -48.76 13.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.663 -1.153 . . . . 72.34 111.51 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -118.98 158.86 24.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.207 0.527 . . . . 44.04 111.451 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.912 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -158.24 165.53 18.4 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.48 -0.782 . . . . 72.2 111.762 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 25.6 Cg_endo -61.9 157.15 59.09 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.158 -1.601 . . . . 54.2 112.915 0.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.597 ' HB1' HD22 ' A' ' 74' ' ' LEU . . . -119.47 164.44 15.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 75.13 109.363 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.533 ' CE2' HG12 ' A' ' 29' ' ' ILE . 2.5 t80 -138.44 131.29 29.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 64.1 111.167 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -122.6 147.42 46.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.54 111.661 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.644 HG21 ' CE2' ' A' ' 113' ' ' PHE . 57.5 mt -129.32 81.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.966 -0.561 . . . . 70.34 109.85 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LEU . 2.3 tt0 -75.4 138.4 41.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 73.21 111.333 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.9 mm-40 -100.65 118.62 37.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.706 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -88.62 20.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 71.32 110.345 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.67 -38.96 2.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.057 -0.519 . . . . 73.15 110.836 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tttt -113.64 -15.25 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.394 -0.367 . . . . 44.12 110.922 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 34.5 t-20 79.6 21.05 0.61 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.237 0.542 . . . . 71.24 109.949 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -84.67 164.65 18.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.321 -0.854 . . . . 63.1 111.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' O ' ' CD ' ' A' ' 94' ' ' PRO . 6.2 mmtt -139.56 99.15 3.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.25 -0.886 . . . . 75.52 110.757 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 17.4 m-85 -101.14 70.99 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.656 -0.702 . . . . 75.52 111.538 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 90.8 Cg_endo -75.39 168.66 24.09 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.554 2.17 . . . . 54.45 112.384 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' HD13 ' A' ' 106' ' ' ILE . 35.0 t80 -88.27 169.33 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.498 . . . . 64.05 110.684 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 2.9 m-20 -83.85 148.26 27.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 71.01 110.885 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 26.6 mt-30 -103.22 28.47 6.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.217 0.532 . . . . 62.53 110.381 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -155.94 18.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.73 -0.668 . . . . 72.43 110.648 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 1.5 ttmt -113.36 -7.89 13.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.137 -0.483 . . . . 71.05 111.611 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 22.3 tt0 83.97 97.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.258 0.552 . . . . 74.2 110.894 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 3.9 mt -72.84 93.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.373 -0.831 . . . . 75.55 111.153 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 4.8 p -111.15 -147.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.609 -0.515 . . . . 72.03 109.609 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.616 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.26 -59.83 1.64 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.39 -0.596 . . . . 72.32 109.39 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.581 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -56.14 -34.0 65.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.068 -0.969 . . . . 72.41 110.83 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.53 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.507 -0.77 . . . . 62.24 112.322 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.747 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.9 mm -89.93 -42.58 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 121.058 0.456 . . . . 74.42 110.552 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.798 ' HB3' HG22 ' A' ' 47' ' ' ILE . 10.8 pttt -61.79 -47.36 85.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.936 -0.764 . . . . 71.12 108.936 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.03 -51.47 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 73.42 110.324 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.753 ' CZ ' HD13 ' A' ' 118' ' ' ILE . 67.9 t80 -54.63 -64.91 0.68 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.015 -0.539 . . . . 73.22 110.894 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 106' ' ' ILE . 6.0 m -51.82 -37.4 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.127 0.489 . . . . 62.44 111.533 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.723 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -67.97 -35.79 78.96 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.694 -1.224 . . . . 40.15 107.694 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER -63.33 -37.27 86.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.347 -1.751 . . . . 75.32 108.025 177.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.806 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -63.8 -66.27 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.981 -1.009 . . . . 73.22 110.268 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 55' ' ' ILE . 10.4 t -58.09 -36.95 59.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.916 -1.038 . . . . 72.02 111.876 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.58 78.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 74.23 111.393 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.78 25.87 2.24 Favored Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 120.535 -0.84 . . . . 74.53 111.724 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -98.12 -57.78 2.13 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.2 -0.5 . . . . 64.42 111.014 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.806 HD12 ' HB2' ' A' ' 113' ' ' PHE . 8.9 mt -71.43 150.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.89 -0.595 . . . . 61.45 110.092 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.12 171.94 5.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.261 -0.427 . . . . 65.14 111.364 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.16 119.51 4.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.607 2.204 . . . . 73.01 112.35 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 122' ' ' ILE . 4.8 p -89.06 -53.43 4.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 64.44 110.857 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 121' ' ' SER . 1.9 pt -159.07 179.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.133 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.46 32.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.852 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.3 t -75.95 152.83 36.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 73.04 110.969 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.68 85.2 6.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 72.43 110.501 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.43 154.02 21.14 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.51 2.14 . . . . 54.23 112.551 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.61 81.89 9.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 72.11 111.039 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.55 -178.51 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.586 2.191 . . . . 63.51 112.271 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.55 136.84 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 71.14 110.897 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -131.95 146.35 52.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 74.35 110.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.03 176.5 5.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.87 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -167.88 -44.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 63.45 110.909 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.379 -1.234 . . . . 73.11 112.527 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.494 -0.243 . . . . 62.4 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.9 144.98 33.91 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.601 2.201 . . . . 75.21 112.318 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.75 150.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 61.53 110.877 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.73 115.07 1.33 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 51.52 112.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 1.1 m -176.43 64.83 0.22 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 54.5 110.903 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.68 ' HB2' HD12 ' A' ' 8' ' ' ILE . 38.6 Cg_exo -59.93 -156.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.499 2.132 . . . . 64.33 112.148 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 mt -57.92 -29.67 65.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 63.43 111.025 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.779 HG23 ' HB3' ' A' ' 57' ' ' PHE . 3.7 mp -56.81 147.52 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 74.44 111.05 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.17 -153.32 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.128 -1.035 . . . . 73.43 112.765 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -94.47 131.54 40.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 73.31 110.367 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.739 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 58.1 mt -84.31 139.97 16.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 71.32 111.318 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.59 -172.46 12.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 74.33 112.543 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.95 -22.23 19.99 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.682 2.255 . . . . 63.4 112.667 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.55 -14.88 21.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.425 -0.352 . . . . 51.21 111.461 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.3 p -99.63 -24.21 14.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 72.42 110.838 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CE1' HG21 ' A' ' 11' ' ' ILE . 1.8 m-85 -51.33 -54.99 20.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 71.45 111.191 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 t -65.88 -22.44 66.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 55.15 111.57 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 0.7 OUTLIER -70.77 -41.47 71.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 72.5 110.92 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 13.3 m-85 -79.53 -24.31 42.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 72.35 109.746 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.628 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.61 -42.41 29.01 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.269 -0.878 . . . . 60.31 110.359 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -85.26 -11.45 54.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 62.32 110.508 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -58.74 -31.4 68.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.818 0.342 . . . . 73.53 111.069 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.27 15.9 56.51 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.798 -0.715 . . . . 63.51 112.708 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 87' ' ' VAL . 1.5 pt -133.28 158.3 76.06 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.699 0.285 . . . . 73.34 110.933 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.46 138.9 88.34 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.631 2.22 . . . . 52.02 112.6 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.848 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.7 tt -99.65 135.94 40.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 71.5 111.007 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.748 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -109.01 100.49 9.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 55.44 111.037 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 11.4 m-85 -85.47 132.03 34.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 73.0 110.057 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 3.2 mt -127.71 83.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.743 -0.383 . . . . 72.45 111.277 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.7 m-85 -71.51 149.79 45.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.195 -0.457 . . . . 73.3 109.801 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -160.57 116.87 2.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.28 0.562 . . . . 72.43 111.257 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 3.4 mt-10 -75.88 -7.97 55.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.208 -0.906 . . . . 74.3 110.027 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -99.84 92.63 5.39 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.179 -0.464 . . . . 75.35 111.094 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.76 6.38 35.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 72.23 111.488 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -34.49 10.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 60.31 110.779 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.98 9.66 16.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 71.43 111.317 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.8 -29.12 1.79 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.767 0.317 . . . . 74.34 111.335 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -54.74 -45.65 74.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 62.44 110.79 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.39 -36.36 81.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.53 110.772 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.976 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -66.4 -62.11 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.02 110.697 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.422 ' OG ' HG21 ' A' ' 59' ' ' THR . 7.2 m -57.68 -25.93 60.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 74.35 110.953 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.6 t0 -62.64 -59.7 4.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.531 0.681 . . . . 72.21 109.569 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -48.56 -33.36 9.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.601 1.191 . . . . 64.25 108.676 177.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.976 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -80.54 -17.58 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.831 -1.531 . . . . 73.32 112.185 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 4.8 tppt? -55.13 -42.84 98.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.207 -0.664 . . . . 63.11 109.207 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.716 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 11.8 Cg_endo -84.93 -38.64 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.69 2.26 . . . . 74.43 110.31 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 106' ' ' ILE . 55.1 mt -50.21 -22.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.507 0 CA-C-N 115.975 -0.557 . . . . 64.11 109.847 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.836 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -112.49 -25.55 9.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.621 -0.718 . . . . 71.12 111.506 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -59.8 -20.4 56.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.255 0.55 . . . . 72.15 109.771 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.37 -30.24 18.52 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.833 0.825 . . . . 60.23 108.969 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.686 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -125.34 42.27 3.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.161 -1.381 . . . . 74.32 110.061 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.5 -29.14 46.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.153 -0.93 . . . . 72.21 111.04 -178.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 11.32 52.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.733 -0.746 . . . . 71.44 112.405 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.5 p -124.97 -33.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.636 0.255 . . . . 75.32 111.419 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 ' HB2' ' A' ' 27' ' ' ALA . 72.5 mt -123.15 142.91 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 65.24 111.166 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.3 m-80 -90.57 87.7 6.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.755 -0.461 . . . . 73.32 109.755 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.836 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.0 m-85 -71.89 119.22 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 74.21 111.896 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.739 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -141.9 125.17 2.64 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.052 -0.976 . . . . 71.14 112.463 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.505 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 2.3 p -82.82 153.89 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.382 . . . . 73.24 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.3 tt -150.68 164.16 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.028 -0.533 . . . . 71.43 110.531 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 60' ' ' ILE . 43.0 t0 -87.13 120.26 28.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.296 -0.411 . . . . 74.25 112.072 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.953 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -85.02 6.25 26.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.965 -0.294 . . . . 43.25 110.898 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 8.1 ttmt -106.04 -33.02 8.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.449 -0.341 . . . . 73.31 111.455 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.3 -30.57 6.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 73.03 110.489 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.66 -11.64 17.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.507 -0.769 . . . . 71.14 111.276 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.03 -37.59 0.18 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 114.119 0.407 . . . . 64.5 114.119 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.71 10.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 74.02 110.483 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -93.0 -8.17 43.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 61.11 111.247 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.862 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -75.16 -46.9 31.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.656 -0.247 . . . . 62.23 111.642 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -97.67 1.41 59.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.982 -1.104 . . . . 71.03 113.784 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -8.56 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.446 -0.576 . . . . 50.32 109.446 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -115.23 -15.61 11.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.398 -0.819 . . . . 64.21 110.17 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.44 -69.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.1 0.476 . . . . 55.4 112.135 -178.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.508 HD13 ' HB1' ' A' ' 81' ' ' ALA . 12.6 mt -42.52 174.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.277 -0.874 . . . . 74.44 112.151 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -120.29 3.67 10.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.539 -0.755 . . . . 72.33 110.345 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p 58.4 35.15 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.698 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' ' CG ' ' A' ' 75' ' ' LYS . 3.5 p30 -89.2 -31.27 18.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 72.34 111.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 79' ' ' PHE . 28.1 tttt -143.53 157.27 44.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.108 0.48 . . . . 44.04 110.707 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.953 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.9 170.72 8.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.731 -0.668 . . . . 72.2 111.584 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 18.2 Cg_endo -60.24 162.09 36.68 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.422 -1.491 . . . . 54.2 113.013 0.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -123.92 162.41 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.755 . . . . 75.13 109.812 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 84' ' ' ILE . 42.0 t80 -138.49 124.6 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 64.1 111.132 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . . . -119.63 148.43 43.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.124 -0.489 . . . . 75.54 111.499 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.853 HD11 ' CE2' ' A' ' 82' ' ' PHE . 12.9 mm -128.58 90.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 70.34 110.346 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.74 139.19 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.467 -0.333 . . . . 73.21 110.899 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.0 mt-10 -108.34 110.38 21.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.269 -0.423 . . . . 74.42 110.76 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 20' ' ' MET . 33.8 m -78.33 0.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.153 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.42 -39.43 8.78 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.434 -0.348 . . . . 73.15 111.17 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 -6.51 9.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.63 -0.259 . . . . 44.12 111.525 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.6 t30 66.19 64.58 0.52 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.546 -0.538 . . . . 71.24 109.546 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.4 tp60 -122.26 169.66 10.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.5 -0.773 . . . . 63.1 111.735 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.609 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -134.96 92.01 2.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.204 -0.907 . . . . 75.52 111.602 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 70.0 m-85 -103.93 66.55 0.11 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.872 -0.603 . . . . 75.52 111.138 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 95.1 Cg_endo -77.18 -175.5 2.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.451 2.1 . . . . 54.45 112.998 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -112.66 168.61 9.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.847 -0.615 . . . . 64.05 110.943 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -72.44 176.3 5.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 71.01 110.733 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -118.18 -16.31 9.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 62.53 111.279 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -119.75 -8.13 9.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 72.43 110.829 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -70.96 -8.46 53.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.861 -0.609 . . . . 71.05 111.559 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.4 tt0 86.73 120.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.214 -0.448 . . . . 74.2 110.596 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 6.0 mt -103.94 110.01 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 75.55 111.59 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -131.21 -153.55 0.57 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.892 -0.781 . . . . 72.03 108.892 178.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.869 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.53 -66.16 0.95 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.624 -0.88 . . . . 72.32 108.624 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.703 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.19 -38.97 9.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.994 -1.003 . . . . 72.41 111.957 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -68.81 -32.88 72.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.69 0.626 . . . . 62.24 112.69 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 47' ' ' ILE . 32.9 mm -91.24 -45.76 14.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.974 0.416 . . . . 74.42 109.942 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.841 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.09 -45.77 83.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.844 -0.798 . . . . 71.12 108.844 178.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.46 -51.36 36.8 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.774 -0.648 . . . . 73.42 110.125 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.741 ' CE1' HD13 ' A' ' 118' ' ' ILE . 48.7 t80 -49.77 -63.83 0.99 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.011 -0.366 . . . . 73.22 110.011 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 106' ' ' ILE . 8.3 m -49.17 -42.85 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.535 . . . . 62.44 109.569 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -52.97 -36.93 60.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.727 0.775 . . . . 40.15 109.204 178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -69.3 -34.8 75.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.357 -1.292 . . . . 75.32 108.398 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.854 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.0 t80 -71.75 -69.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.255 -0.884 . . . . 73.22 110.874 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 55' ' ' ILE . 16.9 t -50.19 -47.46 24.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 72.02 111.987 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -36.96 67.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 74.23 111.019 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.75 29.41 2.24 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 110.864 -0.894 . . . . 74.53 110.864 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.916 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -101.76 -52.92 3.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.792 -0.704 . . . . 64.42 111.561 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.854 HD12 ' HB2' ' A' ' 113' ' ' PHE . 55.9 mt -66.43 152.94 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.483 -0.562 . . . . 61.45 109.483 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.81 168.09 19.04 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.395 -0.366 . . . . 65.14 111.449 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.85 115.17 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.776 2.318 . . . . 73.01 112.728 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 m -73.33 132.93 43.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.017 -0.538 . . . . 64.44 110.65 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 40.96 -92.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.102 -0.499 . . . . 72.42 111.701 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.59 28.97 1.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.821 0.343 . . . . 74.34 111.171 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.0 m 53.24 44.53 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.218 0.533 . . . . 73.04 110.879 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 127' ' ' ILE . 5.8 tp10 -151.61 86.76 4.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.509 -0.769 . . . . 72.43 110.535 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.622 ' C ' HD12 ' A' ' 127' ' ' ILE . 91.9 Cg_endo -80.51 150.7 19.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.509 2.139 . . . . 54.23 112.65 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.622 HD12 ' C ' ' A' ' 126' ' ' PRO . 5.1 mp -148.76 85.87 5.96 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 72.11 110.698 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -43.02 166.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.862 2.375 . . . . 63.51 112.695 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.49 111.16 0.67 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.585 -0.734 . . . . 71.14 110.928 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -142.16 -80.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 74.35 110.912 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -80.27 177.35 9.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.61 -0.723 . . . . 73.21 110.832 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.9 157.61 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 63.45 110.877 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.381 -1.233 . . . . 73.11 112.509 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.509 -0.237 . . . . 62.4 112.509 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.13 126.64 20.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.625 2.216 . . . . 75.21 112.311 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -121.18 134.82 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.53 110.812 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' N ' HD13 ' A' ' 3' ' ' LEU . . . -156.64 110.62 0.45 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.608 -0.806 . . . . 51.52 112.601 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.429 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 0.7 OUTLIER -141.51 64.97 20.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.32 . . . . 54.5 110.802 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 5' ' ' SER . 11.7 Cg_exo -70.77 139.07 35.94 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.741 2.294 . . . . 64.33 112.363 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.99 -64.46 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 63.43 110.479 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.744 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 1.6 pt -79.37 130.15 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.863 -0.608 . . . . 74.44 110.748 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.86 8.77 0.65 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 73.43 113.181 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.97 114.19 7.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.999 0.399 . . . . 73.31 110.894 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.739 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 11.9 mt -118.21 137.97 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 71.32 111.237 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.02 -170.72 12.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.777 -0.725 . . . . 74.33 112.414 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.35 4.06 7.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.728 2.285 . . . . 63.4 112.938 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.84 28.3 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 51.21 111.111 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 p -122.89 -36.78 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 72.42 111.068 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -55.58 -30.88 61.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 71.45 111.113 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -55.59 -24.03 30.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 55.15 111.237 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -83.04 -40.88 19.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 72.5 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' HB2' HD12 ' A' ' 26' ' ' LEU . 15.6 m-85 -77.13 -18.31 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.372 0.606 . . . . 72.35 109.59 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.878 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.6 -32.17 17.23 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.091 -0.959 . . . . 60.31 110.233 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -90.9 -8.64 48.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.694 -0.685 . . . . 62.32 111.006 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.19 -56.21 10.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.935 0.397 . . . . 73.53 110.623 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.35 23.99 2.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.928 -0.653 . . . . 63.51 112.351 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.88 166.44 28.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.746 0.308 . . . . 73.34 111.296 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.1 Cg_exo -65.25 141.49 69.09 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.607 2.205 . . . . 52.02 112.357 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.922 HD22 ' CD1' ' A' ' 28' ' ' TYR . 2.8 tt -105.46 128.04 53.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.522 . . . . 71.5 110.564 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . . . -100.75 86.6 3.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.093 0.473 . . . . 55.44 111.451 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.922 ' CD1' HD22 ' A' ' 26' ' ' LEU . 62.4 m-85 -75.81 136.82 40.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.573 -0.739 . . . . 73.0 110.264 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 44' ' ' LEU . 2.8 mp -130.43 87.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.773 0.32 . . . . 72.45 111.178 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.854 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 2.5 m-85 -71.59 147.09 47.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.683 -0.488 . . . . 73.3 109.683 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.657 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -159.26 119.64 3.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.147 0.499 . . . . 72.43 110.828 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 12.1 mt-10 -74.32 -7.46 52.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.494 -0.776 . . . . 74.3 110.346 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -89.09 126.56 35.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 75.35 111.104 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.85 4.38 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.972 -0.558 . . . . 72.23 110.476 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.1 -38.33 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 60.31 110.474 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -104.34 15.96 27.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 71.43 111.074 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -59.23 -25.81 64.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 74.34 111.035 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -58.13 -44.08 87.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.365 . . . . 62.44 110.855 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.44 -42.93 82.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 74.53 110.981 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -64.06 -53.65 46.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 71.02 110.83 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 44' ' ' LEU . 49.8 m -64.86 -22.84 67.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 74.35 111.214 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 30.3 t0 -65.29 -61.6 2.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.567 0.698 . . . . 72.21 109.244 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -48.41 -32.96 8.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.604 1.192 . . . . 64.25 108.746 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.036 HD11 HG21 ' A' ' 29' ' ' ILE . 43.3 mt -76.62 -24.04 53.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.463 -1.699 . . . . 73.32 112.388 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.618 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.0 mtpt -53.73 -44.68 98.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 63.11 110.13 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.9 Cg_endo -83.21 -38.86 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.532 2.155 . . . . 74.43 110.819 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.842 ' CD1' HD23 ' A' ' 44' ' ' LEU . 58.7 mt -49.78 -23.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.912 -0.585 . . . . 64.11 110.102 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.747 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -110.82 -26.19 9.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.708 -0.678 . . . . 71.12 111.465 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.62 -18.83 61.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.128 0.49 . . . . 72.15 110.04 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.96 -28.94 17.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.76 0.79 . . . . 60.23 109.409 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.708 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.1 pt20 -121.31 38.96 3.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.311 -1.313 . . . . 74.32 110.597 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.1 ptm180 -75.04 -27.05 59.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 72.21 111.406 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.03 14.97 28.59 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.903 -0.665 . . . . 71.44 112.618 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 51' ' ' GLN . 7.5 p -128.81 -44.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 75.32 110.964 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.505 HD12 ' NE2' ' A' ' 51' ' ' GLN . 30.0 mt -118.06 146.24 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 65.24 110.527 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -94.08 102.11 14.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.889 0.376 . . . . 73.32 110.406 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.747 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -80.01 136.69 36.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.348 0.594 . . . . 74.21 111.587 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.739 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -160.6 126.71 1.65 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.148 -0.933 . . . . 71.14 111.879 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 p -88.4 153.67 21.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 73.24 110.415 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.902 HD11 ' CG ' ' A' ' 65' ' ' PHE . 10.8 tt -147.91 162.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 71.43 110.853 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.3 t0 -83.55 117.4 23.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.178 -0.465 . . . . 74.25 112.183 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.947 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -83.05 5.35 22.61 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.673 0.273 . . . . 43.25 110.788 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 17.6 ttmt -103.67 -33.23 9.03 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.526 -0.306 . . . . 73.31 111.622 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.54 -32.42 5.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.224 0.535 . . . . 73.03 110.57 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.902 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -100.33 -16.47 17.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 71.14 111.101 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -30.65 -39.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.442 0.537 . . . . 64.5 114.442 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 76' ' ' THR . . . -52.02 -26.71 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.25 0.548 . . . . 74.02 110.459 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -83.29 -13.48 55.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 61.11 111.611 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.854 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -71.73 -36.76 70.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.667 0.27 . . . . 62.23 111.558 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -108.07 -0.44 33.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.917 -1.135 . . . . 71.03 113.416 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -60.93 -10.68 6.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.507 -0.553 . . . . 50.32 109.507 177.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -113.93 -14.84 12.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.372 -0.831 . . . . 64.21 110.328 179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.716 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -179.31 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.276 0.473 . . . . 55.4 112.276 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.549 HD13 ' HB1' ' A' ' 81' ' ' ALA . 96.6 mt -43.14 178.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.514 -0.766 . . . . 74.44 112.913 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' C ' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -107.94 -24.53 11.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.969 -1.014 . . . . 72.33 110.495 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.5 p 78.95 21.54 0.68 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.206 -0.906 . . . . 74.42 108.609 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.67 -45.16 25.78 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.649 -1.159 . . . . 72.34 111.41 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -123.93 163.2 21.8 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.1 -0.5 . . . . 44.04 111.154 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.947 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -160.59 167.43 13.7 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 72.2 112.023 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 26.2 Cg_endo -62.34 158.1 60.37 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 123.16 -1.6 . . . . 54.2 113.05 0.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.712 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . . . -123.31 167.59 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.737 . . . . 75.13 109.969 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 29' ' ' ILE . 1.7 t80 -138.36 130.32 28.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.669 0.271 . . . . 64.1 110.778 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.711 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -129.68 121.34 26.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.038 0.385 . . . . 75.54 112.038 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.684 HD11 HG12 ' A' ' 110' ' ' VAL . 31.1 mt -103.63 93.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 70.34 110.346 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 92' ' ' LYS . 50.8 tt0 -85.05 141.77 30.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.768 0.318 . . . . 73.21 110.741 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.0 mt-10 -112.43 109.9 19.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.958 0.408 . . . . 74.42 111.072 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.878 HG11 ' O ' ' A' ' 20' ' ' MET . 15.7 t -80.2 -1.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.797 -0.638 . . . . 71.32 110.904 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.87 -42.67 11.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.372 -0.376 . . . . 73.15 110.919 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -118.8 -9.01 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.552 -0.294 . . . . 44.12 111.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 t30 75.46 57.05 0.06 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.353 0.597 . . . . 71.24 109.562 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.645 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -121.49 166.44 14.16 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.179 -0.919 . . . . 63.1 110.932 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.645 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 5.4 mmtt -141.42 98.19 3.31 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.413 -0.812 . . . . 75.52 110.663 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.635 ' O ' HD12 ' A' ' 84' ' ' ILE . 64.1 m-85 -101.76 73.41 0.12 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.838 . . . . 75.52 110.866 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 53.7 Cg_endo -80.05 167.32 20.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 54.45 112.585 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' ' N ' ' A' ' 96' ' ' ASP . 40.5 t80 -96.08 166.15 11.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 64.05 110.828 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -63.67 173.81 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 71.01 110.392 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.712 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 7.1 mm-40 -117.15 -22.9 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.423 . . . . 62.53 111.369 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -127.52 25.61 6.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.378 . . . . 72.43 110.835 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 4.4 tppt? -93.33 -69.37 0.75 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.022 -0.536 . . . . 71.05 110.533 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 9.7 tt0 163.56 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.763 -0.653 . . . . 74.2 109.892 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 8.7 mt -91.25 88.09 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.55 111.735 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -112.25 -154.1 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.574 -0.899 . . . . 72.03 108.574 178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.98 -67.57 0.85 Allowed 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.741 -0.837 . . . . 72.32 108.741 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -46.82 -35.83 6.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.341 -0.845 . . . . 72.41 111.479 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -71.82 -33.38 68.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.817 -0.629 . . . . 62.24 112.426 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.702 ' HB ' HD13 ' A' ' 47' ' ' ILE . 50.0 mm -89.48 -46.43 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 74.42 110.113 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.666 ' CG ' ' HA ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -58.47 -44.93 89.47 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.727 -0.67 . . . . 71.12 109.471 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -70.86 -49.01 50.77 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.696 -0.684 . . . . 73.42 110.123 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.79 ' O ' HD11 ' A' ' 118' ' ' ILE . 27.5 t80 -51.56 -67.2 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 73.22 109.822 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.684 HG12 HD11 ' A' ' 84' ' ' ILE . 21.9 m -47.16 -38.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.322 0.582 . . . . 62.44 109.869 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.9 OUTLIER -57.87 -41.88 83.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.356 -0.838 . . . . 40.15 110.057 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.793 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -77.16 -11.93 59.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.615 -0.721 . . . . 75.32 110.263 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.941 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -82.0 -61.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.74 0.781 . . . . 73.22 109.153 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.543 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 11.5 p -57.94 -37.29 60.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.302 -1.317 . . . . 72.02 110.885 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.05 86.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 74.23 110.431 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.85 1.53 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.722 -0.751 . . . . 74.53 111.558 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.46 -37.13 6.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.296 -0.452 . . . . 64.42 111.704 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.4 mt -86.54 150.0 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.16 0.505 . . . . 61.45 110.508 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.48 162.56 45.92 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.479 -0.782 . . . . 65.14 111.079 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 91' ' ' GLN . 15.8 Cg_exo -68.22 129.66 19.74 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 73.01 112.189 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 t -58.72 -41.67 86.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 64.44 110.12 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.2 pt -145.23 -165.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.738 -0.665 . . . . 72.42 109.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.14 -171.09 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.178 0.514 . . . . 74.34 111.729 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -155.84 -172.67 4.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.456 -0.793 . . . . 73.04 110.429 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.76 82.24 15.82 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.378 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.05 -171.77 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.623 2.215 . . . . 54.23 112.464 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 127' ' ' ILE . 15.0 tt -112.06 81.11 3.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.97 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.14 -179.51 2.68 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.568 2.179 . . . . 63.51 112.332 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -162.89 90.3 0.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 71.14 110.945 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.9 163.28 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 74.35 110.985 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.62 179.11 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 73.21 110.983 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 46.27 -169.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.168 -0.469 . . . . 63.45 111.283 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.307 -1.274 . . . . 73.11 112.43 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.504 -0.239 . . . . 62.4 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -51.85 -26.76 25.2 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 75.21 112.349 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 3' ' ' LEU . 8.1 tt 61.92 103.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 61.53 110.865 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.43 85.77 0.14 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.742 -0.742 . . . . 51.52 112.6 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 152.68 27.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.668 0.27 . . . . 54.5 110.962 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.35 -79.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.605 2.203 . . . . 64.33 112.074 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.803 ' CD1' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -143.33 -135.61 0.09 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.239 -0.652 . . . . 63.43 109.239 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.803 HD13 ' CD1' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -157.89 145.13 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.837 0.351 . . . . 74.44 110.82 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 59' ' ' THR . . . 119.59 17.4 4.76 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.684 -0.77 . . . . 73.43 112.901 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -145.06 104.74 4.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.665 0.269 . . . . 73.31 110.844 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.739 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 23.3 mt -113.0 140.3 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.972 0.415 . . . . 71.32 111.737 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.99 -150.87 6.47 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.86 -0.609 . . . . 74.33 112.311 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.54 -33.07 3.35 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.935 2.423 . . . . 63.4 112.34 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.84 24.67 6.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 51.21 111.155 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 p -136.75 -42.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 72.42 111.142 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -43.92 -56.5 3.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.216 -0.447 . . . . 71.45 111.374 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -64.49 -26.67 68.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 55.15 111.666 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.35 -38.39 60.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 72.5 111.015 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 23.0 m-85 -79.12 -23.44 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.362 0.601 . . . . 72.35 109.593 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.642 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -87.91 -25.47 23.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.118 -0.946 . . . . 60.31 110.379 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 t -95.31 -11.23 28.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.025 -0.534 . . . . 62.32 110.521 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.01 78.5 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.458 -0.337 . . . . 73.53 111.175 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 17.18 39.77 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.8 -0.715 . . . . 63.51 112.666 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.97 161.1 65.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.718 0.294 . . . . 73.34 110.89 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.04 139.57 88.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.624 2.216 . . . . 52.02 112.688 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.898 HD22 ' CD2' ' A' ' 28' ' ' TYR . 2.3 tt -98.42 140.96 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 71.5 111.145 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.782 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -114.94 88.22 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 55.44 111.023 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.898 ' CD2' HD22 ' A' ' 26' ' ' LEU . 81.6 m-85 -76.87 133.97 39.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.69 -0.687 . . . . 73.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.0 mt -125.76 85.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.501 -0.318 . . . . 72.45 111.093 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.6 m-85 -73.24 148.84 43.29 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.299 -0.63 . . . . 73.3 109.299 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -157.18 115.13 3.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.383 0.611 . . . . 72.43 111.326 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -84.72 -1.25 55.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.022 -0.99 . . . . 74.3 109.901 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.4 p -106.6 112.48 25.49 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.974 -0.557 . . . . 75.35 110.662 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.32 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 72.23 111.375 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.36 -55.17 5.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.091 0.472 . . . . 60.31 110.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' OE2' HD23 ' A' ' 40' ' ' LEU . 3.7 pt-20 -82.38 -3.42 55.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.775 -0.648 . . . . 71.43 110.902 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 -44.83 -38.77 4.78 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.185 -0.461 . . . . 74.34 111.15 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.22 -56.11 9.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 62.44 110.676 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 7.4 pt-20 -58.2 -31.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.576 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.74 -57.54 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.042 0.449 . . . . 71.02 110.448 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HA ' HD12 ' A' ' 44' ' ' LEU . 25.6 m -63.43 -20.26 65.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 74.35 111.329 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t0 -65.94 -63.87 0.99 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.609 0.718 . . . . 72.21 109.345 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -47.85 -33.02 6.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.703 1.24 . . . . 64.25 108.684 177.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.913 HD23 HD12 ' A' ' 47' ' ' ILE . 52.1 mt -76.88 -23.32 52.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.43 -1.714 . . . . 73.32 112.467 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 10.8 mtpt -54.45 -43.95 98.37 Favored Pre-proline 0 CA--C 1.517 -0.308 0 CA-C-N 116.431 -0.35 . . . . 63.11 110.073 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 21.0 Cg_endo -82.37 -39.85 0.15 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.428 2.085 . . . . 74.43 110.543 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.993 HG21 HG22 ' A' ' 106' ' ' ILE . 47.1 mt -51.25 -22.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-N 116.045 -0.525 . . . . 64.11 109.948 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.734 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . . . -111.22 -23.99 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.775 -0.648 . . . . 71.12 111.429 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -61.47 -20.74 63.49 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.195 0.521 . . . . 72.15 109.89 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.7 -26.54 19.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.422 -0.808 . . . . 60.23 109.338 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.718 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -125.66 42.21 3.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.441 -1.254 . . . . 74.32 110.793 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -76.32 -32.54 58.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.666 -0.697 . . . . 72.21 111.056 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.4 6.69 53.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.849 -0.691 . . . . 71.44 112.641 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 51' ' ' GLN . 13.1 p -119.09 -34.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.819 0.342 . . . . 75.32 111.23 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.782 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.0 mt -122.94 143.95 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 65.24 111.009 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-80 -93.61 87.0 5.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 73.32 109.927 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.734 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 3.5 m-85 -69.89 136.71 50.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 74.21 111.234 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.739 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -158.63 129.63 2.32 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.389 -0.823 . . . . 71.14 111.961 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 9' ' ' GLY . 50.0 p -89.38 151.58 21.97 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.039 0.447 . . . . 73.24 110.878 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.951 HD11 ' CG ' ' A' ' 65' ' ' PHE . 11.3 tt -148.07 163.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.503 -0.771 . . . . 71.43 110.422 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 60' ' ' ILE . 27.2 t0 -87.08 120.98 28.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.379 -0.373 . . . . 74.25 111.883 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.859 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.98 5.09 23.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.788 -0.365 . . . . 43.25 111.073 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 29.2 ttmt -105.08 -34.15 8.06 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 111.735 0.272 . . . . 73.31 111.735 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.57 -30.51 7.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.218 0.532 . . . . 73.03 110.417 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.951 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.77 -17.99 14.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.413 -0.812 . . . . 71.14 111.167 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 30' ' ' PHE . . . -31.41 -39.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 114.239 0.456 . . . . 64.5 114.239 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.55 -19.03 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.058 0.429 . . . . 74.02 110.691 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -90.66 -11.83 38.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.805 -0.634 . . . . 61.11 111.183 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.19 -51.36 38.75 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.73 0.3 . . . . 62.23 111.048 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.52 1.75 69.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.739 -1.22 . . . . 71.03 113.778 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.61 -9.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.452 0.626 . . . . 50.32 109.668 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -114.29 -15.22 12.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.405 -0.816 . . . . 64.21 110.319 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.73 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER 178.16 -70.02 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.246 0.546 . . . . 55.4 112.264 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CB ' ' A' ' 94' ' ' PRO . 1.6 mm? -40.86 171.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 114.89 -1.05 . . . . 74.44 112.375 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.24 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 72.33 110.832 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 69' ' ' ALA . 16.0 p 53.75 38.13 27.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.903 0.383 . . . . 74.42 110.825 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.64 -29.84 33.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.56 . . . . 72.34 110.769 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -150.69 163.81 37.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.243 -0.435 . . . . 44.04 110.36 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.61 173.15 5.23 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.915 -0.584 . . . . 72.2 111.787 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.597 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 19.1 Cg_endo -60.36 164.63 30.24 Favored 'Cis proline' 0 C--N 1.353 0.793 0 C-N-CA 123.363 -1.515 . . . . 54.2 113.076 0.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.49 167.62 16.04 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.394 -0.821 . . . . 75.13 109.532 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 44' ' ' LEU . 2.1 t80 -143.58 112.1 6.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 64.1 110.645 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -109.44 126.42 53.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.163 -0.471 . . . . 75.54 111.429 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 113' ' ' PHE . 11.8 mt -109.26 88.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.803 0.335 . . . . 70.34 110.42 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -84.92 138.5 32.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 73.21 110.6 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 9.7 mt-10 -100.11 115.28 29.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.922 0.391 . . . . 74.42 110.894 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 20' ' ' MET . 7.0 t -81.61 3.49 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.539 . . . . 71.32 110.827 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.99 -41.5 8.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.292 -0.413 . . . . 73.15 110.857 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -117.79 -15.93 10.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.637 -0.256 . . . . 44.12 111.308 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 35.4 t-20 81.18 40.75 0.05 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.324 0.583 . . . . 71.24 110.268 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 1.1 tp60 -91.6 -174.74 3.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.339 -0.846 . . . . 63.1 111.152 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.621 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -150.28 93.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.56 -0.745 . . . . 75.52 110.713 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.61 ' O ' HD12 ' A' ' 84' ' ' ILE . 75.0 m-85 -105.18 70.07 0.2 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.835 -0.62 . . . . 75.52 111.353 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.889 ' CB ' HD21 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.56 178.65 6.42 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.683 2.255 . . . . 54.45 112.968 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 37.1 t80 -113.05 164.45 13.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 64.05 110.505 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -62.35 174.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 71.01 110.74 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 3.3 mp0 -117.49 -23.27 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 62.53 111.21 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.29 24.93 6.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 72.43 110.847 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.3 tppt? -94.55 -77.3 0.47 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.019 -0.537 . . . . 71.05 110.534 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 3.8 tt0 173.74 105.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.09 -0.504 . . . . 74.2 110.4 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.0 mt -98.63 88.58 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.815 -0.63 . . . . 75.55 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -119.07 -164.68 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.28 -0.637 . . . . 72.03 109.28 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -79.76 -66.32 0.89 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.098 0.475 . . . . 72.32 110.099 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -48.98 -39.23 25.73 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.936 -1.029 . . . . 72.41 111.754 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -71.88 -34.94 69.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.067 -0.97 . . . . 62.24 113.412 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.993 HG22 HG21 ' A' ' 47' ' ' ILE . 46.2 mm -88.05 -44.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.0 0.429 . . . . 74.42 110.201 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -54.66 -42.97 71.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.866 -0.606 . . . . 71.12 109.511 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.81 36.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.621 -0.718 . . . . 73.42 110.139 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.722 ' O ' HD11 ' A' ' 118' ' ' ILE . 32.2 t80 -49.64 -64.74 0.72 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.631 -0.507 . . . . 73.22 109.631 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 111' ' ' ASP . 16.7 m -49.97 -41.8 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.765 -0.458 . . . . 62.44 109.765 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.8 OUTLIER -55.58 -36.96 67.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.686 0.755 . . . . 40.15 109.133 178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.927 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 18.0 t70 -68.03 -34.82 77.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.431 -1.259 . . . . 75.32 108.281 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.88 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -71.52 -69.05 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.099 -0.955 . . . . 73.22 111.025 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.606 ' CG2' HD11 ' A' ' 55' ' ' ILE . 11.9 t -52.36 -46.05 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.284 -0.871 . . . . 72.02 112.101 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.66 69.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.843 0.354 . . . . 74.23 111.235 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.36 31.17 1.9 Allowed Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.86 -0.896 . . . . 74.53 110.86 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.927 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -103.25 -56.22 2.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.848 -0.676 . . . . 64.42 111.373 -178.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.88 HD12 ' HB2' ' A' ' 113' ' ' PHE . 50.4 mt -64.56 150.75 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.403 -0.591 . . . . 61.45 109.403 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.13 157.37 78.44 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 65.14 111.581 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.17 114.5 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.8 2.333 . . . . 73.01 112.611 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.491 ' O ' HG13 ' A' ' 122' ' ' ILE . 19.0 m -92.78 117.81 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 64.44 110.953 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 121' ' ' SER . 1.1 pt 41.84 -173.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.861 -0.609 . . . . 72.42 112.249 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -159.32 133.96 7.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 74.34 110.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.51 107.85 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 73.04 110.405 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -163.46 71.36 1.87 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.175 -0.676 . . . . 72.43 109.175 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.94 178.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.59 2.194 . . . . 54.23 112.539 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.77 84.16 0.62 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 72.11 111.667 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.98 -166.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.523 2.148 . . . . 63.51 111.954 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.38 76.91 1.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 71.14 111.059 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tptt 179.98 159.55 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 74.35 110.947 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 -168.79 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.839 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.74 166.46 22.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 63.45 110.863 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.378 -1.235 . . . . 73.11 112.533 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.492 -0.243 . . . . 62.4 112.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.07 93.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.573 2.182 . . . . 75.21 112.295 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 4' ' ' GLY . 4.3 pp -96.17 146.73 24.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 61.53 110.903 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.472 ' O ' HD12 ' A' ' 3' ' ' LEU . . . -84.35 -155.79 23.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 51.52 112.517 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -177.66 90.26 0.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.671 0.272 . . . . 54.5 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.12 141.47 57.62 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.504 2.136 . . . . 64.33 112.196 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.6 mt -92.3 -77.55 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 63.43 110.992 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -130.83 131.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.84 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 59' ' ' THR . . . 164.78 -56.36 0.27 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.45 -0.881 . . . . 73.43 112.665 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -128.08 135.5 49.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.623 0.249 . . . . 73.31 110.957 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.777 HD11 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -107.21 153.43 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 71.32 111.028 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.63 -159.18 9.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.737 -0.744 . . . . 74.33 112.325 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.96 10.29 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.684 2.256 . . . . 63.4 112.826 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -144.9 25.96 1.4 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.571 0.224 . . . . 51.21 111.512 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 p -123.32 -23.46 4.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 72.42 110.329 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE1' ' OH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -57.83 -38.7 76.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.749 -0.66 . . . . 71.45 111.616 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.7 t -55.86 -30.83 62.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.051 -0.522 . . . . 55.15 111.965 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.678 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 8.7 t0 -87.09 -35.86 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.899 0.38 . . . . 72.5 111.251 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 11.7 m-85 -81.53 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 72.35 110.664 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -108.08 -28.85 9.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 60.31 110.577 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -97.15 -5.87 36.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.982 -0.554 . . . . 62.32 110.882 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.62 -40.12 76.78 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.906 0.384 . . . . 73.53 111.026 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.62 15.67 22.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.859 -0.686 . . . . 63.51 112.459 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.51 ' C ' HG22 ' A' ' 87' ' ' VAL . 2.1 pt -133.35 154.37 80.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.34 111.096 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 19.0 Cg_endo -60.34 145.12 99.27 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.84 2.36 . . . . 52.02 112.604 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.707 HD23 ' N ' ' A' ' 27' ' ' ALA . 3.1 tt -95.97 135.7 37.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.9 -0.591 . . . . 71.5 111.143 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' N ' HD23 ' A' ' 26' ' ' LEU . . . -104.72 95.27 5.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 55.44 110.793 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.659 ' CE1' HD12 ' A' ' 11' ' ' ILE . 6.5 m-85 -82.3 130.75 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 73.0 110.371 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.92 HG21 ' CD1' ' A' ' 44' ' ' LEU . 2.3 mp -124.38 83.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.81 -0.356 . . . . 72.45 111.339 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.821 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.8 m-85 -70.28 143.97 51.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.561 -0.533 . . . . 73.3 109.561 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -158.07 118.47 3.37 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.145 0.497 . . . . 72.43 111.028 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' ' CG ' ' A' ' 79' ' ' PHE . 23.4 mt-10 -71.26 -13.25 61.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 74.3 109.979 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 p -88.64 97.24 11.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.943 -0.571 . . . . 75.35 111.037 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.44 7.59 42.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 72.23 111.456 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -113.3 -46.46 3.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 60.31 110.83 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -92.93 1.55 57.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 71.43 111.381 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.59 -29.87 0.19 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.929 0.344 . . . . 74.34 111.929 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -49.78 -50.04 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 62.44 111.151 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 17.5 mt-10 -63.34 -44.03 96.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 74.53 111.103 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -61.57 -53.68 53.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 71.02 110.905 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 28.6 m -65.06 -19.85 66.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.383 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' LYS . 10.6 t0 -67.53 -62.03 1.62 Allowed 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.312 -0.625 . . . . 72.21 109.312 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.649 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.07 -32.82 10.28 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.844 1.307 . . . . 64.25 108.782 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.92 ' CD1' HG21 ' A' ' 29' ' ' ILE . 63.7 mt -77.65 -23.29 49.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.191 -1.822 . . . . 73.32 111.903 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.614 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 17.8 ttmt -52.27 -45.17 94.6 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.747 -0.661 . . . . 63.11 110.083 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 18.1 Cg_endo -83.96 -37.54 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.628 2.219 . . . . 74.43 110.537 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.875 ' CD1' HD23 ' A' ' 44' ' ' LEU . 60.9 mt -50.33 -21.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 116.068 -0.515 . . . . 64.11 110.196 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -110.87 -32.44 6.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.797 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 2.0 tm-20 -59.39 -18.15 36.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.24 0.543 . . . . 72.15 110.179 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.14 -27.98 19.25 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.42 -0.809 . . . . 60.23 109.527 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.704 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt20 -121.48 36.07 4.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.449 -1.25 . . . . 74.32 110.814 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 48' ' ' ALA . 20.4 ptt-85 -67.08 -32.79 74.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.67 . . . . 72.21 111.326 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 9.61 49.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.645 -0.788 . . . . 71.44 112.83 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 51' ' ' GLN . 14.6 p -123.78 -29.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.742 0.271 . . . . 75.32 111.581 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 27' ' ' ALA . 32.8 mt -132.84 153.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.54 -0.3 . . . . 65.24 110.428 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -102.82 109.8 21.51 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.994 0.426 . . . . 73.32 110.728 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -70.35 125.89 28.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.412 0.625 . . . . 74.21 111.136 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.777 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -150.29 100.43 0.21 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.025 -0.989 . . . . 71.14 112.572 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 9' ' ' GLY . 33.4 p -77.74 152.95 33.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 73.24 110.521 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.969 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.6 tt -150.14 165.65 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 71.43 110.87 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 60' ' ' ILE . 28.8 t0 -88.43 120.7 30.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.197 -0.456 . . . . 74.25 112.077 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.942 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -84.46 3.56 35.69 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.696 0.284 . . . . 43.25 111.0 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 11.1 tttt -104.42 -32.64 8.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.492 -0.322 . . . . 73.31 111.545 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.92 -30.25 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 73.03 110.616 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -103.68 -15.72 15.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.574 -0.739 . . . . 71.14 111.236 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -32.33 -38.09 0.05 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.269 0.467 . . . . 64.5 114.269 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.53 -12.38 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.175 0.487 . . . . 74.02 110.764 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' PHE . 13.3 t-80 -103.08 -4.21 24.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.705 -0.68 . . . . 61.11 110.934 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -73.86 -53.18 10.78 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.739 0.305 . . . . 62.23 111.324 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.82 6.75 73.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 119.868 -1.158 . . . . 71.03 113.504 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -9.8 14.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.09 -0.707 . . . . 50.32 109.09 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -113.74 -15.04 12.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.224 -0.898 . . . . 64.21 110.376 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.727 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER 179.06 -69.92 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.355 0.598 . . . . 55.4 112.288 -178.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 94' ' ' PRO . 1.5 mm? -40.96 173.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.016 -0.993 . . . . 74.44 112.594 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.606 ' C ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -101.89 -32.38 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.733 -0.667 . . . . 72.33 110.894 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.606 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.8 p 85.01 27.34 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.808 -1.087 . . . . 74.42 108.388 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.56 -45.55 17.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.535 -1.211 . . . . 72.34 111.017 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 21.9 tttp -130.1 163.28 26.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.88 -0.6 . . . . 44.04 111.074 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -157.07 169.83 9.96 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.927 -0.578 . . . . 72.2 111.631 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 18.4 Cg_endo -60.61 160.53 42.74 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 123.446 -1.481 . . . . 54.2 113.189 0.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.13 159.93 32.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.379 -0.828 . . . . 75.13 109.812 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HG12 ' A' ' 110' ' ' VAL . 68.4 t80 -136.76 136.83 39.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 64.1 111.748 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -134.77 148.67 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 75.54 111.172 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.886 HG21 ' CE2' ' A' ' 113' ' ' PHE . 12.9 mt -123.66 94.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.33 . . . . 70.34 110.525 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.623 HE22 HG12 ' A' ' 87' ' ' VAL . 9.0 tm0? -77.71 136.67 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.21 110.89 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 4.9 mt-10 -107.39 116.06 31.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.948 0.404 . . . . 74.42 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HE22 ' A' ' 85' ' ' GLN . 34.3 m -82.7 8.51 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.838 -0.619 . . . . 71.32 112.169 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.18 -40.02 3.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.952 0.406 . . . . 73.15 110.813 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -105.7 -14.56 15.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 44.12 111.33 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 74.44 19.56 2.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.925 0.393 . . . . 71.24 111.092 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 6.2 tp-100 -89.12 166.53 13.78 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.122 -0.49 . . . . 63.1 110.681 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 8.6 mmtt -141.06 85.38 1.98 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.819 -0.628 . . . . 75.52 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' O ' HD12 ' A' ' 84' ' ' ILE . 32.5 m-85 -81.31 100.73 0.77 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.665 -0.698 . . . . 75.52 110.688 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 74' ' ' LEU . 40.6 Cg_endo -105.47 168.92 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.431 2.754 . . . . 54.45 113.294 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 96' ' ' ASP . 36.4 t80 -102.85 165.38 11.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 64.05 110.626 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -65.51 175.06 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 71.01 110.528 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 2.4 mt-30 -116.67 -24.61 7.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 62.53 111.218 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 9.5 pt-20 -124.41 25.86 7.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.397 . . . . 72.43 110.825 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 14.5 tppt? -96.34 -72.56 0.63 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.992 -0.549 . . . . 71.05 110.566 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 54.7 tt0 170.46 100.48 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.96 -0.563 . . . . 74.2 110.382 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 80' ' ' PRO . 7.4 mt -94.63 90.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 75.55 111.064 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 103' ' ' PHE . 22.1 p -116.22 -150.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.413 -0.358 . . . . 72.03 110.248 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.696 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -97.35 -56.39 2.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.436 0.636 . . . . 72.32 109.495 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -61.4 -39.29 90.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.733 -1.122 . . . . 72.41 110.722 178.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 109' ' ' PHE . . . -70.75 -33.36 70.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 62.24 112.602 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.664 ' HB ' HD13 ' A' ' 47' ' ' ILE . 51.9 mm -89.49 -41.39 13.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 74.42 110.166 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.599 ' HB3' HG12 ' A' ' 47' ' ' ILE . 3.0 pttp -62.74 -46.23 89.03 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.479 -0.782 . . . . 71.12 109.115 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 107' ' ' LYS . . . -67.35 -49.93 61.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.985 -1.007 . . . . 73.42 110.2 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.672 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.1 t80 -51.4 -65.82 0.49 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 116.295 -0.411 . . . . 73.22 110.023 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 106' ' ' ILE . 12.3 m -48.56 -36.16 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.486 0.66 . . . . 62.44 109.732 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -61.05 -42.97 99.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.092 -0.958 . . . . 40.15 110.062 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.982 ' OD1' HD11 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -72.39 -15.47 61.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 75.32 109.874 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.952 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -81.46 -62.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.729 0.776 . . . . 73.22 109.345 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.464 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.8 p -62.36 -38.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.445 -1.252 . . . . 72.02 111.173 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.11 76.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.542 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.97 30.23 1.26 Allowed Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.628 -0.796 . . . . 74.53 111.731 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -105.99 -38.5 6.3 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.516 -0.342 . . . . 64.42 111.475 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.982 HD11 ' OD1' ' A' ' 112' ' ' ASP . 6.0 mt -87.23 148.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 61.45 110.518 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.25 163.88 44.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.785 -0.643 . . . . 65.14 111.328 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.99 122.52 10.66 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.54 2.16 . . . . 73.01 112.418 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.5 p -86.94 -79.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 64.44 110.551 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.4 162.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.63 97.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 74.34 111.221 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.85 49.22 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 73.04 110.169 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -153.74 87.61 3.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.54 -0.755 . . . . 72.43 110.057 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.436 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 73.8 Cg_endo -73.05 -170.45 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.439 2.093 . . . . 54.23 112.483 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 pt -114.56 84.66 10.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.295 -0.411 . . . . 72.11 111.55 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -58.55 -160.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.79 2.327 . . . . 63.51 111.993 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -106.5 96.46 6.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.991 -0.55 . . . . 71.14 110.859 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -118.64 125.53 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 74.35 110.901 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.34 -168.57 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.21 110.891 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 62.39 149.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 63.45 110.889 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.32 -1.267 . . . . 73.11 112.448 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.535 -0.226 . . . . 62.4 112.535 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.45 100.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.182 . . . . 75.21 112.311 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.78 30.12 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.53 110.87 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.29 114.57 0.36 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 51.52 112.55 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.73 145.26 31.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.662 0.268 . . . . 54.5 110.901 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.52 -25.9 12.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.588 2.192 . . . . 64.33 112.488 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.39 -81.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 63.43 111.077 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG23 ' HB3' ' A' ' 57' ' ' PHE . 2.6 mp -136.59 145.3 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.834 0.349 . . . . 74.44 111.118 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' ' HA2' ' A' ' 58' ' ' GLY . . . 176.57 -168.55 40.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 73.43 112.268 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -86.22 122.11 29.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.866 0.365 . . . . 73.31 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.7 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 34.4 mt -77.73 137.03 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 71.32 110.959 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.66 -170.22 12.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.757 . . . . 74.33 112.55 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.0 3.89 7.22 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.781 2.32 . . . . 63.4 112.853 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.32 26.73 2.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.711 0.291 . . . . 51.21 111.021 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 p -123.34 -35.46 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.42 111.022 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -56.06 -31.83 63.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 71.45 111.055 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.1 m -56.32 -26.01 50.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 55.15 110.848 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 25.0 m-20 -85.64 -35.19 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.749 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 18.3 m-85 -78.47 -15.03 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.326 0.584 . . . . 72.35 109.604 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.729 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.69 -31.34 12.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.217 -0.901 . . . . 60.31 110.16 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.29 -7.11 48.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 62.32 111.056 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -69.41 -51.43 36.48 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 73.53 110.791 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.65 22.68 5.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 63.51 112.35 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 1.2 pt -133.38 169.52 13.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 73.34 111.341 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 15.6 Cg_exo -65.84 134.25 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.595 2.196 . . . . 52.02 112.302 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.4 tt -98.16 125.86 43.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 71.5 110.774 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -101.79 92.2 4.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.021 -0.536 . . . . 55.44 111.408 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.885 ' CD2' HD22 ' A' ' 26' ' ' LEU . 57.6 m-85 -82.17 124.58 30.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.765 -0.652 . . . . 73.0 109.909 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG21 ' CD1' ' A' ' 44' ' ' LEU . 3.4 mt -116.52 83.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.767 -0.373 . . . . 72.45 111.604 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 4.6 m-85 -72.43 142.54 48.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.403 -0.591 . . . . 73.3 109.403 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -156.54 118.21 3.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.085 -0.507 . . . . 72.43 110.277 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 79' ' ' PHE . 15.9 mt-10 -68.83 -14.02 62.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.686 -0.688 . . . . 74.3 110.144 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.38 130.29 42.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.221 0.534 . . . . 75.35 110.896 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.52 8.48 12.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.394 -0.821 . . . . 72.23 110.62 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -105.12 -49.69 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 60.31 110.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -96.08 18.96 12.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.791 -0.64 . . . . 71.43 111.011 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -28.05 37.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.763 0.316 . . . . 74.34 110.872 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -56.37 -46.44 80.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.44 110.48 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -62.35 -48.11 81.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 74.53 110.662 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.38 -60.6 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.145 0.498 . . . . 71.02 110.733 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.7 m -61.65 -23.79 66.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.942 -0.572 . . . . 74.35 111.39 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.5 t0 -62.65 -63.41 1.23 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.235 0.54 . . . . 72.21 109.76 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HZ2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -50.2 -30.15 10.9 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 123.411 1.577 . . . . 64.25 109.3 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.654 ' CD1' HG21 ' A' ' 29' ' ' ILE . 29.4 mt -77.05 -23.8 52.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.029 -1.896 . . . . 73.32 111.966 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.681 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 56.4 mmtt -63.9 -39.78 48.88 Favored Pre-proline 0 CA--C 1.52 -0.196 0 CA-C-N 115.926 -0.579 . . . . 63.11 111.505 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 42.6 Cg_endo -76.77 -49.08 0.11 Allowed 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.249 1.966 . . . . 74.43 111.111 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.739 HD11 ' CG2' ' A' ' 110' ' ' VAL . 1.1 tp -55.09 -27.54 19.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 119.099 -1.041 . . . . 64.11 109.948 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 57' ' ' PHE . . . -92.4 -25.74 18.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.23 -0.441 . . . . 71.12 110.356 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -58.77 -23.78 60.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.357 -0.609 . . . . 72.15 109.357 178.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.95 -27.58 18.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.164 -0.926 . . . . 60.23 109.685 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.72 ' CD ' HD12 ' A' ' 55' ' ' ILE . 1.5 pt20 -129.45 50.55 2.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.787 -1.097 . . . . 74.32 110.586 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.2 ptt-85 -81.69 -28.01 33.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.226 -0.897 . . . . 72.21 111.087 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.56 14.1 27.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.599 -0.728 . . . . 71.44 112.399 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 51' ' ' GLN . 8.7 p -123.05 -41.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.578 0.228 . . . . 75.32 111.089 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.72 HD12 ' CD ' ' A' ' 51' ' ' GLN . 74.3 mt -111.37 139.6 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.364 -0.236 . . . . 65.24 110.364 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 16.1 m-80 -81.77 87.99 6.31 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.909 0.385 . . . . 73.32 110.555 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.639 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -73.59 102.78 3.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 74.21 111.193 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.7 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.33 130.41 6.02 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.928 -0.654 . . . . 71.14 112.756 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.4 p -91.1 140.79 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.24 111.137 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 65' ' ' PHE . 12.4 tt -138.4 163.26 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.942 -0.572 . . . . 71.43 110.462 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' N ' HG12 ' A' ' 60' ' ' ILE . 32.8 t0 -88.34 118.83 28.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 74.25 112.103 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.952 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.64 2.58 32.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.576 -0.283 . . . . 43.25 110.985 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -103.21 -32.57 9.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.482 -0.326 . . . . 73.31 111.507 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 -29.89 6.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 73.03 110.759 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.876 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.33 -11.22 17.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.596 -0.729 . . . . 71.14 111.263 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -36.2 -34.62 0.08 OUTLIER Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.49 -0.386 . . . . 64.5 113.873 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -54.61 -24.3 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.228 0.537 . . . . 74.02 110.261 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -88.77 -10.43 48.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.402 -0.817 . . . . 61.11 111.216 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 74' ' ' LEU . . . -72.53 -44.45 62.15 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.486 -0.325 . . . . 62.23 111.62 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -99.74 1.55 56.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.932 -1.127 . . . . 71.03 113.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.6 OUTLIER -61.28 -9.39 5.03 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.484 -0.561 . . . . 50.32 109.484 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -116.47 -15.29 10.91 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.518 -0.765 . . . . 64.21 110.585 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -177.63 -69.55 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.99 0.424 . . . . 55.4 112.125 -178.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 69' ' ' ALA . 2.8 mt -42.74 172.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.555 -0.748 . . . . 74.44 111.781 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.558 ' C ' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -110.36 -16.69 13.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.724 -0.671 . . . . 72.33 110.235 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 75' ' ' LYS . 1.7 p 79.51 41.93 0.08 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.259 -1.015 . . . . 74.42 108.259 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.16 -50.15 5.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.047 -1.433 . . . . 72.34 111.471 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' C ' ' CG ' ' A' ' 79' ' ' PHE . 46.2 tttt -133.42 161.74 33.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.988 -0.551 . . . . 44.04 110.965 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.952 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -156.44 173.17 5.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 72.2 111.351 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.98 163.81 25.56 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 123.596 -1.418 . . . . 54.2 112.895 0.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.32 162.69 30.41 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.831 -1.077 . . . . 75.13 109.485 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.495 ' HE2' HD11 ' A' ' 84' ' ' ILE . 57.0 t80 -138.53 127.93 24.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.736 0.303 . . . . 64.1 110.411 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -122.79 120.48 33.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.252 0.464 . . . . 75.54 112.252 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 93' ' ' PHE . 15.4 mt -103.51 95.1 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 70.34 110.56 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.64 141.38 28.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 73.21 111.034 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 38.1 mm-40 -108.01 110.21 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.42 111.011 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.729 HG11 ' O ' ' A' ' 20' ' ' MET . 7.3 t -79.63 -0.65 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 71.32 110.793 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.81 -43.04 8.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.274 -0.421 . . . . 73.15 110.876 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -116.48 -8.19 11.58 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.517 -0.31 . . . . 44.12 111.328 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 69.59 60.03 0.29 Allowed 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.312 0.577 . . . . 71.24 109.481 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.533 ' HG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -114.74 179.1 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.84 . . . . 63.1 111.558 -178.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.57 ' HG2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.92 92.15 2.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.419 -0.81 . . . . 75.52 111.159 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CZ ' ' HG2' ' A' ' 91' ' ' GLN . 71.0 m-85 -106.4 72.05 0.27 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.837 -0.62 . . . . 75.52 111.308 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 73.7 Cg_endo -80.71 -176.78 3.34 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.442 2.094 . . . . 54.45 112.927 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 82' ' ' PHE . 38.5 t80 -110.68 175.93 5.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.759 -0.655 . . . . 64.05 110.478 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -78.86 176.94 9.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 71.01 110.714 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 41.0 mt-30 -114.39 -19.09 11.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 62.53 111.326 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.1 16.94 7.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 72.43 110.91 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 2.5 tppp? -90.5 -14.54 32.48 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.059 -0.518 . . . . 71.05 111.376 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 23.3 tt0 88.81 112.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.283 0.563 . . . . 74.2 110.566 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 80' ' ' PRO . 6.1 mt -91.5 96.54 6.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 75.55 111.357 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.663 HG22 ' HZ2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -118.08 -154.19 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 72.03 109.385 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CA ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -94.07 -72.81 0.6 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.584 -0.895 . . . . 72.32 108.584 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.547 ' HA ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.68 -32.6 0.6 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.058 0.456 . . . . 72.41 111.095 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.06 57.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.649 -0.705 . . . . 62.24 112.335 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 110' ' ' VAL . 26.1 mm -87.67 -49.09 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 109.559 -0.534 . . . . 74.42 109.559 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 10.6 pttt -52.78 -48.55 66.76 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.437 -0.801 . . . . 71.12 109.493 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.631 ' N ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.79 -51.95 54.79 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.913 -0.585 . . . . 73.42 110.525 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.84 ' O ' HD11 ' A' ' 118' ' ' ILE . 36.9 t80 -50.53 -63.03 1.25 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.192 -0.458 . . . . 73.22 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 106' ' ' ILE . 2.1 m -52.76 -45.02 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 62.44 110.209 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -52.06 -40.32 60.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.669 0.747 . . . . 40.15 109.113 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 17.7 t70 -61.33 -34.2 74.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.506 -1.225 . . . . 75.32 108.276 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.789 ' CB ' HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -72.85 -66.48 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 73.22 110.922 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.554 ' N ' ' CG ' ' A' ' 113' ' ' PHE . 12.6 p -55.05 -44.46 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.962 -1.017 . . . . 72.02 111.864 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' N ' HG13 ' A' ' 114' ' ' VAL . . . -58.41 -35.86 72.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 74.23 110.898 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.73 32.79 1.83 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 110.663 -0.975 . . . . 74.53 110.663 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.91 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -104.44 -54.01 2.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.688 -0.756 . . . . 64.42 111.852 -178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 109' ' ' PHE . 54.3 mt -63.31 159.11 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.765 0.317 . . . . 61.45 110.424 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.518 ' N ' HG22 ' A' ' 118' ' ' ILE . 16.4 pt-20 -146.24 154.29 49.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 65.14 110.753 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -41.26 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.056 2.504 . . . . 73.01 112.474 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.0 m -66.11 -45.94 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 64.44 110.952 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.412 HG13 ' ND2' ' A' ' 73' ' ' ASN . 9.7 pt -155.25 159.31 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 72.42 111.059 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER 179.8 38.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.788 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -123.8 172.68 8.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.983 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.48 85.11 6.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.501 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.11 154.12 22.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.624 2.216 . . . . 54.23 112.485 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 127' ' ' ILE . 1.4 pp -146.48 82.01 9.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.11 111.085 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.08 -178.03 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.551 2.168 . . . . 63.51 112.245 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.84 47.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.936 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -171.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 74.35 110.79 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -106.22 165.43 11.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 73.21 110.876 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -113.54 158.7 20.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.45 110.904 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.334 -1.259 . . . . 73.11 112.475 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.483 -0.247 . . . . 62.4 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.87 -174.93 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.571 2.18 . . . . 75.21 112.347 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mt 62.01 148.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.53 111.119 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.87 169.13 23.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.851 -0.69 . . . . 51.52 112.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.458 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 3.3 t 179.13 -60.68 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.498 0.19 . . . . 54.5 111.206 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 5' ' ' SER . 19.5 Cg_endo -60.56 -46.58 16.79 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.444 2.096 . . . . 64.33 112.663 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.704 ' HB2' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -108.11 -85.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 63.43 111.133 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 57' ' ' PHE . 4.3 mp -118.69 144.88 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 74.44 111.201 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.75 -145.25 9.92 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.399 -0.905 . . . . 73.43 112.308 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.97 133.2 35.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.977 0.418 . . . . 73.31 110.669 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.725 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.3 mt -87.08 147.35 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 71.32 111.154 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.46 177.79 19.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.546 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.61 -8.52 23.35 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.605 2.203 . . . . 63.4 112.674 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -126.49 27.81 6.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 51.21 110.848 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.8 p -125.66 -39.4 2.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 72.42 111.002 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -53.66 -31.82 49.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 71.45 111.109 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -26.94 32.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 55.15 110.903 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 13.3 m-20 -84.86 -37.09 21.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 72.5 110.64 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' O ' HG21 ' A' ' 87' ' ' VAL . 8.6 m-85 -78.87 -7.81 58.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.235 0.54 . . . . 72.35 109.864 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.424 ' CE ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.67 -29.74 10.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.308 -0.86 . . . . 60.31 110.259 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.5 t -98.54 -2.5 38.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.945 -0.571 . . . . 62.32 111.166 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ASP . . . -72.35 -57.42 4.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.991 0.424 . . . . 73.53 110.885 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.41 22.17 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.988 -0.625 . . . . 63.51 112.291 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.55 162.51 57.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.573 0.225 . . . . 73.34 111.006 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 20.7 Cg_exo -61.38 137.56 70.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.399 2.066 . . . . 52.02 112.569 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD2' ' A' ' 28' ' ' TYR . 3.3 tt -96.66 126.48 41.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 71.5 110.357 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 57' ' ' PHE . . . -100.63 90.79 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.161 -0.472 . . . . 55.44 111.512 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.825 ' CD2' HD22 ' A' ' 26' ' ' LEU . 65.7 m-85 -81.88 124.92 30.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 73.0 110.033 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 2.3 mt -117.99 83.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.797 -0.361 . . . . 72.45 111.669 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.829 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.2 m-85 -70.12 151.86 44.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.476 -0.564 . . . . 73.3 109.476 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -166.52 119.81 1.05 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.15 -0.477 . . . . 72.43 111.111 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 19.9 mt-10 -74.51 -10.67 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.783 -0.644 . . . . 74.3 109.624 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -78.68 110.44 13.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.634 . . . . 75.35 111.215 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.37 2.15 33.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 72.23 111.073 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.78 -35.52 4.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.165 -0.471 . . . . 60.31 111.061 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.86 20.23 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.43 111.216 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.42 72.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.331 . . . . 74.34 110.833 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -55.66 -40.82 72.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 62.44 110.688 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.52 -44.74 81.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 74.53 110.589 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.013 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -62.09 -62.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.704 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -55.85 -26.52 47.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 74.35 111.538 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' LYS . 2.7 t70 -63.64 -59.21 4.9 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.613 0.72 . . . . 72.21 109.706 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -49.9 -31.32 11.96 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.746 1.26 . . . . 64.25 108.742 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.013 HD12 ' O ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -81.47 -17.79 47.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 113.813 -1.54 . . . . 73.32 111.964 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -54.1 -42.77 95.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.944 -0.762 . . . . 63.11 108.944 178.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 9.9 Cg_endo -84.44 -39.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.636 2.224 . . . . 74.43 110.421 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 106' ' ' ILE . 45.6 mt -50.86 -20.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-N 116.173 -0.467 . . . . 64.11 109.965 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 57' ' ' PHE . . . -113.44 -24.6 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.86 -0.609 . . . . 71.12 111.228 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -60.17 -20.46 58.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.17 0.51 . . . . 72.15 109.899 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.85 -27.1 17.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.791 0.805 . . . . 60.23 109.24 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.688 ' HA ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -127.73 46.5 2.54 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.345 -1.298 . . . . 74.32 110.502 -178.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.1 ptt85 -80.0 -30.38 39.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.383 -0.826 . . . . 72.21 111.109 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.18 11.98 33.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.873 -0.68 . . . . 71.44 112.379 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 51' ' ' GLN . 11.3 p -119.8 -35.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.496 0.189 . . . . 75.32 111.25 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 27' ' ' ALA . 91.1 mt -123.46 146.2 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.512 -0.313 . . . . 65.24 110.696 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.46 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 8.6 m-80 -87.15 85.46 7.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.784 0.326 . . . . 73.32 110.171 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.763 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 3.6 m-85 -72.46 110.52 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.284 0.564 . . . . 74.21 111.552 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.725 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -139.92 124.35 2.67 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.304 -0.862 . . . . 71.14 112.2 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 80.0 p -83.2 155.82 23.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.029 0.443 . . . . 73.24 111.315 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 65' ' ' PHE . 13.3 tt -150.98 163.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.785 -0.643 . . . . 71.43 110.206 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' N ' HG12 ' A' ' 60' ' ' ILE . 46.0 t0 -88.78 119.04 28.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.407 -0.361 . . . . 74.25 111.845 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.963 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -82.48 1.04 39.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.548 -0.296 . . . . 43.25 110.975 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 32.9 ttpt -101.67 -32.43 10.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.435 -0.348 . . . . 73.31 111.265 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.88 -29.96 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.105 0.478 . . . . 73.03 110.346 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.927 ' CG ' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -105.25 -15.02 15.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.789 . . . . 71.14 111.057 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -34.23 -36.61 0.06 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 114.1 0.4 . . . . 64.5 114.1 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -55.57 -19.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.481 . . . . 74.02 110.582 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.41 -10.61 40.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.635 -0.711 . . . . 61.11 111.042 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . . . -69.58 -51.53 34.45 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 120.858 0.361 . . . . 62.23 111.007 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -93.7 1.99 69.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.915 -1.135 . . . . 71.03 113.663 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -59.66 -10.24 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.332 0.566 . . . . 50.32 109.667 177.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 73' ' ' ASN . 0.6 OUTLIER -113.49 -17.21 12.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.631 -0.713 . . . . 64.21 109.998 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.683 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.1 m-20 -179.85 -68.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.46 0.541 . . . . 55.4 112.46 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.902 HD21 ' CB ' ' A' ' 94' ' ' PRO . 2.1 mm? -39.85 168.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.24 -0.891 . . . . 74.44 112.241 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -110.14 -4.49 15.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.826 -0.625 . . . . 72.33 111.06 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 p 58.69 36.85 25.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.01 0.433 . . . . 74.42 110.199 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -84.13 -32.0 24.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 72.34 110.825 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -148.74 163.19 38.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 44.04 110.23 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.963 ' CD2' ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -154.45 174.37 3.91 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.897 -0.592 . . . . 72.2 111.215 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.755 ' HB2' HD13 ' A' ' 101' ' ' ILE . 31.9 Cg_exo -58.01 166.74 15.9 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.792 -1.337 . . . . 54.2 113.019 0.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 164.82 27.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.051 -0.977 . . . . 75.13 110.143 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HZ ' ' HB1' ' A' ' 27' ' ' ALA . 1.8 t80 -141.98 133.81 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 64.1 111.49 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -126.41 116.17 20.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 75.54 110.949 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 93' ' ' PHE . 22.9 mt -99.91 90.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 70.34 110.342 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' LEU . 3.0 tm0? -78.95 144.87 34.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 73.21 111.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.469 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 3.7 mt-10 -110.64 111.54 22.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.065 -0.516 . . . . 74.42 110.637 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' VAL . 26.4 t -82.39 9.43 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.726 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.96 -42.86 5.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.257 -0.428 . . . . 73.15 110.314 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.9 mmtt -114.15 -12.41 12.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.278 -0.419 . . . . 44.12 110.912 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 89' ' ' LYS . 10.5 t-20 79.53 22.83 0.52 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.356 0.598 . . . . 71.24 109.688 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.575 HE21 ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -82.2 167.74 18.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.158 -0.928 . . . . 63.1 111.53 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.575 ' H ' HE21 ' A' ' 91' ' ' GLN . 0.9 OUTLIER -139.2 101.06 4.17 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.381 -0.827 . . . . 75.52 111.111 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.679 ' O ' HD12 ' A' ' 84' ' ' ILE . 76.8 m-85 -103.55 74.33 0.2 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.928 -0.578 . . . . 75.52 110.899 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.902 ' CB ' HD21 ' A' ' 74' ' ' LEU . 56.5 Cg_endo -80.8 165.29 20.05 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.795 2.33 . . . . 54.45 113.126 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.431 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 35.7 t80 -95.94 173.29 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.745 -0.661 . . . . 64.05 110.573 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -75.84 177.95 6.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 71.01 110.986 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -112.08 -20.92 11.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.199 -0.455 . . . . 62.53 111.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.83 24.06 4.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.919 0.39 . . . . 72.43 111.069 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -94.4 -11.81 29.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.981 -0.554 . . . . 71.05 111.191 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 99' ' ' LYS . 19.5 tt0 91.02 106.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.9 -0.591 . . . . 74.2 110.661 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 80' ' ' PRO . 7.1 mt -91.73 96.92 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.269 -0.878 . . . . 75.55 111.495 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -121.63 -164.89 1.18 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.226 -0.657 . . . . 72.03 109.226 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.919 ' HA ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -78.22 -71.43 0.43 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.471 -0.566 . . . . 72.32 109.471 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.585 ' HA ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -42.83 -37.72 1.91 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.969 -1.014 . . . . 72.41 111.645 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 104' ' ' GLU . . . -72.68 -35.84 67.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.698 -1.137 . . . . 62.24 113.202 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 47' ' ' ILE . 27.8 mm -89.48 -49.07 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.674 -0.491 . . . . 74.42 109.674 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.834 ' HA ' HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.92 -43.91 60.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.803 -0.635 . . . . 71.12 109.633 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.95 -49.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.679 -0.691 . . . . 73.42 110.202 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.808 ' O ' HD11 ' A' ' 118' ' ' ILE . 21.1 t80 -49.15 -64.13 0.9 Allowed 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.699 -0.482 . . . . 73.22 109.699 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 111' ' ' ASP . 17.7 m -51.05 -43.09 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 62.44 109.954 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 1.2 t0 -50.83 -41.19 57.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.438 0.637 . . . . 40.15 109.954 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.925 ' OD1' ' N ' ' A' ' 118' ' ' ILE . 3.2 t0 -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.944 -1.025 . . . . 75.32 108.795 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.924 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.3 t80 -72.6 -67.02 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.191 -0.913 . . . . 73.22 110.343 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.561 HG22 HD11 ' A' ' 55' ' ' ILE . 17.5 t -49.93 -48.32 22.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.934 . . . . 72.02 111.491 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.41 -38.77 63.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 74.23 110.606 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.49 29.98 2.34 Favored Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 110.709 -0.956 . . . . 74.53 110.709 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.804 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -103.15 -49.21 3.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.917 -0.641 . . . . 64.42 111.661 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.925 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 29.1 mt -63.46 146.84 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.762 -0.458 . . . . 61.45 109.762 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -136.02 171.0 9.53 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.738 -0.665 . . . . 65.14 110.948 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.97 115.46 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.497 2.131 . . . . 73.01 112.319 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.583 ' OG ' HD13 ' A' ' 122' ' ' ILE . 32.7 t -81.97 -66.51 0.88 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.44 111.221 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -115.59 -30.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.287 -0.415 . . . . 72.42 111.04 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -24.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 74.34 112.112 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.0 t -60.44 -179.11 0.1 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.636 -0.711 . . . . 73.04 110.815 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -147.18 85.23 6.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 72.43 110.599 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 -173.76 1.95 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.577 2.184 . . . . 54.23 112.452 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.72 84.44 15.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 72.11 111.08 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.89 -161.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.829 2.353 . . . . 63.51 112.27 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.63 82.19 2.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.81 -0.632 . . . . 71.14 110.908 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -75.76 128.5 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 74.35 110.948 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.19 176.85 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.21 110.785 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 61.5 154.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 63.45 110.913 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.44 -1.2 . . . . 73.11 112.504 -179.948 . . . . . . . . 0 0 . 1 stop_ save_